Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — BNB PLUS CORP.

Accession: 0001104659-26-066610

Filed: 2026-05-27

Period: 2026-05-26

CIK: 0000744452

SIC: 8734 (SERVICES-TESTING LABORATORIES)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Material Modifications to Rights of Security Holders

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — tm2615620d1_8k.htm (Primary)

EX-3.1 — EXHIBIT 3.1 (tm2615620d1_ex3-1.htm)

EX-3.2 — EXHIBIT 3.2 (tm2615620d1_ex3-2.htm)

EX-4.1 — EXHIBIT 4.1 (tm2615620d1_ex4-1.htm)

EX-4.2 — EXHIBIT 4.2 (tm2615620d1_ex4-2.htm)

EX-4.3 — EXHIBIT 4.3 (tm2615620d1_ex4-3.htm)

EX-4.4 — EXHIBIT 4.4 (tm2615620d1_ex4-4.htm)

EX-10.1 — EXHIBIT 10.1 (tm2615620d1_ex10-1.htm)

EX-10.2 — EXHIBIT 10.2 (tm2615620d1_ex10-2.htm)

EX-10.3 — EXHIBIT 10.3 (tm2615620d1_ex10-3.htm)

EX-10.4 — EXHIBIT 10.4 (tm2615620d1_ex10-4.htm)

EX-99.1 — EXHIBIT 99.1 (tm2615620d1_ex99-1.htm)

GRAPHIC (tm2615620d1_ex3-1img001.jpg)

GRAPHIC (tm2615620d1_ex3-1img002.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2615620d1_8k.htm · Sequence: 1

false

--09-30

0000744452

0000744452

2026-05-26

2026-05-26

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):

May 26, 2026

BNB Plus Corp.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction

of incorporation)

001-36745

(Commission File Number)

59-2262718

(IRS Employer

Identification No.)

25 Health Sciences Drive

Stony Brook, New York 11790

(Address of principal executive offices) (Zip Code)

631-240-8800

(Registrants’ telephone number, including

area code)

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on

which registered

Common Stock, $0.001 par value

BNBX

The Nasdaq Stock Market

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ¨

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 1.01 Entry into a Material Definitive

Agreement.

Private Placement and Inducement Transaction

On May 26, 2026, BNB Plus Corp., a Delaware corporation

(the “Company”), entered into agreements to issue in one or more offerings up to an aggregate amount of $5 million (the “Aggregate

Offering Amount”) of the Company’s securities in a convertible preferred equity private placement financing pursuant to: (1)

a Securities Purchase Agreement (the “SPA”) with accredited investors (“Purchasers”) whereby Purchasers will invest

in the Company’s securities in U.S. dollars or stablecoins recognized by the GENIUS Act, and (2) Warrant Inducement and Exchange

Agreements (each an “Inducement Agreement”), with certain investors (each an “Exchanging Holder”) who participated

in the Company’s private placements that closed on October 3, 2025 and October 23, 2025 (collectively the “2025 PIPE”),

whereby each Exchanging Holder will (i) exercise for cash a certain percentage of outstanding Series E Common Stock Purchase Warrants

(the “Series E Warrants”); (ii) exchange common stock of the Company, par value $0.001 per share (“Common Stock”);

and (iii) exchange pre-funded warrants, held by the Exchanging Holder, to receive convertible preferred stock and other securities, as

described in greater detail below.

Pursuant to the SPA and the Inducement Agreement

the Company may accept, up to the Aggregate Offering Amount, subscriptions from Purchasers and agreements to participate in the exchange

transaction governed by the Inducement Agreement by Exchanging Holders for fifteen trading days after the initial SPA and Inducement Agreement

are signed, or until June 11, 2026. The private placement and inducement transaction discussed herein are referred to collectively as

the “Offering”.

The Company intends to use the first $2.3 million

of aggregate proceeds from the Offering (the “General Proceeds”), $300 thousand of which is expected to be used for a prepaid

advisory fee, for a strategic review of its biotechnology assets and for general corporate purposes. Proceeds in excess of the General

Proceeds shall be contributed to the DAT Subsidiaries, as described below, provided, however, that such excess proceeds may be released

to the Company or any subsidiary of the Company in accordance with the SPA.

Securities Purchase Agreement

Pursuant to the SPA, the Company has agreed to

sell and issue to each Purchaser, at an offering price of $1.05 per share, Series B-1 Preferred Stock (defined in Item 5.03 below), and/or

Series B-1 Prefunded Preferred Stock Purchase Warrants in lieu thereof (the “Series B-1 Prefunded Warrants”), and Series F

Common Stock Purchase Warrants (the “Common Warrants”) to purchase a number of shares of Common Stock equal to 100% of the

shares of Common Stock issuable upon conversion of the Series B-1 Preferred Stock (including Series B-1 Preferred Stock underlying Series

B-1 Prefunded Warrants, if any) issued to the Purchaser in connection with the SPA.

The initial closing of the SPA will occur on the

date all closing obligation under the SPA have been met with respect to an aggregate subscription amount of at least $2.3 million (the

“Initial SPA Closing”). On May 26, 2026, the Company entered into the SPA with a Purchaser for an aggregate subscription amount

of $2.5 million and the Initial SPA Closing is expected to occur on May 28, 2026.

In addition to standard representations and warranties,

the Company has agreed to use the proceeds received from the Offering in excess of the General Proceeds solely for contributions to Build

& Build, LLC, a Delaware limited liability company, and BNBX Ltd., a British Virgin Islands business company, each a 100% owned subsidiary

of the Company, and such other wholly-owned subsidiary or subsidiaries of the Company as may from time to time hold Digital Assets, as

defined in the SPA, or may become additional guarantors pursuant to the DATS Guaranty, discussed below (the “DAT Subsidiaries”).

The Company has agreed to promptly, but no later than forty-five (45) days following the Initial Closing of the SPA, contribute or cause

to be contributed, any cash (except for the General Proceeds, certain cash and accounts receivable of the Company, and operating cash

flows attributable to the Company’s LineaRx business) and Digital Assets owned or held by the Company or any of its subsidiaries

that are not DAT Subsidiaries to a DAT Subsidiary that is a guarantor party to the DATS Guaranty, and that such cash and Digital Assets

shall be held solely in a DAT Subsidiary. The Company has also agreed that any Digital Assets acquired by the Company or any of its subsidiaries

that are not DAT Subsidiaries, will be contributed to a DAT Subsidiary that is a guarantor party to the DATS Guaranty on or immediately

following the date of acquisition.

The Company also agreed to reimburse one counsel

for the Purchasers and Exchanging Holders, up to a maximum of $50,000 for the reasonable attorney’s fees and costs incurred in connection

with the SPA and the Inducement Agreement.

Warrant Inducement

Exchange Agreement

Pursuant to the Inducement

Agreement, each Exchanging Holder will agree to (1) exercise a minimum of thirteen percent (13%) (the “Minimum Percentage”)

of the Series E Warrants issued to the Exchanging Holder in the 2025 PIPE at an exercise price of $3.82 per share of Common Stock in consideration

for the Company issuing the Exchanging Holder a number of Series B-1 Preferred Stock pursuant to the formula set forth in the Inducement

Agreement; (2) deliver to the Company all shares of Common Stock issued to the Exchanging Holder in the 2025 PIPE and issued in connection

with the exercise of the Minimum Percentage of Series E Warrants in exchange for the Company issuing the Exchanging Holder the same number

of Series B-2 Preferred Stock (defined in Item 5.03 below and collectively with the Series B-1 Preferred Stock the “Preferred Stock”),

and/or Series B-2 Prefunded Preferred Stock Purchase Warrants in lieu thereof (the “Series B-2 Prefunded Warrants” and collectively

with the Series B-1 Prefunded Warrants the “Prefunded Warrants”); and (3) deliver to the Company all pre-funded warrants issued

to the Exchanging Holder in the 2025 PIPE in exchange for the Company issuing the Exchanging Holder the same number of Series B-2 Prefunded

Warrants.

Exchanging Holders may

choose to exercise more than the Minimum Percentage of Series E Warrants and elect, in their sole discretion, to exchange the shares of

Common Stock received upon such exercise for shares of Series B-2 Preferred Stock, or retain the shares of Common Stock for their own

account and receive a transferable Right pursuant to a Transferable Rights Agreement discussed further below. In the event an Exchanging

Holder would be limited from exercising any Series E Warrants pursuant to the beneficial ownership blocker applicable to the Series E

Warrants (“Limited Warrants”), the Exchanging Holder may elect to deliver the exercise price applicable to such Limited Warrants

and receive in consideration for such exercise price and the Exchanging Holder’s express waiver of the Company’s obligation

to deliver Common Stock underlying the Limited Warrants, Series B-2 Prefunded Warrants.

Each Inducement Agreement will close no later

than the 5th trading day following the date all conditions to closing have been met by the parties. On May 26, 2026, the Company

entered into Inducement Agreements with Exchanging Holders for an exercise of Series E Warrants in an aggregate amount of approximately

$1.65 million. The initial closing of the Inducement Agreements is expected to occur on or before June 2, 2026.

Additional Terms

Each

Series B-1 Prefunded Warrant is exercisable for one share of Series B-1 Preferred Stock at an exercise price of $0.0001 per share of Series

B-1 Preferred Stock underlying the prefunded warrant. Each Series B-2 Prefunded Warrant is exercisable for one share of Series B-2 Preferred

Stock at an exercise price of $0.0001 per share of Series B-2 Preferred Stock underlying the prefunded warrant. The Prefunded Warrants

are immediately exercisable and may be exercised at any time until all of the Prefunded Warrants issued in the private placement and inducement

transaction are exercised in full.

Each

Common Warrant is exercisable for one share of Common Stock at the exercise price of $0.76 per share of Common Stock (the “Common

Warrant Shares”). The Common Warrants are exercisable for cash immediately upon issuance and thereafter may be exercised at any

time until three (3) years after issuance. The Common Warrants may also be exercised on a cashless basis at any time beginning six (6)

months after their initial issuance if, at the time of exercise, there is no effective registration statement registering, or the prospectus

contained therein is not available for, the resale of the Common Warrant Shares by the holder thereof and are subject to cancellation

by the Company if they are not exercised after certain specified trading criteria of the Common Stock is satisfied.

Each

holder’s ability to exercise its Prefunded Warrants in exchange for the applicable shares of Preferred Stock (the “Prefunded

Warrant Shares”) and Common Warrants in exchange for Common Warrant Shares, is subject to certain beneficial ownership limitations

set forth therein.

Transferable Rights

Agreement

In connection with the

Inducement Agreement, the Company has agreed to enter into a Transferable Rights Agreement with Exchanging Holders who elected to retain

Common Stock issuable above the Minimum Percentage of their Series E Warrants, pursuant to which, the Exchanging Holder will receive a

transferable right to exchange a number of shares of Common Stock equal to the number of retained shares for Series B-2 Preferred Stock,

at a ratio of 1-for-1 (each a “Right”). Exchanging Holders will not receive shares of Series B-2 Preferred Stock for any retained

shares at the closing of the Inducement Agreement. The Rights will have a term of three (3) years at which point they will expire. No

Rights may be transferred unless the number of shares of Common Stock that would be required to be delivered upon the exercise of such

Rights, at the time of the transfer, exceeds 13% of the number of shares of Common Stock that would be issued upon the exercise of outstanding

Series E Warrants held by the transferee, at the time of the transfer.

Exemption from Registration

The Preferred

Stock, Preferred Stock Shares (defined in Item 5.03 below), Prefunded Warrants, Prefunded Warrant Shares, Rights, Common Warrants,

and Common Warrant Shares are being offered in reliance upon the exemption from the registration

requirement of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(1) thereof and/or Rule

506(b) of Regulation D promulgated thereunder, and applicable state securities laws. The issuances of the Preferred Stock, Preferred Stock

Shares (defined in Item 5.03 below), Prefunded Warrants, Prefunded Warrant Shares, Common Warrants, and Common Warrant Shares have

not been registered under the Securities Act and such securities may not be offered or sold in the United States absent registration or

an exemption from registration under the Securities Act and any applicable state securities laws.

Guaranty Agreement

In connection with the

SPA and the Inducement Agreement each DATS Subsidiary agreed to enter into a guaranty agreement (the “DATS Guaranty”) in favor

of, at any time, all persons who are, at such time, registered holders of shares of the Preferred Stock or Prefunded Warrants on the books

and records of the Company or its transfer agent, as applicable, and their respective permitted successors, assigns, and transferees who

become registered holders of Preferred Stock (the “Guaranteed Parties”). Pursuant to the DATS Guaranty, each DAT Subsidiary

has agreed to guarantee (a) all cash-payment obligations of the Company to the Guaranteed Parties under the Certificate of Designations,

the SPA, the Inducement Agreement and the other transaction documents in respect of the Preferred Stock or otherwise, whether now existing

or hereafter arising, including, without limitation: (i) all accrued and unpaid dividends (whether or not declared), including but not

limited to compounded dividends, with respect to the Preferred Stock, as and when payable under the Certificate of Designations; (ii)

cash due upon a holder’s redemption of Preferred Stock, if any, (iii) the Liquidation Preference, (as defined in the Certificate

of Designations), payable with respect to the Preferred Stock upon a liquidation event (as defined in the Certificate of Designations);

and (iv) any other monetary amount payable by the Company to any Guaranteed Party pursuant to the Certificate of Designations or the SPA

or any other transaction document related to the Offering; and (b) to the extent legally enforceable as a guaranty under applicable law,

the economic damages suffered by any Guaranteed Party as a result of the Company’s failure to honor any right of exercise or conversion

(or right associated therewith) of such Guaranteed Party under the Certificate of Designations, the Inducement Agreement, the Common Warrants

or Prefunded Warrants that is not susceptible to cash performance by Guarantor, in each case measured by the fair market value, on the

date of the Company’s failure, of the property the Company was required to deliver and failed to deliver.

Pursuant to the DATS

Guaranty, each Guaranteed Party agrees to the appointment KGPLA Holdings LLC ( “the Lead Investor”), as their representative

for the purposes of the following:

(i) distributing notices to the guarantors, including the DAT Subsidiaries. on behalf of the Guaranteed Parties;

(ii) delegating (in its reasonable discretion) all or any portion of the obligations and benefits of Lead Investor;

(iii) enforcing the DATS Guaranty against any or all guarantors subject to approval by Guaranteed Parties holding more than 50% of the aggregate

Liquidation Preference of the then-outstanding shares of Series B-1 Preferred Stock (the “Majority-in-Interest”);

(iv) holding any security interest, lien, pledge, account control, or other collateral package granted by any guarantor under or in connection

with the agreement for the ratable benefit of all Guaranteed Parties, and administering any enforcement or release of such collateral

at the direction of the Majority-in-Interest; and

(v) acting as the sole party with standing and authority to bring any enforcement action, suit, or proceeding with respect to the agreement.

No individual Guaranteed

Party has independent standing to sue any guarantor under the DAT Guaranty, but shall rely upon the Lead Investor for enforcement in accordance

with the DATS Guaranty. Upon an Event of Default, as defined in the DATS Guaranty, the Lead Investor, at the direction of the Majority-in-Interest

may declare all guaranteed obligations to be immediately due and payable.

In addition to certain

covenants and restrictions set forth in the DATS Guaranty, the DATS Subsidiaries have agreed to comply with the “Digital Asset Treasury

Procedures”, which means the procedures governing the management, custody, transfer, and disposition of assets held in the Digital

Asset Treasury, as defined in the DATS Guaranty, to be set forth in a separate instrument agreed upon by the Company and the holders representing

a majority of the outstanding shares of Series B-1 Preferred Stock, not later than thirty (30) days following the Initial Closing of the

SPA , which shall include both (a) the initial procedures for the establishment and contribution of assets to the Digital Asset Treasury

and (b) ongoing procedures for the maintenance, monitoring, and administration thereof

The DATS Guaranty will

terminate when all Guaranteed Obligations have been satisfied in full and no shares of Preferred Stock remain outstanding.

Registration Rights Agreement

In connection with the SPA and the Inducement

Agreement, the Company, Purchasers, and Exchanging Holders entered into a Registration Rights Agreement dated May 26, 2026, pursuant to

which the Company will agree to file a registration statement with the U.S. Securities and Exchange Commission (the “SEC”)

within thirty (30) days of the date of the Registration Rights Agreement, registering, as applicable, the resale of the Preferred Stock

Shares, Prefunded Warrant Shares, and Common Warrant Shares. The Registration Rights Agreement will also cover the registration of the

resale of the Preferred Stock Shares, Prefunded Warrant Shares, and Common Warrant Shares issuable to Purchasers and Exchanging Holders

who enter into the SPA or Inducement Agreement after the initial closing and prior to June 15, 2026.

The foregoing is only

a summary of the SPA, Inducement Agreement, Guaranty Agreement, Registration Rights Agreement, and Transferable Rights Agreement, and

does not purport to be a complete description thereof. Such descriptions are qualified in their entirety by reference to the SPA, Inducement

Agreement, Guaranty Agreement, Registration Rights Agreement, and Transferable Rights Agreement, copies of which are filed as Exhibits

10.1, 10.2, 10.3, 10.4, and 4.4, respectively, to this Current Report on Form 8-K and are incorporated by reference herein.

Item 3.02. Unregistered

Sales of Equity Securities.

To the extent required

by Item 3.02 of Form 8-K, the information contained in Item 1.01 of this Current Report is incorporated herein by reference.

Item 3.03. Material

Modification to Rights of Security Holders.

To the extent required

by Item 3.03 of Form 8-K, the information contained in Item 1.01 and 5.03 of this Current Report is incorporated herein by reference.

Item 5.03. Amendments

to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Creation of Preferred

Stock

Designation

In connection with the Offering, the Company’s

Board of Directors (the “Board”) approved a certificate of designation (the “Series B-1 Certificate of Designation”)

fixing the voting powers, designations, preferences and rights and the qualifications, limitations or restrictions of Series B-1 Convertible

Preferred Stock, par value $0.001 per share (the “Series B-1 Preferred Stock”), a newly created series of preferred stock

of the Company, which became effective upon its filing with the Secretary of State of the State of Delaware on May 26, 2026.

Also in connection with the Offering, the Board

approved a certificate of designation (the “Series B-2 Certificate of Designation” and together with the Series B-1 Certificate

of Designation, the “Certificate of Designations”) fixing the voting powers, designations, preferences and rights and the

qualifications, limitations or restrictions of Series B-2 Convertible Preferred Stock, par value $0.001 per share (the “Series B-2

Preferred Stock”), a newly created series of preferred stock of the Company, which became effective upon its filing with the Secretary

of State of the State of Delaware on May 26, 2026.

Of the Company’s 10,000,000 previously undesignated

shares of preferred stock, par value $0.001 per share, 5,000,000 shares were designated as Series B-1 Preferred Stock, and 5,000,000 shares

were designated as Series B-2 Preferred Stock as of May 26, 2026.

Exchange and Redemption

The Preferred Stock is exchangeable for shares

of Common Stock at the holder’s election such that each share of Preferred Stock is initially convertible into one share of Common

Stock, subject to adjustments set forth in the applicable Certificate of Designation.

Holders of Preferred Stock have the right to require

the Company to redeem all or any portion of such holder’s Preferred Stock for cash upon a Fundamental Transaction (including a Liquidation

Event), Delisting Event, Treasury Value Event, Warrant Ratchet Event, or Event of Default, as each term is defined in the relevant Certificate

of Designation. In addition, the Company may, at its option, require all outstanding shares of Series B-2 Preferred Stock, inclusive of

accrued dividends paid in cash, to convert into Common Stock (or prefunded warrants to purchase shares of Common Stock in lieu thereof)

after certain specified trading criteria is satisfied.

Annual Dividends

The Preferred Stock is entitled to an annual dividend

on the Preferred Stock’s Accumulated Liquidation Preference, defined below, and which shall be payable quarterly in arrears. Until

the first quarterly dividend payment required after the second anniversary of the initial issuance of the Preferred Stock, the Company

may, in its sole discretion, choose to pay dividends required under the Certificate of Designations in a dollar amount expressed as an

amount per shares of Preferred Stock, which amount will increase such Preferred Stock’s stated value. Following the second year

anniversary of the initial issuance of the Preferred Stock all dividend payments are required to be made in cash. The Series B-1 Preferred

Stock carries an annual dividend rate of 8% and the Series B-2 Preferred Stock carries an annual dividend rate of 6%.

Liquidation and Dividend Preferences

As defined in the Certificate of Designations,

the Series B-1 Preferred Stock has an “Initial Liquidation Preference” of $1.05 and an “Accumulated Liquidation Preference”

which equals $1.05 plus any and all dividends, and the Series B-2 Preferred Stock has an “Initial Liquidation Preference”

of $0.38 and an “Accumulated Liquidation Preference” which equals $0.38 plus any and all dividends.

The “Liquidation Preference” of the

Series B-1 Preferred Stock equals an amount equal to (x) 1.5 multiplied by (y) the Accumulated Liquidation Preference plus (z) accrued

and unpaid dividends, whether or not declared, that have not yet been compounded and added to the Accumulated Liquidation Preference.

The “Liquidation Preference” of the Series B-2 Preferred Stock equals an amount equal to the Accumulated Liquidation Preference

plus (z) accrued and unpaid dividends, whether or not declared, that have not yet been compounded and added to the Accumulated Liquidation

Preference.

Subject to a maximum distribution of two (2.0)

times the Liquidation Preference per share, the Series B-1 Preferred Stock ranks senior to Common Stock and Series B-2 Preferred Stock,

and the Series B-2 Preferred Stock ranks senior to Common Stock and junior to Series B-1 Preferred Stock with respect to the distribution

of assets upon the Company’s liquidation, dissolution or winding up, until such Preferred Stock has received an amount equal to

its Liquidation Preference, at which point holders of Preferred Stock will participate on a pro-rata as-converted basis with holders of

Common Stock in the distribution of any remaining assets of the Company available for distribution to stockholders.

In addition, the holders of Preferred Stock may

elect to receive the amounts they would have received upon the distribution of assets upon the Company’s liquidation, dissolution

or winding up, had such holder converted their Preferred Stock into Common Stock immediately prior to the liquidation event.

The Series B-1 Preferred Stock ranks senior to

Common Stock and Series B-2 Preferred Stock, and the Series B-2 Preferred Stock ranks senior to Common Stock and junior to Series B-1

Preferred Stock with respect to the payment of dividends (without regard to whether or not dividends accumulate cumulatively).

The Preferred Stock will rank senior to any class

or series of the Company’s stock whose terms do not expressly provide that such class or series will rank senior to, or equally

with, the Preferred Stock; and junior to any class or series of the Company’s stock whose terms expressly provide that such class

or series will rank senior to the Convertible Preferred Stock with respect to the (i) distribution of assets upon the Company’s

liquidation, dissolution or winding up, and (ii) payment of dividends (without regard to whether or not dividends accumulate cumulatively).

Pursuant to the Certificate of Designations, the

Company cannot issue capital stock that ranks senior to, or equally with, the Preferred Stock with respect to the (i) distribution of

assets upon the Company’s liquidation, dissolution or winding up, and (ii) payment of dividends (without regard to whether or not

dividends accumulate cumulatively), without the prior approval of holders representing a majority of the outstanding shares of Series

B-1 Preferred Stock.

Right to Vote with Holders of Common Stock

The holders of Preferred Stock will have the right

to vote together as a single class with the holders of Common Stock on each matter submitted for a vote or consent by the holders of Common

Stock, and (i) the Preferred Stock of each holder will entitle such holder to be treated as if such holder were the holder of record,

as of the record or other relevant date for such matter, of a number of shares of Common Stock equal to the number of shares of Common

Stock that would be issuable upon conversion of such Preferred Stock, subject to the terms of conversion in the Certificate of Designations,

assuming such Preferred Stock were converted on such record or other relevant date; and (ii) the holders will be entitled to notice of

all stockholder meetings or proposed actions by written consent in accordance with the Company’s Certificate of Incorporation, as

amended, Bylaws, and the Delaware General Corporation Law as if the holders were holders of Common Stock.

The foregoing is only a summary of the voting

powers, designations, preferences and rights and the qualifications, limitations or restrictions of the Series B-1 Preferred Stock and

Series B-2 Preferred Stock, and does not purport to be a complete description thereof. Such descriptions are qualified in their entirety

by reference to the Series B-1 Certificate of Designation and Series B-2 Certificate of Designation, copies of which are filed as Exhibits

3.1 and 3.2, respectively, to this Current Report on Form 8-K and are incorporated by reference herein.

Item 7.01. Regulation

FD Disclosure.

On May 26, 2026, the

Company issued a press release announcing the transactions. A copy of the press release is furnished herewith as Exhibit 99.1.

The

information under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities

Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall

not be deemed to be incorporated by reference into the filings of the Company under the Securities Act or the Exchange Act, except as

shall be expressly set forth by specific reference in such filing.

Forward-Looking Statements

and Disclaimer

This report contains

“forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E

of the Exchange Act. Words like “believe,” “expect,” “may,” “will,” and “would,”

or the negative thereof or other variations thereon or comparable terminology, are used to identify forward-looking statements, although

not all forward-looking statements contain these words. Although the Company believes that it is basing its expectations and beliefs on

reasonable assumptions within the bounds of what is currently known about its business and operations, there can be no assurance that

actual results will not differ materially from what the Company expects or believes. Some of the factors that could cause the Company’s

actual results to differ materially from its expectations or beliefs are disclosed in the “Risk Factors” section, as well

as other sections, of its reports filed with the Securities and Exchange Commission, which include, without limitation, its ability to

maintain the listing of its securities on Nasdaq and comply with Nasdaq’s listing standards. All forward-looking statements speak

only as of the date on which they are made and the Company undertakes no duty to update or revise any forward-looking statements, whether

as a result of new information, future events or otherwise.

Item 9.01. Financial Statements and Exhibits.

(d)       Exhibits.

Exhibit No.

Description

3.1

Certificate of Designation of Series B-1 Preferred Stock

3.2

Certificate of Designation of Series B-2 Preferred Stock

4.1

Form of Series B-1 Prefunded Warrant

4.2

Form of Series B-2 Prefunded Warrant

4.3

Form of Series F Common Stock Purchase Warrant

4.4#

Form of Transferable Rights Agreement, and Form of Rights Certificate as Exhibit A

10.1#

Form of Securities Purchase Agreement, dated May 26, 2026

10.2#

Form of Warrant Inducement and Exchange Agreement, dated May 26, 2026

10.3

Form of Guaranty Agreement, dated May 26, 2026

10.4#

Form of Registration Rights Agreement, dated May 26, 2026

99.1

Press release dated May 26, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

#

Schedules and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company will furnish a copy of any omitted schedule or similar attachment to the Securities and Exchange Commission upon request.

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

BNB Plus Corp.

Date: May 27, 2026

By:

/s/ Clay Shorrock

Name:

Clay Shorrock

Title:

Chief Executive Officer

EX-3.1 — EXHIBIT 3.1

EX-3.1

Filename: tm2615620d1_ex3-1.htm · Sequence: 2

Exhibit 3.1

BNB Plus Corp.

Certificate of Designations

of

Series B-1 Convertible Preferred Stock

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

The undersigned hereby certifies

that on May 19, 2026 the Board of Directors of BNB Plus Corp., a Delaware corporation (the “Company”), adopted

the following resolution designating and creating, out of the authorized and unissued shares of preferred stock of the Company, 5,000,000

authorized shares of a series of preferred stock of the Company titled the “Series B-1 Convertible Preferred Stock”:

RESOLVED that, pursuant

to the Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws and applicable law, a series of preferred stock

of the Company titled the “Series B-1 Convertible Preferred Stock,” and having a par value of $0.001 per share and an

initial number of authorized shares equal to 5,000,000, is hereby designated and created out of the authorized and unissued shares of

preferred stock of the Company, which series has the rights, designations, preferences, voting powers and other provisions set forth

below:

Section 1.         Definitions.

“Accumulated Liquidation

Preference” means the Initial Liquidation Preference per share of Convertible Preferred Stock plus any and all Compounded Dividends.

“Affiliate”

of any Person means any Person, directly or indirectly, Controlling, Controlled by or under common Control with such Person.

“Beneficial Ownership

Limitation” means, with respect to any Holder, the limitation that such Holder may not convert any shares of Convertible Preferred

Stock to the extent that, after giving effect to such conversion, such Holder (together with its Affiliates and any other Persons whose

beneficial ownership of Common Stock would be aggregated with such Holder’s for purposes of Section 13(d) of the Exchange

Act and the applicable regulations of the SEC) would beneficially own in excess of 4.99% (or, at the election of the applicable Holder

prior to the Initial Issue Date, 9.99% or 19.99%) of the number of shares of Common Stock outstanding immediately after giving effect

to the issuance of shares of Common Stock upon such conversion (the “Maximum Percentage”). During any period in which

the Common Stock is not listed on an Eligible Market, Holder may increase or decrease the Maximum Percentage applicable to such Holder

by written notice to the Company; provided that (i) any such increase will not be effective until the sixty-first (61st)

day after such notice is delivered to the Company and (ii) any such increase or decrease shall apply only to such Holder and not

to any other Holder.

“Board of Directors”

means the Company’s board of directors or a committee of such board duly authorized to act on behalf of such board.

1

“Business Day”

means any day other than a Saturday, a Sunday or any day on which the Federal Reserve Bank of New York is authorized or required by law

or executive order to close or be closed.

“Bylaws”

means the Amended and Restated Bylaws of the Company, as the same may be further amended, supplemented or restated.

“Capital Stock”

of any Person means any and all shares of, interests in, rights to purchase, warrants or options for, participations in, or other equivalents

of, in each case however designated, the equity of such Person, but excluding any debt securities convertible into such equity.

“Certificate” means

any Physical Certificate or Electronic Certificate.

“Certificate of

Designations” means this Certificate of Designations, as amended or supplemented from time to time.

“Certificate of

Incorporation” means the Company’s Amended and Restated Certificate of Incorporation, as the same may be further amended,

supplemented or restated.

“Change of Control”

means any of the following events:

(a)            a

“person” or “group” (within the meaning of Section 13(d)(3) of the Exchange Act), other than the Company,

its Wholly Owned Subsidiaries or a Holder (together with its Affiliates), has become the direct or indirect “beneficial owner”

(as defined below) of shares of the Company’s Common Stock representing more than fifty percent (50%) of the voting power of all

of the Company’s then-outstanding common Stock; or (other than one effected in compliance with the terms of the Convertible Preferred

Stock and in which the Company’s stockholders own a majority of the voting power of the surviving or acquiring entity)

(b)            the

consummation of (i) any sale, lease or other transfer, in one transaction or a series of transactions, of all or substantially all

of the assets of the Company and its Subsidiaries, taken as a whole, to any Person (other than to a wholly owned direct or indirect subsidiary;

or (ii) any transaction or series of related transactions in connection with which (whether by means of merger, consolidation, share

exchange, combination, reclassification, recapitalization, acquisition, liquidation or otherwise) all of the Common Stock is exchanged

for, converted into, acquired for, or constitutes solely the right to receive, other securities, cash or other property; provided,

however, that any merger, consolidation, share exchange or combination of the Company pursuant to which the Persons that directly

or indirectly “beneficially owned” (as defined below) the Company’s Common Stock immediately before such transaction

directly or indirectly “beneficially own,” immediately after such transaction, more than fifty percent (50%) of the Common

Stock of the surviving, continuing or acquiring company or other transferee, as applicable, or the parent thereof, in substantially the

same proportions vis-à-vis each other as immediately before such transaction will be deemed not to be a Change of Control pursuant

to this clause (b); and provided further, however, that the foregoing notwithstanding, a merger or consolidation of the Company

approved by the affirmative vote of the Requisite Holders shall not be deemed a Change of Control.

For the purposes of this

definition, (x) any transaction or event described in both clause (a) and in clause (b) above (without regard

to the proviso in clause (b)) will be deemed to occur solely pursuant to clause (b) above (subject to such proviso);

and (y) whether a Person is a “beneficial owner” and whether shares are “beneficially owned”

will be determined in accordance with Rule 13d-3 under the Exchange Act.

2

“Close of Business”

means 5:00 p.m., New York City time.

“Code” means the

U.S. Internal Revenue Code of 1986, as amended.

“Common Stock”

means the common stock, $0.001 par value per share, of the Company, subject to Section 10(h).

“Common Stock Change Event”

has the meaning set forth in Section 10(h).

“Company”

has the meaning set forth in the preamble.

“Compounded Dividends”

has the meaning set forth in Section 5(a).

“Control”

(including its correlative meanings “under common Control with” and “Controlled by”) means, with respect to any

Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person,

whether through ownership of securities or partnership or other interests, by contract or otherwise.

“Conversion Consideration”

means, with respect to the conversion of any Convertible Preferred Stock, the type and amount of consideration payable to settle such

conversion, determined in accordance with Section 10.

“Conversion Share”

means any share of Common Stock issued or issuable upon conversion of any Convertible Preferred Stock.

“Conversion Date”

means the date of an Optional Conversion.

“Conversion Price”

initially means $1.05; provided, however, that the Conversion Price is subject to adjustment pursuant to Section 10(f) and

Section 10(g). Each reference in this Certificate of Designations or the Convertible Preferred Stock to the Conversion Price

as of a particular date without setting forth a particular time on such date will be deemed to be a reference to the Conversion Price

immediately before the Close of Business on such date.

“Convertible Preferred Stock”

has the meaning set forth in Section 3(a).

“Daily VWAP”

means, for any VWAP Trading Day, the per share volume-weighted average price of the Common Stock as displayed under the heading “Bloomberg

VWAP” on Bloomberg page “www.bloomberg.com” (or, if such page is not available, its equivalent successor

page) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session

on such VWAP Trading Day (or, if such volume-weighted average price is unavailable, the market value of one (1) share of Common

Stock on such VWAP Trading Day, determined, using a volume-weighted average price method, by a nationally recognized independent investment

banking firm the Board of Directors selects). The Daily VWAP will be determined without regard to after-hours trading or any other trading

outside of the regular trading session.

3

“Delisting Event”

means: (a) the Common Stock ceases to be listed or quoted on any Eligible Market; (b) the Company fails to maintain the listing

or quotation of the Common Stock on an Eligible Market; or (c) trading in the Common Stock is suspended, halted, or otherwise limited

such that holders are unable to sell shares in the public market for ten (10) consecutive trading days, in each case other than

due solely to market-wide trading halts.

“Depositary” means

The Depository Trust Company or its successor.

“Digital Assets”

means (a) cryptocurrencies, virtual currencies, digital currencies, coins, tokens and stablecoins; (b) native blockchain or

protocol assets; (c) tokenized securities, tokenized commodities and tokenized real-world assets; (d) utility tokens, governance

tokens, staking tokens, liquid staking tokens and wrapped, bridged or synthetic digital assets; (e) any digital or cryptographic

asset, property or store of value that is recorded, represented or transferred using distributed ledger technology, blockchain technology,

cryptographic systems or similar technology; (f) BNB-denominated trust units; (g) any rights to receive, acquire, stake, validate,

delegate, earn, mine or otherwise obtain any of the foregoing; (h) any proceeds, products, distributions, rewards, fees, interest,

yield, airdrops, forks or other property derived from or attributable to any of the foregoing; and (i) any replacements, substitutions,

modifications, successors or forks of any of the foregoing, in each case of (a) through (h), whether now existing or hereafter arising.

“Digital Asset Treasury”

means the immediately available liquid assets of the Company and its subsidiaries, including but not limited to any Digital Assets and

any cash at the DAT Subsidiaries; provided, however, that notwithstanding the foregoing the Digital Asset Treasury shall

be deemed not to include: (i) the General Proceeds; (ii) cash at the Company in an amount equal to $600,000; (iii) accounts

receivable of the Company in an amount equal to $700,000; and (iv) all operating cash flows attributable to the LineaRx business.

“Digital Asset Treasury

Procedures” means the procedures governing the management, custody, transfer, and disposition of assets held in the Digital

Asset Treasury, as set forth in a separate instrument agreed upon by the Company and the Requisite Holders not later than thirty (30)

days following the Initial Closing of the Purchase Agreement, which shall include both (a) the initial procedures for the establishment

and contribution of assets to the Digital Asset Treasury and (b) ongoing procedures for the maintenance, monitoring, and administration

thereof.

“Digital Asset Treasury

Subsidiary” means (i) Build & Build, LLC, a Delaware limited liability company and a wholly owned subsidiary

of the Company, (ii) BNBX Ltd., a wholly owned subsidiary organized under the laws of the British Virgin Islands and (iii) any

other wholly-owned subsidiary of the Company now existing or hereafter formed that is a guarantor party to the Guaranty or holds any

or all of the Digital Asset Treasury.

“Dividend”

means any Regular Dividend.

“Dividend Rights”

means the Holders’ rights under Section 5.

“Dividend Junior

Stock” means any class or series of the Company’s stock whose terms do not expressly provide that such class or series

will rank senior to, or equally with, the Convertible Preferred Stock with respect to the payment of dividends (without regard to whether

or not dividends accumulate cumulatively). Dividend Junior Stock includes the Common Stock and the Series B-2 Preferred Stock.

4

“Dividend Parity

Stock” means any class or series of the Company’s stock (other than the Convertible Preferred Stock) whose terms expressly

provide that such class or series will rank equally with the Convertible Preferred Stock with respect to the payment of dividends (without

regard to whether or not dividends accumulate cumulatively).

“Dividend Senior

Stock” means any class or series of the Company’s stock whose terms expressly provide that such class or series will

rank senior to the Convertible Preferred Stock with respect to the payment of dividends (without regard to whether or not dividends accumulate

cumulatively).

“Electronic Certificate”

means any electronic book-entry maintained by the Transfer Agent that represents any share(s) of Convertible Preferred Stock.

“Eligible Market”

shall mean any of The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market,

the New York Stock Exchange, the NYSE American, the OTCQX Market, or the OTCQB Market (or any successor to any of the foregoing)

or, for a period no longer than 15 consecutive Trading Days, the OTCID Basic Market within the Pink Open

Market, while the Company’s application to the OTCQX or OTCQB is being processed. Notwithstanding the foregoing, any Delisting

Event triggered by a voluntary delisting of the Company from any Eligible Market that is approved in writing by the Requisite Holders

shall not be deemed a Delisting Event.

“Equity-Linked Securities”

means any rights, options or warrants to purchase or otherwise acquire (whether immediately, during specified times, upon the satisfaction

of any conditions or otherwise) any shares of Common Stock.

“Event of Default”

means the occurrence of any of the following: (a) the failure by the Company to pay when due any Dividend or redemption amount (including

without limitation any Participating Amount) required under this Certificate of Designations; (b) the failure by the Company to

comply with any covenant or agreement set forth in this Certificate of Designations (other than a failure covered by clause (a)), which

failure continues for ten (10) consecutive Business Days after written notice thereof from the Requisite Holders (without giving

effect to any other notice or cure period); or (c) any other material breach or default by the Company under any Transaction Document,

which breach or default remains uncured following any applicable notice or cure period explicitly set forth in the applicable Transaction

Document.

“Ex-Dividend Date”

means, with respect to an issuance, dividend or distribution on the Common Stock, the first date on which shares of Common Stock trade

on the applicable exchange or in the applicable market, regular way, without the right to receive such issuance, dividend or distribution

(including pursuant to due bills or similar arrangements required by the relevant stock exchange). For the avoidance of doubt, any alternative

trading convention on the applicable exchange or market in respect of the Common Stock under a separate ticker symbol or CUSIP number

will not be considered “regular way” for this purpose.

“Exchange Act”

means the U.S. Securities Exchange Act of 1934, as amended.

“Expiration

Date” has the meaning set forth in Section 10(f)(i)(2).

“Expiration Time”

has the meaning set forth in Section 10(f)(i)(2).

5

“Fundamental Transaction”

means (a) the occurrence of a “Fundamental Transaction”, as such term may be amended or supplemented from time to time,

or its equivalent, as defined or otherwise used in the Series E Warrants of the Company; or (b) unless explicitly approved

by the Requisite Holders in writing, any occurrence, eligibility or exercisability of a right of, direct or indirect redemption, purchase,

repurchase or other similar right under any agreement, security or other instrument of the Company (i) resulting in an obligation

of the Company (or any Subsidiary) to pay cash, distribute assets, incur indebtedness for such purpose or engage in any

substantially equivalent transaction (or the payment into or set aside for a sinking fund for such purpose) or (ii) which could

reasonably result in a material adverse effect on the capital stock of the Company held by the Holder.

“General Proceeds”

means proceeds from the sale and issuance of Series B-1 Preferred Stock and proceeds from the warrant exercise and exchange for

Series B-2 Preferred Stock as set forth in the Inducement Agreement, in an aggregate cumulative amount not in excess of $2,300,000.

“Holder”

means a person in whose name any Convertible Preferred Stock is registered in the Register.

“Holder Redemption”

means the redemption of any Convertible Preferred Stock by the Company pursuant to Section 7.

“Holder Redemption

Date” means the date fixed, pursuant to Section 7(a)(i), for the redemption of any Convertible Preferred Stock

by the Company pursuant to a Holder Redemption.

“Holder Redemption Demand”

has the meaning set forth in Section 7(a)(i).

“Holder Redemption

Price” means the cash price payable by the Company to redeem any share of Convertible Preferred Stock upon its Holder Redemption,

calculated pursuant to Section 7(a)(ii).

“Initial Issue Date”

means May 27, 2026

“Initial Liquidation

Preference” means $1.05 per share of Convertible Preferred Stock.

“Last Reported Sale

Price” of the Common Stock for any Trading Day means the closing sale price per share (or, if no closing sale price is reported,

the average of the last bid price and the last ask price per share or, if more than one in either case, the average of the average last

bid prices and the average last ask prices per share) of the Common Stock on such Trading Day as reported in composite transactions for

the principal U.S. national or regional securities exchange on which the Common Stock is then listed. If the Common Stock is not listed

on a U.S. national or regional securities exchange on such Trading Day, then the Last Reported Sale Price will be the last quoted bid

price per share of Common Stock on such Trading Day in the over-the-counter market as reported by OTC Markets Group Inc. or a similar

organization. If the Common Stock is not so quoted on such Trading Day, then the Last Reported Sale Price will be the average of the

mid-point of the last bid price and the last ask price per share of Common Stock on such Trading Day from each of at least three nationally

recognized independent investment banking firms the Company selects in good faith.

6

“Lien”

means any mortgage, deed of trust, pledge, hypothecation, security interest, encumbrance, lien, charge,

claim, attachment, garnishment, levy or other restriction of any kind, whether arising by agreement, operation of law or otherwise, including

(i) any conditional sale or other title retention arrangement, (ii) any lease in the nature thereof, (iii) any agreement

to create, suffer, grant or permit any of the foregoing, and (iv) any restriction on the transfer, use or disposition of any asset

that has the economic effect of securing an obligation. For the avoidance of doubt, “Lien” shall include any arrangement

or transaction that has the practical effect of providing a creditor or counterparty with recourse to or priority in respect of any asset

or property, including through netting arrangements, set-off rights, margining, rehypothecation or similar arrangements, including any

arrangement that results in the segregation, earmarking or restriction of assets for the benefit of any creditor or counterparty. “Lien”

shall also include any asserted or pending claim, litigation, proceeding or demand that, if successful, could reasonably be expected

to result in the imposition of any of the foregoing on any asset or property of the Company or any Digital Asset Treasury Subsidiary.

“Liquidation Event”

means the occurrence or consummation of any of the following: (i) a liquidation, dissolution, or winding up of the Company;

or (ii) Change of Control.

“Liquidation Junior

Stock” means any class or series of the Company’s stock whose terms do not expressly provide that such class or series

will rank senior to, or equally with, the Convertible Preferred Stock with respect to the distribution of assets upon the Company’s

liquidation, dissolution or winding up. Liquidation Junior Stock includes the Common Stock and the Series B-2 Preferred Stock.

“Liquidation Parity

Stock” means any class or series of the Company’s stock (other than the Convertible Preferred Stock) whose terms expressly

provide that such class or series will rank equally with the Convertible Preferred Stock with respect to the distribution of assets upon

the Company’s liquidation, dissolution or winding up.

“Liquidation Preference”

means, with respect to the Convertible Preferred Stock, an amount equal to (x) 1.5 multiplied by (y) the Accumulated Liquidation

Preference plus (z) accrued and unpaid Dividends, whether or not declared, that have not yet been compounded and added to the Accumulated

Liquidation Preference.

“Liquidation Senior

Stock” means any class or series of the Company’s stock whose terms expressly provide that such class or series will

rank senior to the Convertible Preferred Stock with respect to the distribution of assets upon the Company’s liquidation, dissolution

or winding up.

“Officer”

means the Chief Executive Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer, any Assistant

Treasurer, the Secretary, or any Vice-President of the Company.

“Open of Business”

means 9:00 a.m., New York City time.

“Optional Conversion”

means the conversion of any Convertible Preferred Stock pursuant to Section 10(b).

“Optional Conversion

Notice” means a notice, substantially in the form of Exhibit B attached hereto and incorporated herein,

delivered in connection with an Optional Conversion in accordance with Section 10(b)(ii).

7

“Participating Amount”

has the meaning set forth in Section 6.

“Permitted

Liens” means (i) Liens for taxes, assessments or other governmental charges not yet due and

payable or that are being contested in good faith by appropriate proceedings; (ii) statutory Liens of landlords, carriers, warehousemen,

mechanics, materialmen and other similar Liens arising in the ordinary course of business securing obligations not yet delinquent or

being contested in good faith; (iii) Liens incurred in the ordinary course of business in connection with workers’ compensation,

unemployment insurance and other social security legislation; (iv) ordinary course purchase money Liens and Liens securing rental

payments under operating or capital lease arrangements for amounts not yet due or payable; (v) Liens arising under applicable securities

laws in connection with the holding of securities in custody accounts; and (vi) such other Liens as may be approved in writing by

the Requisite Holders.

“Person”

or “person” means any individual, corporation, partnership, limited liability company, joint venture, association,

joint-stock company, trust, unincorporated organization or government or other agency or political subdivision thereof. Any division

or series of a limited liability company, limited partnership or trust will constitute a separate “person” under this Certificate

of Designations.

“Physical Certificate”

means any certificate (other than an Electronic Certificate) representing any share(s) of Convertible Preferred Stock, which certificate

is substantially in the form set forth in Exhibit A, registered in the name of the Holder of such share(s) and

duly executed by the Company and countersigned by the Transfer Agent.

“Record Date”

means, with respect to any dividend or distribution on, or issuance to holders of, Convertible Preferred Stock or Common Stock, the date

fixed (whether by law, contract or the Board of Directors or otherwise) to determine the Holders or the holders of Common Stock, as applicable,

that are entitled to such dividend, distribution or issuance.

“Redemption Event”

means a Fundamental Transaction (including a Liquidation Event), Delisting Event, Treasury Value Event, Warrant Ratchet Event or

Event of Default.

“Redemption Event

Notice” has the meaning set forth in Section 7(b).

“Reference Property”

has the meaning set forth in Section 10(h).

“Reference Property Unit”

has the meaning set forth in Section 10(h).

“Register” has the

meaning set forth in Section 3(e).

“Regular Dividends”

has the meaning set forth in Section 5(a)(i).

“Regular Dividend

Payment Date” means, with respect to any share of Preferred Stock, each March 31, June 30, September 30 and

December 31 of each year, beginning on the first such date occurring after the Initial Issue Date (or beginning on such other date

specified in the Certificate evidencing such share).

“Regular Dividend

Period” means each period from, and including, a Regular Dividend Payment Date (or, in the case of the first Regular Dividend

Period, from, and including, the Initial Issue Date) to, but excluding, the next Regular Dividend Payment Date.

“Regular Dividend

Rate” means 8.0% (eight percent) per annum.

8

“Regular Dividend

Record Date” has the following meaning: (a) March 15th, in the case of a Regular Dividend Payment Date

occurring on March 31st; (b) June 15th, in the case of a Regular Dividend Payment Date occurring

on June 30th; (c) September 15th, in the case of a Regular Dividend Payment Date occurring on September 30th;

and (d) December 15th, in the case of a Regular Dividend Payment Date occurring on December 31st.

“Requisite Holders”

is defined in Section 9(b)(i)

“Restricted Stock

Legends” means the legends substantially in the form set forth in Exhibit C.

“Rule 144”

means Rule 144 under the Securities Act (or any successor rule thereto), as the same may be amended from time to time.

“Securities Act”

means the U.S. Securities Act of 1933, as amended.

“Security” means

any Convertible Preferred Stock or Conversion Share.

“Series B-2

Preferred Stock” means the Company’s Series B-2 Convertible Preferred Stock.

“Subsidiary”

means, with respect to any Person, (a) any corporation, association or other business entity (other than a partnership or limited

liability company) of which more than 50% of the total voting power of the Capital Stock entitled (without regard to the occurrence of

any contingency, but after giving effect to any voting agreement or stockholders’ agreement that effectively transfers voting power)

to vote in the election of directors, managers or trustees, as applicable, of such corporation, association or other business entity

is owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of such Person; and (b) any

partnership or limited liability company where (x) more than fifty percent (50%) of the capital accounts, distribution rights, equity

and voting interests, or of the general and limited partnership interests, as applicable, of such partnership or limited liability company

are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of such Person, whether in the

form of membership, general, special or limited partnership or limited liability company interests or otherwise; and (y) such Person

or any one or more of the other Subsidiaries of such Person is a controlling general partner of, or otherwise controls, such partnership

or limited liability company.

“Successor Person”

has the meaning set forth in Section 10(h).

“Tender/Exchange

Offer Valuation Period” has the meaning set forth in Section 10(f)(i)(2).

“Trading Day”

means any day on which (a) trading in the Common Stock generally occurs on the principal U.S. national or regional securities exchange

on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange,

on the principal other market on which the Common Stock is then traded; and (b) there is no VWAP Market Disruption Event. If the

Common Stock is not so listed or traded, then “Trading Day” means a Business Day.

“Transaction Document”

means any of this Certificate of Designations or the Certificate of Designations for the Series B-2 Preferred Stock, the Purchase

Agreement, the Warrant Agreements, the Guaranty, Inducement Agreement, and the Registration Rights Agreement.

9

“Transfer Agent”

means the Company or its successor.

“Transfer-Restricted

Security” means any Security that constitutes a “restricted security” (as defined in Rule 144); provided,

however, that such Security will cease to be a Transfer-Restricted Security upon the earliest to occur of the following events:

(a)            such

Security is sold or otherwise transferred to a Person (other than the Company or an Affiliate of the Company) pursuant to a registration

statement that was effective under the Securities Act at the time of such sale or transfer;

(b)            such

Security is sold or otherwise transferred to a Person (other than the Company or an Affiliate of the Company) pursuant to an available

exemption (including Rule 144) from the registration and prospectus-delivery requirements of, or in a transaction not subject to,

the Securities Act and, immediately after such sale or transfer, such Security ceases to constitute a “restricted security”

(as defined in Rule 144); and

(c)            (i) such

Security is eligible for resale, by a Person that is not an Affiliate of the Company and that has not been an Affiliate of the Company

during the immediately preceding three (3) months, pursuant to Rule 144; and (ii) the Company has received such certificates

or other documentation or evidence as the Company may reasonably require to determine that the security is eligible for resale pursuant

to clause (c) and the Holder, holder or beneficial owner of such Security is not, and has not been during the immediately

preceding three (3) months, an Affiliate of the Company.

“Treasury Regulations”

means the Treasury regulations promulgated under the Code, as amended.

“Treasury

Value Event” means any date on which the US dollar value of the Digital Assets in the Company’s Digital Asset Treasury,

as determined in good faith by the Company based on publicly available market prices as of the applicable date, is less than 100% (one

hundred percent) of the value of the then applicable aggregate Liquidation Preference of the Convertible Preferred Stock on five

(5) or more consecutive Business Days, it being understood that the Company may, in its reasonable

discretion and without any consent of the Requisite Holders, enter into hedging transactions or convert assets in the Digital Asset Treasury

into US dollars or stablecoins recognized by the GENIUS Act in order to maintain the value of such liquid assets at or above such threshold.

“VWAP Market Disruption

Event” means, with respect to any date, (a) the failure by the principal U.S. national or regional securities exchange

on which the Common Stock is then listed, or, if the Common Stock is not then listed on a U.S. national or regional securities exchange,

the principal other market on which the Common Stock is then traded, to open for trading during its regular trading session on such date;

or (b) the occurrence or existence, for more than one half hour period in the aggregate, of any suspension or limitation imposed

on trading (by reason of movements in price exceeding limits permitted by the relevant exchange or otherwise) in the Common Stock or

in any options contracts or futures contracts relating to the Common Stock, and such suspension or limitation occurs or exists at any

time before 1:00 p.m., New York City time, on such date.

10

“VWAP Trading Day”

means a day on which (a) there is no VWAP Market Disruption Event; and (b) trading in the Common Stock generally occurs on

the principal U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then

listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then traded. If

the Common Stock is not so listed or traded, then “VWAP Trading Day” means a Business Day.

“Warrant Agreement”

means the Series F Common Stock Purchase Warrant of the Company and the Pre-Funded Purchase Warrants of the Company issued in connection

with the Purchase Agreement and Inducement Agreement.

“Warrant Ratchet

Event” means: the occurrence of any adjustment, repricing, reset, or other modification to the exercise price, number of underlying

shares, or economic entitlement of any outstanding warrant (or similar Common Stock Equivalent) that results in an increase in the intrinsic

or economic value of such instrument to the holder thereof, in each case as a result of or in connection with:

(a) any issuance or

deemed issuance of equity securities of the Company at a price per share below the then-current exercise price (including any “Dilutive

Issuance” or similar concept);

(b) any formula or mechanism

that references, directly or indirectly, the trading price, volume-weighted average price, or lowest trading price of the Common Stock

over any period of time following such issuance, announcement, or event;

(c) any share combination,

reverse stock split, recapitalization, or similar transaction where the resulting adjustment is based, in whole or in part, on post-event

market prices rather than purely proportional adjustments;

(d) any “variable

rate,” “floating conversion price,” or similar structure in which the effective exercise or conversion price is determined

by reference to future market prices of the Common Stock; or

(e) any transaction

or series of related transactions that has a substantially similar economic effect to any of the foregoing, including through the use

of options, convertible securities, or other derivative instruments;

Provided, however, that in

each case of clauses (a) through (e) above, excluding customary anti-dilution adjustments solely for stock splits, stock dividends,

combinations, reclassifications, or other proportional adjustments that preserve, but do not enhance, the intrinsic or economic value

of such instrument.

“Wholly Owned Subsidiary”

of a Person means any Subsidiary of such Person all of the outstanding Capital Stock or other ownership interests of which (other than

directors’ qualifying shares) are owned by such Person or one or more Wholly Owned Subsidiaries of such Person.

Section 2.               Rules of

Construction. For purposes of this Certificate of Designations:

(a)            “or”

is not exclusive;

(b)            “including”

means “including without limitation”;

(c)            “will”

expresses a command;

11

(d)            the

“average” of a set of numerical values refers to the arithmetic average of such numerical values;

(e)            a

merger involving, or a transfer of assets by, a limited liability company, limited partnership or trust will be deemed to include any

division of or by, or an allocation of assets to a series of, such limited liability company, limited partnership or trust, or any unwinding

of any such division or allocation;

(f)             words

in the singular include the plural and in the plural include the singular, unless the context requires otherwise;

(g)            “hereof”

and other words of similar import refer to this Certificate of Designations as a whole and not to any particular Section or other

subdivision of this Certificate of Designations, unless the context requires otherwise;

(h)            references

to currency mean the lawful currency of the United States of America, unless the context requires otherwise; and

(i)            the

exhibits, schedules and other attachments to this Certificate of Designations are deemed to form part of this Certificate of Designations.

Section 3.                The

Convertible Preferred Stock.

(a)            Designation;

Par Value. A series of stock of the Company titled the “Series B-1 Convertible Preferred Stock” (the “Convertible

Preferred Stock”) is hereby designated and created out of the authorized and unissued shares of preferred stock of the Company.

The par value of the Convertible Preferred Stock is $0.001 per share.

(b)            Number

of Authorized Shares. The total authorized number of shares of Convertible Preferred Stock is 5,000,000; provided, however

that, by resolution of the Board of Directors, the total number of authorized shares of Convertible Preferred Stock may hereafter be

reduced to a number that is not less than the number of shares of Convertible Preferred Stock then outstanding.

(c)            Form,

Dating and Denominations.

(i)            Form and

Date of Certificates Representing Convertible Preferred Stock. Each Certificate representing any Convertible Preferred Stock will

bear the legends required by Section 3(f) and may bear notations, legends or endorsements required by law, stock exchange

rule or usage or the Depositary.

(ii)            Certificates.

(1)            Generally.

The Convertible Preferred Stock will be originally issued initially in the form of one or more Physical Certificates. Physical Certificates

may be exchanged for Electronic Certificates, and Electronic Certificates may be exchanged for Physical Certificates upon request by

the Holder thereof pursuant to customary procedures.

(2)            Electronic

Certificates; Interpretation. For purposes of this Certificate of Designations, (A) each Electronic Certificate will be deemed

to include the text of the stock certificate set forth in Exhibit A; (B) any legend or other notation that is

required to be included on a Certificate pursuant to Section 3 (f) will be deemed to be included in any Electronic Certificate

notwithstanding that such Electronic Certificate may be in a form that does not permit affixing legends thereto; (C) any reference

in this Certificate of Designations to the “delivery” of any Electronic Certificate will be deemed to be satisfied upon the

registration of the electronic book-entry representing such Electronic Certificate in the name of the applicable Holder; and (D) upon

satisfaction of any applicable requirements of the Delaware General Corporation Law, the Certificate of Incorporation and the Bylaws

of the Company, and any related requirements of the Transfer Agent, in each case for the issuance of Convertible Preferred Stock in the

form of one or more Electronic Certificates, such Electronic Certificates will be deemed to be executed by the Company and countersigned

by the Transfer Agent.

12

(iii)            No

Bearer Certificates; Denominations. The Convertible Preferred Stock will be issued only in registered form and only in whole numbers

of shares.

(iv)            Registration

Numbers. Each Certificate representing any Convertible Preferred Stock will bear a unique registration number that is not affixed

to any other Certificate representing any other outstanding share of Convertible Preferred Stock.

(d)            Method

of Payment; Delay When Payment Date is Not a Business Day.

(i)            Method

of Payment. The Company will pay all cash amounts due on any Convertible Preferred Stock by check issued in the name of the Holder

thereof; provided, however, that if such Holder has delivered to the Company, no later than the time set forth in the next

sentence, a written request to receive payment by wire transfer to an account of such Holder within the United States, then the Company

will pay all such cash amounts by wire transfer of immediately available funds to such account. To be timely, such written request must

be delivered no later than the Close of Business on the following date: (x) with respect to the payment of any declared cash Participating

Amount, the related Record Date; and (y) with respect to any other payment, the date that is seven (7) calendar days immediately

before the date such payment is due.

(ii)            Delay

of Payment when Payment Date is Not a Business Day. If the due date for a payment on any Convertible Preferred Stock as provided

in this Certificate of Designations is not a Business Day, then, notwithstanding anything to the contrary in this Certificate of Designations,

such payment may be made on the immediately following Business Day and no interest, dividend or other amount will accrue or accumulate

on such payment as a result of the related delay. Solely for purposes of the immediately preceding sentence, a day on which the applicable

place of payment is authorized or required by law or executive order to close or be closed will be deemed not to be a “Business

Day.”

(e)            Transfer

Agent; Register. The Company or any of its Subsidiaries may act as the Transfer Agent. The Company will, or will retain another Person

(who may be the Transfer Agent) to act as registrar who will, keep a record (the “Register”) of the names and addresses

of the Holders, the number of shares of Convertible Preferred Stock held by each Holder and the transfer, exchange, repurchase, redemption

and conversion of the Convertible Preferred Stock. Absent manifest error, the entries in the Register will be conclusive and the Company

and the Transfer Agent may treat each Person whose name is recorded as a Holder in the Register as a Holder for all purposes. The Register

will be in written form or in any form capable of being converted into written form reasonably promptly. The Company will promptly provide

a copy of the Register to any Holder upon its request.

13

(f)            Legends.

(i)            Restricted

Stock Legend.

(1)            Each

Certificate representing any share of Convertible Preferred Stock that is a Transfer-Restricted Security will bear the Restricted Stock

Legend.

(2)            If

any share of Convertible Preferred Stock is issued in exchange for, in substitution of, or to effect a partial conversion of, any other

share(s) of Convertible Preferred Stock (such other share(s) being referred to as the “old share(s)” for purposes

of this Section 3(f)(i)(2)), including pursuant to Section 3(h) or Section 3(j), then the Certificate

representing such share will bear the Restricted Stock Legends if the Certificate representing such old share(s) bore the Restricted

Stock Legends at the time of such exchange or substitution, or on the related Conversion Date with respect to such conversion, as applicable;

provided, however, that the Certificate representing such share need not bear the Restricted Stock Legends if such share

does not constitute a Transfer-Restricted Security immediately after such exchange or substitution, or as of such Conversion Date, as

applicable.

(ii)            Other

Legends. The Certificate representing any Convertible Preferred Stock may bear any other legend or text, not inconsistent with this

Certificate of Designations, as may be required by applicable law or by any securities exchange or automated quotation system on which

such Convertible Preferred Stock is traded or quoted or as may be otherwise reasonably determined by the Company to be appropriate.

(iii)            Acknowledgement

and Agreement by the Holders. A Holder’s acceptance of any Convertible Preferred Stock represented by a Certificate bearing

any legend required by this Section 3(f) will constitute such Holder’s acknowledgement of, and agreement to comply

with, the restrictions set forth in such legend.

(iv)            Legends

on Conversion Shares.

(1)            Each

Conversion Share will bear legends substantially to the same effect as the Restricted Stock Legends if the Convertible Preferred Stock

upon the conversion of which such Conversion Share was issued was (or would have been had it not been converted) a Transfer-Restricted

Security at the time such Conversion Share was issued; provided, however, that such Conversion Share need not bear such

legends if the Company determines, in its reasonable discretion, that such Conversion Share need not bear such legends.

(2)            Notwithstanding

anything to the contrary in Section 3(f)(iv)(1), a Conversion Share need not bear legends pursuant to Section 3(f)(iv)(1) if

such Conversion Share is issued in an uncertificated form that does not permit affixing legends thereto, provided the Company

takes measures (including the assignment thereto of a “restricted” CUSIP number) that it reasonably deems appropriate to

enforce the transfer restrictions referred to in such legends.

14

(g)            Transfers

and Exchanges; Transfer Taxes; Certain Transfer Restrictions.

(i)            Provisions

Applicable to All Transfers and Exchanges.

(1)            Generally.

A Holder may, without the prior written consent of the Company, sell, assign, transfer, pledge or dispose of all or any portion of such

Holder’s shares of Convertible Preferred Stock in compliance with applicable law.

(2)            No

Services Charge; Transfer Taxes. The Company will not impose any service charge on any Holder for any transfer, exchange or conversion

of any Convertible Preferred Stock, but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental

charge that may be imposed in connection with any transfer or exchange of Convertible Preferred Stock, other than exchanges pursuant

to Section 3(h) or Section 3(p) not involving any transfer.

(3)            No

Transfers or Exchanges of Fractional Shares. Notwithstanding anything to the contrary in this Certificate of Designations, all transfers

or exchanges of Convertible Preferred Stock must be in an amount representing a whole number of shares of Convertible Preferred Stock,

and no fractional share of Convertible Preferred Stock may be transferred or exchanged.

(4)            Legends.

Each Certificate representing any share of Convertible Preferred Stock that is issued upon transfer of, or in exchange for, another share

of Convertible Preferred Stock will bear each legend, if any, required by Section 3(f).

(5)            Settlement

of Transfers and Exchanges. Upon satisfaction of the requirements of this Certificate of Designations to effect a transfer or exchange

of any Convertible Preferred Stock as well as the delivery of all documentation reasonably required by the Transfer Agent or the Company

in order to effect any transfer or exchange, the Company will cause such transfer or exchange to be effected as soon as reasonably practicable

but in no event later than the second (2nd) Business Day after the date of such satisfaction.

(ii)            Transfers

of Shares Subject to Redemption or Conversion. Notwithstanding anything to the contrary in this Certificate of Designations, the

Company will not be required to register the transfer of or exchange any share of Convertible Preferred Stock:

(1)            that

has been surrendered for conversion; or

(2)            as

to which a Holder Redemption Demand has been duly delivered, and not withdrawn, pursuant to Section 7, except to the extent

that the Company fails to pay the related Holder Redemption Price when due.

(h)            Exchange

and Cancellation of Convertible Preferred Stock to Be Converted or Redeemed.

(i)            Partial

Conversions and Redemptions of Certificates. If only a portion of a Holder’s Convertible Preferred Stock represented by a Certificate

(such Certificate being referred to as the “old Certificate” for purposes of this Section 3(h)(i)) is to be converted

pursuant to Section 10, repurchased or redeemed pursuant to Section 7, then, as soon as reasonably practicable

after such Certificate is surrendered for such conversion, repurchase or redemption, as applicable, the Company will cause such Certificate

to be exchanged for (1) one or more Certificates that each represent a whole number of shares of Convertible Preferred Stock and,

in the aggregate, represent a total number of shares of Convertible Preferred Stock equal to the number of shares of Convertible Preferred

Stock represented by such old Certificate that are not to be so converted, repurchased or redeemed, as applicable, and deliver such Certificate(s) to

such Holder; and (2) a Certificate representing a whole number of shares of Convertible Preferred Stock equal to the number of shares

of Convertible Preferred Stock represented by such old Certificate that are to be so converted, repurchased or redeemed, as applicable,

which Certificate will be converted, repurchased or redeemed, as applicable, pursuant to the terms of this Certificate of Designations;

provided, however, that the Certificate referred to in this clause (2) need not be issued at any time after

which such shares subject to such conversion, repurchased or redemption, as applicable, are deemed to cease to be outstanding pursuant

to Section 3(n).

15

(ii)            Cancellation

of Convertible Preferred Stock that Is Converted, Repurchased or Redeemed. If a Holder’s Convertible Preferred Stock represented

by a Certificate (or any portion thereof that has not theretofore been exchanged pursuant to Section 3(h)(i)) (such Certificate

being referred to as the “old Certificate” for purposes of this Section 3(h)(ii)) is to be converted pursuant

to Section 10, repurchased or redeemed pursuant to Section 7 or Section 8, then, promptly after the

later of the time such Convertible Preferred Stock is deemed to cease to be outstanding pursuant to Section 3(n) and

the time such Certificate is surrendered for such conversion, repurchased or redemption, as applicable, (A) such Certificate will

be cancelled pursuant to Section 3(l); and (B) in the case of a partial conversion, repurchased or redemption, the Company

will issue, execute and deliver to such Holder, and cause the Transfer Agent to countersign one or more Certificates that (x) each

represent a whole number of shares of Convertible Preferred Stock and, in the aggregate, represent a total number of shares of Convertible

Preferred Stock equal to the number of shares of Convertible Preferred Stock represented by such old Certificate that are not to be so

converted, repurchased or redeemed, as applicable; (y) are registered in the name of such Holder; and (z) bear each legend,

if any, required by Section 3(f).

(i)            Status

of Retired Shares. Upon any share of Convertible Preferred Stock ceasing to be outstanding, such share will be deemed to be retired

and to resume the status of an authorized and unissued share of preferred stock of the Company, and such share cannot thereafter be reissued

as Convertible Preferred Stock.

(j)            Replacement

Certificates. If a Holder of any Convertible Preferred Stock claims that the Certificate(s) representing such Convertible Preferred

Stock have been mutilated, lost, destroyed or wrongfully taken, then the Company will issue, execute and deliver, and cause the Transfer

Agent to countersign, in each case in accordance with Section 3(c), a replacement Certificate representing such Convertible

Preferred Stock upon surrender to the Company or the Transfer Agent of such mutilated Certificate, or upon delivery to the Company or

the Transfer Agent of evidence of such loss, destruction or wrongful taking reasonably satisfactory to the Transfer Agent and the Company.

In the case of a lost, destroyed or wrongfully taken Certificate representing any Convertible Preferred Stock, the Company and the Transfer

Agent may require the Holder thereof to provide such security or indemnity that is reasonably satisfactory to the Company and the Transfer

Agent to protect the Company and the Transfer Agent from any loss that any of them may suffer if such Certificate is replaced. Every

replacement Convertible Preferred Stock issued pursuant to this Section 3(j) will, upon such replacement, be deemed

to be outstanding Convertible Preferred Stock, entitled to all of the benefits of this Certificate of Designations equally and ratably

with all other Convertible Preferred Stock then outstanding.

16

(k)            Registered

Holders. Only the Holder of any Convertible Preferred Stock will have rights under this Certificate of Designations as the owner

of such Convertible Preferred Stock.

(l)            Cancellation.

The Company may at any time deliver Convertible Preferred Stock to the Transfer Agent for cancellation. The Company will cause the Transfer

Agent to promptly cancel all shares of Convertible Preferred Stock so surrendered to it in accordance with its customary procedures.

(m)            Shares

Held by the Company or its Affiliates. Without limiting the generality of Section 3(o) and Section 3(n),

in determining whether the Holders of the required number of outstanding shares of Convertible Preferred Stock have concurred in any

direction, waiver or consent, shares of Convertible Preferred Stock owned by the Company or any of its Subsidiaries will be deemed not

to be outstanding.

(n)            Outstanding

Shares.

(i)            Generally.

The shares of Convertible Preferred Stock that are outstanding at any time will be deemed to be those shares of Convertible Preferred

Stock that, at such time, have been duly executed by the Company and countersigned by the Transfer Agent, excluding those shares of Convertible

Preferred Stock that have theretofore been (1) cancelled by the Transfer Agent or delivered to the Transfer Agent for cancellation

in accordance with Section 3(l); (2) paid in full upon their conversion, repurchase or redemption in accordance with

this Certificate of Designations; or (3) deemed to cease to be outstanding to the extent provided in, and subject to, Section 3(n)(ii),

Section 3(n)(iii), or Section 3(n)(iv) of this Section 3(n).

(ii)           Replaced

Shares. If any Certificate representing any share of Convertible Preferred Stock is replaced pursuant to Section 3(j),

then such share will cease to be outstanding at the time of such replacement, unless the Transfer Agent and the Company receive proof

reasonably satisfactory to them that such share is held by a “bona fide purchaser” under applicable law.

(iii)          Shares

to Be Redeemed. If, on a Holder Redemption Date, the Company has segregated, solely for the benefit of the applicable Holders, consideration

in kind and amount that is sufficient to pay the aggregate Holder Redemption Price due on such date, then (unless there occurs a default

in the payment of the Holder Redemption Price) (1) the Convertible Preferred Stock to be redeemed on such date will be deemed, as

of such date, to cease to be outstanding (without limiting the Company’s obligations pursuant to Section 5); and (2) the

rights of the Holders of such Convertible Preferred Stock, as such, will terminate with respect to such Convertible Preferred Stock,

other than the right to receive the Holder Redemption Price, as applicable, as provided in Section 7 (and, if applicable,

declared Participating Amounts as provided in Section 6).

17

(iv)          Shares

to Be Converted. If any Convertible Preferred Stock is to be converted, then, at the Close of Business on the Conversion Date for

such conversion (unless there occurs a default in the delivery of the Conversion Consideration due pursuant to Section 10 upon

such conversion): (1) such Convertible Preferred Stock will be deemed to cease to be outstanding (without limiting the Company’s

obligations pursuant to Section 5); and (2) the rights of the Holders of such Convertible Preferred Stock, as such,

will terminate with respect to such Convertible Preferred Stock, other than the right to receive such Conversion Consideration as provided

in Section 10 (and, if applicable, declared Participating Amounts as provided in Section 6).

(o)            Repurchases

by the Company and its Subsidiaries. Without limiting the generality Section 3(l) and the next sentence, the Company

may, from time to time, repurchase Convertible Preferred Stock from Holders in negotiated transactions without delivering prior notice

to other Holders. The Company will promptly deliver to the Transfer Agent for cancellation all Convertible Preferred Stock that the Company

or any of its Subsidiaries have purchased or otherwise acquired.

(p)            Notations

and Exchanges. Without limiting any rights of Holders pursuant to Section 9, if any amendment, supplement or waiver to

the Certificate of Incorporation or this Certificate of Designations changes the terms of any Convertible Preferred Stock, then the Company

may, in its discretion, require the Holder of the Certificate representing such Convertible Preferred Stock to deliver such Certificate

to the Transfer Agent so that the Transfer Agent may place an appropriate notation prepared by the Company on such Certificate and return

such Certificate to such Holder. Alternatively, at its discretion, the Company may, in exchange for such Convertible Preferred Stock,

issue, execute and deliver, and cause the Transfer Agent to countersign, in each case in accordance with Section 3(c), a

new Certificate representing such Convertible Preferred Stock that reflects the changed terms. The failure to make any appropriate notation

or issue a new Certificate representing any Convertible Preferred Stock pursuant to this Section 3(p) will not impair

or affect the validity of such amendment, supplement or waiver.

(q)            CUSIP

and ISIN Numbers. The Company may use one or more CUSIP or ISIN numbers to identify any of the Convertible Preferred Stock, and,

if so, the Company will use such CUSIP or ISIN number(s) in notices to Holders; provided, however, that the effectiveness

of any such notice will not be affected by any defect in, or omission of, any such CUSIP or ISIN number.

Section 4.               Ranking.

(a)            The

Convertible Preferred Stock will rank (a) senior to (i) Dividend Junior Stock with respect to the payment of dividends; and

(ii) Liquidation Junior Stock with respect to the distribution of assets upon any Liquidation Event; and (b) equally with (i) Dividend

Parity Stock with respect to the payment of dividends; and (ii) Liquidation Parity Stock with respect to the distribution of assets

upon any Liquidation Event. For the avoidance of doubt, the issuance of Dividend Parity Stock, Dividend Senior Stock, Liquidation Parity

Stock or Liquidation Senior Stock is prohibited without the prior approval of the Requisite Holders in accordance with Section 9

hereof.

(b)            Priority

Acknowledgment. For the avoidance of doubt, the Convertible Preferred Stock ranks senior to the Series B-2 Preferred Stock with

respect to (i) the payment of dividends, (ii) payment of amounts (other than Participating Amounts) due in connection with

optional redemption by holders of Convertible Preferred Stock, and (iii) the distribution of assets upon any Liquidation Event (other

than Participating Amounts). The Series B-2 Preferred Stock constitutes Liquidation

Junior Stock and Dividend Junior Stock (but is not included in Liquidation Junior Stock or Dividend Junior Stock for purposes of the

restrictions on Distributions set forth in Section 9(b)(i)(5)).

18

Section 5.               Dividends.

(a)            Regular

Dividends.

(i)            Accumulation

and Payment of Regular Dividends. The Convertible Preferred Stock will accumulate cumulative dividends at a rate per annum equal

to the Regular Dividend Rate on the then Accumulated Liquidation Preference in respect of the Convertible Preferred Stock, whether or

not declared (and including, for the avoidance of doubt, any In-Kind Dividend Payments with respect of the Convertible Preferred Stock

which have been added to the Liquidation Preference pursuant to Section 5(b)(i) on a compounding basis (the “Compounded

Dividends”) thereof (calculated in accordance with Section 5(a)(ii)), regardless of whether or not declared or

funds are legally available for their payment (such dividends that accumulate on the Preferred Stock pursuant to this sentence, “Regular

Dividends”). Subject to the other provisions of this Section 5 (including, for the avoidance of doubt, Section 5(b)(i)),

such Regular Dividends will be payable quarterly in arrears on each Regular Dividend Payment Date, to the Holders as of the Close of

Business on the immediately preceding Regular Dividend Record Date. Regular Dividends on the Convertible Preferred Stock will accumulate

daily from, and including, the last date on which Regular Dividends have been paid (or, if no Regular Dividends have been paid, from,

and including, the Initial Issue Date) to, but excluding, the next Regular Dividend Payment Date.

(ii)           Computation

of Accumulated Regular Dividends. Regular Dividends will be computed on the basis of a 360-day year comprised of twelve 30-day months.

Regular Dividends on each share of Convertible Preferred Stock will accrue on the then Accumulated Liquidation Preference (whether or

not declared) of such share as of immediately before the Close of Business on the preceding Regular Dividend Payment Date (or, if there

is no preceding Regular Dividend Payment Date, on the Initial Issue Date of such share).

(b)            Calculation

of Regular Dividends.

(i)            Generally.

Regular Dividends shall be payable in cash; provided, however, that during the period from, and including, the Initial Issue Date until,

but excluding, the Regular Dividend Payment Date next following the second anniversary of the Initial Issue Date (the “PIK Period”),

Dividends may be paid, in the Company’s sole discretion, in the dollar amount (expressed as an amount per share of Convertible

Preferred Stock) of each Regular Dividend on the Convertible Preferred Stock (whether or not declared) that has accumulated on the Convertible

Preferred Stock in respect of the Regular Dividend Period ending on, but excluding, a Regular Dividend Payment Date (each an “In-Kind

Dividend Payment”). During the PIK Period, any cash payments for Regular Dividends not received before the Close of Business

on the related Regular Dividend Payment Date, shall be construed at the Company’s election to pay such Regular Dividend as an In-Kind

Dividend Payment, which will be added, effective immediately before the Close of Business on the related Regular Dividend Payment Date,

to the then Accumulated Liquidation Preference of each share of Preferred Stock outstanding as of such time on a compounding basis. Such

addition (if any) will occur automatically, without the need for any action on the part of the Company or any other Person. Following

the expiration of the PIK Period, Regular Dividends shall be payable in cash.

19

(ii)           Construction.

Any In-Kind Dividend Payments added to the Accumulated Liquidation Preference of any share of Convertible Preferred Stock pursuant to

Section 5(b)(i) for any Dividends will be deemed to be “declared” and “paid” on such share of

Convertible Preferred Stock for all purposes of this Certificate of Designations.

(c)            Treatment

of Dividends Upon Redemption. If the Holder Redemption Date of any share of Convertible Preferred Stock is after a Record Date for

a declared Dividend on the Convertible Preferred Stock and on or before the next Dividend Payment Date, then the Holder of such share

at the Close of Business on such Record Date will be entitled, notwithstanding the related Holder Redemption to receive, on or, at the

Company’s election, before such Dividend Payment Date, such Dividend on such share. In addition, if the Holder Redemption Date

of any share of Convertible Preferred Stock is after a Regular Dividend Payment Date, then the Holder of such share on such applicable

date will be entitled, notwithstanding the related Holder Redemption, to receive, on such applicable date the amount of the Regular Dividend

accrued since the preceding Regular Dividend Payment Date up through such applicable date (including, without duplication, any Regular

Dividend not yet paid or compounded).

(d)            Dividend

Priority. For the avoidance of doubt, Dividends on the Convertible Preferred Stock shall be paid in full before any Dividends are

declared or paid on the Series B-2 Preferred Stock. The Company shall not declare or pay any Dividend on the Series B-2 Preferred

Stock unless all accrued and unpaid Dividends on the Convertible Preferred Stock have been paid in full or set aside for payment. To

the extent that funds available for the payment of Dividends are insufficient to pay Dividends on both the Convertible Preferred Stock

and the Series B-2 Preferred Stock in full, Dividends on the Convertible Preferred Stock shall be paid first, and any remaining

funds shall be applied to the payment of Dividends on the Series B-2 Preferred Stock.

Section 6.               Rights

Upon Liquidation, Dissolution or Winding Up.

(a)            Generally.

Upon any Liquidation Event, then, subject to the rights of any of the Company’s creditors, each share of Convertible Preferred

Stock will entitle the Holder thereof to receive payment in cash of the then applicable Liquidation Preference per share of Convertible

Preferred Stock, before any such assets or funds are distributed to, or set aside for the benefit of, any Liquidation Junior Stock.

(b)            Participation.

Following the payment in full of the Liquidation Preference to the Holders pursuant to clause (a) and

the payment in full of the liquidation preference pursuant to Section 6(a) of the Series B-2 Preferred Stock, the Holders

shall be entitled to participate, together with the holders of Common Stock (and any other capital stock

of the Company entitled to participate therein as stockholders), in any remaining assets of the Company available for distribution to

stockholders, on a pro-rata as-converted basis, as if the shares of Convertible Preferred Stock had been converted into Common Stock

immediately prior to such Liquidation Event (such participation rights, the “Participating Amount”); provided that

the aggregate amount of consideration payable or otherwise deliverable with respect to each share of Convertible Preferred Stock pursuant

to this Section 6 (including, without limitation, amounts paid pursuant to Section 6(a) and Section 6(b))

shall not exceed two (2.0) times the Liquidation Preference per share (the “Maximum Return”). For the avoidance of

doubt, and without limiting the ability of a Holder to convert Convertible Preferred Stock into Common Stock in accordance with the terms

of Section 10 or a Holder’s rights pursuant to Section 6(c), once a Holder has received aggregate consideration

pursuant to this Section 6 equal to the Maximum Return with respect to any share of Convertible Preferred Stock, such share

shall cease to participate in any further distributions in connection with such Liquidation Event.

20

(c)            As-Converted

Alternative. Notwithstanding the foregoing, in lieu of receiving the amounts described in Sections 6(a) and 6(b), each

Holder shall have the right, at its election, to receive the amount such holder would have received if such holder had converted such

share of Convertible Preferred Stock into Common Stock immediately prior to the consummation of the Liquidation Event pursuant to Section 10.

The Company shall provide reasonable prior written notice of any Liquidation Event, including a good faith estimate of the consideration

payable under each alternative described herein.

(d)            Liquidation

Priority. For the avoidance of doubt, upon any Liquidation Event, the Liquidation Preference of all outstanding shares of Convertible

Preferred Stock shall be paid in full before any distribution is made to holders of Series B-2 Preferred Stock or Liquidation Junior

Stock; provided, however, in the event that any Holder of Convertible Preferred Stock does not exercise its optional redemption right,

or is otherwise not immediately eligible for payment of the Liquidation Preference with respect to its Convertible Preferred Stock, (i) the

Company shall segregate, solely for the benefit of the applicable Holders, consideration in kind and amount that is sufficient to pay

the applicable Liquidation Preferences due with respect and (ii) the rights of the Holders of such Convertible Preferred Stock,

as such, will terminate with respect to such Convertible Preferred Stock, other than the right to receive the Holder Redemption Price,

as applicable, as provided in Section 7 (and, if applicable, declared Participating Amounts as provided in Section 6).

No distribution shall be made to holders of Series B-2 Preferred Stock or Liquidation Junior Stock upon any Liquidation Event unless

and until the Liquidation Preference of all outstanding shares of Convertible Preferred Stock has been paid in full or segregated in

accordance with the immediately preceding sentence.

Section 7.                Holder

Redemption.

(a)            Mandatory

Redemption Upon Holder’s Option. Subject to the terms of this Section 7(a) and the Delaware General Corporation

Law, each Holder shall have the right, at any time and from time to time following the occurrence of a Redemption Event, to require the

Company to redeem all or any portion of such Holder’s Convertible Preferred Stock for a cash purchase price equal to the Holder

Redemption Price (a “Holder Redemption”).

(i)            Redemption

Demand; Mandatory Redemption Date. In order to exercise a Holder Redemption, Holder shall deliver to the Company, at its principal

executive offices, a written notice (a “Holder Redemption Demand”) specifying (1) that such Holder elects to

have the Company redeem shares of Convertible Preferred Stock held by such Holder, (2) the number of shares to be so redeemed, which

may be all or any portion of the shares of Convertible Preferred Stock then held by such Holder, and (3) the Business Day on which

such redemption is to occur (the “Holder Redemption Date”); provided that the Holder Redemption Date shall

be a Business Day that is not earlier than five (5) Business Days nor later than thirty (30) Business Days after the date on which

the Holder Redemption Demand is delivered to the Company, or such other date as the Company and such Holder may mutually agree.

21

(ii)           Holder

Redemption Price. On each Holder Redemption Date, subject to Section 7(a)(iv), the Company shall redeem the number of shares

of Convertible Preferred Stock specified in the applicable Holder Redemption Demand by paying to such Holder, in cash, by wire transfer

of immediately available funds, an amount (the “Holder Redemption Price”) equal to the Liquidation Preference of such

share, and, solely to the extent the applicable Redemption Event arises from or in connection with a Liquidation Event or a Fundamental

Transaction that would generate distributable proceeds, any Participating Dividends that would be payable pursuant to Section 6(b) (subject

to the Maximum Return)) on such share to, but excluding, the applicable Holder Redemption Date in accordance with Section 5(c).

(iii)          Surrender

of Certificates. On or before the applicable Holder Redemption Date, each Holder electing a Holder Redemption shall surrender to

the Company at its principal executive offices the certificate or certificates, if any, representing the shares of Convertible Preferred

Stock to be redeemed, (or if such shares held as an Electronic Certificate, shall comply with the applicable procedures of the Company's

Transfer Agent). Upon receipt of such certificate(s) or confirmation of book-entry transfer and payment of the Holder Redemption

Price in respect of such shares in accordance with Sections 7(a)(ii) and 7(c), the shares so redeemed shall be canceled and shall

no longer be outstanding.

(iv)          Limitations;

Insufficient Legally Available Funds. (i) Notwithstanding anything to the contrary contained herein, the Company shall not be

required to redeem any shares of Convertible Preferred Stock pursuant to this Section 7(a)(iv) to the extent that such redemption

would violate the Delaware General Corporation Law or any other applicable law governing distributions to stockholders or applicable

exchange rules, (ii) in the event that, as of any Holder Redemption Date, the aggregate funds of the Company legally available for

the redemption of shares of Convertible Preferred Stock pursuant to this Section 7(a)(iv) are insufficient to redeem in full

all shares of Convertible Preferred Stock that are subject to Holder Redemption on such date, whether pursuant to one or more Holder

Redemption Demands outstanding, the Company shall (A) redeem pro rata among all holders who have delivered Holder Redemption Demands

to the extent of such legally available funds, the maximum number of shares of Convertible Preferred Stock that can be redeemed with

such funds at the applicable Holder Redemption Price and, thereafter, from time to time as funds become legally available for the redemption

of such shares in accordance with the Delaware General Corporation Law, promptly redeem the balance of the shares of Convertible Preferred

Stock then subject to Holder Redemption, pro rata among the holders remaining entitled to redemption, at the applicable Holder Redemption

Price. The shares of Convertible Preferred Stock not redeemed on any Holder Redemption Date as a result of the limitations in this Section 7(a)(iv) shall

remain outstanding and shall continue to be entitled to all of the rights and preferences provided herein, including the right to future

Holder Redemption in accordance with this Section 7.

22

(v)           Conversion

in Lieu of Cash Redemption. To the extent that cash redemption of any shares of Convertible Preferred Stock is prohibited by the

Delaware General Corporation Law, the applicable Holder may, at its election, convert all or any portion of such shares into shares of

Common Stock in accordance with Section 10 in lieu of receiving a cash redemption payment for such portion. Any portion of the Convertible

Preferred Stock that is neither redeemed nor converted pursuant to this Section 7(a)(v) shall remain outstanding and shall

continue to accrue dividends, and the Company shall redeem such remaining portion as soon as legally available funds become available.

(vi)          Individual

Holder Right. The Holder Redemption right, set forth in this Section 7, is a separate and individual right of each Holder and

may be exercised from time to time at the election of any such Holder with respect to all or any portion of the shares of Convertible

Preferred Stock then held by such Holder, without the consent of any other Holder and whether or not any other Holder elects to exercise

such right. No vote or consent of the Holders of Convertible Preferred Stock, voting together or separately as a class, shall be required

for any individual Holder to exercise its Holder Redemption right pursuant to this Section 7.

(b)            Redemption

Event Notice by Company. Upon the occurrence of a Redemption Event (or, if earlier, upon the Company determining in good faith that

a Redemption Event is reasonably likely to occur), the Company will send to each Holder a notice of such Redemption Event (a “Redemption

Event Notice”) containing the information set forth below:

(i)            briefly,

the events comprising a Redemption Event;

(ii)           the

effective date of such Redemption Event;

(iii)          the

Holder Redemption Price per share of Convertible Preferred Stock as of the date of such Redemption Event;

(iv)          the

Conversion Price in effect on the date of such Redemption Event Notice and a description and quantification of any adjustments to the

Conversion Price that may result from such Redemption Event;

(vi)          that

shares of Convertible Preferred Stock for which a Holder Redemption Demand has been duly tendered and not duly withdrawn must be delivered

to the Company for the Holder thereof to be entitled to receive the Holder Redemption Price;

(vii)          that

shares of Convertible Preferred Stock that are subject to a Holder Redemption Demand that has been duly tendered may be converted only

if such Holder Redemption Demand is withdrawn in accordance with this Certificate of Designations; and

(viii)        the

CUSIP and ISIN numbers, if any, of the Convertible Preferred Stock.

23

The failure of the Company to

deliver any Redemption Event Notice shall not impair, limit or otherwise affect the rights of any Holder to exercise any right or remedy

arising as a result of such Redemption Event, including, without limitation, the right to require redemption pursuant to the terms hereof,

nor shall such failure delay the time at which any such rights become exercisable.

(c)            Payment

of the Holder Redemption Price. The Company will cause the Holder Redemption Price for each share of Convertible Preferred Stock

to be redeemed pursuant to a Holder Redemption to be paid to the Holder thereof on or before the later of (i) ten (10) Business

Days following the Company’s receipt of the applicable Holder Redemption Demand; and (ii) the date such share of Convertible

Preferred Stock is tendered to the Transfer Agent or the Company.

(d)            Redemption

Priority. For the avoidance of doubt, upon any Holder Redemption, the Holder Redemption Price for all shares of Convertible Preferred

Stock subject to Holder Redemption shall be paid in full before any Holder Redemption Price is paid to holders of Series B-2 Preferred

Stock; provided, however, in the event that any Holder of Convertible Preferred Stock does not exercise its optional redemption right,

or is otherwise not immediately eligible for payment of the Liquidation Preference with respect to its Convertible Preferred Stock, (i) the

Company shall segregate, solely for the benefit of the applicable Holders, consideration in kind and amount that is sufficient to pay

the applicable Liquidation Preferences due with respect thereto plus all accrued and unpaid dividends, whether or not declared (and including,

for the avoidance of doubt, any Compounded Dividends) and (ii) the rights of the Holders of such Convertible Preferred Stock, as

such, will terminate with respect to such Convertible Preferred Stock, other than the right to receive the Holder Redemption Price, as

applicable, as provided in Section 7 (and, if applicable, declared Participating Amounts as provided in Section 6). If on any

Holder Redemption Date, funds legally available for redemption are insufficient to redeem (or segregate in accordance with the immediately

sentence) in full all shares of Convertible Preferred Stock and Series B-2 Preferred Stock that are subject to Holder Redemption

on such date, the Company shall first redeem shares of Convertible Preferred Stock (or segregate in accordance with the immediately preceding

sentence) pro rata among holders thereof until all such shares are redeemed in full, and only thereafter redeem shares of Series B-2

Preferred Stock pro rata among holders thereof.

Section 8.               [RESERVED]

Section 9.                Voting

Rights.

(a)            Right

to Vote with Holders of Common Stock on an As-Converted Basis. Subject to the other provisions of, and without limiting the other

voting rights provided in, this Section 9, and except as provided in the Certificate of Incorporation or required by the

Delaware General Corporation Law, the Holders will have the right to vote together as a single class with the holders of the Common Stock

on each matter submitted for a vote or consent by the holders of the Common Stock, and, for these purposes, (i) the Convertible

Preferred Stock of each Holder will entitle such Holder to be treated as if such Holder were the holder of record, as of the record or

other relevant date for such matter, of a number of shares of Common Stock equal to the number of shares of Common Stock that would be

issuable (determined in accordance with Section 10(e), including Section 10(e)(ii), but without regarding to

Section 10(e)(iii)) upon conversion of such Convertible Preferred Stock assuming such Convertible Preferred Stock were converted

with a Conversion Date occurring on such record or other relevant date; and (ii) the Holders will be entitled to notice of all stockholder

meetings or proposed actions by written consent in accordance with the Certificate of Incorporation, the Bylaws of the Company, and the

Delaware General Corporation Law as if the Holders were holders of Common Stock.

24

(b)            Voting

and Consent Rights with Respect to Specified Matters.

(i)            Generally.

Subject to the other provisions of this Section 9, while any Convertible Preferred Stock is outstanding, each of the following

events will require, and cannot be effected without, the affirmative vote or consent of Holders representing a majority of the outstanding

shares of Convertible Preferred Stock (the “Requisite Holders”):

(1)            authorization

or issuance of additional shares of Convertible Preferred Stock or Series B-2 Preferred Stock or any amendment or modification of

the Certificate of Incorporation to authorize or create, or to increase the authorized number of shares of, any class or series of, or

Equity-Linked Security or other equity interest convertible into, Dividend Parity Stock, Liquidation Parity Stock, Dividend Senior Stock

or Liquidation Senior Stock;

(2)            any

amendment, modification or repeal of any provision of the Certificate of Incorporation, Bylaws or this Certificate of Designations that

adversely affects the rights, preferences or voting powers of the Convertible Preferred Stock (other than an amendment, modification

or repeal permitted by Section 9(b)(ii));

(3)            consummation

of a Liquidation Event or Fundamental Transaction unless (x) the aggregate consideration payable pursuant to such Liquidation Event

or Fundamental Transaction equals or exceeds the Liquidation Preference payable to the Holders and the holders of Series B-2 Preferred

Stock and (y) the Holders, and the holders of Series B-2 Preferred Stock, may elect to be paid the Liquidation Preference in

cash (or other liquid assets that may be held in the Digital Asset Treasury);

(4)            creation,

issuance, or designation of any new class or series of Capital Stock ranking senior to or pari passu with the Convertible Preferred Stock

with respect to liquidation preference or dividends;

(5)            declaration

or payment of any dividends or distributions upon, or redemptions, repurchases or other acquisitions of Dividend Junior Stock or Liquidation

Junior Stock (“Distributions”) other than the payment of Dividends on the Series B-2 Preferred Stock;

(6)            direct

or indirect redemption, repurchase or other acquisition through the payment of cash, distribution of assets, incurrence of indebtedness

for such purpose, or any substantially equivalent transaction (or the payment into or set aside for a sinking fund for such purpose)

of any shares of Junior Stock or Parity Stock, except for (i) repurchases of Common Stock from employees, officers, directors or

consultants of the Company or its subsidiaries pursuant to equity incentive plans or agreements approved by the Board, or (ii) other

repurchases expressly approved in writing by the Requisite Holders.

25

(7)            direct

or indirect creation, incurrence, assumption or allowance to exist of any Lien on (x) any assets of

the Digital Asset Treasury Subsidiary, except for Liens permitted pursuant to the Digital Asset Treasury Procedures and arising in connection

with custody, staking, or other customary operational arrangements in the ordinary course of business that do not secure indebtedness

for borrowed money or (y) any other assets or property of the Company or any Subsidiary, whether now owned or hereafter, acquired

other than in the case of this clause (y), Permitted Liens.

(8)            distribution

of any material asset from the Digital Asset Treasury, including the transfer of assets to counterparties (including protocols) not in

compliance with the Digital Asset Treasury Procedures, or any failure to house all Digital Assets and designated cash of the Company

and its Subsidiaries (other than General Proceeds) in a Digital Asset Treasury Subsidiary (such that all such assets remain subject to

the Guaranty).

(9)            incurrence,

assumption, or guarantee of indebtedness for borrowed money in excess of $1,000,000 in the aggregate other than: (a) trade payables

and operating liabilities incurred in the ordinary course not exceeding $1,000,000 in the aggregate; and (b) indebtedness existing

as of Closing and disclosed in the Transaction Documents.

(10)          any

action with respect to any Digital Asset Treasury Subsidiary of the Company that, if taken by the Company, would require approval of

the Requisite Holders pursuant to the protective provisions set forth in clauses (1) through (9) above.

(11)          waive,

or otherwise permit to exist and continue, an Event of Default; provided that any cure or waiver of such Event of Default in accordance

with the terms of the applicable Transaction Document shall automatically cure the corresponding cross-default hereunder.

(12)          with

respect to any Digital Asset Treasury Subsidiary: (A) the formation, dissolution, liquidation, winding up or termination of any

Digital Asset Treasury Subsidiary; (B) any amendment, modification or restatement of the certificate of incorporation, certificate

of formation, bylaws, operating agreement or other organizational documents of any Digital Asset Treasury Subsidiary; (C) any change

of the jurisdiction of organization or formation of any Digital Asset Treasury Subsidiary; (D) any voluntary filing of a petition

for bankruptcy, reorganization, arrangement, insolvency or similar relief, or the consent to the filing of any involuntary petition,

with respect to any Digital Asset Treasury Subsidiary; (E) any merger, consolidation, conversion, division or other business combination

involving any Digital Asset Treasury Subsidiary; (F) any sale, lease, transfer or other disposition of all or substantially all

of the assets of any Digital Asset Treasury Subsidiary (other than distributions to the Company or another Digital Asset Treasury Subsidiary

permitted pursuant to the Digital Asset Treasury Procedures); (G) unless determined by the board of directors of the Company to

be required to satisfy its fiduciary duties, any intercompany loan, dividend, distribution or other transfer of value from any Digital

Asset Treasury Subsidiary to the Company or any other Subsidiary (other than a Digital Asset Treasury Subsidiary), except as expressly

permitted pursuant to the Digital Asset Treasury Procedures; (H) unless determined by the board of directors of the Company to be

required to satisfy its fiduciary duties, any commingling of assets of any Digital Asset Treasury Subsidiary with assets of the Company

or any other Subsidiary that is not a Digital Asset Treasury Subsidiary; (I) any amendment, modification, termination or waiver

of any material provision of the Guaranty; or (J) any action that would reasonably be expected to impair the validity or enforceability

of the Guaranty.

26

(ii)          Certain

Amendments Permitted Without Consent. Notwithstanding anything to the contrary in Section 9(b)(i), the Company may amend,

modify or repeal any of the terms of the Convertible Preferred Stock without the vote or consent of any Holder to:

(1)            cure

any ambiguity or correct any omission, defect or inconsistency in this Certificate of Designations or the Certificates representing the

Convertible Preferred Stock, including the filing of a certificate of correction, or a corrected instrument, pursuant to Section 103(f) of

the Delaware General Corporation Law in connection therewith; or

(2)            make

any other change to the Certificate of Incorporation, this Certificate of Designations or the Certificates representing the Convertible

Preferred Stock that does not, individually or in the aggregate with all other such changes, adversely affect the rights of any Holder

(other than any Holders that have consented to such change), as such, in any material respect (as determined by the Board of Directors

in good faith).

(iii)            Amendment

Coordination with Series B-2 Preferred Stock. Notwithstanding anything to the contrary in this Section 9, any amendment,

modification or repeal of any provision of this Certificate of Designations that would (1) reduce the Convertible Preferred Stock’s

liquidation or dividend priority relative to the Series B-2 Preferred Stock, (2) make the Series B-2 Preferred Stock pari

passu with or senior to the Convertible Preferred Stock with respect to dividends or liquidation, or (3) modify the payment waterfall

provisions set forth in Section 5(e), Section 6(d) or Section 7(d), shall require the affirmative

vote or consent of the Requisite Holders

(c)            Procedures

for Voting and Consents.

(i)            Rules and

Procedures Governing Votes and Consents. If any vote or consent of the Holders will be held or solicited, including at a regular

annual meeting or a special meeting of stockholders, then (1) the Board of Directors will adopt customary rules and procedures

at its discretion to govern such vote or consent, subject to the other provisions of this Section 9; and (2) such rules and

procedures may include fixing a record date to determine the Holders that are entitled to vote or provide consent, as applicable, and

rules governing the solicitation and use of proxies or written consents; provided, however, that with respect to any

voting rights of the Holders pursuant to Section 9(c), such rules and procedures will be the same rules and procedures

that apply to holders of the Common Stock with respect to the applicable matter referred to in Section 9(c).

(ii)            Written

Consent in Lieu of Stockholder Meeting. A consent or affirmative vote of the Holders pursuant to Section 9(b)(i) may

be given or obtained either in writing without a meeting or in person or by proxy at a regular annual meeting or a special meeting of

stockholders.

27

Section 10.              Conversion.

(a)            Generally.

Subject to the provisions of this Section 10, the Convertible Preferred Stock may be converted only pursuant to an Optional

Conversion.

(b)            Conversion

at the Option of the Holders.

(i)            Conversion

Right; When Shares May Be Submitted for Optional Conversion. Holders will have the right to submit all, or any whole number

of shares that is less than all, of their shares of Convertible Preferred Stock pursuant to an Optional Conversion at any time subject

to, unless waived in writing by such Holder the Beneficial Ownership Limitation; provided, however, that, notwithstanding

anything to the contrary in this Certificate of Designations, if a Holder Redemption Demand is validly delivered pursuant to Section 7

with respect to any share of Convertible Preferred Stock, then such share may not be submitted for Optional Conversion, except to the

extent (A) such share is not subject to such notice; (B) such notice is withdrawn in accordance with Section 7;

or (C) the Company fails to pay the Holder Redemption Price for such share in accordance with this Certificate of Designations.

(ii)           Conversions

of Fractional Shares Not Permitted. Notwithstanding anything to the contrary in this Certificate of Designations, in no event will

any Holder be entitled to convert a number of shares of Convertible Preferred Stock that is not a whole number.

(iii)           Contingent

Conversion Notice. A Holder delivering an Optional Conversion Notice hereunder may specify in such Optional Conversion Notice that

its election to effect such conversion is contingent upon the consummation of a Change of Control, in which case such Optional Conversion

shall not occur until such time as such Change of Control has been consummated, and if such Change of Control is terminated or cancelled,

such Optional Conversion Notice shall be deemed to be withdrawn. For the avoidance of doubt, any such contingent Optional Conversion

shall occur prior to the Holder Redemption that would have otherwise been effected in connection with such Change of Control.

(d)            Conversion

Procedures.

(i) Requirements for Holders

to Exercise Optional Conversion Right.

(1)            Generally.

To convert any share of Convertible Preferred Stock pursuant to an Optional Conversion, the Holder of such share must (w) complete,

manually sign and deliver to the Company an Optional Conversion Notice; (x) deliver any Physical Certificate(s) representing

such Convertible Preferred Stock to the Company (at which time such Optional Conversion will become irrevocable); (y) furnish any

endorsements and transfer documents that the Company may require; and (z) if applicable, pay any documentary or other taxes.

(2)            Optional

Conversion Permitted only During Business Hours.

28

Convertible Preferred Stock may be

surrendered for Optional Conversion only after the Open of Business and before the Close of Business on a day that is a Business Day.

(ii) When

Holders Become Stockholders of Record of the Shares of Common Stock Issuable Upon Conversion. The Person in whose name any share

of Common Stock is issuable upon conversion of any Convertible Preferred Stock will be deemed to become the holder of record of such

share as of the Close of Business on the Conversion Date for such conversion.

(e)            Settlement

upon Conversion.

(i)            Generally.

Subject to Section 5, Section 10(e)(ii), Section 12(b), and, unless waived in writing by the applicable

Holder, the Beneficial Ownership Limitation the consideration due upon settlement of the conversion of each share of Convertible Preferred

Stock will consist of a number of shares of Common Stock equal to the quotient obtained by dividing (I) the Initial Liquidation

Preference of such share of Convertible Preferred Stock immediately before the Close of Business on the Conversion Date for such conversion;

by (II) the Conversion Price in effect immediately before the Close of Business on such Conversion Date, such that each share of

Convertible Preferred Stock is initially convertible into one (1) share of Common Stock, subject to adjustment for stock splits,

stock dividends, combinations and similar events in accordance with Section 10(f).

(ii)           Payment

of Cash in Lieu of any Fractional Share of Common Stock.

Subject to Section 12(b),

in lieu of delivering any fractional share of Common Stock otherwise due upon conversion of any Convertible Preferred Stock, the Company

will, to the extent it is legally able to do so and permitted under the terms of its indebtedness for borrowed money, pay cash based

on the Last Reported Sale Price per share of Common Stock on the Conversion Date for such conversion (or, if such Conversion Date is

not a Trading Day, the immediately preceding Trading Day).

(iii)          [deleted].

(iv)          Delivery

of Conversion Consideration. Except as provided in Section 10(f)(i)(2) and Section 10(h), the Company

will pay or deliver, as applicable, the Conversion Consideration due upon conversion of any Convertible Preferred Stock on or before

the second (2nd) Trading Day immediately after the Conversion Date for such conversion.

(f)            Conversion

Price Adjustments.

(i)            Events

Requiring an Adjustment to the Conversion Price. The Conversion Price will be adjusted from time to time as follows:

(1)            Stock

Dividends, Splits and Combinations. If the Company issues solely shares of Common Stock as a dividend or distribution on all or substantially

all shares of the Common Stock, or if the Company effects a stock split or a stock combination of the Common Stock (in each case excluding

an issuance solely pursuant to a Common Stock Change Event, as to which Section 10(h) will apply), then the Conversion

Price will be adjusted based on the following formula:

29

where:

CP0

=

the

Conversion Price in effect immediately before the Close of Business on the Record Date for such dividend or distribution, or immediately

before the Close of Business on the effective date of such stock split or stock combination, as applicable;

CP1

=

the

Conversion Price in effect immediately after the Close of Business on such Record Date or effective date, as applicable;

OS0

=

the

number of shares of Common Stock outstanding immediately before the Close of Business on such Record Date or effective date, as applicable,

without giving effect to such dividend, distribution, stock split or stock combination; and

OS1

=

the

number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, stock split or stock

combination.

If any dividend, distribution, stock split or

stock combination of the type described in this Section 10(f)(i)(1) is declared or announced, but not so paid or made,

then the Conversion Price will be readjusted, effective as of the date the Board of Directors, or any Officer acting pursuant to authority

conferred by the Board of Directors, determines not to pay such dividend or distribution or to effect such stock split or stock combination,

to the Conversion Price that would then be in effect had such dividend, distribution, stock split or stock combination not been declared

or announced.

(2)            Tender

Offers or Exchange Offers. If the Company or any of its Subsidiaries makes a payment in respect of a tender offer or exchange offer

for shares of Common Stock (other than solely pursuant to an odd-lot tender offer pursuant to Rule 13e-4(h)(5) under the Exchange

Act), and the value (determined as of the Expiration Time by the Board of Directors) of the cash and other consideration paid per share

of Common Stock in such tender or exchange offer exceeds the Last Reported Sale Price per share of Common Stock on the Trading Day immediately

after the last date (the “Expiration Date”) on which tenders or exchanges may be made pursuant to such tender or exchange

offer (as it may be amended), then the Conversion Price will be decreased based on the following formula:

where:

CP0

=

the Conversion Price

in effect immediately before the time (the “Expiration Time”) such tender or exchange offer expires;

CP1

=

the Conversion Price

in effect immediately after the Expiration Time;

30

SP

=

the average of the Last Reported Sale Prices per share of Common Stock over the ten (10) consecutive Trading Day period (the “Tender/Exchange Offer Valuation Period”) beginning on, and including, the Trading Day immediately after the Expiration Date;

OS0

=

the number of shares of Common Stock outstanding immediately before the Expiration Time (including all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);

AC

=

the aggregate value (determined as of the Expiration Time by the Board of Directors) of all cash and other consideration paid for shares of Common Stock purchased or exchanged in such tender or exchange offer; and

OS1

=

the number of shares of Common Stock outstanding immediately after the Expiration Time (excluding all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);

provided, however, that the Conversion

Price will in no event be adjusted up pursuant to this Section 10(f)(i)(2), except to the extent provided in the immediately

following paragraph. The adjustment to the Conversion Price pursuant to this Section 10(f)(i)(2) will be calculated

as of the Close of Business on the last Trading Day of the Tender/Exchange Offer Valuation Period but will be given effect immediately

after the Expiration Time, with retroactive effect. If the Conversion Date for any share of Convertible Preferred Stock to be converted

occurs on the Expiration Date or during the Tender/Exchange Offer Valuation Period, then, notwithstanding anything to the contrary in

this Certificate of Designations, the Company will, if necessary, delay the settlement of such conversion until the second (2nd) Business

Day after the last Trading Day of the Tender/Exchange Offer Valuation Period.

To the extent such tender or exchange offer is

announced but not consummated (including as a result of being precluded from consummating such tender or exchange offer under applicable

law), or any purchases or exchanges of shares of Common Stock in such tender or exchange offer are rescinded, the Conversion Price will

be readjusted to the Conversion Price that would then be in effect had the adjustment been made on the basis of only the purchases or

exchanges of shares of Common Stock, if any, actually made, and not rescinded, in such tender or exchange offer.

31

(ii)            No

Adjustments in Certain Cases.

(1)            Certain

Events. Without limiting the operation of Section 5 and Section 10(e)(i), the Company will not be required

to adjust the Conversion Price except pursuant to Section 10(f)(i). Without limiting the foregoing, the Company will not

be required to adjust the Conversion Price on account of:

(A)            the

sale of shares of Common Stock for a purchase price that is less than the market price per share of Common Stock or less than the Conversion

Price;

(B)            the

issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest

payable on the Company’s securities and the investment of additional optional amounts in shares of Common Stock under any such

plan;

(C)            the

issuance of any shares of Common Stock or options or rights to purchase shares of Common Stock pursuant to any present or future employee,

director or consultant benefit plan or program of, or assumed by, the Company or any of its Subsidiaries;

(D)            the

issuance of any shares of Common Stock pursuant to any option, warrant, right or convertible or exchangeable security of the Company

outstanding as of the Initial Issue Date;

(E)

the issuance of any shares of Common Stock pursuant to any

option, warrant, right or convertible or exchangeable security of the Company in connection with any commercial arrangement between the

Company and a third party approved by the Requisite Holders, which third party receives securities of the Company in connection with

any such commercial agreement; or

(F)            solely

a change in the par value of the Common Stock.

(iii)           Adjustment

Deferral. If an adjustment to the Conversion Price otherwise required by this Certificate of Designations would result in a change

of less than one percent (1%) to the Conversion Price, then the Company may, at its election, defer such adjustment, except that all

such deferred adjustments must be given effect immediately upon the earliest of the following: (1) when all such deferred adjustments

would result in a change of at least one percent (1%) to the Conversion Price; (2) the Conversion Date of any share of Convertible

Preferred Stock; (3) the Holder Redemption Date for any Holder Redemption; and (4) the occurrence of any vote of the stockholders

of the Company.

(iv)          Stockholder

Rights Plans. If any shares of Common Stock are to be issued upon conversion of any Convertible Preferred Stock and, at the time

of such conversion, the Company has in effect any stockholder rights plan, then the Holder of such Convertible Preferred Stock will be

entitled to receive, in addition to, and concurrently with the delivery of, the consideration otherwise due upon such conversion, the

rights set forth in such stockholder rights plan.

32

(v)            Determination

of the Number of Outstanding Shares of Common Stock. For purposes of Section 10(f)(i), the number of shares of Common

Stock outstanding at any time will (1) include shares issuable in respect of scrip certificates issued in lieu of fractions of shares

of Common Stock; and (2) exclude shares of Common Stock held in the Company’s treasury (unless the Company pays any dividend

or makes any distribution on shares of Common Stock held in its treasury).

(vi)         Calculations.

All calculations with respect to the Conversion Price and adjustments thereto will be made to the nearest 1/100th of a cent (with 5/1,000ths

rounded upward).

(vii)         Notice

of Conversion Price Adjustments. Upon the effectiveness of any adjustment to the Conversion Price pursuant to Section 10(f)(i),

the Company will, as soon as reasonably practicable and no later than ten (10) Business Days after the date of such effectiveness,

send notice to the Holders containing (1) a brief description of the transaction or other event on account of which such adjustment

was made; (2) the Conversion Price in effect immediately after such adjustment; and (3) the effective time of such adjustment.

(g)            Voluntary

Conversion Price Decreases.

(i)            Generally.

To the extent permitted by law and applicable stock exchange rules, the Company, from time to time, may (but is not required to) decrease

the Conversion Price by any amount if (1) the Board of Directors determines that such decrease is in the Company’s best interest

or that such decrease is advisable to avoid or diminish any income tax imposed on holders of Common Stock or rights to purchase Common

Stock as a result of any dividend or distribution of shares (or rights to acquire shares) of Common Stock or any similar event; (2) such

decrease is in effect for a period of at least twenty (20) Business Days; and (3) such decrease is irrevocable during such period;

provided, however, that any such decrease that would reasonably be expected to result in any income tax imposed on holders of Convertible

Preferred Stock shall require the affirmative vote or consent of Holders representing a majority of the outstanding shares of Convertible

Preferred Stock.

(ii)           Notice

of Voluntary Decrease. If the Board of Directors determines to decrease the Conversion Price pursuant to Section 10(g)(i),

then, no later than the first Business Day of the related twenty (20) Business Day period referred to in Section 10(g)(i),

the Company will send notice to each Holder of such decrease to the Conversion Price, the amount thereof and the period during which

such decrease will be in effect.

(h)            Effect

of Common Stock Change Event.

(i)            Generally.

If there occurs any:

(1)            recapitalization,

reclassification or change of the Common Stock, other than (x) changes solely resulting from a subdivision or combination of the

Common Stock, (y) a change only in par value or from par value to no par value or no par value to par value or (z) stock splits

and stock combinations that do not involve the issuance of any other series or class of securities;

(2)            consolidation,

merger, combination or binding or statutory share exchange involving the Company;

(3)            sale,

lease or other transfer of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to any Person;

or

33

(4)            other

similar event, and, as a result of which, the Common Stock is converted into, or is exchanged for, or represents solely the right to

receive, other securities, cash or other property, or any combination of the foregoing (such an event, a “Common Stock Change

Event,” and such other securities, cash or property, the “Reference Property,” and the amount and kind of

Reference Property that a holder of one (1) share of Common Stock would be entitled to receive on account of such Common Stock Change

Event (without giving effect to any arrangement not to issue or deliver a fractional portion of any security or other property), a “Reference

Property Unit”), then, notwithstanding anything to the contrary in this Certificate of Designations,

(A)            from

and after the effective time of such Common Stock Change Event, (I) the consideration due upon conversion of any Convertible Preferred

Stock will be determined in the same manner as if each reference to any number of shares of Common Stock in this Section 10

or in Section 11, or in any related definitions, were instead a reference to the same number of Reference Property Units;

(II) for purposes of Section 7 and Section 8, each reference to any number of shares of Common Stock in

such Sections (or in any related definitions) will instead be deemed to be a reference to the same number of Reference Property Units;

and (III) for purposes of the definition of “Change of Control,” the term “Common Stock” will be deemed

to mean the common equity (including depositary receipts representing common equity), if any, forming part of such Reference Property;

and

(B)            for

these purposes, (I) the Daily VWAP of any Reference Property Unit or portion thereof that consists of a class of common equity securities

will be determined by reference to the definition of “Daily VWAP,” substituting, if applicable, the Bloomberg page for

such class of securities in such definition; and (II) the Daily VWAP of any Reference Property Unit or portion thereof that does

not consist of a class of common equity securities, and the Last Reported Sale Price of any Reference Property Unit or portion thereof

that does not consist of a class of securities, will be the fair value of such Reference Property Unit or portion thereof, as applicable,

determined in good faith by the Company (or, in the case of cash denominated in U.S. dollars, the face amount thereof).

If the Reference

Property consists of more than a single type of consideration to be determined based in part upon any form of stockholder election, then

the composition of the Reference Property Unit will be deemed to be the weighted average of the types and amounts of consideration actually

received, per share of Common Stock, by the holders of Common Stock. The Company will notify the Holders of such weighted average as

soon as practicable after such determination is made.

(ii)            Compliance

Covenant. The Company will not become a party to any Common Stock Change Event unless its terms are consistent with this Section 10(h).

34

(iii)          Execution

of Supplemental Instruments. On or before the date the Common Stock Change Event becomes effective, the Company and, if applicable,

the resulting, surviving or transferee Person (if not the Company) of such Common Stock Change Event (the “Successor Person”)

will execute and deliver such supplemental instruments, if any, as the Company reasonably determines are necessary or desirable to (1) provide

for subsequent adjustments to the Conversion Price pursuant to Section 10(f)(i) in a manner consistent with this Section 10(h);

and (2) give effect to such other provisions, if any, as the Company reasonably determines are appropriate to preserve the economic

interests of the Holders and to give effect to Section 10(h). If the Reference Property includes shares of stock or other

securities or assets of a Person other than the Successor Person, then such other Person will also execute such supplemental instrument(s) and

such supplemental instrument(s) will contain such additional provisions, if any, that the Company reasonably determines are appropriate

to preserve the economic interests of Holders.

(iv)          Notice

of Common Stock Change Event. The Company will provide notice of each Common Stock Change Event to Holders no later than the second

(2nd) Business Day after the effective date of the Common Stock Change Event.

(i)             Conversion

Ledger. The Company shall maintain a running tally of all shares of Common Stock issued upon conversion of the Convertible Preferred

Stock and the Series B-2 Preferred Stock, and shall make such ledger available to any Holder upon request.

Section 11.             Certain

Provisions Relating to the Issuance of Common Stock.

(a)            Equitable

Adjustments to Prices. Whenever this Certificate of Designations requires the Company to calculate the average of the Last Reported

Sale Prices or Daily VWAPs, or any function thereof, over a period of multiple days (including to calculate an adjustment to the Conversion

Price), the Company will make appropriate adjustments, if any, to those calculations to account for any adjustment to the Conversion

Price pursuant to Section 10(f)(i) that becomes effective, or any event requiring such an adjustment to the Conversion

Price where the Ex-Dividend Date, effective date or Expiration Date, as applicable, of such event occurs, at any time during such period.

(b)            Reservation

of Shares of Common Stock. The Company will reserve, out of its authorized, unreserved and not outstanding shares of Common Stock,

for delivery upon conversion of the Convertible Preferred Stock, a number of shares of Common Stock that would be sufficient to settle

the conversion of all shares of Convertible Preferred Stock then outstanding, if any. To the extent the Company delivers shares of Common

Stock held in the Company’s treasury in settlement of any obligation under this Certificate of Designations to deliver shares of

Common Stock, each reference in this Certificate of Designations to the issuance of shares of Common Stock in connection therewith will

be deemed to include such delivery.

(c)            Status

of Shares of Common Stock. Each share of Common Stock delivered upon conversion of on the Convertible Preferred Stock of any Holder

will be a newly issued or treasury share and will be duly and validly issued, fully paid, non-assessable, free from preemptive rights

and free of any lien or adverse claim (except to the extent of any lien or adverse claim created by the action or inaction of such Holder

or the Person to whom such share of Common Stock will be delivered). If the Common Stock is then listed on any securities exchange, or

quoted on any inter-dealer quotation system, then the Company will cause each such share of Common Stock, when so delivered, to be admitted

for listing on such exchange or quotation on such system.

35

(d)           Taxes

Upon Issuance of Common Stock. The Company will pay any documentary, stamp or similar issue or transfer tax or duty due on the issue

of any shares of Common Stock upon conversion of the Convertible Preferred Stock of any Holder, except any tax or duty that is due because

such Holder requests those shares to be registered in a name other than such Holder’s name.

Section 12.             Calculations.

(a)            Responsibility;

Schedule of Calculations. Except as otherwise provided in this Certificate of Designations, the Company will be responsible for making

all calculations called for under this Certificate of Designations or the Convertible Preferred Stock, including determinations of the

Conversion Price, the Daily VWAPs and the Last Reported Sale Prices. The Company will make all calculations in good faith, and, absent

manifest error, its calculations will be final and binding on all Holders. The Company will provide a schedule of such calculations to

any Holder upon written request.

(b)            Calculations

Aggregated for Each Holder. The composition of the Conversion Consideration due upon conversion of the Convertible Preferred Stock

of any Holder will be computed based on the total number of shares of Convertible Preferred Stock of such Holder being converted with

the same Conversion Date. For these purposes, any cash amounts due to such Holder in respect thereof will be rounded to the nearest cent.

Section 13.             Tax

Treatment. Notwithstanding anything to the contrary in this Certificate of Designations, for U.S. federal and other applicable state

and local income tax purposes, it is intended that the Convertible Preferred Stock will not be treated as “preferred stock”

within the meaning of Section 305(b)(4) of Code and Treasury Regulations Section 1.305-5(a). The Company will, and will

cause its Subsidiaries and agents to, report consistently with, and take no positions or actions inconsistent with, the foregoing treatment

unless otherwise required by a determination within the meaning of Section 1313(a) of the Code.

Section 14.              Notices.

(a)            Generally.

The Company will send all notices or communications to Holders pursuant to this Certificate of Designations in writing and delivered

personally, by facsimile or e-mail (with confirmation of receipt from the recipient, in the case of e-mail), or sent by nationally recognized

overnight courier service to the Holder’s respective addresses shown on the Register. Notwithstanding anything in the Certificate

of Designations to the contrary, any defect in the delivery of any such notice or communication will not impair or affect the validity

of such notice or communication and the failure to give any such notice or communication to all the Holders will not impair or affect

the validity of such notice or communication to whom such notice is sent.

(b)            Notice

Coordination with Series B-2 Preferred Stock. In addition to any other notice requirements set forth in this Certificate of

Designations, the Company shall promptly provide to all Holders copies of any notices delivered to holders of Series B-2 Preferred

Stock relating to (i) any Redemption Event, (ii) any Event of Default (as defined in the Certificate of Designations of the

Series B-2 Preferred Stock), (iii) any Liquidation Event, (iv) any Mandatory Conversion (as defined in the Certificate

of Designations of the Series B-2 Preferred Stock), (v) any Treasury Value Event, and (vi) any other material event affecting

the rights of holders of Series B-1 Preferred Stock.

36

Section 15.             No

Other Rights. The Convertible Preferred Stock will have no rights, preferences or voting powers except as provided in this Certificate

of Designations or the Certificate of Incorporation or as required by applicable law.

Section 16.             Guaranty

by Digital Asset Treasury Subsidiary. Each Digital Asset Treasury Subsidiary shall irrevocably and unconditionally guarantee, on

a joint and several basis, the due and punctual payment and performance of all obligations of the Company (a) in respect of the

Convertible Preferred Stock, including, without limitation, the payment of any Liquidation Preference, Holder Redemption Price, Dividends,

and any other amounts (including without limitation Participating Amounts) payable with respect to the Convertible Preferred Stock, and

(b) in connection with any other Transaction Document. The terms and conditions of such guaranty shall be set forth in the Guaranty,

which shall be executed and delivered on or prior to the Initial Issue Date. The ability of a Holder to individually realize the benefit

of such Guaranty may be limited by the provisions thereof, including without limitation requirements for certain majority approvals.

[The Remainder of This Page Intentionally

Left Blank; Signature Page Follows]

37

IN WITNESS WHEREOF,

the Company has caused this Certificate of Designations to be duly executed as of the date first written above.

BNB Plus Corp.

By:

/s/ Clay Shorrock

Name:

Clay Shorrock

Title:

Chief Executive Officer and President

[Signature Page to

Certificate of Designations]

38

EXHIBIT A

FORM OF CONVERTIBLE

PREFERRED STOCK

BNB Plus Corp.

Series B-1 Convertible

Preferred Stock [Certificate No.: [___]]                            No. Shares*

[___]] BNB Plus Corp., a Delaware corporation (the “Company”), certifies that [_______] is the registered owner of

[___] shares of the Company’s Series B-1 Convertible Preferred Stock (the “Convertible Preferred Stock”)

represented by this certificate (this “Certificate”). The special rights, preferences and voting powers of the Convertible

Preferred Stock are set forth in the Certificate of Designations of the Company establishing the Convertible Preferred Stock (the “Certificate

of Designations”). Capitalized terms used in this Certificate without definition have the respective meanings ascribed to them

in the Certificate of Designations.

Additional terms of this Certificate are set

forth on the other side of this Certificate.

[The Remainder of This

Page Intentionally Left Blank; Signature Page Follows]

* Insert number of shares for Physical Certificate

only.

IN WITNESS WHEREOF,

BNB Plus Corp has caused this instrument to be duly executed as of the date set forth below.

BNB PLUS CORP

Date:

By:

Name:

Title:

Date:

By:

Name:

Title:

REVERSE OF SECURITY

BNB PLUS CORP

THE COMPANY WILL FURNISH WITHOUT CHARGE TO EACH

STOCKHOLDER WHO SO REQUESTS, A SUMMARY OF THE POWERS, DESIGNATIONS AND PREFERENCES, OR OTHER SPECIAL RIGHTS OF EACH CLASS OF STOCK

OF THE COMPANY AND THE QUALIFICATIONS, LIMITATIONS OR RESTRICTIONS OF SUCH PREFERENCES AND RIGHTS, AND THE VARIATIONS IN RIGHTS, PREFERENCES

AND LIMITATIONS DETERMINED FOR EACH SERIES, WHICH ARE FIXED BY THE CERTIFICATE OF INCORPORATION OF THE COMPANY, AS AMENDED, AND THE RESOLUTIONS

OF THE BOARD OF DIRECTORS OF THE COMPANY, AND THE AUTHORITY OF THE BOARD OF DIRECTORS TO DETERMINE VARIATIONS FOR FUTURE SERIES. SUCH

REQUEST MAY BE MADE TO THE OFFICE OF THE SECRETARY OF THE COMPANY OR TO THE TRANSFER AGENT. THE BOARD OF DIRECTORS MAY REQUIRE

THE OWNER OF A LOST OR DESTROYED STOCK CERTIFICATE, OR HIS LEGAL REPRESENTATIVES TO GIVE THE COMPANY A BOND TO INDEMNIFY IT AND ITS TRANSFER

AGENTS AND REGISTRARS AGAINST ANY CLAIM THAT MAY BE MADE AGAINST THEM ON ACCOUNT OF THE ALLEGED LOSS OR DESTRUCTION OF AY SUCH CERTIFICATE.

THE SHARES REPRESENTED BY THIS CERTIFICATE

MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN ACCORDANCE WITH THE CERTIFICATE OF

DESIGNATIONS. ANY ATTEMPTED SALE

ASSIGNMENT, TRANSFER, PLEDGE OR OTHER ATTEMPT TO DISPOSE OF THE SHARES REPRESENTED BY THIS CERTIFICATE NOT IN ACCORDANCE WITH THE

TERMS OF THE CERTIFICATE OF DESIGNATION SHALL BE VOID.

FOR VALUE RECEIVED, ________________ hereby sell, assign and transfer

unto

(Insert assignee’s social security or tax identification number)

(Insert address and zip code of assignee)

Shares of the Series B-1 Convertible Preferred

Stock represented by the within Certificate, and do hereby irrevocably constitute and appoint agent to transfer the said shares of Series B-1

Convertible Preferred Stock evidenced hereby on the books of the within-named Company with full power of substitution in the premises.

Date:

Signature

(Sign exactly as your name appears on the other side of this Series B-1

Convertible Preferred Stock)

Signature Guarantee:

† Signature must be guaranteed by an “eligible

guarantor institution” that is a bank, stockbroker, savings and loan association or credit union reasonably acceptable to the Company

or meeting the requirements of any transfer agent appointed by the Company from time to time, which requirements include membership or

participation in the Securities Transfer Agents Medallion Program (“STAMP”) or such other “signature guarantee program”

as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange

Act of 1934, as amended.

EXHIBIT B

OPTIONAL CONVERSION NOTICE

BNB Plus Corp

Series B-1 Convertible Preferred Stock

Subject

to the terms of the Certificate of Designations, by executing and delivering this Optional Conversion Notice, the undersigned Holder

of the Convertible Preferred Stock identified below directs the Company to convert (check one):

¨

all of the shares of Convertible Preferred Stock

¨

†shares of Convertible Preferred Stock

identified

by CUSIP No. and Certificate No.

Date:

(Legal Name of Holder)

By:

Name:

Title:

Signature Guaranteed Participant in a Recognized Signature Guarantee Medallion Program

By:

Authorized Signatory

† Must be a whole number

EXHIBIT C

FORM OF RESTRICTED STOCK LEGEND

NEITHER THIS SECURITY NOR THE SECURITIES INTO

WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY

STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE

SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS

EXERCISABLE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL

INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED

BY SUCH SECURITIES.

EX-3.2 — EXHIBIT 3.2

EX-3.2

Filename: tm2615620d1_ex3-2.htm · Sequence: 3

Exhibit 3.2

BNB Plus Corp.

Certificate of Designations

of

Series B-2 Convertible Preferred Stock

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

The undersigned hereby certifies

that on May 19, 2026 the Board of Directors of BNB Plus Corp., a Delaware corporation (the “Company”), adopted

the following resolution designating and creating, out of the authorized and unissued shares of preferred stock of the Company, 5,000,000

authorized shares of a series of preferred stock of the Company titled the “Series B-2 Convertible Preferred Stock”:

RESOLVED that, pursuant

to the Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws and applicable law, a series of preferred stock

of the Company titled the “Series B-2 Convertible Preferred Stock,” and having a par value of $0.001 per share and an

initial number of authorized shares equal to 5,000,000, is hereby designated and created out of the authorized and unissued shares of

preferred stock of the Company, which series has the rights, designations, preferences, voting powers and other provisions set forth

below:

Section 1.         Definitions.

“Accumulated Liquidation

Preference” means the Initial Liquidation Preference per share of Convertible Preferred Stock plus any and all Compounded Dividends.

“Affiliate”

of any Person means any Person, directly or indirectly, Controlling, Controlled by or under common Control with such Person.

“Beneficial Ownership

Limitation” means, with respect to any Holder, the limitation that such Holder may not convert any shares of Convertible Preferred

Stock to the extent that, after giving effect to such conversion, such Holder (together with its Affiliates and any other Persons whose

beneficial ownership of Common Stock would be aggregated with such Holder’s for purposes of Section 13(d) of the Exchange

Act and the applicable regulations of the SEC) would beneficially own in excess of 4.99% (or, at the election of the applicable Holder

prior to the Initial Issue Date, 9.99% or 19.99%) of the number of shares of Common Stock outstanding immediately after giving effect

to the issuance of shares of Common Stock upon such conversion (the “Maximum Percentage”). During any period in which

the Common Stock is not listed on an Eligible Market, Holder may increase or decrease the Maximum Percentage applicable to such Holder

by written notice to the Company; provided that (i) any such increase will not be effective until the sixty-first (61st)

day after such notice is delivered to the Company and (ii) any such increase or decrease shall apply only to such Holder and not

to any other Holder.

“Board of Directors”

means the Company’s board of directors or a committee of such board duly authorized to act on behalf of such board.

1

“Business Day”

means any day other than a Saturday, a Sunday or any day on which the Federal Reserve Bank of New York is authorized or required by law

or executive order to close or be closed.

“Bylaws”

means the Amended and Restated Bylaws of the Company, as the same may be further amended, supplemented or restated.

“Capital Stock”

of any Person means any and all shares of, interests in, rights to purchase, warrants or options for, participations in, or other equivalents

of, in each case however designated, the equity of such Person, but excluding any debt securities convertible into such equity.

“Certificate” means

any Physical Certificate or Electronic Certificate.

“Certificate of

Designations” means this Certificate of Designations, as amended or supplemented from time to time.

“Certificate of

Incorporation” means the Company’s Amended and Restated Certificate of Incorporation, as the same may be further amended,

supplemented or restated.

“Change of Control”

means any of the following events:

(a)            a

“person” or “group” (within the meaning of Section 13(d)(3) of the Exchange Act), other than the Company,

its Wholly Owned Subsidiaries or a Holder (together with its Affiliates), has become the direct or indirect “beneficial owner”

(as defined below) of shares of the Company’s Common Stock representing more than fifty percent (50%) of the voting power of all

of the Company’s then-outstanding common Stock; or (other than one effected in compliance with the terms of the Convertible Preferred

Stock and in which the Company’s stockholders own a majority of the voting power of the surviving or acquiring entity)

(b)            the

consummation of (i) any sale, lease or other transfer, in one transaction or a series of transactions, of all or substantially all

of the assets of the Company and its Subsidiaries, taken as a whole, to any Person (other than to a wholly owned direct or indirect subsidiary;

or (ii) any transaction or series of related transactions in connection with which (whether by means of merger, consolidation, share

exchange, combination, reclassification, recapitalization, acquisition, liquidation or otherwise) all of the Common Stock is exchanged

for, converted into, acquired for, or constitutes solely the right to receive, other securities, cash or other property; provided,

however, that any merger, consolidation, share exchange or combination of the Company pursuant to which the Persons that directly

or indirectly “beneficially owned” (as defined below) the Company’s Common Stock immediately before such transaction

directly or indirectly “beneficially own,” immediately after such transaction, more than fifty percent (50%) of the Common

Stock of the surviving, continuing or acquiring company or other transferee, as applicable, or the parent thereof, in substantially the

same proportions vis-à-vis each other as immediately before such transaction will be deemed not to be a Change of Control pursuant

to this clause (b); and provided further, however, that the foregoing notwithstanding, a merger or consolidation of the Company

approved by the affirmative vote of the Requisite Holders shall not be deemed a Change of Control.

For the purposes of this

definition, (x) any transaction or event described in both clause (a) and in clause (b) above (without regard

to the proviso in clause (b)) will be deemed to occur solely pursuant to clause (b) above (subject to such proviso);

and (y) whether a Person is a “beneficial owner” and whether shares are “beneficially owned”

will be determined in accordance with Rule 13d-3 under the Exchange Act.

2

“Close of Business”

means 5:00 p.m., New York City time.

“Code” means the

U.S. Internal Revenue Code of 1986, as amended.

“Common Stock”

means the common stock, $0.001 par value per share, of the Company, subject to Section 10(h).

“Common Stock Change Event”

has the meaning set forth in Section 10(h).

“Company”

has the meaning set forth in the preamble.

“Compounded Dividends”

has the meaning set forth in Section 5(a).

“Control”

(including its correlative meanings “under common Control with” and “Controlled by”) means, with respect to any

Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person,

whether through ownership of securities or partnership or other interests, by contract or otherwise.

“Conversion Consideration”

means, with respect to the conversion of any Convertible Preferred Stock, the type and amount of consideration payable to settle such

conversion, determined in accordance with Section 10.

“Conversion Share”

means any share of Common Stock issued or issuable upon conversion of any Convertible Preferred Stock.

“Conversion Date”

means the date of an Optional Conversion.

“Conversion Price”

initially means $0.38; provided, however, that the Conversion Price is subject to adjustment pursuant to Section 10(f) and

Section 10(g). Each reference in this Certificate of Designations or the Convertible Preferred Stock to the Conversion Price

as of a particular date without setting forth a particular time on such date will be deemed to be a reference to the Conversion Price

immediately before the Close of Business on such date.

“Convertible Preferred Stock”

has the meaning set forth in Section 3(a).

“Daily VWAP”

means, for any VWAP Trading Day, the per share volume-weighted average price of the Common Stock as displayed under the heading “Bloomberg

VWAP” on Bloomberg page “www.bloomberg.com” (or, if such page is not available, its equivalent successor

page) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session

on such VWAP Trading Day (or, if such volume-weighted average price is unavailable, the market value of one (1) share of Common

Stock on such VWAP Trading Day, determined, using a volume-weighted average price method, by a nationally recognized independent investment

banking firm the Board of Directors selects). The Daily VWAP will be determined without regard to after-hours trading or any other trading

outside of the regular trading session.

3

“Delisting Event”

means: (a) the Common Stock ceases to be listed or quoted on any Eligible Market; (b) the Company fails to maintain the listing

or quotation of the Common Stock on an Eligible Market; or (c) trading in the Common Stock is suspended, halted, or otherwise limited

such that holders are unable to sell shares in the public market for ten (10) consecutive trading days, in each case other than

due solely to market-wide trading halts.

“Depositary” means

The Depository Trust Company or its successor.

“Digital Assets”

means (a) cryptocurrencies, virtual currencies, digital currencies, coins, tokens and stablecoins; (b) native blockchain or

protocol assets; (c) tokenized securities, tokenized commodities and tokenized real-world assets; (d) utility tokens, governance

tokens, staking tokens, liquid staking tokens and wrapped, bridged or synthetic digital assets; (e) any digital or cryptographic

asset, property or store of value that is recorded, represented or transferred using distributed ledger technology, blockchain technology,

cryptographic systems or similar technology; (f) BNB-denominated trust units; (g) any rights to receive, acquire, stake, validate,

delegate, earn, mine or otherwise obtain any of the foregoing; (h) any proceeds, products, distributions, rewards, fees, interest,

yield, airdrops, forks or other property derived from or attributable to any of the foregoing; and (i) any replacements, substitutions,

modifications, successors or forks of any of the foregoing, in each case of (a) through (h), whether now existing or hereafter arising.

“Digital Asset Treasury”

means the immediately available liquid assets of the Company and its subsidiaries, including but not limited to any Digital Assets and

any cash at the DAT Subsidiaries; provided, however, that notwithstanding the foregoing the Digital Asset Treasury shall

be deemed not to include: (i) the General Proceeds; (ii) cash at the Company in an amount equal to $600,000; (iii) accounts

receivable of the Company in an amount equal to $700,000; and (iv) all operating cash flows attributable to the LineaRx business.

“Digital Asset Treasury

Procedures” means the procedures governing the management, custody, transfer, and disposition of assets held in the Digital

Asset Treasury, as set forth in a separate instrument agreed upon by the Company and the Requisite Holders not later than thirty (30)

days following the Initial Closing of the Purchase Agreement, which shall include both (a) the initial procedures for the establishment

and contribution of assets to the Digital Asset Treasury and (b) ongoing procedures for the maintenance, monitoring, and administration

thereof.

“Digital Asset Treasury

Subsidiary” means (i) Build & Build, LLC, a Delaware limited liability company and a wholly owned subsidiary

of the Company, (ii) BNBX Ltd., a wholly owned subsidiary organized under the laws of the British Virgin Islands and (iii) any

other wholly-owned subsidiary of the Company now existing or hereafter formed that is a guarantor party to the Guaranty or holds any

or all of the Digital Asset Treasury.

“Dividend”

means any Regular Dividend.

“Dividend Rights”

means the Holders’ rights under Section 5.

“Dividend

Junior Stock” means any class or series of the Company’s stock whose terms do not expressly provide that such class or

series will rank senior to, or equally with, the Convertible Preferred Stock with respect to the payment of dividends (without regard

to whether or not dividends accumulate cumulatively). Dividend Junior Stock includes the Common Stock.

4

“Dividend Parity

Stock” means any class or series of the Company’s stock (other than the Convertible Preferred Stock) whose terms expressly

provide that such class or series will rank equally with the Convertible Preferred Stock with respect to the payment of dividends (without

regard to whether or not dividends accumulate cumulatively).

“Dividend

Senior Stock” means any class or series of the Company’s stock whose terms expressly provide that such class or series

will rank senior to the Convertible Preferred Stock with respect to the payment of dividends (without regard to whether or not dividends

accumulate cumulatively). Dividend Senior Stock includes the Series B-1 Preferred Stock.

“Electronic Certificate”

means any electronic book-entry maintained by the Transfer Agent that represents any share(s) of Convertible Preferred Stock.

“Eligible Market”

shall mean any of The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market,

the New York Stock Exchange, the NYSE American, the OTCQX Market, or the OTCQB Market (or any successor to any of the foregoing)

or, for a period no longer than 15 consecutive Trading Days, the OTCID Basic Market within the Pink Open

Market, while the Company’s application to the OTCQX or OTCQB is being processed. Notwithstanding the foregoing, any Delisting

Event triggered by a voluntary delisting of the Company from any Eligible Market that is approved in writing by the Requisite Holders

shall not be deemed a Delisting Event.

“Equity-Linked Securities”

means any rights, options or warrants to purchase or otherwise acquire (whether immediately, during specified times, upon the satisfaction

of any conditions or otherwise) any shares of Common Stock.

“Event of Default”

means the occurrence of any of the following: (a) the failure by the Company to pay when due any Dividend or redemption amount (including

without limitation any Participating Amount) required under this Certificate of Designations; (b) the failure by the Company to

comply with any covenant or agreement set forth in this Certificate of Designations (other than a failure covered by clause (a)), which

failure continues for ten (10) consecutive Business Days after written notice thereof from the Requisite Holders (without giving

effect to any other notice or cure period); or (c) any other material breach or default by the Company under any Transaction Document,

which breach or default remains uncured following any applicable notice or cure period explicitly set forth in the applicable Transaction

Document.

“Ex-Dividend Date”

means, with respect to an issuance, dividend or distribution on the Common Stock, the first date on which shares of Common Stock trade

on the applicable exchange or in the applicable market, regular way, without the right to receive such issuance, dividend or distribution

(including pursuant to due bills or similar arrangements required by the relevant stock exchange). For the avoidance of doubt, any alternative

trading convention on the applicable exchange or market in respect of the Common Stock under a separate ticker symbol or CUSIP number

will not be considered “regular way” for this purpose.

“Exchange Act”

means the U.S. Securities Exchange Act of 1934, as amended.

“Expiration

Date” has the meaning set forth in Section 10(f)(i)(2).

“Expiration Time”

has the meaning set forth in Section 10(f)(i)(2).

5

“Fundamental Transaction”

means (a) the occurrence of a “Fundamental Transaction”, as such term may be amended or supplemented from time to time,

or its equivalent, as defined or otherwise used in the Series E Warrants of the Company; or (b) unless explicitly approved

by the Requisite Holders in writing, any occurrence, eligibility or exercisability of a right of, direct or indirect redemption, purchase,

repurchase or other similar right under any agreement, security or other instrument of the Company (i) resulting in an obligation

of the Company (or any Subsidiary) to pay cash, distribute assets, incur indebtedness for such purpose or engage in any

substantially equivalent transaction (or the payment into or set aside for a sinking fund for such purpose) or (ii) which could

reasonably result in a material adverse effect on the capital stock of the Company held by the Holder.

“General Proceeds”

means proceeds from the sale and issuance of Series B-1 Preferred Stock and proceeds from the warrant exercise and exchange for

Series B-2 Preferred Stock as set forth in the Inducement Agreement, in an aggregate cumulative amount not in excess of $2,300,000.

“Holder”

means a person in whose name any Convertible Preferred Stock is registered in the Register.

“Holder Redemption”

means the redemption of any Convertible Preferred Stock by the Company pursuant to Section 7.

“Holder Redemption

Date” means the date fixed, pursuant to Section 7(a)(i), for the redemption of any Convertible Preferred Stock

by the Company pursuant to a Holder Redemption.

“Holder Redemption Demand”

has the meaning set forth in Section 7(a)(i).

“Holder Redemption

Price” means the cash price payable by the Company to redeem any share of Convertible Preferred Stock upon its Holder Redemption,

calculated pursuant to Section 7(a)(ii).

“Initial Issue Date”

means May 27, 2026

“Initial Liquidation

Preference” means $0.38 per share of Convertible Preferred Stock.

“Last Reported Sale

Price” of the Common Stock for any Trading Day means the closing sale price per share (or, if no closing sale price is reported,

the average of the last bid price and the last ask price per share or, if more than one in either case, the average of the average last

bid prices and the average last ask prices per share) of the Common Stock on such Trading Day as reported in composite transactions for

the principal U.S. national or regional securities exchange on which the Common Stock is then listed. If the Common Stock is not listed

on a U.S. national or regional securities exchange on such Trading Day, then the Last Reported Sale Price will be the last quoted bid

price per share of Common Stock on such Trading Day in the over-the-counter market as reported by OTC Markets Group Inc. or a similar

organization. If the Common Stock is not so quoted on such Trading Day, then the Last Reported Sale Price will be the average of the

mid-point of the last bid price and the last ask price per share of Common Stock on such Trading Day from each of at least three nationally

recognized independent investment banking firms the Company selects in good faith.

6

“Lien”

means any mortgage, deed of trust, pledge, hypothecation, security interest, encumbrance, lien, charge,

claim, attachment, garnishment, levy or other restriction of any kind, whether arising by agreement, operation of law or otherwise, including

(i) any conditional sale or other title retention arrangement, (ii) any lease in the nature thereof, (iii) any agreement

to create, suffer, grant or permit any of the foregoing, and (iv) any restriction on the transfer, use or disposition of any asset

that has the economic effect of securing an obligation. For the avoidance of doubt, “Lien” shall include any arrangement

or transaction that has the practical effect of providing a creditor or counterparty with recourse to or priority in respect of any asset

or property, including through netting arrangements, set-off rights, margining, rehypothecation or similar arrangements, including any

arrangement that results in the segregation, earmarking or restriction of assets for the benefit of any creditor or counterparty. “Lien”

shall also include any asserted or pending claim, litigation, proceeding or demand that, if successful, could reasonably be expected

to result in the imposition of any of the foregoing on any asset or property of the Company or any Digital Asset Treasury Subsidiary.

“Liquidation Event”

means the occurrence or consummation of any of the following: (i) a liquidation, dissolution, or winding up of the Company;

or (ii) Change of Control.

“Liquidation

Junior Stock” means any class or series of the Company’s stock whose terms do not expressly provide that such class or

series will rank senior to, or equally with, the Convertible Preferred Stock with respect to the distribution of assets upon the Company’s

liquidation, dissolution or winding up. Liquidation Junior Stock includes the Common Stock.

“Liquidation Parity

Stock” means any class or series of the Company’s stock (other than the Convertible Preferred Stock) whose terms expressly

provide that such class or series will rank equally with the Convertible Preferred Stock with respect to the distribution of assets upon

the Company’s liquidation, dissolution or winding up.

“Liquidation

Preference” means, with respect to the Convertible Preferred Stock, an amount equal to the Accumulated Liquidation Preference

plus accrued and unpaid Dividends, whether or not declared, that have not yet been compounded and added to the Accumulated Liquidation

Preference.

“Liquidation

Senior Stock” means any class or series of the Company’s stock whose terms expressly provide that such class or series

will rank senior to the Convertible Preferred Stock with respect to the distribution of assets upon the Company’s liquidation,

dissolution or winding up. Liquidation Senior Stock includes the Series B-1 Preferred Stock

“Officer”

means the Chief Executive Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer, any Assistant

Treasurer, the Secretary, or any Vice-President of the Company.

“Open of Business”

means 9:00 a.m., New York City time.

“Optional Conversion”

means the conversion of any Convertible Preferred Stock pursuant to Section 10(b).

“Optional Conversion

Notice” means a notice, substantially in the form of Exhibit B attached hereto and incorporated herein,

delivered in connection with an Optional Conversion in accordance with Section 10(b)(ii).

7

“Participating Amount”

has the meaning set forth in Section 6.

“Permitted

Liens” means (i) Liens for taxes, assessments or other governmental charges not yet due and

payable or that are being contested in good faith by appropriate proceedings; (ii) statutory Liens of landlords, carriers, warehousemen,

mechanics, materialmen and other similar Liens arising in the ordinary course of business securing obligations not yet delinquent or

being contested in good faith; (iii) Liens incurred in the ordinary course of business in connection with workers’ compensation,

unemployment insurance and other social security legislation; (iv) ordinary course purchase money Liens and Liens securing rental

payments under operating or capital lease arrangements for amounts not yet due or payable; (v) Liens arising under applicable securities

laws in connection with the holding of securities in custody accounts; and (vi) such other Liens as may be approved in writing by

the Requisite Holders.

“Person”

or “person” means any individual, corporation, partnership, limited liability company, joint venture, association,

joint-stock company, trust, unincorporated organization or government or other agency or political subdivision thereof. Any division

or series of a limited liability company, limited partnership or trust will constitute a separate “person” under this Certificate

of Designations.

“Physical Certificate”

means any certificate (other than an Electronic Certificate) representing any share(s) of Convertible Preferred Stock, which certificate

is substantially in the form set forth in Exhibit A, registered in the name of the Holder of such share(s) and

duly executed by the Company and countersigned by the Transfer Agent.

“Record Date”

means, with respect to any dividend or distribution on, or issuance to holders of, Convertible Preferred Stock or Common Stock, the date

fixed (whether by law, contract or the Board of Directors or otherwise) to determine the Holders or the holders of Common Stock, as applicable,

that are entitled to such dividend, distribution or issuance.

“Redemption Event”

means a Fundamental Transaction (including a Liquidation Event), Delisting Event, Treasury Value Event, Warrant Ratchet Event or

Event of Default.

“Redemption Event

Notice” has the meaning set forth in Section 7(b).

“Reference Property”

has the meaning set forth in Section 10(h).

“Reference Property Unit”

has the meaning set forth in Section 10(h).

“Register” has the

meaning set forth in Section 3(e).

“Regular Dividends”

has the meaning set forth in Section 5(a)(i).

“Regular Dividend

Payment Date” means, with respect to any share of Preferred Stock, each March 31, June 30, September 30 and

December 31 of each year, beginning on the first such date occurring after the Initial Issue Date (or beginning on such other date

specified in the Certificate evidencing such share).

“Regular Dividend

Period” means each period from, and including, a Regular Dividend Payment Date (or, in the case of the first Regular Dividend

Period, from, and including, the Initial Issue Date) to, but excluding, the next Regular Dividend Payment Date.

“Regular

Dividend Rate” means 6.0% (six percent) per

annum.

8

“Regular Dividend

Record Date” has the following meaning: (a) March 15th, in the case of a Regular Dividend Payment Date

occurring on March 31st; (b) June 15th, in the case of a Regular Dividend Payment Date occurring

on June 30th; (c) September 15th, in the case of a Regular Dividend Payment Date occurring on September 30th;

and (d) December 15th, in the case of a Regular Dividend Payment Date occurring on December 31st.

“Requisite Holders”

is defined in Section 9(b)(i)

“Restricted Stock

Legends” means the legends substantially in the form set forth in Exhibit C.

“Rule 144”

means Rule 144 under the Securities Act (or any successor rule thereto), as the same may be amended from time to time.

“Securities Act”

means the U.S. Securities Act of 1933, as amended.

“Security” means

any Convertible Preferred Stock or Conversion Share.

“Series B-2

Preferred Stock” means the Company’s Series B-2 Convertible Preferred Stock.

“Subsidiary”

means, with respect to any Person, (a) any corporation, association or other business entity (other than a partnership or limited

liability company) of which more than 50% of the total voting power of the Capital Stock entitled (without regard to the occurrence of

any contingency, but after giving effect to any voting agreement or stockholders’ agreement that effectively transfers voting power)

to vote in the election of directors, managers or trustees, as applicable, of such corporation, association or other business entity

is owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of such Person; and (b) any

partnership or limited liability company where (x) more than fifty percent (50%) of the capital accounts, distribution rights, equity

and voting interests, or of the general and limited partnership interests, as applicable, of such partnership or limited liability company

are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of such Person, whether in the

form of membership, general, special or limited partnership or limited liability company interests or otherwise; and (y) such Person

or any one or more of the other Subsidiaries of such Person is a controlling general partner of, or otherwise controls, such partnership

or limited liability company.

“Successor Person”

has the meaning set forth in Section 10(h).

“Tender/Exchange

Offer Valuation Period” has the meaning set forth in Section 10(f)(i)(2).

“Trading Day”

means any day on which (a) trading in the Common Stock generally occurs on the principal U.S. national or regional securities exchange

on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange,

on the principal other market on which the Common Stock is then traded; and (b) there is no VWAP Market Disruption Event. If the

Common Stock is not so listed or traded, then “Trading Day” means a Business Day.

“Transaction Document”

means any of this Certificate of Designations or the Certificate of Designations for the Series B-1 Preferred Stock, the Purchase

Agreement, the Warrant Agreements, the Guaranty, Inducement Agreement, and the Registration Rights Agreement.

9

“Transfer Agent”

means the Company or its successor.

“Transfer-Restricted

Security” means any Security that constitutes a “restricted security” (as defined in Rule 144); provided,

however, that such Security will cease to be a Transfer-Restricted Security upon the earliest to occur of the following events:

(a)            such

Security is sold or otherwise transferred to a Person (other than the Company or an Affiliate of the Company) pursuant to a registration

statement that was effective under the Securities Act at the time of such sale or transfer;

(b)            such

Security is sold or otherwise transferred to a Person (other than the Company or an Affiliate of the Company) pursuant to an available

exemption (including Rule 144) from the registration and prospectus-delivery requirements of, or in a transaction not subject to,

the Securities Act and, immediately after such sale or transfer, such Security ceases to constitute a “restricted security”

(as defined in Rule 144); and

(c)            (i) such

Security is eligible for resale, by a Person that is not an Affiliate of the Company and that has not been an Affiliate of the Company

during the immediately preceding three (3) months, pursuant to Rule 144; and (ii) the Company has received such certificates

or other documentation or evidence as the Company may reasonably require to determine that the security is eligible for resale pursuant

to clause (c) and the Holder, holder or beneficial owner of such Security is not, and has not been during the immediately

preceding three (3) months, an Affiliate of the Company.

“Treasury Regulations”

means the Treasury regulations promulgated under the Code, as amended.

“Treasury

Value Event” means any date on which the US dollar value of the Digital Assets in the Company’s Digital Asset Treasury,

as determined in good faith by the Company based on publicly available market prices as of the applicable date, is less than 100% (one

hundred percent) of the value of the then applicable aggregate Liquidation Preference of the Series B-1 Preferred Stock on five

(5) or more consecutive Business Days, it being understood that the Company may, in its reasonable discretion

and without any consent of the Requisite Holders, enter into hedging transactions or convert assets in the Digital Asset Treasury into

US dollars or stablecoins recognized by the GENIUS Act in order to maintain the value of such liquid assets at or above such threshold.

“VWAP Market Disruption

Event” means, with respect to any date, (a) the failure by the principal U.S. national or regional securities exchange

on which the Common Stock is then listed, or, if the Common Stock is not then listed on a U.S. national or regional securities exchange,

the principal other market on which the Common Stock is then traded, to open for trading during its regular trading session on such date;

or (b) the occurrence or existence, for more than one half hour period in the aggregate, of any suspension or limitation imposed

on trading (by reason of movements in price exceeding limits permitted by the relevant exchange or otherwise) in the Common Stock or

in any options contracts or futures contracts relating to the Common Stock, and such suspension or limitation occurs or exists at any

time before 1:00 p.m., New York City time, on such date.

10

“VWAP Trading Day”

means a day on which (a) there is no VWAP Market Disruption Event; and (b) trading in the Common Stock generally occurs on

the principal U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then

listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then traded. If

the Common Stock is not so listed or traded, then “VWAP Trading Day” means a Business Day.

“Warrant Agreement”

means the Series F Common Stock Purchase Warrant of the Company and the Pre-Funded Purchase Warrants of the Company issued in connection

with the Purchase Agreement and Inducement Agreement.

“Warrant Ratchet

Event” means: the occurrence of any adjustment, repricing, reset, or other modification to the exercise price, number of underlying

shares, or economic entitlement of any outstanding warrant (or similar Common Stock Equivalent) that results in an increase in the intrinsic

or economic value of such instrument to the holder thereof, in each case as a result of or in connection with:

(a) any issuance or

deemed issuance of equity securities of the Company at a price per share below the then-current exercise price (including any “Dilutive

Issuance” or similar concept);

(b) any formula or mechanism

that references, directly or indirectly, the trading price, volume-weighted average price, or lowest trading price of the Common Stock

over any period of time following such issuance, announcement, or event;

(c) any share combination,

reverse stock split, recapitalization, or similar transaction where the resulting adjustment is based, in whole or in part, on post-event

market prices rather than purely proportional adjustments;

(d) any “variable

rate,” “floating conversion price,” or similar structure in which the effective exercise or conversion price is determined

by reference to future market prices of the Common Stock; or

(e) any transaction

or series of related transactions that has a substantially similar economic effect to any of the foregoing, including through the use

of options, convertible securities, or other derivative instruments;

Provided, however, that in

each case of clauses (a) through (e) above, excluding customary anti-dilution adjustments solely for stock splits, stock dividends,

combinations, reclassifications, or other proportional adjustments that preserve, but do not enhance, the intrinsic or economic value

of such instrument.

“Wholly Owned Subsidiary”

of a Person means any Subsidiary of such Person all of the outstanding Capital Stock or other ownership interests of which (other than

directors’ qualifying shares) are owned by such Person or one or more Wholly Owned Subsidiaries of such Person.

Section 2.               Rules of

Construction. For purposes of this Certificate of Designations:

(a)            “or”

is not exclusive;

(b)            “including”

means “including without limitation”;

(c)            “will”

expresses a command;

11

(d)            the

“average” of a set of numerical values refers to the arithmetic average of such numerical values;

(e)            a

merger involving, or a transfer of assets by, a limited liability company, limited partnership or trust will be deemed to include any

division of or by, or an allocation of assets to a series of, such limited liability company, limited partnership or trust, or any unwinding

of any such division or allocation;

(f)             words

in the singular include the plural and in the plural include the singular, unless the context requires otherwise;

(g)            “hereof”

and other words of similar import refer to this Certificate of Designations as a whole and not to any particular Section or other

subdivision of this Certificate of Designations, unless the context requires otherwise;

(h)            references

to currency mean the lawful currency of the United States of America, unless the context requires otherwise; and

(i)            the

exhibits, schedules and other attachments to this Certificate of Designations are deemed to form part of this Certificate of Designations.

Section 3.                The

Convertible Preferred Stock.

(a)            Designation;

Par Value. A series of stock of the Company titled the “Series B-2 Convertible Preferred Stock” (the “Convertible

Preferred Stock”) is hereby designated and created out of the authorized and unissued shares of preferred stock of the Company.

The par value of the Convertible Preferred Stock is $0.001 per share.

(b)            Number

of Authorized Shares. The total authorized number of shares of Convertible Preferred Stock is 5,000,000; provided, however

that, by resolution of the Board of Directors, the total number of authorized shares of Convertible Preferred Stock may hereafter be

reduced to a number that is not less than the number of shares of Convertible Preferred Stock then outstanding.

(c)            Form,

Dating and Denominations.

(i)            Form and

Date of Certificates Representing Convertible Preferred Stock. Each Certificate representing any Convertible Preferred Stock will

bear the legends required by Section 3(f) and may bear notations, legends or endorsements required by law, stock exchange

rule or usage or the Depositary.

(ii)            Certificates.

(1)            Generally.

The Convertible Preferred Stock will be originally issued initially in the form of one or more physical Certificates. Physical Certificates

may be exchanged for Electronic Certificates, and Electronic Certificates may be exchanged for Physical Certificates upon request by

the Holder thereof pursuant to customary procedures.

(2)            Electronic

Certificates; Interpretation. For purposes of this Certificate of Designations, (A) each Electronic Certificate will be deemed

to include the text of the stock certificate set forth in Exhibit A; (B) any legend or other notation that is

required to be included on a Certificate pursuant to Section 3 (f) will be deemed to be included in any Electronic Certificate

notwithstanding that such Electronic Certificate may be in a form that does not permit affixing legends thereto; (C) any reference

in this Certificate of Designations to the “delivery” of any Electronic Certificate will be deemed to be satisfied upon the

registration of the electronic book-entry representing such Electronic Certificate in the name of the applicable Holder; and (D) upon

satisfaction of any applicable requirements of the Delaware General Corporation Law, the Certificate of Incorporation and the Bylaws

of the Company, and any related requirements of the Transfer Agent, in each case for the issuance of Convertible Preferred Stock in the

form of one or more Electronic Certificates, such Electronic Certificates will be deemed to be executed by the Company and countersigned

by the Transfer Agent.

12

(iii)            No

Bearer Certificates; Denominations. The Convertible Preferred Stock will be issued only in registered form and only in whole numbers

of shares.

(iv)            Registration

Numbers. Each Certificate representing any Convertible Preferred Stock will bear a unique registration number that is not affixed

to any other Certificate representing any other outstanding share of Convertible Preferred Stock.

(d)            Method

of Payment; Delay When Payment Date is Not a Business Day.

(i)            Method

of Payment. The Company will pay all cash amounts due on any Convertible Preferred Stock by check issued in the name of the Holder

thereof; provided, however, that if such Holder has delivered to the Company, no later than the time set forth in the next

sentence, a written request to receive payment by wire transfer to an account of such Holder within the United States, then the Company

will pay all such cash amounts by wire transfer of immediately available funds to such account. To be timely, such written request must

be delivered no later than the Close of Business on the following date: (x) with respect to the payment of any declared cash Participating

Amount, the related Record Date; and (y) with respect to any other payment, the date that is seven (7) calendar days immediately

before the date such payment is due.

(ii)            Delay

of Payment when Payment Date is Not a Business Day. If the due date for a payment on any Convertible Preferred Stock as provided

in this Certificate of Designations is not a Business Day, then, notwithstanding anything to the contrary in this Certificate of Designations,

such payment may be made on the immediately following Business Day and no interest, dividend or other amount will accrue or accumulate

on such payment as a result of the related delay. Solely for purposes of the immediately preceding sentence, a day on which the applicable

place of payment is authorized or required by law or executive order to close or be closed will be deemed not to be a “Business

Day.”

(e)            Transfer

Agent; Register. The Company or any of its Subsidiaries may act as the Transfer Agent. The Company will, or will retain another Person

(who may be the Transfer Agent) to act as registrar who will, keep a record (the “Register”) of the names and addresses

of the Holders, the number of shares of Convertible Preferred Stock held by each Holder and the transfer, exchange, repurchase, redemption

and conversion of the Convertible Preferred Stock. Absent manifest error, the entries in the Register will be conclusive and the Company

and the Transfer Agent may treat each Person whose name is recorded as a Holder in the Register as a Holder for all purposes. The Register

will be in written form or in any form capable of being converted into written form reasonably promptly. The Company will promptly provide

a copy of the Register to any Holder upon its request.

13

(f)            Legends.

(i)            Restricted

Stock Legend.

(1)            Each

Certificate representing any share of Convertible Preferred Stock that is a Transfer-Restricted Security will bear the Restricted Stock

Legend.

(2)            If

any share of Convertible Preferred Stock is issued in exchange for, in substitution of, or to effect a partial conversion of, any other

share(s) of Convertible Preferred Stock (such other share(s) being referred to as the “old share(s)” for purposes

of this Section 3(f)(i)(2)), including pursuant to Section 3(h) or Section 3(j), then the Certificate

representing such share will bear the Restricted Stock Legends if the Certificate representing such old share(s) bore the Restricted

Stock Legends at the time of such exchange or substitution, or on the related Conversion Date with respect to such conversion, as applicable;

provided, however, that the Certificate representing such share need not bear the Restricted Stock Legends if such share

does not constitute a Transfer-Restricted Security immediately after such exchange or substitution, or as of such Conversion Date, as

applicable.

(ii)            Other

Legends. The Certificate representing any Convertible Preferred Stock may bear any other legend or text, not inconsistent with this

Certificate of Designations, as may be required by applicable law or by any securities exchange or automated quotation system on which

such Convertible Preferred Stock is traded or quoted or as may be otherwise reasonably determined by the Company to be appropriate.

(iii)            Acknowledgement

and Agreement by the Holders. A Holder’s acceptance of any Convertible Preferred Stock represented by a Certificate bearing

any legend required by this Section 3(f) will constitute such Holder’s acknowledgement of, and agreement to comply

with, the restrictions set forth in such legend.

(iv)            Legends

on Conversion Shares.

(1)            Each

Conversion Share will bear legends substantially to the same effect as the Restricted Stock Legends if the Convertible Preferred Stock

upon the conversion of which such Conversion Share was issued was (or would have been had it not been converted) a Transfer-Restricted

Security at the time such Conversion Share was issued; provided, however, that such Conversion Share need not bear such

legends if the Company determines, in its reasonable discretion, that such Conversion Share need not bear such legends.

(2)            Notwithstanding

anything to the contrary in Section 3(f)(iv)(1), a Conversion Share need not bear legends pursuant to Section 3(f)(iv)(1) if

such Conversion Share is issued in an uncertificated form that does not permit affixing legends thereto, provided the Company

takes measures (including the assignment thereto of a “restricted” CUSIP number) that it reasonably deems appropriate to

enforce the transfer restrictions referred to in such legends.

14

(g)            Transfers

and Exchanges; Transfer Taxes; Certain Transfer Restrictions.

(i)            Provisions

Applicable to All Transfers and Exchanges.

(1)            Generally.

A Holder may, without the prior written consent of the Company, sell, assign, transfer, pledge or dispose of all or any portion of such

Holder’s shares of Convertible Preferred Stock in compliance with applicable law.

(2)            No

Services Charge; Transfer Taxes. The Company will not impose any service charge on any Holder for any transfer, exchange or conversion

of any Convertible Preferred Stock, but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental

charge that may be imposed in connection with any transfer or exchange of Convertible Preferred Stock, other than exchanges pursuant

to Section 3(h) or Section 3(p) not involving any transfer.

(3)            No

Transfers or Exchanges of Fractional Shares. Notwithstanding anything to the contrary in this Certificate of Designations, all transfers

or exchanges of Convertible Preferred Stock must be in an amount representing a whole number of shares of Convertible Preferred Stock,

and no fractional share of Convertible Preferred Stock may be transferred or exchanged.

(4)            Legends.

Each Certificate representing any share of Convertible Preferred Stock that is issued upon transfer of, or in exchange for, another share

of Convertible Preferred Stock will bear each legend, if any, required by Section 3(f).

(5)            Settlement

of Transfers and Exchanges. Upon satisfaction of the requirements of this Certificate of Designations to effect a transfer or exchange

of any Convertible Preferred Stock as well as the delivery of all documentation reasonably required by the Transfer Agent or the Company

in order to effect any transfer or exchange, the Company will cause such transfer or exchange to be effected as soon as reasonably practicable

but in no event later than the second (2nd) Business Day after the date of such satisfaction.

(ii)            Transfers

of Shares Subject to Redemption or Conversion. Notwithstanding anything to the contrary in this Certificate of Designations, the

Company will not be required to register the transfer of or exchange any share of Convertible Preferred Stock:

(1)            that

has been surrendered for conversion; or

(2)            as

to which a Holder Redemption Demand has been duly delivered, and not withdrawn, pursuant to Section 7, except to the extent

that the Company fails to pay the related Holder Redemption Price when due.

(h)            Exchange

and Cancellation of Convertible Preferred Stock to Be Converted or Redeemed.

(i)            Partial

Conversions and Redemptions of Certificates. If only a portion of a Holder’s Convertible Preferred Stock represented by a Certificate

(such Certificate being referred to as the “old Certificate” for purposes of this Section 3(h)(i)) is to be converted

pursuant to Section 10, repurchased or redeemed pursuant to Section 7, then, as soon as reasonably practicable

after such Certificate is surrendered for such conversion, repurchase or redemption, as applicable, the Company will cause such Certificate

to be exchanged for (1) one or more Certificates that each represent a whole number of shares of Convertible Preferred Stock and,

in the aggregate, represent a total number of shares of Convertible Preferred Stock equal to the number of shares of Convertible Preferred

Stock represented by such old Certificate that are not to be so converted, repurchased or redeemed, as applicable, and deliver such Certificate(s) to

such Holder; and (2) a Certificate representing a whole number of shares of Convertible Preferred Stock equal to the number of shares

of Convertible Preferred Stock represented by such old Certificate that are to be so converted, repurchased or redeemed, as applicable,

which Certificate will be converted, repurchased or redeemed, as applicable, pursuant to the terms of this Certificate of Designations;

provided, however, that the Certificate referred to in this clause (2) need not be issued at any time after

which such shares subject to such conversion, repurchased or redemption, as applicable, are deemed to cease to be outstanding pursuant

to Section 3(n).

15

(ii)            Cancellation

of Convertible Preferred Stock that Is Converted, Repurchased or Redeemed. If a Holder’s Convertible Preferred Stock represented

by a Certificate (or any portion thereof that has not theretofore been exchanged pursuant to Section 3(h)(i)) (such Certificate

being referred to as the “old Certificate” for purposes of this Section 3(h)(ii)) is to be converted pursuant

to Section 10, repurchased or redeemed pursuant to Section 7 or Section 8, then, promptly after the

later of the time such Convertible Preferred Stock is deemed to cease to be outstanding pursuant to Section 3(n) and

the time such Certificate is surrendered for such conversion, repurchased or redemption, as applicable, (A) such Certificate will

be cancelled pursuant to Section 3(l); and (B) in the case of a partial conversion, repurchased or redemption, the Company

will issue, execute and deliver to such Holder, and cause the Transfer Agent to countersign one or more Certificates that (x) each

represent a whole number of shares of Convertible Preferred Stock and, in the aggregate, represent a total number of shares of Convertible

Preferred Stock equal to the number of shares of Convertible Preferred Stock represented by such old Certificate that are not to be so

converted, repurchased or redeemed, as applicable; (y) are registered in the name of such Holder; and (z) bear each legend,

if any, required by Section 3(f).

(i)            Status

of Retired Shares. Upon any share of Convertible Preferred Stock ceasing to be outstanding, such share will be deemed to be retired

and to resume the status of an authorized and unissued share of preferred stock of the Company, and such share cannot thereafter be reissued

as Convertible Preferred Stock.

(j)            Replacement

Certificates. If a Holder of any Convertible Preferred Stock claims that the Certificate(s) representing such Convertible Preferred

Stock have been mutilated, lost, destroyed or wrongfully taken, then the Company will issue, execute and deliver, and cause the Transfer

Agent to countersign, in each case in accordance with Section 3(c), a replacement Certificate representing such Convertible

Preferred Stock upon surrender to the Company or the Transfer Agent of such mutilated Certificate, or upon delivery to the Company or

the Transfer Agent of evidence of such loss, destruction or wrongful taking reasonably satisfactory to the Transfer Agent and the Company.

In the case of a lost, destroyed or wrongfully taken Certificate representing any Convertible Preferred Stock, the Company and the Transfer

Agent may require the Holder thereof to provide such security or indemnity that is reasonably satisfactory to the Company and the Transfer

Agent to protect the Company and the Transfer Agent from any loss that any of them may suffer if such Certificate is replaced. Every

replacement Convertible Preferred Stock issued pursuant to this Section 3(j) will, upon such replacement, be deemed

to be outstanding Convertible Preferred Stock, entitled to all of the benefits of this Certificate of Designations equally and ratably

with all other Convertible Preferred Stock then outstanding.

16

(k)            Registered

Holders. Only the Holder of any Convertible Preferred Stock will have rights under this Certificate of Designations as the owner

of such Convertible Preferred Stock.

(l)            Cancellation.

The Company may at any time deliver Convertible Preferred Stock to the Transfer Agent for cancellation. The Company will cause the Transfer

Agent to promptly cancel all shares of Convertible Preferred Stock so surrendered to it in accordance with its customary procedures.

(m)            Shares

Held by the Company or its Affiliates. Without limiting the generality of Section 3(o) and Section 3(n),

in determining whether the Holders of the required number of outstanding shares of Convertible Preferred Stock have concurred in any

direction, waiver or consent, shares of Convertible Preferred Stock owned by the Company or any of its Subsidiaries will be deemed not

to be outstanding.

(n)            Outstanding

Shares.

(i)            Generally.

The shares of Convertible Preferred Stock that are outstanding at any time will be deemed to be those shares of Convertible Preferred

Stock that, at such time, have been duly executed by the Company and countersigned by the Transfer Agent, excluding those shares of Convertible

Preferred Stock that have theretofore been (1) cancelled by the Transfer Agent or delivered to the Transfer Agent for cancellation

in accordance with Section 3(l); (2) paid in full upon their conversion, repurchase or redemption in accordance with

this Certificate of Designations; or (3) deemed to cease to be outstanding to the extent provided in, and subject to, Section 3(n)(ii),

Section 3(n)(iii), or Section 3(n)(iv) of this Section 3(n).

(ii)           Replaced

Shares. If any Certificate representing any share of Convertible Preferred Stock is replaced pursuant to Section 3(j),

then such share will cease to be outstanding at the time of such replacement, unless the Transfer Agent and the Company receive proof

reasonably satisfactory to them that such share is held by a “bona fide purchaser” under applicable law.

(iii)          Shares

to Be Redeemed. If, on a Holder Redemption Date, the Company has segregated, solely for the benefit of the applicable Holders, consideration

in kind and amount that is sufficient to pay the aggregate Holder Redemption Price due on such date, then (unless there occurs a default

in the payment of the Holder Redemption Price) (1) the Convertible Preferred Stock to be redeemed on such date will be deemed, as

of such date, to cease to be outstanding (without limiting the Company’s obligations pursuant to Section 5); and (2) the

rights of the Holders of such Convertible Preferred Stock, as such, will terminate with respect to such Convertible Preferred Stock,

other than the right to receive the Holder Redemption Price, as applicable, as provided in Section 7 (and, if applicable,

declared Participating Amounts as provided in Section 6).

17

(iv)          Shares

to Be Converted. If any Convertible Preferred Stock is to be converted, then, at the Close of Business on the Conversion Date for

such conversion (unless there occurs a default in the delivery of the Conversion Consideration due pursuant to Section 10 upon

such conversion): (1) such Convertible Preferred Stock will be deemed to cease to be outstanding (without limiting the Company’s

obligations pursuant to Section 5); and (2) the rights of the Holders of such Convertible Preferred Stock, as such,

will terminate with respect to such Convertible Preferred Stock, other than the right to receive such Conversion Consideration as provided

in Section 10 (and, if applicable, declared Participating Amounts as provided in Section 6).

(o)            Repurchases

by the Company and its Subsidiaries. Without limiting the generality Section 3(l) and the next sentence, the Company

may, from time to time, repurchase Convertible Preferred Stock from Holders in negotiated transactions without delivering prior notice

to other Holders. The Company will promptly deliver to the Transfer Agent for cancellation all Convertible Preferred Stock that the Company

or any of its Subsidiaries have purchased or otherwise acquired.

(p)            Notations

and Exchanges. Without limiting any rights of Holders pursuant to Section 9, if any amendment, supplement or waiver to

the Certificate of Incorporation or this Certificate of Designations changes the terms of any Convertible Preferred Stock, then the Company

may, in its discretion, require the Holder of the Certificate representing such Convertible Preferred Stock to deliver such Certificate

to the Transfer Agent so that the Transfer Agent may place an appropriate notation prepared by the Company on such Certificate and return

such Certificate to such Holder. Alternatively, at its discretion, the Company may, in exchange for such Convertible Preferred Stock,

issue, execute and deliver, and cause the Transfer Agent to countersign, in each case in accordance with Section 3(c), a

new Certificate representing such Convertible Preferred Stock that reflects the changed terms. The failure to make any appropriate notation

or issue a new Certificate representing any Convertible Preferred Stock pursuant to this Section 3(p) will not impair

or affect the validity of such amendment, supplement or waiver.

(q)            CUSIP

and ISIN Numbers. The Company may use one or more CUSIP or ISIN numbers to identify any of the Convertible Preferred Stock, and,

if so, the Company will use such CUSIP or ISIN number(s) in notices to Holders; provided, however, that the effectiveness

of any such notice will not be affected by any defect in, or omission of, any such CUSIP or ISIN number.

Section 4.               Ranking.

(a)

The Convertible Preferred Stock will rank (a) senior to (i) Dividend Junior Stock with respect to the payment of dividends; and (ii)

Liquidation Junior Stock with respect to the distribution of assets upon any Liquidation Event; and (b) equally with (i) Dividend Parity

Stock with respect to the payment of dividends; and (ii) Liquidation Parity Stock with respect to the distribution of assets upon any

Liquidation Event. For the avoidance of doubt, the issuance of Dividend Parity Stock, Dividend Senior Stock (other than the Series B-1

Preferred Stock), Liquidation Parity Stock or Liquidation Senior Stock (other than the Series B-1 Preferred Stock) is prohibited without

the prior approval of the Requisite Holders in accordance with Section 9 hereof.

(b)            Priority

Acknowledgment. For the avoidance of doubt, the Convertible Preferred Stock ranks senior to the Series B-2 Preferred Stock with

respect to (i) the payment of dividends, (ii) payment of amounts (other than Participating Amounts) due in connection with

optional redemption by holders of Convertible Preferred Stock, and (iii) the distribution of assets upon any Liquidation Event (other

than Participating Amounts). The Series B-2 Preferred Stock constitutes Liquidation

Junior Stock and Dividend Junior Stock (but is not included in Liquidation Junior Stock or Dividend Junior Stock for purposes of the

restrictions on Distributions set forth in Section 9(b)(i)(5)).

18

Section 5.               Dividends.

(a)            Regular

Dividends.

(i)            Accumulation

and Payment of Regular Dividends. The Convertible Preferred Stock will accumulate cumulative dividends at a rate per annum equal

to the Regular Dividend Rate on the then Accumulated Liquidation Preference in respect of the Convertible Preferred Stock, whether or

not declared (and including, for the avoidance of doubt, any In-Kind Dividend Payments with respect of the Convertible Preferred Stock

which have been added to the Liquidation Preference pursuant to Section 5(b)(i) on a compounding basis (the “Compounded

Dividends”) thereof (calculated in accordance with Section 5(a)(ii)), regardless of whether or not declared or

funds are legally available for their payment (such dividends that accumulate on the Preferred Stock pursuant to this sentence, “Regular

Dividends”). Subject to the other provisions of this Section 5 (including, for the avoidance of doubt, Section 5(b)(i)),

such Regular Dividends will be payable quarterly in arrears on each Regular Dividend Payment Date, to the Holders as of the Close of

Business on the immediately preceding Regular Dividend Record Date. Regular Dividends on the Convertible Preferred Stock will accumulate

daily from, and including, the last date on which Regular Dividends have been paid (or, if no Regular Dividends have been paid, from,

and including, the Initial Issue Date) to, but excluding, the next Regular Dividend Payment Date.

(ii)           Computation

of Accumulated Regular Dividends. Regular Dividends will be computed on the basis of a 360-day year comprised of twelve 30-day months.

Regular Dividends on each share of Convertible Preferred Stock will accrue on the then Accumulated Liquidation Preference (whether or

not declared) of such share as of immediately before the Close of Business on the preceding Regular Dividend Payment Date (or, if there

is no preceding Regular Dividend Payment Date, on the Initial Issue Date of such share).

(b)            Calculation

of Regular Dividends.

(i)            Generally.

Regular Dividends shall be payable in cash; provided, however, that during the period from, and including, the Initial Issue Date until,

but excluding, the Regular Dividend Payment Date next following the second anniversary of the Initial Issue Date (the “PIK Period”),

Dividends may be paid, in the Company’s sole discretion, in the dollar amount (expressed as an amount per share of Convertible

Preferred Stock) of each Regular Dividend on the Convertible Preferred Stock (whether or not declared) that has accumulated on the Convertible

Preferred Stock in respect of the Regular Dividend Period ending on, but excluding, a Regular Dividend Payment Date (each an “In-Kind

Dividend Payment”). During the PIK Period, any cash payments for Regular Dividends not received before the Close of Business

on the related Regular Dividend Payment Date, shall be construed at the Company’s election to pay such Regular Dividend as an In-Kind

Dividend Payment, which will be added, effective immediately before the Close of Business on the related Regular Dividend Payment Date,

to the then Accumulated Liquidation Preference of each share of Preferred Stock outstanding as of such time on a compounding basis. Such

addition (if any) will occur automatically, without the need for any action on the part of the Company or any other Person. Following

the expiration of the PIK Period, Regular Dividends shall be payable in cash.

19

(ii)           Construction.

Any In-Kind Dividend Payments added to the Accumulated Liquidation Preference of any share of Convertible Preferred Stock pursuant to

Section 5(b)(i) for any Dividends will be deemed to be “declared” and “paid” on such share of

Convertible Preferred Stock for all purposes of this Certificate of Designations.

(c)            Treatment

of Dividends Upon Redemption. If the Holder Redemption Date of any share of Convertible Preferred Stock is after a Record Date for

a declared Dividend on the Convertible Preferred Stock and on or before the next Dividend Payment Date, then the Holder of such share

at the Close of Business on such Record Date will be entitled, notwithstanding the related Holder Redemption to receive, on or, at the

Company’s election, before such Dividend Payment Date, such Dividend on such share. In addition, if the Holder Redemption Date

of any share of Convertible Preferred Stock is after a Regular Dividend Payment Date, then the Holder of such share on such applicable

date will be entitled, notwithstanding the related Holder Redemption, to receive, on such applicable date the amount of the Regular Dividend

accrued since the preceding Regular Dividend Payment Date up through such applicable date (including, without duplication, any Regular

Dividend not yet paid or compounded).

(d)            Dividend

Priority. For the avoidance of doubt, Dividends on the Convertible Preferred Stock shall be paid in full before any Dividends are

declared or paid on the Series B-2 Preferred Stock. The Company shall not declare or pay any Dividend on the Series B-2 Preferred

Stock unless all accrued and unpaid Dividends on the Convertible Preferred Stock have been paid in full or set aside for payment. To

the extent that funds available for the payment of Dividends are insufficient to pay Dividends on both the Convertible Preferred Stock

and the Series B-2 Preferred Stock in full, Dividends on the Convertible Preferred Stock shall be paid first, and any remaining

funds shall be applied to the payment of Dividends on the Series B-2 Preferred Stock.

Section 6.               Rights

Upon Liquidation, Dissolution or Winding Up.

(a)           Generally.

Upon any Liquidation Event, then, subject to the rights of any of the Company’s creditors or holders of any outstanding Liquidation

Senior Stock, each share of Convertible Preferred Stock will entitle the Holder thereof to receive payment in cash of the then applicable

Liquidation Preference per share of Convertible Preferred Stock, before any such assets or funds are distributed to, or set aside for

the benefit of, any Liquidation Junior Stock.

(b)            Participation.

Following the payment in full of the Liquidation Preference to the Holders pursuant to clause (a) and

the payment in full of the liquidation preference pursuant to Section 6(a) of the Series B-2 Preferred Stock, the Holders

shall be entitled to participate, together with the holders of Common Stock (and any other capital stock

of the Company entitled to participate therein as stockholders), in any remaining assets of the Company available for distribution to

stockholders, on a pro-rata as-converted basis, as if the shares of Convertible Preferred Stock had been converted into Common Stock

immediately prior to such Liquidation Event (such participation rights, the “Participating Amount”); provided that

the aggregate amount of consideration payable or otherwise deliverable with respect to each share of Convertible Preferred Stock pursuant

to this Section 6 (including, without limitation, amounts paid pursuant to Section 6(a) and Section 6(b))

shall not exceed two (2.0) times the Liquidation Preference per share (the “Maximum Return”). For the avoidance of

doubt, and without limiting the ability of a Holder to convert Convertible Preferred Stock into Common Stock in accordance with the terms

of Section 10 or a Holder’s rights pursuant to Section 6(c), once a Holder has received aggregate consideration

pursuant to this Section 6 equal to the Maximum Return with respect to any share of Convertible Preferred Stock, such share

shall cease to participate in any further distributions in connection with such Liquidation Event.

20

(c)            As-Converted

Alternative. Notwithstanding the foregoing, in lieu of receiving the amounts described in Sections 6(a) and 6(b), each

Holder shall have the right, at its election, to receive the amount such holder would have received if such holder had converted such

share of Convertible Preferred Stock into Common Stock immediately prior to the consummation of the Liquidation Event pursuant to Section 10.

The Company shall provide reasonable prior written notice of any Liquidation Event, including a good faith estimate of the consideration

payable under each alternative described herein.

(d)            Liquidation

Priority. For the avoidance of doubt, upon any Liquidation Event, the Liquidation Preference of all outstanding shares of Convertible

Preferred Stock shall be paid in full before any distribution is made to holders of Series B-2 Preferred Stock or Liquidation Junior

Stock; provided, however, in the event that any Holder of Convertible Preferred Stock does not exercise its optional redemption right,

or is otherwise not immediately eligible for payment of the Liquidation Preference with respect to its Convertible Preferred Stock, (i) the

Company shall segregate, solely for the benefit of the applicable Holders, consideration in kind and amount that is sufficient to pay

the applicable Liquidation Preferences due with respect and (ii) the rights of the Holders of such Convertible Preferred Stock,

as such, will terminate with respect to such Convertible Preferred Stock, other than the right to receive the Holder Redemption Price,

as applicable, as provided in Section 7 (and, if applicable, declared Participating Amounts as provided in Section 6).

No distribution shall be made to holders of Series B-2 Preferred Stock or Liquidation Junior Stock upon any Liquidation Event unless

and until the Liquidation Preference of all outstanding shares of Convertible Preferred Stock has been paid in full or segregated in

accordance with the immediately preceding sentence.

Section 7.                Holder

Redemption.

(a)            Mandatory

Redemption Upon Holder’s Option. Subject to the terms of this Section 7(a) and the Delaware General Corporation

Law, each Holder shall have the right, at any time and from time to time following the occurrence of a Redemption Event, to require the

Company to redeem all or any portion of such Holder’s Convertible Preferred Stock for a cash purchase price equal to the Holder

Redemption Price (a “Holder Redemption”).

(i)            Redemption

Demand; Mandatory Redemption Date. In order to exercise a Holder Redemption, Holder shall deliver to the Company, at its principal

executive offices, a written notice (a “Holder Redemption Demand”) specifying (1) that such Holder elects to

have the Company redeem shares of Convertible Preferred Stock held by such Holder, (2) the number of shares to be so redeemed, which

may be all or any portion of the shares of Convertible Preferred Stock then held by such Holder, and (3) the Business Day on which

such redemption is to occur (the “Holder Redemption Date”); provided that the Holder Redemption Date shall

be a Business Day that is not earlier than five (5) Business Days nor later than thirty (30) Business Days after the date on which

the Holder Redemption Demand is delivered to the Company, or such other date as the Company and such Holder may mutually agree.

21

(ii)           Holder

Redemption Price. On each Holder Redemption Date, subject to Section 7(a)(iv), the Company shall redeem the number of shares

of Convertible Preferred Stock specified in the applicable Holder Redemption Demand by paying to such Holder, in cash, by wire transfer

of immediately available funds, an amount (the “Holder Redemption Price”) equal to the Liquidation Preference of such

share, and, solely to the extent the applicable Redemption Event arises from or in connection with a Liquidation Event or a Fundamental

Transaction that would generate distributable proceeds, any Participating Dividends that would be payable pursuant to Section 6(b) (subject

to the Maximum Return)) on such share to, but excluding, the applicable Holder Redemption Date in accordance with Section 5(c).

(iii)          Surrender

of Certificates. On or before the applicable Holder Redemption Date, each Holder electing a Holder Redemption shall surrender to

the Company at its principal executive offices the certificate or certificates, if any, representing the shares of Convertible Preferred

Stock to be redeemed, (or if such shares held as an Electronic Certificate, shall comply with the applicable procedures of the Company's

Transfer Agent). Upon receipt of such certificate(s) or confirmation of book-entry transfer and payment of the Holder Redemption

Price in respect of such shares in accordance with Sections 7(a)(ii) and 7(c), the shares so redeemed shall be canceled and shall

no longer be outstanding.

(iv)          Limitations;

Insufficient Legally Available Funds. (i) Notwithstanding anything to the contrary contained herein, the Company shall not be

required to redeem any shares of Convertible Preferred Stock pursuant to this Section 7(a)(iv) to the extent that such redemption

would violate the Delaware General Corporation Law or any other applicable law governing distributions to stockholders or applicable

exchange rules, (ii) in the event that, as of any Holder Redemption Date, the aggregate funds of the Company legally available for

the redemption of shares of Convertible Preferred Stock pursuant to this Section 7(a)(iv) are insufficient to redeem in full

all shares of Convertible Preferred Stock that are subject to Holder Redemption on such date, whether pursuant to one or more Holder

Redemption Demands outstanding, the Company shall (A) redeem pro rata among all holders who have delivered Holder Redemption Demands

to the extent of such legally available funds, the maximum number of shares of Convertible Preferred Stock that can be redeemed with

such funds at the applicable Holder Redemption Price and, thereafter, from time to time as funds become legally available for the redemption

of such shares in accordance with the Delaware General Corporation Law, promptly redeem the balance of the shares of Convertible Preferred

Stock then subject to Holder Redemption, pro rata among the holders remaining entitled to redemption, at the applicable Holder Redemption

Price. The shares of Convertible Preferred Stock not redeemed on any Holder Redemption Date as a result of the limitations in this Section 7(a)(iv) shall

remain outstanding and shall continue to be entitled to all of the rights and preferences provided herein, including the right to future

Holder Redemption in accordance with this Section 7.

22

(v)           Conversion

in Lieu of Cash Redemption. To the extent that cash redemption of any shares of Convertible Preferred Stock is prohibited by the

Delaware General Corporation Law, the applicable Holder may, at its election, convert all or any portion of such shares into shares of

Common Stock in accordance with Section 10 in lieu of receiving a cash redemption payment for such portion. Any portion of the Convertible

Preferred Stock that is neither redeemed nor converted pursuant to this Section 7(a)(v) shall remain outstanding and shall

continue to accrue dividends, and the Company shall redeem such remaining portion as soon as legally available funds become available.

(vi)          Individual

Holder Right. The Holder Redemption right, set forth in this Section 7, is a separate and individual right of each Holder and

may be exercised from time to time at the election of any such Holder with respect to all or any portion of the shares of Convertible

Preferred Stock then held by such Holder, without the consent of any other Holder and whether or not any other Holder elects to exercise

such right. No vote or consent of the Holders of Convertible Preferred Stock, voting together or separately as a class, shall be required

for any individual Holder to exercise its Holder Redemption right pursuant to this Section 7.

(b)            Redemption

Event Notice by Company. Upon the occurrence of a Redemption Event (or, if earlier, upon the Company determining in good faith that

a Redemption Event is reasonably likely to occur), the Company will send to each Holder a notice of such Redemption Event (a “Redemption

Event Notice”) containing the information set forth below:

(i)            briefly,

the events comprising a Redemption Event;

(ii)           the

effective date of such Redemption Event;

(iii)          the

Holder Redemption Price per share of Convertible Preferred Stock as of the date of such Redemption Event;

(iv)          the

Conversion Price in effect on the date of such Redemption Event Notice and a description and quantification of any adjustments to the

Conversion Price that may result from such Redemption Event;

(vi)          that

shares of Convertible Preferred Stock for which a Holder Redemption Demand has been duly tendered and not duly withdrawn must be delivered

to the Company for the Holder thereof to be entitled to receive the Holder Redemption Price;

(vii)          that

shares of Convertible Preferred Stock that are subject to a Holder Redemption Demand that has been duly tendered may be converted only

if such Holder Redemption Demand is withdrawn in accordance with this Certificate of Designations; and

(viii)        the

CUSIP and ISIN numbers, if any, of the Convertible Preferred Stock.

The failure of the Company to

deliver any Redemption Event Notice shall not impair, limit or otherwise affect the rights of any Holder to exercise any right or remedy

arising as a result of such Redemption Event, including, without limitation, the right to require redemption pursuant to the terms hereof,

nor shall such failure delay the time at which any such rights become exercisable.

(c)            Payment

of the Holder Redemption Price. The Company will cause the Holder Redemption Price for each share of Convertible Preferred Stock

to be redeemed pursuant to a Holder Redemption to be paid to the Holder thereof on or before the later of (i) ten (10) Business

Days following the Company’s receipt of the applicable Holder Redemption Demand; and (ii) the date such share of Convertible

Preferred Stock is tendered to the Transfer Agent or the Company.

23

(d)            Redemption

Priority. For the avoidance of doubt, upon any Holder Redemption, the Holder Redemption Price for all shares of Convertible Preferred

Stock subject to Holder Redemption shall be paid in full before any Holder Redemption Price is paid to holders of Series B-2 Preferred

Stock; provided, however, in the event that any Holder of Convertible Preferred Stock does not exercise its optional redemption right,

or is otherwise not immediately eligible for payment of the Liquidation Preference with respect to its Convertible Preferred Stock, (i) the

Company shall segregate, solely for the benefit of the applicable Holders, consideration in kind and amount that is sufficient to pay

the applicable Liquidation Preferences due with respect thereto plus all accrued and unpaid dividends, whether or not declared (and including,

for the avoidance of doubt, any Compounded Dividends) and (ii) the rights of the Holders of such Convertible Preferred Stock, as

such, will terminate with respect to such Convertible Preferred Stock, other than the right to receive the Holder Redemption Price, as

applicable, as provided in Section 7 (and, if applicable, declared Participating Amounts as provided in Section 6). If on any

Holder Redemption Date, funds legally available for redemption are insufficient to redeem (or segregate in accordance with the immediately

sentence) in full all shares of Convertible Preferred Stock and Series B-2 Preferred Stock that are subject to Holder Redemption

on such date, the Company shall first redeem shares of Convertible Preferred Stock (or segregate in accordance with the immediately preceding

sentence) pro rata among holders thereof until all such shares are redeemed in full, and only thereafter redeem shares of Series B-2

Preferred Stock pro rata among holders thereof.

(e)             Mandatory

Redemption. The Company may, at its option, require all (but not less than all) outstanding shares of Convertible Preferred Stock,

inclusive of accrued dividends paid in cash or additional shares of Common Stock, to convert into fully paid and non-assessable shares

of Common Stock (a “Mandatory Conversion”) upon written notice to holders if:

(i)        the

closing price of the Common Stock equals or exceeds 2.5x the then- applicable Liquidation Preference for any 20 Trading Days within any

consecutive 30 Trading Day period (the “Price Trigger”), provided that no Price Trigger may be declared earlier than

six (6) months following the Closing Date;

(ii)        the

average daily dollar trading volume of the Common Stock during the 30 Trading Day period applicable for the Price Trigger is not less

than 25% of the value of the total Liquidation Preference of the Convertible Preferred Stock subject to Mandatory Conversion; and

(iii)     with

respect to any holder subject to a then-applicable voting cap, any shares of Convertible Preferred Stock that cannot be converted into

common stock by reason of such voting cap shall, in lieu of remaining outstanding as Preferred Stock, be automatically exchanged for

prefunded warrants exercisable for the number of shares of common stock into which such preferred stock would otherwise have converted,

subject to the voting cap limitation elected by each applicable holder.

Section 8.               [RESERVED]

Section 9.                Voting

Rights.

(a)            Right

to Vote with Holders of Common Stock on an As-Converted Basis. Subject to the other provisions of, and without limiting the other

voting rights provided in, this Section 9, and except as provided in the Certificate of Incorporation or required by the

Delaware General Corporation Law, the Holders will have the right to vote together as a single class with the holders of the Common Stock

on each matter submitted for a vote or consent by the holders of the Common Stock, and, for these purposes, (i) the Convertible

Preferred Stock of each Holder will entitle such Holder to be treated as if such Holder were the holder of record, as of the record or

other relevant date for such matter, of a number of shares of Common Stock equal to the number of shares of Common Stock that would be

issuable (determined in accordance with Section 10(e), including Section 10(e)(ii), but without regarding to

Section 10(e)(iii)) upon conversion of such Convertible Preferred Stock assuming such Convertible Preferred Stock were converted

with a Conversion Date occurring on such record or other relevant date; and (ii) the Holders will be entitled to notice of all stockholder

meetings or proposed actions by written consent in accordance with the Certificate of Incorporation, the Bylaws of the Company, and the

Delaware General Corporation Law as if the Holders were holders of Common Stock.

24

(b)            Voting

and Consent Rights with Respect to Specified Matters.

(i)            Generally.

Subject to the other provisions of this Section 9, while any Convertible Preferred Stock is outstanding, each of the following

events will require, and cannot be effected without, the affirmative vote or consent of Holders representing a majority of the outstanding

shares of Series B-1 Preferred Stock (the “Requisite Holders”):

(1)            authorization

or issuance of additional shares of Convertible Preferred Stock or Series B-2 Preferred Stock or any amendment or modification of

the Certificate of Incorporation to authorize or create, or to increase the authorized number of shares of, any class or series of, or

Equity-Linked Security or other equity interest convertible into, Dividend Parity Stock, Liquidation Parity Stock, Dividend Senior Stock

or Liquidation Senior Stock;

(2)            any

amendment, modification or repeal of any provision of the Certificate of Incorporation, Bylaws or this Certificate of Designations that

adversely affects the rights, preferences or voting powers of the Convertible Preferred Stock (other than an amendment, modification

or repeal permitted by Section 9(b)(ii));

(3)            consummation

of a Liquidation Event or Fundamental Transaction unless (x) the aggregate consideration payable pursuant to such Liquidation Event

or Fundamental Transaction equals or exceeds the Liquidation Preference payable to the Holders and the holders of Series B-2 Preferred

Stock and (y) the Holders, and the holders of Series B-2 Preferred Stock, may elect to be paid the Liquidation Preference in

cash (or other liquid assets that may be held in the Digital Asset Treasury);

(4)            creation,

issuance, or designation of any new class or series of Capital Stock ranking senior to or pari passu with the Convertible Preferred Stock

with respect to liquidation preference or dividends;

(5)            declaration

or payment of any dividends or distributions upon, or redemptions, repurchases or other acquisitions of Dividend Junior Stock or Liquidation

Junior Stock (“Distributions”) other than the payment of Dividends on the Series B-2 Preferred Stock;

(6)            direct

or indirect redemption, repurchase or other acquisition through the payment of cash, distribution of assets, incurrence of indebtedness

for such purpose, or any substantially equivalent transaction (or the payment into or set aside for a sinking fund for such purpose)

of any shares of Junior Stock or Parity Stock, except for (i) repurchases of Common Stock from employees, officers, directors or

consultants of the Company or its subsidiaries pursuant to equity incentive plans or agreements approved by the Board, or (ii) other

repurchases expressly approved in writing by the Requisite Holders.

25

(7)            direct

or indirect creation, incurrence, assumption or allowance to exist of any Lien on (x) any assets of

the Digital Asset Treasury Subsidiary, except for Liens permitted pursuant to the Digital Asset Treasury Procedures and arising in connection

with custody, staking, or other customary operational arrangements in the ordinary course of business that do not secure indebtedness

for borrowed money or (y) any other assets or property of the Company or any Subsidiary, whether now owned or hereafter, acquired

other than in the case of this clause (y), Permitted Liens.

(8)            distribution

of any material asset from the Digital Asset Treasury, including the transfer of assets to counterparties (including protocols) not in

compliance with the Digital Asset Treasury Procedures, or any failure to house all Digital Assets and designated cash of the Company

and its Subsidiaries (other than General Proceeds) in a Digital Asset Treasury Subsidiary (such that all such assets remain subject to

the Guaranty).

(9)            incurrence,

assumption, or guarantee of indebtedness for borrowed money in excess of $1,000,000 in the aggregate other than: (a) trade payables

and operating liabilities incurred in the ordinary course not exceeding $1,000,000 in the aggregate; and (b) indebtedness existing

as of Closing and disclosed in the Transaction Documents.

(10)          any

action with respect to any Digital Asset Treasury Subsidiary of the Company that, if taken by the Company, would require approval of

the Requisite Holders pursuant to the protective provisions set forth in clauses (1) through (9) above.

(11)          waive,

or otherwise permit to exist and continue, an Event of Default; provided that any cure or waiver of such Event of Default in accordance

with the terms of the applicable Transaction Document shall automatically cure the corresponding cross-default hereunder.

(12)          with

respect to any Digital Asset Treasury Subsidiary: (A) the formation, dissolution, liquidation, winding up or termination of any

Digital Asset Treasury Subsidiary; (B) any amendment, modification or restatement of the certificate of incorporation, certificate

of formation, bylaws, operating agreement or other organizational documents of any Digital Asset Treasury Subsidiary; (C) any change

of the jurisdiction of organization or formation of any Digital Asset Treasury Subsidiary; (D) any voluntary filing of a petition

for bankruptcy, reorganization, arrangement, insolvency or similar relief, or the consent to the filing of any involuntary petition,

with respect to any Digital Asset Treasury Subsidiary; (E) any merger, consolidation, conversion, division or other business combination

involving any Digital Asset Treasury Subsidiary; (F) any sale, lease, transfer or other disposition of all or substantially all

of the assets of any Digital Asset Treasury Subsidiary (other than distributions to the Company or another Digital Asset Treasury Subsidiary

permitted pursuant to the Digital Asset Treasury Procedures); (G) unless determined by the board of directors of the Company to

be required to satisfy its fiduciary duties, any intercompany loan, dividend, distribution or other transfer of value from any Digital

Asset Treasury Subsidiary to the Company or any other Subsidiary (other than a Digital Asset Treasury Subsidiary), except as expressly

permitted pursuant to the Digital Asset Treasury Procedures; (H) unless determined by the board of directors of the Company to be

required to satisfy its fiduciary duties, any commingling of assets of any Digital Asset Treasury Subsidiary with assets of the Company

or any other Subsidiary that is not a Digital Asset Treasury Subsidiary; (I) any amendment, modification, termination or waiver

of any material provision of the Guaranty; or (J) any action that would reasonably be expected to impair the validity or enforceability

of the Guaranty.

26

(ii)          Certain

Amendments Permitted Without Consent. Notwithstanding anything to the contrary in Section 9(b)(i), the Company may amend,

modify or repeal any of the terms of the Convertible Preferred Stock without the vote or consent of any Holder to:

(1)            cure

any ambiguity or correct any omission, defect or inconsistency in this Certificate of Designations or the Certificates representing the

Convertible Preferred Stock, including the filing of a certificate of correction, or a corrected instrument, pursuant to Section 103(f) of

the Delaware General Corporation Law in connection therewith; or

(2)            make

any other change to the Certificate of Incorporation, this Certificate of Designations or the Certificates representing the Convertible

Preferred Stock that does not, individually or in the aggregate with all other such changes, adversely affect the rights of any Holder

(other than any Holders that have consented to such change), as such, in any material respect (as determined by the Board of Directors

in good faith).

(iii)            Amendment

Coordination with Series B-2 Preferred Stock. Notwithstanding anything to the contrary in this Section 9, any amendment,

modification or repeal of any provision of this Certificate of Designations that would (1) reduce the Convertible Preferred Stock’s

liquidation or dividend priority relative to the Series B-2 Preferred Stock, (2) make the Series B-2 Preferred Stock pari

passu with or senior to the Convertible Preferred Stock with respect to dividends or liquidation, or (3) modify the payment waterfall

provisions set forth in Section 5(e), Section 6(d) or Section 7(d), shall require the affirmative

vote or consent of the Requisite Holders

(c)            Procedures

for Voting and Consents.

(i)            Rules and

Procedures Governing Votes and Consents. If any vote or consent of the Holders will be held or solicited, including at a regular

annual meeting or a special meeting of stockholders, then (1) the Board of Directors will adopt customary rules and procedures

at its discretion to govern such vote or consent, subject to the other provisions of this Section 9; and (2) such rules and

procedures may include fixing a record date to determine the Holders that are entitled to vote or provide consent, as applicable, and

rules governing the solicitation and use of proxies or written consents; provided, however, that with respect to any

voting rights of the Holders pursuant to Section 9(c), such rules and procedures will be the same rules and procedures

that apply to holders of the Common Stock with respect to the applicable matter referred to in Section 9(c).

(ii)            Written

Consent in Lieu of Stockholder Meeting. A consent or affirmative vote of the Holders pursuant to Section 9(b)(i) may

be given or obtained either in writing without a meeting or in person or by proxy at a regular annual meeting or a special meeting of

stockholders.

27

Section 10.              Conversion.

(a)            Generally.

Subject to the provisions of this Section 10, the Convertible Preferred Stock may be converted only pursuant to an Optional

Conversion.

(b)            Conversion

at the Option of the Holders.

(i)            Conversion

Right; When Shares May Be Submitted for Optional Conversion. Holders will have the right to submit all, or any whole number

of shares that is less than all, of their shares of Convertible Preferred Stock pursuant to an Optional Conversion at any time subject

to, unless waived in writing by such Holder the Beneficial Ownership Limitation; provided, however, that, notwithstanding

anything to the contrary in this Certificate of Designations, if a Holder Redemption Demand is validly delivered pursuant to Section 7

with respect to any share of Convertible Preferred Stock, then such share may not be submitted for Optional Conversion, except to the

extent (A) such share is not subject to such notice; (B) such notice is withdrawn in accordance with Section 7;

or (C) the Company fails to pay the Holder Redemption Price for such share in accordance with this Certificate of Designations.

(ii)           Conversions

of Fractional Shares Not Permitted. Notwithstanding anything to the contrary in this Certificate of Designations, in no event will

any Holder be entitled to convert a number of shares of Convertible Preferred Stock that is not a whole number.

(iii)           Contingent

Conversion Notice. A Holder delivering an Optional Conversion Notice hereunder may specify in such Optional Conversion Notice that

its election to effect such conversion is contingent upon the consummation of a Change of Control, in which case such Optional Conversion

shall not occur until such time as such Change of Control has been consummated, and if such Change of Control is terminated or cancelled,

such Optional Conversion Notice shall be deemed to be withdrawn. For the avoidance of doubt, any such contingent Optional Conversion

shall occur prior to the Holder Redemption that would have otherwise been effected in connection with such Change of Control.

(d)            Conversion

Procedures.

(i)      Requirements

for Holders to Exercise Optional Conversion Right.

(1)            Generally.

To convert any share of Convertible Preferred Stock pursuant to an Optional Conversion, the Holder of such share must (w) complete,

manually sign and deliver to the Company an Optional Conversion Notice; (x) deliver any Physical Certificate(s) representing

such Convertible Preferred Stock to the Company (at which time such Optional Conversion will become irrevocable); (y) furnish any

endorsements and transfer documents that the Company may require; and (z) if applicable, pay any documentary or other taxes.

(2)            Optional

Conversion Permitted only During Business Hours.

28

Convertible Preferred Stock may be

surrendered for Optional Conversion only after the Open of Business and before the Close of Business on a day that is a Business Day.

(ii)      When

Holders Become Stockholders of Record of the Shares of Common Stock Issuable Upon Conversion. The Person in whose name any share

of Common Stock is issuable upon conversion of any Convertible Preferred Stock will be deemed to become the holder of record of such

share as of the Close of Business on the Conversion Date for such conversion.

(e)            Settlement

upon Conversion.

(i)            Generally.

Subject to Section 5, Section 10(e)(ii), Section 12(b), and, unless waived in writing by the applicable

Holder, the Beneficial Ownership Limitation the consideration due upon settlement of the conversion of each share of Convertible Preferred

Stock will consist of a number of shares of Common Stock equal to the quotient obtained by dividing (I) the Initial Liquidation

Preference of such share of Convertible Preferred Stock immediately before the Close of Business on the Conversion Date for such conversion;

by (II) the Conversion Price in effect immediately before the Close of Business on such Conversion Date, such that each share of

Convertible Preferred Stock is initially convertible into one (1) share of Common Stock, subject to adjustment for stock splits,

stock dividends, combinations and similar events in accordance with Section 10(f).

(ii)           Payment

of Cash in Lieu of any Fractional Share of Common Stock.

Subject to Section 12(b),

in lieu of delivering any fractional share of Common Stock otherwise due upon conversion of any Convertible Preferred Stock, the Company

will, to the extent it is legally able to do so and permitted under the terms of its indebtedness for borrowed money, pay cash based

on the Last Reported Sale Price per share of Common Stock on the Conversion Date for such conversion (or, if such Conversion Date is

not a Trading Day, the immediately preceding Trading Day).

(iii)          [deleted].

(iv)          Delivery

of Conversion Consideration. Except as provided in Section 10(f)(i)(2) and Section 10(h), the Company

will pay or deliver, as applicable, the Conversion Consideration due upon conversion of any Convertible Preferred Stock on or before

the second (2nd) Trading Day immediately after the Conversion Date for such conversion.

(f)            Conversion

Price Adjustments.

(i)            Events

Requiring an Adjustment to the Conversion Price. The Conversion Price will be adjusted from time to time as follows:

(1)            Stock

Dividends, Splits and Combinations. If the Company issues solely shares of Common Stock as a dividend or distribution on all or substantially

all shares of the Common Stock, or if the Company effects a stock split or a stock combination of the Common Stock (in each case excluding

an issuance solely pursuant to a Common Stock Change Event, as to which Section 10(h) will apply), then the Conversion

Price will be adjusted based on the following formula:

29

where:

CP0

=

the

Conversion Price in effect immediately before the Close of Business on the Record Date for such dividend or distribution, or immediately

before the Close of Business on the effective date of such stock split or stock combination, as applicable;

CP1

=

the

Conversion Price in effect immediately after the Close of Business on such Record Date or effective date, as applicable;

OS0

=

the

number of shares of Common Stock outstanding immediately before the Close of Business on such Record Date or effective date, as applicable,

without giving effect to such dividend, distribution, stock split or stock combination; and

OS1

=

the

number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, stock split or stock

combination.

If any dividend, distribution, stock split or

stock combination of the type described in this Section 10(f)(i)(1) is declared or announced, but not so paid or made,

then the Conversion Price will be readjusted, effective as of the date the Board of Directors, or any Officer acting pursuant to authority

conferred by the Board of Directors, determines not to pay such dividend or distribution or to effect such stock split or stock combination,

to the Conversion Price that would then be in effect had such dividend, distribution, stock split or stock combination not been declared

or announced.

(2)            Tender

Offers or Exchange Offers. If the Company or any of its Subsidiaries makes a payment in respect of a tender offer or exchange offer

for shares of Common Stock (other than solely pursuant to an odd-lot tender offer pursuant to Rule 13e-4(h)(5) under the Exchange

Act), and the value (determined as of the Expiration Time by the Board of Directors) of the cash and other consideration paid per share

of Common Stock in such tender or exchange offer exceeds the Last Reported Sale Price per share of Common Stock on the Trading Day immediately

after the last date (the “Expiration Date”) on which tenders or exchanges may be made pursuant to such tender or exchange

offer (as it may be amended), then the Conversion Price will be decreased based on the following formula:

where:

CP0

=

the Conversion Price

in effect immediately before the time (the “Expiration Time”) such tender or exchange offer expires;

CP1

=

the Conversion Price

in effect immediately after the Expiration Time;

30

SP

=

the average of the Last Reported Sale Prices per share of Common Stock over the ten (10) consecutive Trading Day period (the “Tender/Exchange Offer Valuation Period”) beginning on, and including, the Trading Day immediately after the Expiration Date;

OS0

=

the number of shares of Common Stock outstanding immediately before the Expiration Time (including all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);

AC

=

the aggregate value (determined as of the Expiration Time by the Board of Directors) of all cash and other consideration paid for shares of Common Stock purchased or exchanged in such tender or exchange offer; and

OS1

=

the number of shares of Common Stock outstanding immediately after the Expiration Time (excluding all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);

provided, however, that the Conversion

Price will in no event be adjusted up pursuant to this Section 10(f)(i)(2), except to the extent provided in the immediately

following paragraph. The adjustment to the Conversion Price pursuant to this Section 10(f)(i)(2) will be calculated

as of the Close of Business on the last Trading Day of the Tender/Exchange Offer Valuation Period but will be given effect immediately

after the Expiration Time, with retroactive effect. If the Conversion Date for any share of Convertible Preferred Stock to be converted

occurs on the Expiration Date or during the Tender/Exchange Offer Valuation Period, then, notwithstanding anything to the contrary in

this Certificate of Designations, the Company will, if necessary, delay the settlement of such conversion until the second (2nd) Business

Day after the last Trading Day of the Tender/Exchange Offer Valuation Period.

To the extent such tender or exchange offer is

announced but not consummated (including as a result of being precluded from consummating such tender or exchange offer under applicable

law), or any purchases or exchanges of shares of Common Stock in such tender or exchange offer are rescinded, the Conversion Price will

be readjusted to the Conversion Price that would then be in effect had the adjustment been made on the basis of only the purchases or

exchanges of shares of Common Stock, if any, actually made, and not rescinded, in such tender or exchange offer.

31

(ii)            No

Adjustments in Certain Cases.

(1)            Certain

Events. Without limiting the operation of Section 5 and Section 10(e)(i), the Company will not be required

to adjust the Conversion Price except pursuant to Section 10(f)(i). Without limiting the foregoing, the Company will not

be required to adjust the Conversion Price on account of:

(A)            the

sale of shares of Common Stock for a purchase price that is less than the market price per share of Common Stock or less than the Conversion

Price;

(B)            the

issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest

payable on the Company’s securities and the investment of additional optional amounts in shares of Common Stock under any such

plan;

(C)            the

issuance of any shares of Common Stock or options or rights to purchase shares of Common Stock pursuant to any present or future employee,

director or consultant benefit plan or program of, or assumed by, the Company or any of its Subsidiaries;

(D)            the

issuance of any shares of Common Stock pursuant to any option, warrant, right or convertible or exchangeable security of the Company

outstanding as of the Initial Issue Date;

(E)            the

issuance of any shares of Common Stock pursuant to any option, warrant, right or convertible or exchangeable security of the Company

in connection with any commercial arrangement between the Company and a third party approved by the Requisite Holders, which third party

receives securities of the Company in connection with any such commercial agreement; or

(F)           solely

a change in the par value of the Common Stock.

(iii)           Adjustment

Deferral. If an adjustment to the Conversion Price otherwise required by this Certificate of Designations would result in a change

of less than one percent (1%) to the Conversion Price, then the Company may, at its election, defer such adjustment, except that all

such deferred adjustments must be given effect immediately upon the earliest of the following: (1) when all such deferred adjustments

would result in a change of at least one percent (1%) to the Conversion Price; (2) the Conversion Date of any share of Convertible

Preferred Stock; (3) the Holder Redemption Date for any Holder Redemption; and (4) the occurrence of any vote of the stockholders

of the Company.

(iv)          Stockholder

Rights Plans. If any shares of Common Stock are to be issued upon conversion of any Convertible Preferred Stock and, at the time

of such conversion, the Company has in effect any stockholder rights plan, then the Holder of such Convertible Preferred Stock will be

entitled to receive, in addition to, and concurrently with the delivery of, the consideration otherwise due upon such conversion, the

rights set forth in such stockholder rights plan.

32

(v)            Determination

of the Number of Outstanding Shares of Common Stock. For purposes of Section 10(f)(i), the number of shares of Common

Stock outstanding at any time will (1) include shares issuable in respect of scrip certificates issued in lieu of fractions of shares

of Common Stock; and (2) exclude shares of Common Stock held in the Company’s treasury (unless the Company pays any dividend

or makes any distribution on shares of Common Stock held in its treasury).

(vi)         Calculations.

All calculations with respect to the Conversion Price and adjustments thereto will be made to the nearest 1/100th of a cent (with 5/1,000ths

rounded upward).

(vii)         Notice

of Conversion Price Adjustments. Upon the effectiveness of any adjustment to the Conversion Price pursuant to Section 10(f)(i),

the Company will, as soon as reasonably practicable and no later than ten (10) Business Days after the date of such effectiveness,

send notice to the Holders containing (1) a brief description of the transaction or other event on account of which such adjustment

was made; (2) the Conversion Price in effect immediately after such adjustment; and (3) the effective time of such adjustment.

(g)            Voluntary

Conversion Price Decreases.

(i)            Generally.

To the extent permitted by law and applicable stock exchange rules, the Company, from time to time, may (but is not required to) decrease

the Conversion Price by any amount if (1) the Board of Directors determines that such decrease is in the Company’s best interest

or that such decrease is advisable to avoid or diminish any income tax imposed on holders of Common Stock or rights to purchase Common

Stock as a result of any dividend or distribution of shares (or rights to acquire shares) of Common Stock or any similar event; (2) such

decrease is in effect for a period of at least twenty (20) Business Days; and (3) such decrease is irrevocable during such period;

provided, however, that any such decrease that would reasonably be expected to result in any income tax imposed on holders of Convertible

Preferred Stock shall require the affirmative vote or consent of Holders representing a majority of the outstanding shares of Convertible

Preferred Stock.

(ii)           Notice

of Voluntary Decrease. If the Board of Directors determines to decrease the Conversion Price pursuant to Section 10(g)(i),

then, no later than the first Business Day of the related twenty (20) Business Day period referred to in Section 10(g)(i),

the Company will send notice to each Holder of such decrease to the Conversion Price, the amount thereof and the period during which

such decrease will be in effect.

(h)            Effect

of Common Stock Change Event.

(i)            Generally.

If there occurs any:

(1)            recapitalization,

reclassification or change of the Common Stock, other than (x) changes solely resulting from a subdivision or combination of the

Common Stock, (y) a change only in par value or from par value to no par value or no par value to par value or (z) stock splits

and stock combinations that do not involve the issuance of any other series or class of securities;

(2)            consolidation,

merger, combination or binding or statutory share exchange involving the Company;

(3)            sale,

lease or other transfer of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to any Person;

or

33

(4)           other

similar event, and, as a result of which, the Common Stock is converted into, or is exchanged for, or represents solely the right to

receive, other securities, cash or other property, or any combination of the foregoing (such an event, a “Common Stock Change

Event,” and such other securities, cash or property, the “Reference Property,” and the amount and kind of

Reference Property that a holder of one (1) share of Common Stock would be entitled to receive on account of such Common Stock Change

Event (without giving effect to any arrangement not to issue or deliver a fractional portion of any security or other property), a “Reference

Property Unit”), then, notwithstanding anything to the contrary in this Certificate of Designations,

(A)            from

and after the effective time of such Common Stock Change Event, (I) the consideration due upon conversion of any Convertible Preferred

Stock will be determined in the same manner as if each reference to any number of shares of Common Stock in this Section 10

or in Section 11, or in any related definitions, were instead a reference to the same number of Reference Property Units;

(II) for purposes of Section 7 and Section 8, each reference to any number of shares of Common Stock in

such Sections (or in any related definitions) will instead be deemed to be a reference to the same number of Reference Property Units;

and (III) for purposes of the definition of “Change of Control,” the term “Common Stock” will be deemed

to mean the common equity (including depositary receipts representing common equity), if any, forming part of such Reference Property;

and

(B)            for

these purposes, (I) the Daily VWAP of any Reference Property Unit or portion thereof that consists of a class of common equity securities

will be determined by reference to the definition of “Daily VWAP,” substituting, if applicable, the Bloomberg page for

such class of securities in such definition; and (II) the Daily VWAP of any Reference Property Unit or portion thereof that does

not consist of a class of common equity securities, and the Last Reported Sale Price of any Reference Property Unit or portion thereof

that does not consist of a class of securities, will be the fair value of such Reference Property Unit or portion thereof, as applicable,

determined in good faith by the Company (or, in the case of cash denominated in U.S. dollars, the face amount thereof).

If the Reference

Property consists of more than a single type of consideration to be determined based in part upon any form of stockholder election, then

the composition of the Reference Property Unit will be deemed to be the weighted average of the types and amounts of consideration actually

received, per share of Common Stock, by the holders of Common Stock. The Company will notify the Holders of such weighted average as

soon as practicable after such determination is made.

(ii)            Compliance

Covenant. The Company will not become a party to any Common Stock Change Event unless its terms are consistent with this Section 10(h).

34

(iii)          Execution

of Supplemental Instruments. On or before the date the Common Stock Change Event becomes effective, the Company and, if applicable,

the resulting, surviving or transferee Person (if not the Company) of such Common Stock Change Event (the “Successor Person”)

will execute and deliver such supplemental instruments, if any, as the Company reasonably determines are necessary or desirable to (1) provide

for subsequent adjustments to the Conversion Price pursuant to Section 10(f)(i) in a manner consistent with this Section 10(h);

and (2) give effect to such other provisions, if any, as the Company reasonably determines are appropriate to preserve the economic

interests of the Holders and to give effect to Section 10(h). If the Reference Property includes shares of stock or other

securities or assets of a Person other than the Successor Person, then such other Person will also execute such supplemental instrument(s) and

such supplemental instrument(s) will contain such additional provisions, if any, that the Company reasonably determines are appropriate

to preserve the economic interests of Holders.

(iv)          Notice

of Common Stock Change Event. The Company will provide notice of each Common Stock Change Event to Holders no later than the second

(2nd) Business Day after the effective date of the Common Stock Change Event.

(i)             Conversion

Ledger. The Company shall maintain a running tally of all shares of Common Stock issued upon conversion of the Convertible Preferred

Stock and the Series B-2 Preferred Stock, and shall make such ledger available to any Holder upon request.

Section 11.             Certain

Provisions Relating to the Issuance of Common Stock.

(a)            Equitable

Adjustments to Prices. Whenever this Certificate of Designations requires the Company to calculate the average of the Last Reported

Sale Prices or Daily VWAPs, or any function thereof, over a period of multiple days (including to calculate an adjustment to the Conversion

Price), the Company will make appropriate adjustments, if any, to those calculations to account for any adjustment to the Conversion

Price pursuant to Section 10(f)(i) that becomes effective, or any event requiring such an adjustment to the Conversion

Price where the Ex-Dividend Date, effective date or Expiration Date, as applicable, of such event occurs, at any time during such period.

(b)            Reservation

of Shares of Common Stock. The Company will reserve, out of its authorized, unreserved and not outstanding shares of Common Stock,

for delivery upon conversion of the Convertible Preferred Stock, a number of shares of Common Stock that would be sufficient to settle

the conversion of all shares of Convertible Preferred Stock then outstanding, if any. To the extent the Company delivers shares of Common

Stock held in the Company’s treasury in settlement of any obligation under this Certificate of Designations to deliver shares of

Common Stock, each reference in this Certificate of Designations to the issuance of shares of Common Stock in connection therewith will

be deemed to include such delivery.

(c)            Status

of Shares of Common Stock. Each share of Common Stock delivered upon conversion of on the Convertible Preferred Stock of any Holder

will be a newly issued or treasury share and will be duly and validly issued, fully paid, non-assessable, free from preemptive rights

and free of any lien or adverse claim (except to the extent of any lien or adverse claim created by the action or inaction of such Holder

or the Person to whom such share of Common Stock will be delivered). If the Common Stock is then listed on any securities exchange, or

quoted on any inter-dealer quotation system, then the Company will cause each such share of Common Stock, when so delivered, to be admitted

for listing on such exchange or quotation on such system.

35

(d)           Taxes

Upon Issuance of Common Stock. The Company will pay any documentary, stamp or similar issue or transfer tax or duty due on the issue

of any shares of Common Stock upon conversion of the Convertible Preferred Stock of any Holder, except any tax or duty that is due because

such Holder requests those shares to be registered in a name other than such Holder’s name.

Section 12.             Calculations.

(a)            Responsibility;

Schedule of Calculations. Except as otherwise provided in this Certificate of Designations, the Company will be responsible for making

all calculations called for under this Certificate of Designations or the Convertible Preferred Stock, including determinations of the

Conversion Price, the Daily VWAPs and the Last Reported Sale Prices. The Company will make all calculations in good faith, and, absent

manifest error, its calculations will be final and binding on all Holders. The Company will provide a schedule of such calculations to

any Holder upon written request.

(b)            Calculations

Aggregated for Each Holder. The composition of the Conversion Consideration due upon conversion of the Convertible Preferred Stock

of any Holder will be computed based on the total number of shares of Convertible Preferred Stock of such Holder being converted with

the same Conversion Date. For these purposes, any cash amounts due to such Holder in respect thereof will be rounded to the nearest cent.

Section 13.             Tax

Treatment. Notwithstanding anything to the contrary in this Certificate of Designations, for U.S. federal and other applicable state

and local income tax purposes, it is intended that the Convertible Preferred Stock will not be treated as “preferred stock”

within the meaning of Section 305(b)(4) of Code and Treasury Regulations Section 1.305-5(a). The Company will, and will

cause its Subsidiaries and agents to, report consistently with, and take no positions or actions inconsistent with, the foregoing treatment

unless otherwise required by a determination within the meaning of Section 1313(a) of the Code.

Section 14.              Notices.

(a)            Generally.

The Company will send all notices or communications to Holders pursuant to this Certificate of Designations in writing and delivered

personally, by facsimile or e-mail (with confirmation of receipt from the recipient, in the case of e-mail), or sent by nationally recognized

overnight courier service to the Holder’s respective addresses shown on the Register. Notwithstanding anything in the Certificate

of Designations to the contrary, any defect in the delivery of any such notice or communication will not impair or affect the validity

of such notice or communication and the failure to give any such notice or communication to all the Holders will not impair or affect

the validity of such notice or communication to whom such notice is sent.

(b)        Notice

Coordination with Series B-1 Preferred Stock. In addition to any other notice requirements set forth in this Certificate of Designations,

the Company shall promptly provide to all Holders copies of any notices delivered to holders of Series B-1 Preferred Stock relating to

(i) any Redemption Event, (ii) any Event of Default (as defined in the Certificate of Designations of the Series B-1 Preferred Stock),

(iii) any Liquidation Event, (iv) any Treasury Value Event, and (v) any other material event affecting the rights of holders of Series

B-2 Preferred Stock.

36

Section 15.             No

Other Rights. The Convertible Preferred Stock will have no rights, preferences or voting powers except as provided in this Certificate

of Designations or the Certificate of Incorporation or as required by applicable law.

Section 16.             Guaranty

by Digital Asset Treasury Subsidiary. Each Digital Asset Treasury Subsidiary shall irrevocably and unconditionally guarantee, on

a joint and several basis, the due and punctual payment and performance of all obligations of the Company (a) in respect of the

Convertible Preferred Stock, including, without limitation, the payment of any Liquidation Preference, Holder Redemption Price, Dividends,

and any other amounts (including without limitation Participating Amounts) payable with respect to the Convertible Preferred Stock, and

(b) in connection with any other Transaction Document. The terms and conditions of such guaranty shall be set forth in the Guaranty,

which shall be executed and delivered on or prior to the Initial Issue Date. The ability of a Holder to individually realize the benefit

of such Guaranty may be limited by the provisions thereof, including without limitation requirements for certain majority approvals.

[The Remainder of This Page Intentionally

Left Blank; Signature Page Follows]

37

IN WITNESS WHEREOF,

the Company has caused this Certificate of Designations to be duly executed as of the date first written above.

BNB PLUS CORP.

By:

/s/ Clay Shorrock

Name:

Clay Shorrock

Title:

Chief Executive Officer and President

[Signature Page to

Certificate of Designations]

38

EXHIBIT A

FORM OF CONVERTIBLE

PREFERRED STOCK

BNB Plus Corp.

Series B-2 Convertible

Preferred Stock [Certificate No.: [___]]                                   No. Shares*

[___]] BNB Plus Corp., a Delaware corporation (the “Company”), certifies that [_______] is the registered owner of

[___] shares of the Company’s Series B-2 Convertible Preferred Stock (the “Convertible Preferred Stock”)

represented by this certificate (this “Certificate”). The special rights, preferences and voting powers of the Convertible

Preferred Stock are set forth in the Certificate of Designations of the Company establishing the Convertible Preferred Stock (the “Certificate

of Designations”). Capitalized terms used in this Certificate without definition have the respective meanings ascribed to them

in the Certificate of Designations.

Additional terms of this Certificate are set

forth on the other side of this Certificate.

[The Remainder of This

Page Intentionally Left Blank; Signature Page Follows]

* Insert number of shares for Physical Certificate

only.

IN WITNESS WHEREOF,

BNB Plus Corp has caused this instrument to be duly executed as of the date set forth below.

BNB PLUS CORP

Date:

By:

Name:

Title:

Date:

By:

Name:

Title:

REVERSE OF SECURITY

BNB PLUS CORP

THE COMPANY WILL FURNISH WITHOUT CHARGE TO EACH

STOCKHOLDER WHO SO REQUESTS, A SUMMARY OF THE POWERS, DESIGNATIONS AND PREFERENCES, OR OTHER SPECIAL RIGHTS OF EACH CLASS OF STOCK

OF THE COMPANY AND THE QUALIFICATIONS, LIMITATIONS OR RESTRICTIONS OF SUCH PREFERENCES AND RIGHTS, AND THE VARIATIONS IN RIGHTS, PREFERENCES

AND LIMITATIONS DETERMINED FOR EACH SERIES, WHICH ARE FIXED BY THE CERTIFICATE OF INCORPORATION OF THE COMPANY, AS AMENDED, AND THE RESOLUTIONS

OF THE BOARD OF DIRECTORS OF THE COMPANY, AND THE AUTHORITY OF THE BOARD OF DIRECTORS TO DETERMINE VARIATIONS FOR FUTURE SERIES. SUCH

REQUEST MAY BE MADE TO THE OFFICE OF THE SECRETARY OF THE COMPANY OR TO THE TRANSFER AGENT. THE BOARD OF DIRECTORS MAY REQUIRE

THE OWNER OF A LOST OR DESTROYED STOCK CERTIFICATE, OR HIS LEGAL REPRESENTATIVES TO GIVE THE COMPANY A BOND TO INDEMNIFY IT AND ITS TRANSFER

AGENTS AND REGISTRARS AGAINST ANY CLAIM THAT MAY BE MADE AGAINST THEM ON ACCOUNT OF THE ALLEGED LOSS OR DESTRUCTION OF AY SUCH CERTIFICATE.

THE SHARES REPRESENTED BY THIS CERTIFICATE

MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN ACCORDANCE WITH THE CERTIFICATE OF

DESIGNATIONS. ANY ATTEMPTED SALE ASSIGNMENT, TRANSFER, PLEDGE OR OTHER ATTEMPT TO DISPOSE OF THE

SHARES REPRESENTED BY THIS CERTIFICATE NOT IN ACCORDANCE WITH THE TERMS OF THE CERTIFICATE OF DESIGNATION SHALL BE VOID.

FOR VALUE RECEIVED, ________________ hereby sell, assign and transfer

unto

(Insert assignee’s social security or tax identification number)

(Insert address and zip code of assignee)

Shares of the Series B-2 Convertible Preferred

Stock represented by the within Certificate, and do hereby irrevocably constitute and appoint agent to transfer the said shares of Series B-2

Convertible Preferred Stock evidenced hereby on the books of the within-named Company with full power of substitution in the premises.

Date:

Signature

(Sign exactly as your name appears on the other side of this Series B-2

Convertible Preferred Stock)

Signature Guarantee:

† Signature must be guaranteed by an “eligible

guarantor institution” that is a bank, stockbroker, savings and loan association or credit union reasonably acceptable to the Company

or meeting the requirements of any transfer agent appointed by the Company from time to time, which requirements include membership or

participation in the Securities Transfer Agents Medallion Program (“STAMP”) or such other “signature guarantee program”

as may be determined by the Transfer Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange

Act of 1934, as amended.

EXHIBIT B

OPTIONAL CONVERSION NOTICE

BNB Plus Corp

Series B-2 Convertible

Preferred Stock

Subject

to the terms of the Certificate of Designations, by executing and delivering this Optional Conversion Notice, the undersigned Holder

of the Convertible Preferred Stock identified below directs the Company to convert (check one):

¨

all of the shares of Convertible Preferred Stock

¨

†shares of Convertible Preferred Stock

identified

by CUSIP No. and Certificate No.

Date:

(Legal Name of Holder)

By:

Name:

Title:

Signature Guaranteed Participant in a Recognized Signature Guarantee Medallion Program

By:

Authorized Signatory

† Must be a whole number

EXHIBIT C

FORM OF RESTRICTED STOCK LEGEND

NEITHER THIS SECURITY NOR THE SECURITIES INTO

WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY

STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE

SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS

EXERCISABLE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL

INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED

BY SUCH SECURITIES.

EX-4.1 — EXHIBIT 4.1

EX-4.1

Filename: tm2615620d1_ex4-1.htm · Sequence: 4

Exhibit 4.1

NEITHER THIS SECURITY NOR THE SECURITIES INTO

WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY

STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE

SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS

EXERCISABLE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL

INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED

BY SUCH SECURITIES.

PREFUNDED SERIES B-1 PREFERRED STOCK PURCHASE

WARRANT

BNB

PLUS CORP.

Warrant Shares:

[______]

Issuance

Date:       ___, 2026

THIS PREFUNDED SERIES B-1 PREFERRED

STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______________]

or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the

conditions hereinafter set forth, at any time on or after the Issuance Date (the “Initial Exercise Date”) and until

this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from

BNB Plus Corp., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder,

the “Warrant Shares”) of Preferred Stock. The purchase price of one share of Preferred Stock under this Warrant shall

be equal to the Exercise Price, as defined in Section 2(b).

Section 1.               Definitions.

In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

“Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

“Business

Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized

or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed

to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential

employee”  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of

any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The

City of New York generally are open for use by customers on such day.

“Commission”

means the United States Securities and Exchange Commission.

“Common

Stock” means the shares of common stock of the Company, par value $0.001 per share.

“Common

Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire

at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is

at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Inducement

Agreement” means each Warrant Inducement Exchange Agreement dated May 26, 2026, by and between the Company and each of

the purchasers signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms.

“Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability

company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Preferred

Stock” means the Series B-1 Preferred Stock of the Company, par value $0.001 per share, and any other class of securities

into which such securities may hereafter be reclassified or changed.

“Preferred

Stock Shares” means the shares of Common Stock issuable upon conversion of the Preferred Stock.

“Purchase

Agreement” means the Securities Purchase Agreement, dated as of May 26, 2026, by and between the Company and each of the

purchasers signatory thereto, including any Purchasers who become a party thereto through joinder, as amended, modified or supplemented

from time to time in accordance with its terms.

“Securities

Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Subsidiary”

means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed

or acquired after the date hereof.

“Trading

Day” means a day on which the Common Stock is traded on a Trading Market.

“Trading

Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date

in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock

Exchange, the OTCQB or OTCQX (or any successors to any of the foregoing) or, for a period no longer than 15 successive Business Days

while the Company’s application to the OTCQX or OTCQB is being processed, the OTCID Basic Market within the Pink Open Market.

“Transaction

Documents” means the Warrants, the Purchase Agreement, the Inducement Agreement, the Registration Rights Agreement (in the

form attached to the Purchase Agreement and Inducement Agreement), all exhibits and schedules thereto and hereto and any other documents

or agreements executed in connection with the transactions contemplated thereunder.

“Transfer

Agent” means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 90 Park Avenue,

New York, New York 10016 and an email address of admin3@equiniti.com, and any successor transfer agent of the Company.

“Warrants”

means this Warrant and other Prefunded Series B-1 Preferred Stock Purchase Warrants issued by the Company pursuant to the Purchase

Agreement and/or Inducement Agreement.

Section 2.               Exercise.

a)             Exercise

of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on

or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted

by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”).

Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period

(as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate

Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United

States bank. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)

of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically

surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has

been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading

Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases

of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant

Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall

maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection

to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance

of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the

Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount

stated on the face hereof.

b)            Exercise

Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded

to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise

price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant.

The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any

circumstance or for any reason whatsoever. The remaining unpaid exercise price per share of Preferred Stock under this Warrant shall

be $0.0001, subject to adjustment hereunder (the “Exercise Price”).

c)             [Reserved]

d)             Mechanics

of Exercise

i.              Delivery

of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transferred by the Transfer

Agent to the Holder if there is an applicable exemption from registration under the Securities Act for the issuance of the Warrant Shares

to the Holder, and otherwise by physical delivery of a certificate or book entry statement, registered in the Company’s share register

in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise

to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) one (1) Trading Day

after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise

Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company

of the Notice of Exercise (such date, the “Warrant Share Delivery Date”).

If the Company fails

for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company

shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise,

$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading

Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. As used herein,

“Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s

primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

Upon delivery of

the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares

with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment

of the aggregate Exercise Price is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading

Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.

ii.             Delivery

of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and

upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing

the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other

respects be identical with this Warrant.

iii.            Rescission

Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares by the Warrant Share Delivery

Date, then the Holder will have the right to rescind such exercise.

iv.            Compensation

for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if

the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above

pursuant to an exercise on or before the Warrant Share Delivery Date, and if the Preferred Stock is convertible pursuant to its terms

on the Warrant Share Delivery Date and after such date the Holder is required by its broker to purchase (in an open market transaction

or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by

the Holder of the Preferred Stock Shares issuable upon conversion of the Warrant Shares which the Holder anticipated receiving upon such

exercise of this Warrant and conversion of the Warrant Shares (a “Buy-In”), then the Company shall (A) pay in

cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if

any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Preferred

Stock Shares issuable upon conversion of the Warrant Shares that the Company was required to deliver to the Holder in connection with

the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at

the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise

was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Warrant Shares that would

have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases

Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of share of Preferred Stock

Shares issuable upon conversion of the Warrant Shares with an aggregate sale price giving rise to such purchase obligation of $10,000,

under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall

provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company,

evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder,

at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s

failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.

v.             No

Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this

Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,

at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the

Exercise Price or round up to the next whole share.

vi.            Charges,

Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other

incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and

such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,

that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for

exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as

a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all

Transfer Agent fees required for same-day processing of any Notice of Exercise. For the avoidance of doubt, nothing in this Section 2(d)(vi) shall

require the Company to deliver the Warrant Shares on a date earlier than the Warrant Share Delivery Date.

vii.           Closing

of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,

pursuant to the terms hereof.

e)             Holder’s

Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise

any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise

as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting

as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),

would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence,

the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number

of Preferred Stock Shares underlying the Warrant Shares issuable upon exercise of this Warrant with respect to which such determination

is being made, but shall exclude the number of Preferred Stock Shares underlying the Warrant Shares which would be issuable upon (i) exercise

of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties

and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without

limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained

herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,

for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange

Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing

to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible

for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies,

the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates

and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission

of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to

other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,

in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy

of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with

Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e),

in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock

as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a

more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting

forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one

Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the

number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the

Company, including the Preferred Stock Shares underlying the Warrant Shares issuable upon the exercise of this Warrant, by the Holder

or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The

“Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants,

9.99% or 19.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of the Warrant Shares

issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation

provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% or 19.99% of the number

of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Warrant Shares issuable upon exercise

of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial

Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions

of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to

correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation

herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations

contained in this paragraph shall apply to a successor holder of this Warrant.

Section 3.               Certain

Adjustments.

a)             Stock

Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise

makes a distribution or distributions on shares of its Preferred Stock or any other equity or equity equivalent securities payable in

shares of Preferred Stock (which, for avoidance of doubt, shall not include any shares of Preferred Stock issued by the Company upon

exercise of this Warrant), (ii) subdivides outstanding shares of Preferred Stock into a larger number of shares, (iii) combines

(including by way of reverse stock split) outstanding shares of Preferred Stock into a smaller number of shares, or (iv) issues

by reclassification of shares of the Preferred Stock any shares of capital stock of the Company, then in each case the Exercise Price

shall be multiplied by a fraction of which the numerator shall be the number of shares of Preferred Stock outstanding immediately before

such event and of which the denominator shall be the number of shares of Preferred Stock outstanding immediately after such event, and

the number of Warrant Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise

Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately

after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective

immediately after the effective date in the case of a subdivision, combination or re-classification.

b)            Subsequent

Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues

or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders

of any class of capital stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms

applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if (i) the Holder had held

the number of Preferred Stock Shares issuable upon conversion of the Warrant Shares acquirable upon complete exercise of this Warrant

(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation), or (ii) the

number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including

without limitation, the Beneficial Ownership Limitation), depending on which class of capital stock such Purchase Rights are being granted,

issued, or sold, immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or,

if no such record is taken, the date as of which the record holders of shares of capital stock are to be determined for the grant, issue

or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase

Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate

in such Purchase Right to such extent (or beneficial ownership of such capital stock as a result of such Purchase Right to such extent)

and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would

not result in the Holder exceeding the Beneficial Ownership Limitation).

c)             Pro

Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution

of its assets (or rights to acquire its assets) to holders of capital stock, by way of return of capital or otherwise (including, without

limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,

corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after

the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent

that the Holder would have participated therein if (i) the Holder had held the number of Preferred Stock Shares issuable upon conversion

of the Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including

without limitation, the Beneficial Ownership Limitation), or (ii) the number of Warrant Shares acquirable upon complete exercise

of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation),

depending on which class of capital stock such dividend or other distribution of assets are being made, immediately before the date of

which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of capital

stock are to be determined for the participation in such Distribution (provided, however, that, to the extent that

the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,

then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares

of capital stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for

the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership

Limitation).

d)             Fundamental

Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related

transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,

directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially

all of its assets in one or a series of related transactions, provided, however that the sale by the Company of any Subsidiary, other

than a Material Subsidiary, does not constitute a Fundamental Transaction, (iii) any, direct or indirect, purchase offer, tender

offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of capital stock are permitted

to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the required holders of the

outstanding capital stock or voting power of the capital equity of the Company, (iv) the Company, directly or indirectly, in one

or more related transactions effects any reclassification, reorganization or recapitalization of its capital stock or any compulsory

share exchange pursuant to which the capital stock is effectively converted into or exchanged for other securities, cash or property,

or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement

or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement)

with another Person, including such Person’s Attribution Parties, whereby such other Person (including such Person’s Attribution

Parties) acquires greater than 50% of the outstanding shares of common stock or voting power of the capital equity of the Company (each

a “Fundamental Transaction”); provided, however, that notwithstanding the foregoing, any merger or consolidation of

the Company that is approved by the affirmative vote of a majority of the Series B-1 Preferred Stock then outstanding (the “Requisite

Holders”) shall not be deemed a Fundamental Transaction; then, upon any subsequent exercise of this Warrant, the Holder shall have

the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of

such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise

of this Warrant), the number of shares of capital stock of the successor or acquiring corporation or of the Company, if it is the surviving

corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental

Transaction by a holder of the number of Warrant Shares for which this Warrant is convertible immediately prior to such Fundamental Transaction

(without regard to any limitation in Section 2(e) on the exercise of this Warrant). “Material Subsidiary” shall

mean any subsidiary of the Company that is material to the business and operations of the Company (or has material assets to the Company

on a consolidated basis) as described in the Company’s public filings with the Commission. For purposes of any such exercise, the

determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate

Consideration issuable in respect of one share of Preferred Stock in such Fundamental Transaction, and the Company shall apportion the

Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of

the Alternate Consideration. If holders of Preferred Stock are given any choice as to the securities, cash or property to be received

in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise

of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in

which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the

Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and

substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction

and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced

by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of

shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Warrant Shares acquirable and receivable upon

exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and

with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative

value of the shares of Preferred Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number

of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately

prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.

Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term “Company” under

this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this

Warrant and the other Transaction Documents referring to the “Company” shall refer instead to each of the Company and the

Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally

with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall

assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect

as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the

avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether

the Company has sufficient authorized shares of Preferred Stock for the issuance of Warrant Shares, (ii) whether the Company has

sufficient authorized shares of Common Stock for issuance upon the conversion of the Preferred Stock Shares issuable upon conversion

of the Warrant Shares, and/or (iii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.

e)             Calculations.

All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For

purposes of this Section 3, the number of shares of Preferred Stock deemed to be issued and outstanding as of a given date shall

be the sum of the number of shares of Preferred Stock issued and outstanding.

f)             Notice

to Holder.

i.             Adjustment

to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly

deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number

of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

ii.             Notice

to Allow Exercise by the Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on

the Preferred Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Preferred Stock,

(C) the Company shall authorize the granting to all holders of the Preferred Stock rights or warrants to subscribe for or purchase

any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required

in connection with any reclassification of the Preferred Stock, any consolidation or merger to which the Company (or any of its Subsidiaries)

is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Preferred Stock

is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,

liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the

Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the

applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the

purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders

of the Preferred Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined

or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective

or close, and the date as of which it is expected that holders of the Preferred Stock of record shall be entitled to exchange their shares

of the Preferred Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer

or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect

the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant

constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously

file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this

Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may

otherwise be expressly set forth herein.

Section 4.              Transfer

of Warrant.

a)            Transferability.

Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions

of Section 4.1 of the Purchase Agreement or the Inducement Agreement, as applicable, this Warrant and all rights hereunder (including,

without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office

of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto

duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.

Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the

assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall

issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.

Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company

unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three

(3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The

Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having

a new Warrant issued.

b)            New

Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,

together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or

its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,

the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in

accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and

shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c)             Warrant

Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant

Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder

of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other

purposes, absent actual notice to the contrary.

d)            Transfer

Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this

Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable

state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information

requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee

of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement or the Inducement Agreement,

as applicable.

e)             Representation

by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise

hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or

reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant

to sales registered or exempted under the Securities Act.

Section 5.              Miscellaneous.

a)             No

Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends

or other rights as a holder of Preferred Stock of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except

as expressly set forth in Section 3. Without limiting any rights of a Holder or to receive cash payments pursuant to Section 2(d)(i) and

Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.

b)             Loss,

Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory

to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case

of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include

the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make

and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

c)             Saturdays,

Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or

granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business

Day.

d)             Authorized

Shares.

The Company covenants

that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Preferred Stock a sufficient number

of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant, and from its

authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of Preferred Stock Shares upon conversion

of the Warrant Shares. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers

who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The

Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein

without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Preferred Stock Shares

may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented

by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance

herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the

Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

Except and to the

extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate

of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or

any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all

times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate

to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the

Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately

prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may

validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially

reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,

as may be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any

action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,

the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory

body or bodies having jurisdiction thereof.

e)             Governing

Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and

construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of

law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions

contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,

partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.

Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,

Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby

or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is

not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient

venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any

such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)

to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient

service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any

other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,

the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’

fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

f)              Restrictions.

The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions

upon resale imposed by state and federal securities laws, including but not limited to the restrictive legend set forth in the Purchase

Agreement or Inducement Agreement, as applicable.

g)             Nonwaiver

and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as

a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of

this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material

damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,

but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting

any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

h)             Notices.

Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any

Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,

addressed to the Company, at BNB Plus Corp., 25 Health Sciences Drive, Stony Brook, NY 11790, Attention: Beth Jantzen, email address:

beth.jantzen@bnb.plus, or such other email address or address as the Company may specify for such purposes by notice to the Holders.

Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,

by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of

such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and

effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail

address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after

the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on

a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day

following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the

party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material,

non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission

pursuant to a Current Report on Form 8-K.

i)              Limitation

of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant

Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase

price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the

Company.

j)              Remedies.

The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific

performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss

incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any

action for specific performance that a remedy at law would be adequate.

k)             Successors

and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the

benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.

The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable

by the Holder or holder of Warrant Shares.

l)             Amendment.

This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and

the Holder or the beneficial owner of this Warrant, on the other hand.

m)            Severability.

Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,

but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the

extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

n)             Headings.

The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this

Warrant.

********************

(Signature Page Follows)

IN WITNESS WHEREOF, the Company

has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

BNB Plus

Corp.

By:

Name:

Title:

NOTICE OF EXERCISE

To:             Bnb

plus corp.

(1)           The

undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised

in full), and subject to the current Beneficial Ownership Limitation of (check one) ¨

4.99% ¨ 9.99% or ¨ 19.99%, and tenders herewith payment of the exercise price in full, together with all applicable transfer

taxes, if any.

(2)            Payment

shall be made in the form of lawful money of the United States.

(3)           Please

issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

(4)           Accredited

Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act

of 1933, as amended.

[SIGNATURE

OF HOLDER]

Name of Investing Entity:

Signature

of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:

Date:

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute

this form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and

all rights evidenced thereby are hereby assigned to

Name:

(Please Print)

Address:

(Please Print)

Phone Number:

Email Address:

Dated: _______________ __, ______

Holder’s Signature:____________________

Holder’s Address:_____________________

EX-4.2 — EXHIBIT 4.2

EX-4.2

Filename: tm2615620d1_ex4-2.htm · Sequence: 5

Exhibit 4.2

NEITHER THIS SECURITY NOR THE SECURITIES INTO

WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY

STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE

SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE

MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION

THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

PREFUNDED SERIES B-2 PREFERRED STOCK PURCHASE

WARRANT

BNB

PLUS CORP.

Warrant Shares: [______]

Issuance Date:       ___ , 2026

THIS PREFUNDED SERIES B-2 PREFERRED

STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______________]

or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the

conditions hereinafter set forth, at any time on or after the Issuance Date (the “Initial Exercise Date”) and until

this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from BNB

Plus Corp., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the

“Warrant Shares”) of Preferred Stock. The purchase price of one share of Preferred Stock under this Warrant shall be

equal to the Exercise Price, as defined in Section 2(b).

Section 1.          Definitions.

In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

“Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

“Business

Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized

or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed

to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential

employee”  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of

any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The

City of New York generally are open for use by customers on such day.

“Commission”

means the United States Securities and Exchange Commission.

“Common

Stock” means the shares of common stock of the Company, par value $0.001 per share.

“Common

Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire

at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is

at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,

joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Preferred

Stock” means the Series B-2 Preferred Stock of the Company, par value $0.001 per share, and any other class of securities

into which such securities may hereafter be reclassified or changed.

“Preferred

Stock Shares” means the shares of Common Stock issuable upon conversion of the Preferred Stock.

“Purchase

Agreement” means the Securities Purchase Agreement, dated as of May 26, 2026, by and between the Company and each of the

purchasers signatory thereto, including any Purchasers who become a party thereto through joinder, as amended, modified or supplemented

from time to time in accordance with its terms.

“Securities

Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Subsidiary”

means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed

or acquired after the date hereof.

“Trading

Day” means a day on which the Common Stock is traded on a Trading Market.

“Trading

Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date

in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock

Exchange, the OTCQB or OTCQX (or any successors to any of the foregoing) or, for a period no longer than 15 successive Business Days while

the Company’s application to the OTCQX or OTCQB is being processed, the OTCID Basic Market within the Pink Open Market.

“Transaction

Documents” means the Warrants, the Purchase Agreement, the Inducement Agreement, the Registration Rights Agreement (in the form

attached to the Purchase Agreement and Inducement Agreement), all exhibits and schedules thereto and hereto and any other documents or

agreements executed in connection with the transactions contemplated thereunder.

“Transfer

Agent” means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 90 Park Avenue,

New York, New York 10016 and an email address of admin3@equiniti.com, and any successor transfer agent of the Company.

“Inducement

Agreement” means each Warrant Inducement Exchange Agreement, dated as of May 26, 2026, by and between the Company and each

of the purchasers signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms.

“Warrants”

means this Warrant and other Prefunded Series B-2 Preferred Stock Purchase Warrants issued by the Company pursuant to the Inducement

Agreement.

Section 2.               Exercise.

a)             Exercise

of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on

or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted

by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within

the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as

defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise

Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States

bank. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)

of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically

surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has

been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading

Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases

of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant

Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall

maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection

to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance

of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the

Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount

stated on the face hereof.

b)            Exercise

Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded

to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise

price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The

Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance

or for any reason whatsoever. The remaining unpaid exercise price per share of Preferred Stock under this Warrant shall be $0.0001, subject

to adjustment hereunder (the “Exercise Price”).

c)             [Reserved]

d)             Mechanics

of Exercise

i.              Delivery

of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transferred by the Transfer

Agent to the Holder if there is an applicable exemption from registration under the Securities Act for the issuance of the Warrant Shares

to the Holder, and otherwise by physical delivery of a certificate or book entry statement, registered in the Company’s share register

in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise

to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) one (1) Trading Day

after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise

Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company

of the Notice of Exercise (such date, the “Warrant Share Delivery Date”).

If the Company fails

for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company

shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise,

$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading

Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. As used herein, “Standard

Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary

Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

Upon delivery of the

Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with

respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of

the aggregate Exercise Price is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days

comprising the Standard Settlement Period following delivery of the Notice of Exercise.

ii.             Delivery

of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and

upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing

the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects

be identical with this Warrant.

iii.            Rescission

Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares by the Warrant Share Delivery

Date, then the Holder will have the right to rescind such exercise.

iv.            Compensation

for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if

the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above

pursuant to an exercise on or before the Warrant Share Delivery Date, and if the Preferred Stock is convertible pursuant to its terms

on the Warrant Share Delivery Date and after such date the Holder is required by its broker to purchase (in an open market transaction

or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by

the Holder of the Preferred Stock Shares issuable upon conversion of the Warrant Shares which the Holder anticipated receiving upon such

exercise of this Warrant and conversion of the Warrant Shares (a “Buy-In”), then the Company shall (A) pay in

cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if

any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Preferred

Stock Shares issuable upon conversion of the Warrant Shares that the Company was required to deliver to the Holder in connection with

the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at

the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise

was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Warrant Shares that would

have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases

Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of share of Preferred Stock

Shares issuable upon conversion of the Warrant Shares with an aggregate sale price giving rise to such purchase obligation of $10,000,

under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide

the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence

of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder,

at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s

failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.

v.             No

Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this

Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,

at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the

Exercise Price or round up to the next whole share.

vi.            Charges,

Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental

expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant

Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,

that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for

exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as

a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all

Transfer Agent fees required for same-day processing of any Notice of Exercise. For the avoidance of doubt, nothing in this Section 2(d)(vi) shall

require the Company to deliver the Warrant Shares on a date earlier than the Warrant Share Delivery Date.

vii.           Closing

of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,

pursuant to the terms hereof.

e)             Holder’s

Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise

any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise

as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting

as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),

would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence,

the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number

of Preferred Stock Shares underlying the Warrant Shares issuable upon exercise of this Warrant with respect to which such determination

is being made, but shall exclude the number of Preferred Stock Shares underlying the Warrant Shares which would be issuable upon (i) exercise

of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties

and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without

limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained

herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,

for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange

Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing

to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible

for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies,

the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates

and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission

of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to

other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,

in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy

of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with

Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e),

in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock

as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a

more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth

the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading

Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of

outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,

including the Preferred Stock Shares underlying the Warrant Shares issuable upon the exercise of this Warrant, by the Holder or its Affiliates

or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial

Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99% or 19.99%)

of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of the Warrant Shares issuable upon

exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions

of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% or 19.99% of the number of shares

of the Common Stock outstanding immediately after giving effect to the issuance of the Warrant Shares issuable upon exercise of this Warrant

held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership

Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this

paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to

correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation

herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations

contained in this paragraph shall apply to a successor holder of this Warrant.

Section 3.               Certain

Adjustments.

a)             Stock

Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes

a distribution or distributions on shares of its Preferred Stock or any other equity or equity equivalent securities payable in shares

of Preferred Stock (which, for avoidance of doubt, shall not include any shares of Preferred Stock issued by the Company upon exercise

of this Warrant), (ii) subdivides outstanding shares of Preferred Stock into a larger number of shares, (iii) combines (including

by way of reverse stock split) outstanding shares of Preferred Stock into a smaller number of shares, or (iv) issues by reclassification

of shares of the Preferred Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied

by a fraction of which the numerator shall be the number of shares of Preferred Stock outstanding immediately before such event and of

which the denominator shall be the number of shares of Preferred Stock outstanding immediately after such event, and the number of Warrant

Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant

shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record

date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after

the effective date in the case of a subdivision, combination or re-classification.

b)            Subsequent

Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues

or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders

of any class of capital stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms

applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if (i) the Holder had held

the number of Preferred Stock Shares issuable upon conversion of the Warrant Shares acquirable upon complete exercise of this Warrant

(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation), or (ii) the

number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including

without limitation, the Beneficial Ownership Limitation), depending on which class of capital stock such Purchase Rights are being granted,

issued, or sold, immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if

no such record is taken, the date as of which the record holders of shares of capital stock are to be determined for the grant, issue

or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase

Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in

such Purchase Right to such extent (or beneficial ownership of such capital stock as a result of such Purchase Right to such extent) and

such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result

in the Holder exceeding the Beneficial Ownership Limitation).

c)             Pro

Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution

of its assets (or rights to acquire its assets) to holders of capital stock, by way of return of capital or otherwise (including, without

limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,

corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after

the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent

that the Holder would have participated therein if (i) the Holder had held the number of Preferred Stock Shares issuable upon conversion

of the Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including

without limitation, the Beneficial Ownership Limitation), or (ii) the number of Warrant Shares acquirable upon complete exercise

of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation),

depending on which class of capital stock such dividend or other distribution of assets are being made, immediately before the date of

which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of capital

stock are to be determined for the participation in such Distribution (provided, however, that, to the extent that

the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then

the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of capital

stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit

of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

d)             Fundamental

Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related

transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,

directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially

all of its assets in one or a series of related transactions, provided, however that the sale by the Company of any Subsidiary, other

than a Material Subsidiary, does not constitute a Fundamental Transaction, (iii) any, direct or indirect, purchase offer, tender

offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of capital stock are permitted

to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the required holders of the outstanding

capital stock or voting power of the capital equity of the Company, (iv) the Company, directly or indirectly, in one or more related

transactions effects any reclassification, reorganization or recapitalization of its capital stock or any compulsory share exchange pursuant

to which the capital stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,

directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination

(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person, including

such Person’s Attribution Parties, whereby such other Person (including such Person’s Attribution Parties) acquires greater

than 50% of the outstanding shares of common stock or voting power of the capital equity of the Company (each a “Fundamental

Transaction”); provided, however, that notwithstanding the foregoing, any merger or consolidation of the Company that is approved

by the affirmative vote of a majority of the Series B-1 Preferred Stock then outstanding (the “Requisite Holders”) shall

not be deemed a Fundamental Transaction; then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive,

for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction,

at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of

shares of capital stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional

consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of

the number of Warrant Shares for which this Warrant is convertible immediately prior to such Fundamental Transaction (without regard to

any limitation in Section 2(e) on the exercise of this Warrant). “Material Subsidiary” shall mean any subsidiary

of the Company that is material to the business and operations of the Company (or has material assets to the Company on a consolidated

basis) as described in the Company’s public filings with the Commission. For purposes of any such exercise, the determination of

the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration

issuable in respect of one share of Preferred Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price

among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.

If holders of Preferred Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,

then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following

such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the

survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in

accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory

to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of

the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially

similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor

Entity (or its parent entity) equivalent to the Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard

to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the

exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Preferred Stock

pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such

exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental

Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,

the Successor Entity shall be added to the term “Company” under this Warrant (so that from and after the occurrence or consummation

of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the “Company”

shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity

or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the

Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other

Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had

been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless

of (i) whether the Company has sufficient authorized shares of Preferred Stock for the issuance of Warrant Shares, (ii) whether

the Company has sufficient authorized shares of Common Stock for issuance upon the conversion of the Preferred Stock Shares issuable upon

conversion of the Warrant Shares, and/or (iii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.

e)             Calculations.

All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For

purposes of this Section 3, the number of shares of Preferred Stock deemed to be issued and outstanding as of a given date shall

be the sum of the number of shares of Preferred Stock issued and outstanding.

f)             Notice

to Holder.

i.             Adjustment

to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly

deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number

of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

ii.             Notice

to Allow Exercise by the Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on

the Preferred Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Preferred Stock,

(C) the Company shall authorize the granting to all holders of the Preferred Stock rights or warrants to subscribe for or purchase

any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required

in connection with any reclassification of the Preferred Stock, any consolidation or merger to which the Company (or any of its Subsidiaries)

is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Preferred Stock

is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,

liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder

at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable

record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of

such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the

Preferred Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the

date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,

and the date as of which it is expected that holders of the Preferred Stock of record shall be entitled to exchange their shares of the

Preferred Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or

share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the

validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes,

or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file

such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant

during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise

be expressly set forth herein.

Section 4.              Transfer

of Warrant.

a)            Transferability.

Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions

of the Inducement Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,

in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written

assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient

to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall

execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations

specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so

assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required

to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall

surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to

the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder

for the purchase of Warrant Shares without having a new Warrant issued.

b)            New

Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,

together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or

its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,

the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance

with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be

identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c)             Warrant

Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant

Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder

of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other

purposes, absent actual notice to the contrary.

d)            Transfer

Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this

Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable

state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information

requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee

of this Warrant, as the case may be, comply with the provisions of the Inducement Agreement.

e)             Representation

by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise

hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or

reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant

to sales registered or exempted under the Securities Act.

Section 5.              Miscellaneous.

a)             No

Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends

or other rights as a holder of Preferred Stock of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except

as expressly set forth in Section 3. Without limiting any rights of a Holder or to receive cash payments pursuant to Section 2(d)(i) and

Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.

b)             Loss,

Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory

to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case

of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include

the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make

and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

c)             Saturdays,

Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or

granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business

Day.

d)             Authorized

Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued

Preferred Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights

under this Warrant, and from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of Preferred

Stock Shares upon conversion of the Warrant Shares. The Company further covenants that its issuance of this Warrant shall constitute full

authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights

under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued

as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the

Preferred Stock Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase

rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant

Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges

created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such

issue).

Except and to the

extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate

of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or

any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all

times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate

to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the

Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately

prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly

and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable

efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may

be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any

action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,

the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory

body or bodies having jurisdiction thereof.

e)             Governing

Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and

construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of

law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions

contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,

partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.

Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough

of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed

herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally

subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.

Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding

by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address

in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and

notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted

by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in

such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and

expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

f)              Restrictions.

The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions

upon resale imposed by state and federal securities laws, including but not limited to the restrictive legend set forth in the Inducement

Agreement.

g)             Nonwaiver

and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as

a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this

Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages

to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but

not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts

due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

h)             Notices.

Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice

of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed

to the Company, at BNB Plus Corp., 25 Health Sciences Drive, Stony Brook, NY 11790, Attention: Beth Jantzen, email address: beth.jantzen@bnb.plus,

or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other

communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent

by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing

on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest

of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this

Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission,

if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading

Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing,

if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is

required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding

the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on

Form 8-K.

i)              Limitation

of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant

Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase

price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the

Company.

j)              Remedies.

The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific

performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss

incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any

action for specific performance that a remedy at law would be adequate.

k)             Successors

and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the

benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.

The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable

by the Holder or holder of Warrant Shares.

l)             Amendment.

This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and

the Holder or the beneficial owner of this Warrant, on the other hand.

m)            Severability.

Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,

but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the

extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

n)             Headings.

The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

(Signature Page Follows)

IN WITNESS WHEREOF, the Company

has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

BNB Plus

Corp.

By:

Name:

Title:

NOTICE OF EXERCISE

To:             Bnb

plus corp.

(1)          The

undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if

exercised in full), and subject to the current Beneficial Ownership Limitation of (check one) ¨

4.99% ¨ 9.99% or ¨ 19.99%, and

tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2)           Payment

shall be made in the form of lawful money of the United States.

(3)           Please

issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

(4)           Accredited

Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act

of 1933, as amended.

[SIGNATURE

OF HOLDER]

Name of Investing Entity:

Signature of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:

Date:

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this

form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and

all rights evidenced thereby are hereby assigned to

Name:

(Please Print)

Address:

(Please Print)

Phone Number:

Email Address:

Dated: _______________ __, ______

Holder’s Signature:____________________

Holder’s Address:_____________________

EX-4.3 — EXHIBIT 4.3

EX-4.3

Filename: tm2615620d1_ex4-3.htm · Sequence: 6

Exhibit 4.3

NEITHER THIS SECURITY NOR THE SECURITIES INTO

WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY

STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE

SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE

MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION

THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

SERIES F COMMON STOCK PURCHASE WARRANT

BNB PLUS CORP.

Warrant Shares: [______]

Issuance Date: ___, 2026

THIS SERIES F COMMON STOCK PURCHASE

WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”)

is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after

the Issuance Date hereof (as defined above) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York

City time) on the three year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter,

to subscribe for and purchase from BNB Plus Corp., a Delaware corporation (the “Company”), up to [____________] shares

(as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common

Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Section 1.               Definitions.

In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

“Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

“Beneficial

Ownership Limitation” has the meaning as set forth in Section 2(e) hereof. “Bid Price” means, for

any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted

on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market

on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York

City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted average price

of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not

then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a

similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock

so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser

selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,

the fees and expenses of which shall be paid by the Company.

“Board

of Directors” means the board of directors of the Company.

“Business

Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized

or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed

to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential

employee”  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of

any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The

City of New York generally are open for use by customers on such day.

“Commission”

means the United States Securities and Exchange Commission.

“Common

Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such

securities may hereafter be reclassified or changed.

“Common

Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire

at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is

at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Inducement

Agreement” means each Warrant Inducement Exchange Agreement dated May 26, 2026, by and between the Company and each of

the purchasers signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms.

“Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,

joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Purchase

Agreement” means the Securities Purchase Agreement, dated as of May 26, 2026, by and between the Company and each of the

purchasers signatory thereto, including any Purchasers who become a party thereto through joinder, as amended, modified or supplemented

from time to time in accordance with its terms.

“Securities

Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Subsidiary”

means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed

or acquired after the date hereof.

“Trading

Day” means a day on which the Common Stock is traded on a Trading Market.

“Trading

Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date

in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the NYSE

American, the OTCQX or OTCQB (or any successors to any of the foregoing) or, for a period no longer than 15 consecutive Trading Days,

the OTCID Basic Market within the Pink Open Market, while the Company’s application to the OTCQX or OTCQB is being processed.

“Transaction

Documents” means the Warrants, the Purchase Agreement, the Inducement Agreement, the Registration Rights Agreement (in the form

attached to the Purchase Agreement and Inducement Agreement), all exhibits and schedules thereto and hereto and any other documents or

agreements executed in connection with the transactions contemplated thereunder.

“Transfer Agent” means

Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 90 Park Avenue, New York, New York 10016

and an email address of admin3@equiniti.com, and any successor transfer agent of the Company.

“VWAP”

means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed

or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)

on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30

a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume

weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if

the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the

Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per

share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined

by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably

acceptable to the Company, the fees and expenses of which shall be paid by the Company.

2

“Warrants”

means this Warrant and other Series F Common Stock Purchase Warrants issued by the Company pursuant to the Purchase Agreement.

Section 2.               Exercise.

a)             Exercise

of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on

or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted

by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within

the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as

defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise

Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States

bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.

No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of

any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender

this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised

in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of

the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of

a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant

Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall

maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection

to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance

of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the

Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount

stated on the face hereof.

b)             Exercise

Price. The exercise price per share of Common Stock under this Warrant shall be $0.76, subject

to adjustment hereunder (the “Exercise Price”).

c)             Cashless

Exercise. If, at any time after the six (6) month anniversary of the Issuance Date, at the time of exercise hereof there is no

effective registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant Shares

by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise”

in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by

(A), where:

(A)

= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

3

(B)

= the Exercise Price of this Warrant, as adjusted hereunder; and

(X)

= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

If Warrant Shares

are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities

Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.  The Company

agrees not to take any position contrary to this Section 2(c).

d)

Mechanics of Exercise.

i.               Delivery

of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer

Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company

through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system

and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant

Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations

pursuant to Rule 144 (assuming cashless exercise of the Warrant), and otherwise by physical delivery of a certificate or a book entry

statement, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares

to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date

that is the earliest of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading

Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement

Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”).

Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of

the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,

provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of

(i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery

of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise

by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each

$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),

$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading

Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees

to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As

used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days,

on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

4

ii.              Delivery

of New Warrant Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and

upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing

the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects

be identical with this Warrant.

iii.             Rescission

Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by

the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

iv.            Compensation

for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if

the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above

pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase

(in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver

in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”),

then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price

(including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying

(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue

times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the

Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in

which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been

issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common

Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with

an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence

the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable

to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit

a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree

of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock

upon exercise of the Warrant as required pursuant to the terms hereof.

v.             No

Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this

Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,

at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the

Exercise Price or round up to the next whole share.

vi.             Charges,

Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental

expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant

Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,

that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for

exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as

a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all

Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another

established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares. For the

avoidance of doubt, nothing in this Section 2(d)(vi) shall require the Company to deliver the Warrant Shares on a date earlier

than the Warrant Share Delivery Date.

5

vii.           Closing

of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,

pursuant to the terms hereof.

e)             Holder’s

Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise

any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise

as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting

as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),

would beneficially own in excess of the Beneficial Ownership Limitation.  For purposes of the foregoing sentence, the number of shares

of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common

Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares

of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned

by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted

portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation

on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution

Parties.  Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated

in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged

by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of

the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that

the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation

to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is

exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s

determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates

and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,

and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any

group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and

regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common

Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent

periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or

(C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.

Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the

number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined

after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates

or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial

Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99% or 19.99%) of the

number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise

of this Warrant. During any time that the Common Stock is not listed on a Trading Market, the Holder, upon not less than 61 days’

prior written notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e);

provided that the Beneficial Ownership Limitation shall in no event exceed 19.99% of the number of shares of Common Stock outstanding

immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant held by the Holder without

stockholder approval pursuant to Nasdaq Listing Rule 5635(b) and the provisions of this Section 2(e) shall continue

to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered

to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with

the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with

the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give

effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

6

f)              Call

Provision. Subject to the provisions of Section 2(e) and this Section 2(f), if, after the Effective Date, (i) the

VWAP for fifteen (15) out of thirty (30) consecutive Trading Days (the “Measurement Period,” which 30 consecutive

Trading Day period shall not have commenced until after the date that is six (6) months after the Effective Date) exceeds 300% of

the then-applicable Exercise Price subject to adjustment for forward and reverse stock splits, recapitalizations, stock dividends and

the like after the Initial Exercise Date), (ii) the average daily dollar volume for such Measurement Period exceeds $500,000 per

Trading Day and (iii) the Holder is not in possession of any information that constitutes, or might constitute, material non-public

information which was provided by the Company, any of its Subsidiaries, or any of their officers, directors, employees, agents or Affiliates,

then the Company may, within 1 Trading Day of the end of such Measurement Period, call for cancellation of all or any portion of this

Warrant for which a Notice of Exercise has not yet been delivered (such right, a “Call”) for consideration equal to

$0.001 per Warrant Share. To exercise this right, the Company must deliver to the Holder an irrevocable written notice (a “Call

Notice”), indicating therein the portion of unexercised portion of this Warrant to which such notice applies. If the conditions

set forth below for such Call are satisfied from the period from the date of the Call Notice through and including the Call Date (as defined

below), then any portion of this Warrant subject to such Call Notice for which a Notice of Exercise shall not have been received by the

Call Date will be cancelled at 6:30 p.m. (New York City time) on the tenth Trading Day after the date the Call Notice is received

by the Holder (such date and time, the “Call Date”). Any unexercised portion of this Warrant to which the Call Notice

does not pertain will be unaffected by such Call Notice. In furtherance thereof, the Company covenants and agrees that it will honor all

Notices of Exercise with respect to Warrant Shares subject to a Call Notice that are tendered through 6:30 p.m. (New York City time)

on the Call Date. The parties agree that any Notice of Exercise delivered following a Call Notice which calls less than all of the Warrants

shall first reduce to zero the number of Warrant Shares subject to such Call Notice prior to reducing the remaining Warrant Shares available

for purchase under this Warrant. For example, if (A) this Warrant then permits the Holder to acquire 100 Warrant Shares, (B) a

Call Notice pertains to 75 Warrant Shares, and (C) prior to 6:30 p.m. (New York City time) on the Call Date the Holder tenders

a Notice of Exercise in respect of 50 Warrant Shares, then (x) on the Call Date the right under this Warrant to acquire 25 Warrant

Shares will be automatically cancelled, (y) the Company, in the time and manner required under this Warrant, will have issued and

delivered to the Holder 50 Warrant Shares in respect of the exercises following receipt of the Call Notice, and (z) the Holder may,

until the Termination Date, exercise this Warrant for 25 Warrant Shares (subject to adjustment as herein provided and subject to subsequent

Call Notices). Subject again to the provisions of this Section 2(f), the Company may deliver subsequent Call Notices for any portion

of this Warrant for which the Holder shall not have delivered a Notice of Exercise. Notwithstanding anything to the contrary set forth

in this Warrant, the Company may not deliver a Call Notice or require the cancellation of this Warrant (and any such Call Notice shall

be void), unless, from the beginning of the Measurement Period through the Call Date, (1) the Company shall have honored in accordance

with the terms of this Warrant all Notices of Exercise delivered by 6:30 p.m. (New York City time) on the Call Date, and (2) the

Registration Statement shall be effective as to all Warrant Shares and the prospectus thereunder available for use by the Holder for the

resale of all such Warrant Shares, and (3) the Common Stock shall be listed or quoted for trading on the Trading Market, and (4) there

is a sufficient number of authorized shares of Common Stock for issuance of all Securities under the Transaction Documents, and (5) the

issuance of all Warrant Shares subject to a Call Notice shall not cause a breach of any provision of Section 2(e) or Section 2(g) herein,

and (6) no Delisting Event (as defined below) shall have occurred and be continuing. The Company’s right to call the Warrants

under this Section 2(f) shall be exercised ratably among the Holders based on each Holder’s initial purchase of Warrants.

g)            Beneficial

Ownership Limitation. Notwithstanding anything to the contrary contained herein, the Company shall not effect any exercise of this

Warrant, and no Holder of this Warrant shall have the right to exercise any portion of this Warrant, to the extent that, after giving

effect to the issuance of Warrant Shares upon such exercise, such Holder (together with such Holder’s Affiliates and any other Persons

whose beneficial ownership of Common Stock would be aggregated with such Holder’s for purposes of Section 13(d) of the

Exchange Act and the rules and regulations promulgated thereunder) would beneficially own in excess of the Beneficial Ownership Limitation.

For purposes of this Section 2(g), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange

Act and the rules and regulations promulgated thereunder, and the provisions of Section 2(e) regarding the calculation

of beneficial ownership, the Holder’s determination of exercisability and the Company’s obligation to confirm the number of

outstanding shares of Common Stock shall apply mutatis mutandis to the Beneficial Ownership Limitation. For the avoidance of doubt,

this Section 2(g) is in addition to, and not in lieu of, the limitations in Section 2(e), and in the event of any conflict

the more restrictive limitation shall apply. No Holder may waive or increase the Beneficial Ownership Limitation, and any purported exercise

that would result in a Holder exceeding the Beneficial Ownership Limitation shall be null and void ab initio to the extent of such

excess. Any portion of this Warrant that cannot be exercised by reason of the Beneficial Ownership Limitation shall remain outstanding

and exercisable at such time as such exercise would not result in a violation of this Section 2(g). The limitations contained in

this Section 2(g) shall apply to any successor Holder of this Warrant.

7

(h)            Delisting

Event. A “Delisting Event” shall mean: (a) the Common Stock ceases to be listed or quoted on any Trading Market;

(b) the Company fails to maintain the listing or quotation of the Common Stock on a Trading Market; or (c) trading in the Common

Stock is suspended, halted, or otherwise limited such that Holders are unable to sell shares in the public market for ten (10) consecutive

Trading Days, in each case other than due solely to market-wide trading halts. Notwithstanding the foregoing, any Delisting Event triggered

by a voluntary delisting of the Company from any Trading Market that is approved in writing by Holders of a majority of the then-outstanding

Warrants shall not be deemed a Delisting Event. Upon the occurrence of a Delisting Event, and for so long as such Delisting Event is continuing,

the Holder shall be entitled to exercise this Warrant by means of a cashless exercise pursuant to Section 2(c) regardless of

whether any registration statement is then effective or available.

Section 3.               Certain

Adjustments.

a)             Stock

Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes

a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of

Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this

Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way

of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of

shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction

of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before

such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the

number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this

Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the

record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately

after the effective date in the case of a subdivision, combination or re-classification.

b)             Subsequent

Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues

or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders

of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the

terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the

number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,

including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant,

issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common

Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s

right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder

shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as

a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until

such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

8

c)             Pro

Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution

of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,

without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,

corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after

the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent

that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise

of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)

immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the

record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however,

that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial

Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership

of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance

for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership

Limitation).

d)               Fundamental

Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related

transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,

directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially

all of its assets in one or a series of related transactions, provided, however that the sale by the Company of any Subsidiary, other

than a Material Subsidiary, does not constitute a Fundamental Transaction, (iii) any, direct or indirect, purchase offer, tender

offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted

to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50%

of the outstanding Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly

or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock

or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash

or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase

agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme

of arrangement) with another Person, including such Person’s Attribution Parties, whereby such other Person (including such Person’s

Attribution Parties) acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the

common equity of the Company (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant,

the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior

to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on

the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it

is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result

of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately

prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). “Material

Subsidiary” shall mean any subsidiary of the Company that is material to the business and operations of the Company (or has material

assets to the Company on a consolidated basis) as described in the Company’s public filings with the Commission.

9

For purposes of any such exercise, the

determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate

Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise

Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate

Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental

Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant

following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company

or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30

days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental

Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined

below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however,

that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors,

the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the

same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders

of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock

or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration

in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company

are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received

common stock of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental

Transaction. “Black Scholes Value” means the value of this Warrant based on the Black-Scholes Option Pricing Model

obtained from the “OV” function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction

for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the

time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an

expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization

factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the

underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash,

if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the VWAP immediately

preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental

Transaction, if earlier), (D) the sum of the remaining option time equal to the time between the date of the public announcement

of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the

Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five

Business Days of the Holder’s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall

cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”)

to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant

to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)

prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security

of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable

for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common

Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior

to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock

(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such

shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic

value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in

form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the

term “Company” under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,

each and every provision of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead

to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,

jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor

Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with

the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company

herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless

of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether

a Fundamental Transaction occurs prior to the Initial Exercise Date.

10

e)             Calculations.

All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For

purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be

the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

f)              Notice

to Holder.

i.                Adjustment

to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly

deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number

of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

ii.               Notice

to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the

Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the

Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of

capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection

with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party,

any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted

into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation

or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its

last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record

or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,

distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock

of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on

which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the

date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock

for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;

provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the

corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,

material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with

the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period

commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set

forth herein.

g)             Voluntary

Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term

of this Warrant, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors

of the Company.

11

Section 4.               Transfer

of Warrant.

a)             Transferability.

Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and the provisions

of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration

rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated

agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its

agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if

required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,

and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing

the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,

the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,

in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder

delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may

be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

b)             New

Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,

together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or

its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,

the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance

with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be

identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c)             Warrant

Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant

Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder

of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other

purposes, absent actual notice to the contrary.

d)             Transfer

Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this

Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable

state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information

requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee

of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.

e)             Representation

by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise

hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or

reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant

to sales registered or exempted under the Securities Act.

Section 5.               Miscellaneous.

a)             No

Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends

or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly

set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant

to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in

no event shall the Company be required to net cash settle an exercise of this Warrant.

12

b)             Loss,

Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory

to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case

of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include

the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make

and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

c)             Saturdays,

Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or

granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business

Day.

d)             Authorized

Shares.

The Company covenants

that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number

of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further

covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the

necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action

as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,

or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares

which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented

by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable

and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any

transfer occurring contemporaneously with such issue).

Except and to the

extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate

of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or

any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all

times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate

to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the

Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately

prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly

and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable

efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may

be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any

action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,

the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory

body or bodies having jurisdiction thereof.

e)             Governing

Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and

construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of

law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions

contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,

partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.

Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough

of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed

herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally

subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.

Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding

by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address

in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and

notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted

by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in

such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and

expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

13

f)              Restrictions.

The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not

utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

g)             Nonwaiver

and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as

a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this

Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages

to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but

not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts

due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

h)             Notices.

Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice

of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed

to the Company, at BNB Plus Corp., 25 Health Sciences Drive, Stony Brook, NY 11790, Attention: Beth Jantzen, email address: beth.jantzen@bnb.plus,

or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other

communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent

by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing

on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest

of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this

Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission,

if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading

Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing,

if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is

required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding

the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on

Form 8-K.

i)              Limitation

of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant

Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase

price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the

Company.

14

j)              Remedies.

The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific

performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss

incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any

action for specific performance that a remedy at law would be adequate. The Company acknowledges and agrees that a breach by the Company

of any provision of this Warrant would cause irreparable harm to the Holder for which monetary damages alone would not be an adequate

remedy. Accordingly, in the event of any such breach or threatened breach by the Company, the Holder shall be entitled, in addition to

all other rights and remedies available at law or in equity (including recovery of damages), to seek and obtain equitable relief, including

a decree of specific performance and temporary, preliminary, and permanent injunctive relief. The rights and remedies provided in this

Section are cumulative and shall not be exclusive of any other rights or remedies available to the Holder under this Warrant, the

Purchase Agreement or applicable law. For the avoidance of doubt, no rights of the Holder contemplated in this Section shall be impaired

by rights and remedies available to the Holder pursuant to any other Transaction Document.

k)             Successors

and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the

benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.

The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable

by the Holder or holder of Warrant Shares.

l)              Amendment.

This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and

the Holder or the beneficial owner of this Warrant, on the other hand.

m)            Severability.

Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,

but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the

extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

n)             Headings.

The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

(Signature Page Follows)

15

IN WITNESS WHEREOF, the Company

has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

BNB Plus corp.

By:

Name:

Title:

16

NOTICE OF EXERCISE

To:               BNB

Plus Corp.

(1)            The

undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if

exercised in full), and subject to the current Beneficial Ownership Limitation of (check one) ¨

4.99% ¨ 9.99% or ¨ 19.99%, and

tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2)            Payment

shall take the form of (check applicable box):

¨

in lawful money of the United States; or

¨

if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in

subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless

exercise procedure set forth in subsection 2(c).

(3)           Please

issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

The Warrant Shares shall be delivered to the following

DWAC Account Number:

(4)           Accredited

Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act

of 1933, as amended.

[SIGNATURE

OF HOLDER]

Name of Investing Entity:

Signature of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:

Date:

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this

form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and

all rights evidenced thereby are hereby assigned to

Name:

(Please Print)

Address:

(Please Print)

Phone Number:

Email Address:

Dated: _______________ __, ______

Holder’s Signature:____________________

Holder’s Address:_____________________

EX-4.4 — EXHIBIT 4.4

EX-4.4

Filename: tm2615620d1_ex4-4.htm · Sequence: 7

Exhibit 4.4

TRANSFERABLE RIGHTS AGREEMENT

This Transferable Rights

Agreement (this “Agreement”) is made as of May 26, 2026 between BNB Plus Corp., a Delaware corporation (the “Company”),

and the holder identified on the signature page, including its successors and assigns (the “Holder”).

WHEREAS, pursuant to the

terms of the Warrant Inducement and Exchange Agreement (the “Inducement Agreement”) entered into between the Company

and the Holder as of the date hereof, the Holder has agreed to exercise for cash a percentage of certain common stock purchase warrants

and exchange the shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) issuable

upon the exercise thereof in consideration of the Company issuing the Holder shares of Series B-2 Preferred Stock, par value $0.001

per share, which preferred stock is convertible into shares of Common Stock and shall be governed by the Delaware Certificate of Designation

of the Series B-2 Preferred Stock in the form of Exhibit A attached to the Inducement Agreement (the “Series B-2

Preferred Stock”);

WHEREAS, pursuant to the

terms of the Inducement Agreement, the Holder has elected to retain a number of shares of Common Stock issuable upon exercise of the

common stock purchase warrants set forth on the signature page hereto (the “Retained Shares”) and receive in

lieu of Series B-2 Preferred Stock for the exchange thereof, a transferable right (the “Right” and collectively, the

“Rights”) to exchange a number of shares of Common Stock equal to the number of Retained Shares for a Series B-2

Preferred Stock, subject to the terms herein.

WHEREAS, the Company and

Holder desire to provide for the form and provisions of the Rights, the terms upon which they shall be issued, and the respective rights,

limitation of rights, and immunities of the Company and the Holder.

NOW,

THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

1.            Form of

Right. Each Right shall be issued in registered form only, unless a registered holder (defined below) requests that their Rights

be issued in certificated form. Any Rights issued in certificated form shall be in substantially the form of Exhibit A hereto

(each a “Right Certificate”), the provisions of which are incorporated herein and shall be signed by, or bear the

facsimile signature of any two, the Chairman of the Board, Chief Executive Officer, or Chief Financial Officer of the Company (each an

“Authorized Signatory”). Unless signed by an Authorized Signatory pursuant to this Agreement, a certificated Right

shall be invalid and of no effect and may not be exchanged for Series B-2 Preferred Stock. In the event an Authorized Signatory

whose facsimile signature has been placed upon any Right shall have ceased to serve in the capacity in which such person signed the Right

before such Right is issued, such Right may be issued with the same effect as if such Authorized Signatory had not ceased to be such

at the date of issuance.

2.            Registration.

a)            Right

Register. The Company shall maintain books (“Right Register”) for the registration of original issuance and the

registration of transfer of the Rights. Upon the initial issuance of the Rights, the Company shall issue and register the Rights in the

names of the respective holders thereof.

b)            Registered

Holder. Prior to due presentment for registration of transfer of any Right, the Company may deem and treat the person in whose name

such Right shall be registered upon the Right Register (“registered holder”) as the absolute owner of such Right and

of each Right represented thereby, notwithstanding any notation of ownership or other writing on a Right Certificate made by anyone other

than the Company, for the purpose of the exchange thereof, and for all other purposes, and the Company shall not be affected by any notice

to the contrary.

3.            Terms

and Exchange of Rights.

a)            Each

Right shall entitle the registered holder thereof to exchange shares of Common Stock held by the registered holder for shares of Series B-2

Preferred Stock, at a ratio of one-for-one, subject to any adjustments set forth in Section 7(d), upon the happening of an Exchange

Event (described below). No additional consideration shall be paid by a registered holder of Rights in order to receive his, her or its

Series B-2 Preferred Stock upon an Exchange Event as consideration for the Series B-2 Preferred Stock has been received in

connection with the transactions described in the Inducement Agreement and will be received at the time of an Exchange Event with the

exchange of Common Stock by the registered holder pursuant to this Agreement. In no event will the Company be required to net cash settle

the Rights or issue fractional shares of Series B-2 Preferred Stock.

b)            Exchange

Event. An “Exchange Event” shall occur upon a registered holder delivering or causing to be delivered to the Company

each of:

i. written notice of the registered holder’s

election to exchange, in full or part, Rights held by such registered holder (such rights

referred to herein as the “Exchanged Rights”);

ii. if held in certificated form, certificated

Right(s) for the Exchanged Rights; and

iii. all whole shares of Common Stock required

to be delivered to the Company in connection with the Exchanged Rights. The registered holder

shall not be required to deliver fractional shares upon any exchange of Rights. At the time

of an Exchange Event, the shares of Common Stock required to be delivered to the Company

by the Holder shall be rounded down to the nearest whole share.

c)            Exchange

of Rights.

i. Issuance of Shares. As soon as

practicable upon the occurrence of an Exchange Event, the Company shall automatically exchange

all Exchanged Rights and issue to the registered holder of such Exchanged Rights the number

of whole shares of Series B-2 Preferred Stock to which he, she or it is entitled in

such holder’s name in book-entry form. Notwithstanding the foregoing, or any provision

contained in this Agreement to the contrary, in no event will the Company be required to

net cash settle the Rights. The Company shall not issue fractional shares upon exchange of

Rights. At the time of an Exchange Event, the Company will round down any Series B-2

Preferred Stock to be issued to the registered holder to the nearest whole share.

ii. Issuance of Remaining Rights upon

Partial Exchange. Upon an Exchange Event for the partial exchange of any Rights held

in book-entry form, the Company shall update the Rights Register to reflect the exchange

of the Exchanged Rights and the Rights that were not exchanged (the “Excess Rights”)

in the registered holder’s name. Notwithstanding anything herein to the contrary, upon

a partial exchange of any Rights held in certificated form, a registered holder exchanging

such Rights in part shall be required to physically surrender the certificated Right(s) to

the Company upon an Exchange Event, even if such certificated Right(s) represent more

Rights than the Exchanged Rights, and the Company shall register the Excess Rights in the

registered holder’s name on the Rights Register in registered form only, unless the

registered holder requests such Excess Rights to be issued in certificated form; provided,

however, that in the event a Right surrendered for exchange bears a restrictive legend and

the new Rights to be issued will not bear a restrictive legend, the Company shall not issue

new Rights in exchange therefor until it has received an opinion of counsel for the Company

stating that such issuance may be made indicating no restrictive legend is required.

iii. Valid Issuance. All shares of

Series B-2 Preferred Stock issued upon an Exchange Event in conformity with this Agreement

shall be validly issued, fully paid and nonassessable.

iv. Date of Issuance. Each person

in whose name any such book-entry position for shares of Series B-2 Preferred Stock

is issued shall for all purposes be deemed to have become the holder of record of such shares

on the date of the Exchange Event, irrespective of the date of delivery of such entry of

position.

v. Duration of Rights. The Rights

shall expire and shall be worthless on the three year anniversary of the date hereof.

4.            Transfer

and Exchange of Rights.

a)            Registration

of Transfer. Subject to compliance with any applicable securities laws and the limitation set forth in Section 4(c) below,

the Company shall register the transfer, from time to time, of any outstanding Right upon the Rights Register, upon surrender of such

Right for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon

any such transfer, a new Right representing an equal aggregate number of Rights shall be issued and the old Right shall be cancelled

by the Company.

b)            Procedure

for Surrender of Transferred Rights. Rights may be surrendered to the Company, together with a written request for transfer, and

thereupon the Company shall issue in exchange therefor one or more new Rights as requested by the registered holder of the Rights so

surrendered, representing an equal aggregate number of Rights; provided, however, that in the event that a Right surrendered for transfer

bears a restrictive legend and the new Rights to be issued will not bear a restrictive legend, the Company shall not cancel such Right

and issue new Rights in exchange therefor until it has received an opinion of counsel for the Company stating that such transfer may

be made indicating no restrictive legend is required.

c)            Limitation

on Transfers. No Rights may be transferred by a registered holder unless the number of shares of Common Stock that would be required

to be delivered upon the exercise of such Rights, at the time of the transfer, exceeds 13% of the number of shares of Common Stock that

would be issued upon the exercise of outstanding Series E Common Stock Purchase Warrants of the Company held by such transferee,

at the time of the transfer.

5.            Other

Provisions Relating to Rights of Holders of Rights.

a)            No

Rights as Preferred Stock Holder. Until exchange of a Right as provided for herein, a Right does not entitle the registered holder

thereof to any of the rights of a holder of Series B-2 Preferred Stock of the Company.

b)            Lost,

Stolen, Mutilated, or Destroyed Rights. If any Right Certificate is lost, stolen, mutilated, or destroyed, the Company may on such

terms as to indemnity or otherwise as it may in its discretion impose (which shall, in the case of a mutilated Right Certificate, include

the surrender thereof), issue a new Right Certificate of like denomination, tenor, and date as the Right Certificate so lost, stolen,

mutilated, or destroyed. Any such new Right Certificate shall constitute a substitute contractual obligation of the Company, whether

or not the allegedly lost, stolen, mutilated, or destroyed Right Certificate shall be at any time enforceable by anyone.

c)            Reservation

of Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Series B-2

Preferred Stock that will be sufficient to permit the exchange of all outstanding Rights issued pursuant to this Agreement.

6.            Representations

and Warranties. The Company agrees to the representations, warranties and covenants set forth on Annex A attached hereto,

as of the date hereof and the date of any Exchange Event. The Holder represents and warrants that, as of the date hereof it is, or on

the date which it exchanges any Rights it will be, an “accredited investor” as defined in Rule 501 of Regulation

D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), and agrees that the Series B-2

Preferred Stock will contain restrictive legends when issued, and the Rights and Series B-2 Preferred Stock will not be registered

under the Securities Act. Also, the Holder represents and warrants that it is acquiring the Rights and Series B-2 Preferred Stock

as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or

regarding the distribution of the Rights or Series B-2 Preferred Stock.

7.            Restrictions.

The registered holder understands that issuance of the Rights and the Series B-2 Preferred Stock issuable upon the exchange of a

Right, is not, and may never be, registered under the Securities Act, or the securities laws of any state and, accordingly, each statement

evidencing a Right and Series B-2 Preferred Stock, or any certificate, if any, representing such securities, shall bear a legend

substantially similar to the following:

“NEITHER THIS SECURITY NOR THE

SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES

COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES

ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION

STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS

OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY

IS EXERCISABLE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A

FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN

SECURED BY SUCH SECURITIES.”

Any statement evidencing the Rights and Series B-2

Preferred Stock issuable upon exchange thereof shall not contain any legend (including the legend set forth above), (i) following

any sale or transfer of such Right or Series B-2 Preferred Stock pursuant to Rule 144 under the Securities Act, or (ii) if

such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements

issued by the staff of the Securities and Exchange Commission (the “Commission”) and the earliest of clauses (i) and

(ii), the “Delegend Date”)). The Company shall cause its counsel to issue a legal opinion to the Company’s transfer

agent promptly after the Delegend Date if required by the Company and/or its transfer agent to effect the removal of the legend hereunder,

or at the request of the registered holder, which opinion shall be in form and substance reasonably acceptable to the Company’s

transfer agent. From and after the Delegend Date, such Rights and Series B-2 Preferred Stock shall be issued free of all legends.

The Company agrees that following the Delegend Date or at such time as such legend is no longer required under this Section, it will,

no later than one (1) trading day, deliver or cause to be delivered to the registered holder a book-entry statement representing

such securities that is free from all restrictive and other legends

8.     Other

Matters.

a)            No

Fractional Rights. The Company shall not be required to effect any registration of transfer or exchange which will result in the

issuance of a Right, whether in registered or certificated form, for a fraction of a Right.

b)            Service

Charges. No service charge shall be made for any exchange or registration of exchange or transfer of Rights.

c)            Payment

of Taxes. The Company will promptly pay all taxes and charges that may be imposed upon the Company in respect of the issuance or

delivery of shares of Series B-2 Preferred Stock upon the exchange of Rights, but the Company shall not be obligated to pay any

transfer taxes in respect of the Rights or such shares of Series B-2 Preferred Stock.

d)            Adjustments

to Conversion Ratios. The number of shares of Series B-2 Preferred Stock that the registered holders of Rights are entitled

to receive as a result of the occurrence of an Exchange Event and the number of shares of Common Stock that the registered holders of

Rights are required to deliver to the Company as a result of the occurrence of an Exchange Event shall be equitably adjusted to reflect

appropriately the effect of any share split, reverse share split, share dividend, reorganization, recapitalization, reclassification,

combination, exchange of shares or other like change with respect to the shares of Series B-2 Preferred Stock and Common Stock,

as applicable, occurring on or after the date hereof and prior to the Exchange Event.

9.     Miscellaneous

Provisions.

a)            Successors.

All the covenants and provisions of this Agreement by or for the benefit of the Company shall bind and inure to the benefit of its respective

successors and assigns. Subject to applicable securities laws, the Rights and this Agreement, and the rights and obligations evidenced

thereby and hereby, shall inure to the benefit of and be binding upon the successors and permitted assigns of the Holder.

b)            Notices.

Any and all notices or other communications or deliveries to be provided by the registered holder hereunder including, without limitation,

any notice of exercise shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier

service, addressed to the Company, at BNB Plus Corp., 25 Health Sciences Drive, Stony Brook, NY 11790, Attention: Beth Jantzen, email

address: beth.jantzen@bnb.plus, or such other email address or address as the Company may specify for such purposes by notice to the

registered holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing

and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each registered holder

at the e-mail address or address of such registered holder appearing on the books of the Company. Any notice or other communication or

deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication

is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date,

(ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail

address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading

Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,

or (iv) upon actual receipt by the party to whom such notice is required to be given.

c)            Governing

Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and

construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of

law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions

contemplated by this Agreement (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,

partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.

Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,

Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby

or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is

not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient

venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any

such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)

to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and

sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process

in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this

Agreement, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’

fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

d)            Persons

Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions

hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the

registered holders of the Rights, any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation,

promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be

for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the registered holders of the Rights.

e)            Remedies.

The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific

performance of its rights under this Agreement. The Company agrees that monetary damages would not be adequate compensation for any loss

incurred by reason of a breach by it of the provisions of this Agreement and hereby agrees to waive and not to assert the defense in

any action for specific performance that a remedy at law would be adequate. The Company acknowledges and agrees that a breach by the

Company of any provision of this Agreement would cause irreparable harm to the Holder for which monetary damages alone would not be an

adequate remedy. Accordingly, in the event of any such breach or threatened breach by the Company, the Holder shall be entitled, in addition

to all other rights and remedies available at law or in equity (including recovery of damages), to seek and obtain equitable relief,

including a decree of specific performance and temporary, preliminary, and permanent injunctive relief. The rights and remedies provided

in this Section are cumulative and shall not be exclusive of any other rights or remedies available to the Holder under this Agreement

or applicable law.

f)            Successors

and Assigns. Subject to applicable securities laws, this Agreement and the rights and obligations evidenced hereby shall inure to

the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.

The provisions of this Agreement are intended to be for the benefit of any registered holder from time to time of this Agreement and

shall be enforceable by the Holder or registered holder of a Right.

g)            Amendment.

This Agreement may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and

the Holder or the registered holder of a Right, on the other hand.

h)            Severability.

Wherever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable

law, but if any provision of this Agreement shall be prohibited by or invalid under applicable law, such provision shall be ineffective

to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of

this Agreement.

i)            Headings.

The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this

Warrant.

[Signature Page Follows]

IN WITNESS WHEREOF, this

Agreement has been duly executed by the parties hereto as of the day and year first above written.

BNB

PLUS CORP.

By:

Name:

Title:

HOLDER

By:

Name:

Title:

Retained Shares:

[Signature Page to Rights Agreement]

Exhibit A

NEITHER THIS SECURITY NOR THE SECURITIES INTO

WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY

STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE

SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS

EXERCISABLE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL

INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED

BY SUCH SECURITIES.

NUMBER [_]

[_]

RIGHTS

BNB PLUS CORP.

INCORPORATED UNDER THE LAWS OF THE DELAWARE

RIGHT

SEE REVERSE FOR

CERTAIN DEFINITIONS

THIS CERTIFIES THAT, for value received

___________________________is the registered

holder of a right or rights (each, a “Right”) to exchange shares of BNB Plus Corp. common stock, par value $0.001

per share (“Common Stock”) for shares of BNB Plus Corp. Series B-2 Preferred Stock, at an initial ratio of one-for-one

and as adjustment pursuant to the Transferable Rights Agreement between the Company and the abovesigned as the Holder, successor or assign

thereof (the “Rights Agreement”), for each Right evidenced by this Rights Certificate upon surrender of this Right

Certificate pursuant to the Rights Agreement. Certain capitalized terms used herein are defined in the Rights Agreement. In no event

will the Company be required to net cash settle the Rights or issue fractional shares of Series B-2 Preferred Stock.

The Rights shall expire and shall be worthless

on May 26, 2029.

Upon due presentment for registration of transfer

of the Right Certificate at the office or agency of the Company, a new Right Certificate or Right Certificates of like tenor and evidencing

in the aggregate a like number of Rights shall be issued to the transferee in exchange for this Right Certificate, without charge except

for any applicable tax or other governmental charge. The Company shall not issue fractional shares upon exchange of Rights. The Company

reserves the right to deal with any fractional entitlement at the relevant time in any manner (as provided in the Rights Agreement).

The Company and may deem and treat the registered

holder as the absolute owner of this Right Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone),

for the purpose of any conversion or exchange hereof, of any distribution to the registered holder, and for all other purposes, and the

Company shall not be affected by any notice to the contrary.

This Right does not entitle the registered holder

to any of the rights of a holder of Series B-2 Preferred Stock of the Company prior to the exchange therefor contemplated herein.

Dated:

CHIEF EXECUTIVE OFFICER

CHIEF FINANCIAL OFFICER

CHAIRMAN OF THE BOARD OF DIRECTORS

The following abbreviations,

when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to

applicable laws or regulations:

TEN COM

-

as tenants in common

UNIF/GIFT/MIN/

ACT

-

Custodian

(Cust)

(Minor)

TEN ENT

-

as tenants by the entireties

JT TEN

-

as joint tenants with right

of survivorship and not as tenants in common

under Uniform Gifts to Minors

Act

(State)

Additional Abbreviations may also be used though

not in the above list.

BNB Plus Corp.

The Company will furnish

without charge to each rightsholder who so requests the powers, designations, preferences and relative, participating, optional or other

special rights of each class of shares or series thereof of the Company and the qualifications, limitations, or restrictions of such

preferences and/or rights. This certificate and the rights represented thereby are issued and shall be held subject to all the provisions

of the Certificate of Incorporation of the Company and all amendments thereto and resolutions of the Board of Directors providing for

the issue of shares of Series B-2 Preferred Stock (copies of which may be obtained from the secretary of the Company), to all of

which the holder of this certificate by acceptance hereof assents.

For value received, ___________________________

hereby sell, assign and transfer unto

PLEASE INSERT

SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE

(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP

CODE, OF ASSIGNEE)

rights represented by the within Certificate,

and do hereby irrevocably constitute and appoint

____________________________________________________________________________

Attorney to transfer said rights on the books of the within named Company will full power of substitution in the premises.

Dated

Notice:

The signature to this assignment

must correspond with the name as written upon the face of the certificate in every particular, without alteration or enlargement

or any change whatever.

Signature(s) Guaranteed:

THE SIGNATURE(S) SHOULD

BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP

IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).

Annex A

In addition to the terms

defined elsewhere in this Annex A, for all purposes of this Annex A to the Transferable Rights Agreement, the following terms have the

meanings set forth below:

“DATS Guaranty”

means the irrevocable and unconditional guarantee by the DAT Subsidiaries in favor of the purchaser parties to the Securities Purchase

Agreement and the parties to the Inducement Agreement.

“DAT Subsidiaries”

Build & Build, LLC, a Delaware limited liability company, and BNBX Ltd., a British Virgin Islands business company, wholly owned

subsidiaries of the Company and wholly owned subsidiaries that may be formed hereafter to hold Digital Assets or may become additional

guarantors pursuant to the DATS Guaranty.

“Preferred Stock”

means, collectively, the Series B-1 Preferred Stock and the Series B-2 Preferred Stock issued in connection with the Transaction

Documents.

“Prefunded Warrants”

means, collectively, the Series B-1 Prefunded Preferred Stock Purchase Warrants and the Series B-2 Prefunded Preferred Stock

Purchase Warrants issued in connection with the Transaction Documents.

“Prefunded Warrant

Shares” means the shares of Preferred Stock issuable upon exercise of the Prefunded Warrants.

“Registration Rights

Agreement” means the Registration Rights Agreement, by and among the Company and the parties to the Securities Purchase Agreement

and the Inducement Agreement.

“Securities Purchase

Agreement” means the agreement dated May 26, 2026, between the Company and the purchasers party thereto, including any

purchasers who become a party thereto through joinder.

“Series B-1

Preferred Stock” mean, collectively, Series B-1 Convertible Preferred Stock, par value $0.001 per share, which preferred

stock is convertible into shares of Common Stock and shall be governed by the Delaware Certificate of Designation of the Series B-1

Preferred Stock, issued in connection with the Transaction Documents;

“Series B-1

Prefunded Warrants” means, collectively, the Series B-1 Prefunded Preferred Stock Purchase Warrants issued in connection

with the Transaction Documents.

Representations, Warranties

and Covenants of the Company. The Company hereby makes the following representations, warranties and covenants to the Holder:

a)

SEC Reports; Financial

Statements. Except as set forth on Schedule A, the Company has filed all reports, schedules, forms, statements and other documents

required to be filed by the Company under the Securities Act and the Exchange Act of 1934, as amended (the “Exchange Act”),

including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter

period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto

and documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”) on

a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration

of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the

Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a

material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,

in the light of the circumstances under which they were made, not misleading. The Company is not currently subject to Rule 144(i) under

the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable

accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.

Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on

a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial

statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and

fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the

dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,

to normal, immaterial, year-end audit adjustments.

b)

Organization and Qualification.

Each of the Company and the DAT Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good

standing (if applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization, with the requisite

power and authority to own and use its properties and assets and to carry on its business as currently conducted, and neither the

Company nor any DAT Subsidiary is in violation nor in default of any of the provisions of its respective certificate or articles

of incorporation, bylaws or other organizational or charter documents. Except as would otherwise not, individually or in the aggregate,

reasonably be expected to have a Material Adverse Effect, each subsidiary of the Company including any direct or indirect subsidiary

of the Company formed or acquired after the date hereof (each a “Subsidiary”) other than a DAT Subsidiary, is an entity

duly incorporated or otherwise organized, validly existing and in good standing (if applicable in such jurisdiction) under the laws

of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and

assets and to carry on its business as currently conducted, and no such Subsidiary is in violation nor in default of any of the provisions

of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company

and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each

jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where

the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a

material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect

on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,

taken as a whole, or (iii) a material adverse effect on the ability of the Company or the DAT Subsidiaries to perform in any

material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material

Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking

to revoke, limit or curtail such power and authority or qualification.

c)

Authorization; Enforcement.

The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this

Transferable Rights Agreement and each of the Prefunded Warrants, the Inducement Agreement, the Registration Rights Agreement, and

the DATS Guaranty, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with

the transactions contemplated hereunder (the “Transaction Documents”) and otherwise to carry out its obligations

hereunder and thereunder. The execution and delivery of this Transferable Rights Agreement and each of the other Transaction Documents

by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary

action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company's stockholders

in connection herewith or therewith other than in connection with the Required Approvals. This Transferable Rights Agreement and

each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and,

when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligations of the Company

enforceable against the Company in accordance with their terms, except (i) as limited by general equitable principles and applicable

bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors' rights

generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable

remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. The DAT Subsidiaries

have the requisite corporate power and authority to enter into and to consummate the transactions contemplated by the DATS Guaranty,

and all exhibits and schedules thereto, and otherwise to carry out its obligations thereunder. The execution and delivery of the

DATS Guaranty and the consummation by it of the transactions contemplated thereby have been duly authorized by all necessary action

on the part of the DAT Subsidiaries and no further action is required by the DAT Subsidiaries in connection therewith other than

in connection with the Required Approvals. The DAT Guarantee has been (or upon delivery will have been) duly executed by the DAT

Subsidiaries and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligations

of the DAT Subsidiaries enforceable against the DAT Subsidiaries in accordance with their terms, except (i) as limited by general

equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting

enforcement of creditors' rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive

relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable

law.

d)

Issuance of the Securities.

The Preferred Stock, Prefunded Warrants, Prefunded Warrant Shares, and Rights are duly authorized and, when issued and paid for in

accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear

of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has

reserved from its duly authorized capital stock the maximum number of shares of Series B-2 Preferred Stock and Common Stock

issuable pursuant to this Transferable Rights Agreement. As used herein “Liens” means any mortgage, deed of trust,

pledge, hypothecation, security interest, encumbrance, lien, charge, claim, attachment, garnishment, levy or other restriction of

any kind, whether arising by agreement, operation of law or otherwise, including any conditional sale or other title retention agreement,

any lease in the nature thereof, any restriction on transfer or disposition, and any agreement to create or suffer any of the foregoing,

and including any asserted or pending claim, litigation, proceeding or demand that could reasonably be expected to result in the

imposition of any of the foregoing on any asset or property of the Company or any subsidiary, including any Subsidiary holding digital

assets.

e)

No Conflicts. The

execution, delivery and performance by the Company of this Transferable Rights Agreement and the other Transaction Documents to which

it is a party, the issuance and sale of the Rights and the consummation by it of the transactions contemplated hereby do not and

will not (i) conflict with or violate any provision of the Company's or any Subsidiary's certificate or articles of incorporation,

bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice

or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of

the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without

notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt

or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company

or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of

any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which

the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or

asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could

not have or reasonably be expected to result in a Material Adverse Effect.

f)

Filings, Consents and

Approvals. Except as would otherwise not, individually or in the aggregate, reasonably be expected to have a Material Adverse

Effect, the Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing

or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with

the execution, delivery and performance by the Company of this Transferable Rights Agreement or the Transaction Documents, other

than: (i) the filing of the Certificate of Designations for the Preferred Stock with the Secretary of State of the State of

Delaware, (ii) the filings required by this Transferable Rights Agreement, (iii) the filing of registration statements

with the Commission pursuant to the Registration Rights Agreement, (iv) the notice and/or application(s) to each applicable

Trading Market for the issuance and sale of the securities and the listing of the Common Stock underlying such securities issuable

in connection with the Transaction Documents, or trading thereon in the time and manner required thereby, (v) if required, the

notice and/or application(s) to each applicable Trading Market for the issuance and sale of securities and the listing of shares

of Common Stock underlying such securities issuable in connection with this Transferable Rights Agreement, or trading thereon in

the time and manner required thereby, and (vi) the filing of Form D with the Commission and such filings as are required

to be made under applicable state securities laws (collectively, the “Required Approvals”).

g)

Listing of Common Stock.

The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common Stock on a Trading

Market, and concurrently with the Closing of the Inducement Agreement, the Company shall apply to list or quote all of the Common

Stock issuable upon conversion of the Preferred Stock and shares of Common Stock issuable upon conversion of the Prefunded Warrant

Shares (the “Conversion Shares”) on the Trading Market on which it is currently listed and promptly secure the

listing of all of the Conversion Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common

Stock traded on any other Trading Market, it will then include in such application all of the Conversion Shares, and will take such

other action as is necessary to cause all of the Conversion Shares to be listed or quoted on such other Trading Market as promptly

as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on

a Trading Market and will comply in all respects with the Company's reporting, filing and other obligations under the bylaws or rules of

the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository

Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository

Trust Company or such other established clearing corporation in connection with such electronic transfer. The Company shall promptly

notify the Holder in writing of (i) any notice received from any Trading Market regarding the Company’s compliance with

listing or maintenance requirements, (ii) any determination by the Company to list on a different Trading Market, and (iii) any

delisting, suspension of trading, or threatened delisting or suspension affecting the Common Stock. Any information filed or furnished

by the Company with the Commission and delivered to (a) purchasers party to the Securities Purchase Agreement which purchased

at least 50.1% in interest of the Conversion Shares and Common Warrant Shares, as defined in the Securities Purchase Agreement, based

on the initial subscription amounts thereunder, or (b) the designee or delegate thereof, that includes the information required

by this Annex A Section (g)(i), (ii), or (iii) within the timeframe required by the Commission and the applicable Trading

Market, shall constitute prompt written notice to the Holder by the Company required by this Annex A Section (g).

EX-10.1 — EXHIBIT 10.1

EX-10.1

Filename: tm2615620d1_ex10-1.htm · Sequence: 8

Exhibit 10.1

SECURITIES

PURCHASE AGREEMENT

This Securities Purchase

Agreement (this “Agreement”), is dated as of May 26, 2026, between BNB Plus Corp., a Delaware corporation (the

“Company”), and each purchaser identified on the signature pages hereto or that becomes a purchaser in accordance

with Section 2.1(b)(each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms

and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and Rule 506

promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires

to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION

of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which

are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

1.1           Definitions.

In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings

set forth in this Section 1.1:

“2025

PIPE” means the private placement financing transactions between the Company and the investing parties thereto that closed

on October 3, 2025 and October 23, 2025.

“Acquiring

Person” shall have the meaning ascribed to such term in Section 4.5.

“Action”

shall have the meaning ascribed to such term in Section 3.1(j).

“Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

“Board

of Directors” means the board of directors of the Company.

“Business

Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized

or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized

or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee”

or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority

so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally

are open for use by customers on such day.

“Certificate

of Designations” means the Series B-1 Preferred Stock Certificate of Designation and the Series B-2 Preferred Stock

Certificate of Designation.

“Closing”

means the closing of the purchase and sale of the Securities pursuant to Section 2.1.

“Closing

Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties

thereto, and all conditions precedent to (i) the Purchasers' obligations to pay the Subscription Amount and (ii) the Company's

obligations to deliver the Securities, in each case, have been satisfied or waived. “Initial Closing” means the occurrence

of the Closing Date with respect to an aggregate Subscription Amount, and related obligations for delivery of Securities, equal to not

less than $2,300,000. In the event one or more additional Purchasers subscribe pursuant to Section 2.1(b), the “Closing Date”

shall be deemed to mean the effective date of the joinder executed by each such Purchaser in accordance with Section 2.1(b)(iii) and

delivered to the Company pursuant to Section 2.2(b)(i).

“Commission”

means the United States Securities and Exchange Commission.

“Common

Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such

securities may hereafter be reclassified or changed.

“Common

Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire

at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is

at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

“Common

Warrants” means collectively, the Series F Common Stock Purchase Warrants delivered to the Purchasers at the Closing in

accordance with Section 2.2(a) hereof, which warrants shall be exercisable immediately and have a term of exercise equal to

three years, in the form of Exhibit C attached hereto.

“Common

Warrant Shares” means the shares of Common Stock issuable upon exercise of the Common Warrants.

“Company

Counsel” means Harter Secrest & Emery LLP, with offices located at 1600 Bausch & Lomb Pl, Rochester, NY 14604.

“Conversion

Shares” means the shares of Common Stock issuable upon the conversion of the Preferred Stock and the shares of Common Stock

issuable upon conversion of the Prefunded Warrant Shares.

“DAT Subsidiaries”

means Build & Build, LLC, a Delaware limited liability company, and BNBX Ltd., a British Virgin Islands business company, each

a 100% owned subsidiary of the Company, and such other wholly-owned subsidiary or subsidiaries of the Company as may from time to time

hold Digital Assets or may become additional guarantors pursuant to the DATS Guaranty.

“DATS

Guaranty” means the irrevocable and unconditional guarantee by the DAT Subsidiaries in favor of the Purchasers and the Exchanging

Holders in the form of the Guaranty Agreement attached hereto as Exhibit E.

“Digital

Assets” means (a) cryptocurrencies, virtual currencies, digital currencies, coins, tokens and stablecoins; (b) native

blockchain or protocol assets; (c) tokenized securities, tokenized commodities and tokenized real-world assets; (d) utility

tokens, governance tokens, staking tokens, liquid staking tokens and wrapped, bridged or synthetic digital assets; (e) any digital

or cryptographic asset, property or store of value that is recorded, represented or transferred using distributed ledger technology,

blockchain technology, cryptographic systems or similar technology; (f) BNB-denominated trust units, (g) any rights to receive,

acquire, stake, validate, delegate, earn, mine or otherwise obtain any of the foregoing; (h) any proceeds, products, distributions,

rewards, fees, interest, yield, airdrops, forks or other property derived from or attributable to any of the foregoing; and (i) any

replacements, substitutions, modifications, successors or forks of any of the foregoing, in each case of (a) through (h), whether

now existing or hereafter arising.

“Digital

Asset Treasury” means the immediately available liquid assets of the Company and its subsidiaries except as set forth on Schedule

1.1, including but not limited to any Digital Assets and any cash at the DAT Subsidiaries.

“Disclosure

Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.

“Disclosure

Time” means, 9:00 am (New York City time) on the next Trading Day after the signing of this Agreement.

“Effective

Date” means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission,

(b) all of the Preferred Stock or Conversion Shares and Common Warrant Shares have been sold pursuant to Rule 144 or may be

sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required

under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date

provided that the applicable holder is not an affiliate of the Company, or (d) all of the Preferred Stock, Conversion Shares and

Common Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without

volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified opinion that resales

may then be made by such holders of the Preferred Stock, Conversion Shares and Common Warrant Shares pursuant to such exemption which

opinion shall be in form and substance reasonably acceptable to such holders.

“Evaluation

Date” shall have the meaning ascribed to such term in Section 3.1(s).

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Exchanging

Holders” means the investors that participated in the 2025 PIPE and are parties to the Inducement Agreement.

“Exempt

Issuance” means the issuance of (a) Common Stock, options or other equity awards to employees, officers, consultants,

members of its strategic advisory board, or directors of the Company pursuant to any stock or option plan or employee stock purchase

plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members

of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon

the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for

or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not

been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price

or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities,

(c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of

the Company, provided that such securities are issued as “restricted securities” (as defined in Rule 144), and provided

that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,

an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company

additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities

primarily for the purpose of raising capital or to an entity whose primary business is investing in securities, (d) any existing

at the market offering facility or equity line of credit facility, (e) the issuance of securities in connection with the Inducement

Agreement, and (f) any dividends in kind paid to Series B-1 Preferred Stock or Series B-2 Preferred Stock pursuant to

their respective Certificate of Designations.

“FCPA”

means the Foreign Corrupt Practices Act of 1977, as amended.

“FDA”

shall have the meaning ascribed to such term in Section 3.1(kk).

“FDCA”

shall have the meaning ascribed to such term in Section 3.1(kk).

“GAAP”

shall have the meaning ascribed to such term in Section 3.1(h).

“General

Proceeds” means proceeds from the sale of the Securities hereunder and from the exercise of the Series E Warrants pursuant

to the Inducement Agreement, in an aggregate cumulative amount of not in excess of $2,300,000.

“GENIUS

Act” means the Guiding and Establishing National Innovation for U.S. Stablecoins Act of 2025

“Indebtedness”

shall have the meaning ascribed to such term in Section 3.1(bb).

“Intellectual

Property Rights” shall have the meaning ascribed to such term in Section 3.1(p).

“Joinder

Agreement” means a joinder agreement substantially in the form attached hereto as Exhibit A, executed by each additional

Purchaser referenced in Section 2.1(b).

“Lead

Purchaser” means (i) collectively, Purchasers which purchased at least 50.1% in interest of the Conversion Shares and

Common Warrant Shares based on the initial Subscription Amounts hereunder, or (ii) the designee or delegate thereof.

“Legend

Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).

“Liens”

means any mortgage, deed of trust, pledge, hypothecation, security interest, encumbrance, lien, charge, claim, attachment, garnishment,

levy or other restriction of any kind, whether arising by agreement, operation of law or otherwise, including any conditional sale or

other title retention agreement, any lease in the nature thereof, any restriction on transfer or disposition, and any agreement to create

or suffer any of the foregoing, and including any asserted or pending claim, litigation, proceeding or demand that could reasonably be

expected to result in the imposition of any of the foregoing on any asset or property of the Company or any subsidiary, including any

Subsidiary holding digital assets.

“Material

Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

“Material

Permits” shall have the meaning ascribed to such term in Section 3.1(n).

“Per Share

Purchase Price” equals $1.05, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations

and other similar transactions of the Preferred Stock that occur after the date of this Agreement, provided that the purchase price per

Prefunded Warrant shall be the initial unadjusted Per Share Purchase Price at Closing minus $0.0001.

“Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability

company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Pharmaceutical

Product” shall have the meaning ascribed to such term in Section 3.1(kk).

“Preferred

Stock” means the Series B-1 Preferred Stock delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof.

“Prefunded

Warrants” means, collectively, the Series B-1 Prefunded Preferred Stock Purchase Warrants delivered to the Purchasers

at the Closing in accordance with Section 2.2(a) hereof.

“Prefunded

Warrant Shares” means the shares of Series B-1 Preferred Stock issuable upon exercise of the Prefunded Warrants.

“Proceeding”

means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,

such as a deposition), whether commenced or threatened.

“Public

Information Failure” shall have the meaning ascribed to such term in Section 4.2(b).

“Public

Information Failure Payments” shall have the meaning ascribed to such term in Section 4.2(b).

“Purchaser

Party” shall have the meaning ascribed to such term in Section 4.8.

“Registration

Rights Agreement” means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers

in the form of Exhibit F attached hereto.

“Registration

Statement” means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering

the resale by the Purchasers of the Conversion Shares and Common Warrant Shares issuable in connection with this Agreement.

“Required

Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

“Rule 144”

means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from

time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect

as such Rule.

“Rule 424”

means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from

time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect

as such Rule.

“SEC Reports”

shall have the meaning ascribed to such term in Section 3.1(h).

“Securities”

means the Preferred Stock, the Prefunded Warrants, the Conversion Shares, the Common Warrants, and the Common Warrant Shares.

“Securities

Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Series B-1

Preferred Stock” means the Series B-1 Convertible Preferred Stock to be delivered to Purchasers pursuant to this Agreement

and Exchanging Holders pursuant to the Inducement Agreement, which preferred stock shall be governed by the Series B-1 Preferred

Stock Certificate of Designation.

“Series B-1

Preferred Stock Certificate of Designation” means the Delaware Certificate of Designation of the Series B-1 Preferred

Stock in the form of Exhibit B attached hereto, filed with the Secretary of State of the State of Delaware on or about the

date hereof (as amended, restated, supplemented or otherwise modified from time to time).

“Series B-1

Prefunded Warrants” means, collectively, the Series B-1 Prefunded Preferred Stock Purchase Warrants to be delivered to

Purchasers pursuant to this Agreement and Exchanging Holders pursuant to the Inducement Agreement, which prefunded warrants shall be

exercisable immediately and shall expire when exercised in full, in the form of Exhibit D attached hereto.

“Series B-1

Prefunded Warrant Shares” means the shares of Series B-1 Preferred Stock issuable upon exercise of the Series B-1

Prefunded Warrants.

“Series B-2

Conversion Shares” means the shares of Common Stock issuable upon the conversion of the Series B-2 Preferred Stock and

the shares of Common Stock issuable upon conversion of the Series B-2 Prefunded Warrant Shares.

“Series B-2

Preferred Stock” means the Series B-2 Convertible Preferred Stock to be delivered to Exchanging Holders in connection

with the Inducement Agreement, which preferred stock shall be governed by the Series B-2 Preferred Stock Certificate of Designation.

“Series B-2

Preferred Stock Certificate of Designation” means the Delaware Certificate of Designation of the Series B-2 Preferred

Stock in the form attached to the Inducement Agreement, filed with the Secretary of State of the State of Delaware on or about the date

hereof (as amended, restated, supplemented or otherwise modified from time to time).

“Series B-2

Prefunded Warrants” means, collectively, the Series B-2 Prefunded Preferred Stock Purchase Warrants to be delivered to

Exchanging Holders in connection with the Inducement Agreement.

“Series B-2

Prefunded Warrant Shares” means the shares of Series B-2 Preferred Stock issuable upon exercise of the Series B-2

Prefunded Warrants.

“Short

Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall

not be deemed to include locating and/or borrowing shares of Common Stock).

“Subscription

Amount” means, as to each Purchaser, the aggregate amount to be paid for Preferred Stock and Common Warrants purchased hereunder

as specified below such Purchaser's name on the signature page of this Agreement and next to the heading “Subscription Amount,”

in United States dollars and in immediately available funds (minus, if applicable, a Purchaser's aggregate exercise price of the Prefunded

Warrants, which amounts shall be paid as and when such Prefunded Warrants are exercised).

“Subsidiary”

means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed

or acquired after the date hereof.

“Trading

Day” means a day on which the principal Trading Market is open for trading.

“Trading

Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date

in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the NYSE

American, the OTCQX Market, or the OTCQB Market (or any successors to any of the foregoing) or, for a period no longer than 15 consecutive

Trading Days, the OTCID Basic Market within the Pink Open Market, while the Company’s application to the OTCQX or OTCQB is being

processed.

“Transaction

Documents” means this Agreement, the Inducement Agreement, the Common Warrants, the Prefunded Warrants, the Registration Rights

Agreement, the Rights (in the form attached to the Transferable Rights Agreement), the Transferable Rights Agreement (in the form attached

to the Inducement Agreement), and the DATS Guaranty, all exhibits and schedules thereto and hereto and any other documents or agreements

executed in connection with the transactions contemplated hereunder.

“Transfer

Agent” means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 90 Park Avenue,

New York, New York 10016, and any successor transfer agent of the Company.

“VWAP”

means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed

or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)

on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30

a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB Venture Market (“OTCQB”)

or OTCQX Best Market (“OTCQX”) is not a Trading Market, the volume weighted average price of the Common Stock for

such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted

for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (“Pink Market”)

operated by OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent

bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock

as determined by an independent appraiser selected in good faith by the Guaranteed Parties (as defined in the DATS Guaranty) holding

more than 50% of the aggregate Liquidation Preference (as defined in the Series B-1 Preferred Stock Certificate of Designation)

of the then-outstanding shares of Series B-1 Preferred Stock, and reasonably acceptable to the Company, the fees and expenses of

which shall be paid by the Company.

“Inducement

Agreement” means the Warrant Inducement and Exchange Agreement between the Company and Exchanging Holders, to close concurrently

with the Closing, whereby such Exchanging Holders shall simultaneously (1) exercise outstanding Series E Warrants held by such

Exchanging Holders issued in connection with the 2025 PIPE, at an exercise price of $3.82 per share for shares of Common Stock, a number

of shares of Series B-1 Preferred Stock pursuant to a formula set forth in the Inducement Agreement (or Series B-1 Prefunded

Warrants, if applicable); (2) exchange all shares of Common Stock received by such Exchanging Holder in the 2025 PIPE and upon the

exercise of the Series E Warrants in (1) above for an equal number of shares of Series B-2 Preferred Stock (or Series B-2

Prefunded Warrants, if applicable); and (3) exchange any outstanding prefunded warrants issued to the Exchanging Holder in the 2025

PIPE for an equal number of Series B-2 Prefunded Warrants.

ARTICLE II.

PURCHASE AND SALE

2.1           Closing.

(a)           On

the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally

and not jointly, agree to purchase, up to an aggregate of $5 million of Preferred Stock and Common Warrants; provided, however,

that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser's Affiliates,

and any Person acting as a group together with such Purchaser or any of such Purchaser's Affiliates) would beneficially own in excess

of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Preferred Stock such Purchaser

may elect to purchase Prefunded Warrants in such manner to result in the same Subscription Amount being paid by such Purchaser to the

Company. The “Beneficial Ownership Limitation” shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%

or 19.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities

on the Closing Date. Additionally and notwithstanding anything herein to the contrary, the Company may re-allocate a portion of each

Purchaser's Subscription Amount to Prefunded Warrants in lieu of Preferred Stock solely to the lesser of (x) the amount in excess

of 19.99% and (y) the minimum extent necessary to avoid a violation of the rules and regulations of the Trading Market the

Common Stock is then traded on, if any; provided, that the Company shall give the Holder prior written notice of any such re-allocation,

identify the applicable rule or regulation requiring such re-allocation, and use commercially reasonable efforts to structure such

re-allocation in a manner that preserves the economic and voting position that the Holder would have received absent such re-allocation.

The Holder’s calculation of its beneficial ownership for purposes of this paragraph shall be conclusive absent manifest error.

Each Purchaser shall deliver to the Company, via wire transfer, immediately available funds equal to such Purchaser's Subscription Amount

as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective

Preferred Stock and a Common Warrant, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver

the other items set forth in Section 2.2 deliverable at the Closing. Notwithstanding anything herein to the contrary, in lieu of

cash, a Purchaser may deliver the cash equivalent of crypto-currency stablecoins recognized by the GENIUS Act acceptable (in form and

value) to the Company in the Company’s sole discretion. Upon satisfaction of the covenants and conditions set forth in Sections

2.2 and 2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation.

(b)           Subject

to the terms and conditions of this Agreement and in reliance upon the representations and warranties of the Company set forth herein,

the Company may, at any time and from time to time during the period commencing on the date of this Agreement and ending on the fifteenth

Trading Day thereafter, sell and issue additional Preferred Stock (or, as the case may be, Prefunded Warrants) and Common Warrants to

one or more additional Purchasers; provided, however, that:

(i)           the

aggregate gross proceeds from the sale of Preferred Stock (or, as the case may be, Prefunded Warrants) and Common Warrants to all Purchasers

across all Closings shall not exceed $5 million;

(ii)          the

purchase price per Preferred Stock (or, as the case may be, Prefunded Warrants) and Common Warrants for any additional Purchaser shall

be identical to the purchase price Preferred Stock (or, as the case may be, Prefunded Warrants) and Common Warrants paid by Purchasers

at the Initial Closing;

(iii)         each

additional Purchaser shall execute and deliver to the Company a Joinder Agreement, pursuant to which such additional Purchaser shall

become a party to, and be bound by the terms and conditions of, this Agreement and each other Transaction Document to the same extent

as if such additional Purchaser had been an original signatory hereto;

(iv)         such

sale shall not require registration under the Securities Act or qualification under any applicable state securities laws, it being the

intent of the parties that all such sales shall be made pursuant to the exemption from registration provided by Section 4(a)(2) of

the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder; and

(v)          during

any period in which the Common Stock is listed on a Trading Market, such sale shall not violate a listing standard of the Trading Market

on which the Common Stock is then traded, including but not limited to Nasdaq listing rule 5635.

2.2           Deliveries.

(a)           On

or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:

(i)           this

Agreement duly executed by the Company, or for each Purchaser who becomes a Purchaser by Joinder pursuant to Section 2.1(b), a Joinder

duly executed by the Company;

(ii)          a

certified copy of the effective Series B-1 Preferred Stock Certificate of Designation filed with the Secretary of State of Delaware;

(iii)         a

copy of the certificate registered in the name of such Purchaser evidencing a number of Preferred Stock equal to such Purchaser's Subscription

Amount divided by the Per Share Purchase Price, which shall be promptly delivered to the Purchaser after the Closing Date;

(iv)         a

copy of the of the fully executed Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common

Stock equal to 100% of such Purchaser's Conversion Shares, with an exercise price equal to $0.76, subject to adjustment therein, which

shall be promptly delivered to the Purchaser after the Closing Date;

(v)          for

each Purchaser of Prefunded Warrants pursuant to Section 2.1, a copy of the fully executed Prefunded Warrant registered in the name

of such Purchaser to purchase up to a number of shares of Preferred Stock equal to the portion of such Purchaser's Subscription Amount

applicable to Prefunded Warrants divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001, subject

to adjustment therein which shall be promptly delivered to the Purchaser after the Closing Date;

(vi)         the

Registration Rights Agreement duly executed by the Company;

(vii)        The

DATS Guaranty duly executed by the Company and the DAT Subsidiaries;

(viii)       certificates

from the state or jurisdiction of incorporation, dated within ten (10) days before the Closing Date, certifying that the Company

and each DAT Subsidiary are in good standing under the laws of the applicable state or jurisdiction of incorporation; provided,

however, that any good standing certificate for BNBX Ltd. may be obtained within ten (10) days after the Closing Date;

(ix)          a

copy of the Inducement Agreement, duly executed by the Company and each Exchanging Holder party thereto; and

(x)           a

copy of the Transferable Rights Agreement, duly executed by the Company and each Exchanging Holder party thereto.

(b)           On

or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, as applicable, the following:

(i)           this

Agreement duly executed by such Purchaser, or for each Purchaser who becomes a Purchaser by Joinder pursuant to Section 2.1(b),

a Joinder duly executed by such Purchaser;

(ii)          such

Purchaser's Subscription Amount by wire transfer to the account specified by the Company or, if approved by the Company in its sole discretion,

cash equivalent crypto-currency stablecoins recognized by the GENIUS Act to the digital wallet specified by the Company; and

(iii)         the

Registration Rights Agreement duly executed by such Purchaser.

2.3           Closing

Conditions.

(a)           The

obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

(i)           the

accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on

the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which

case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in

all respects) as of such date);

(ii)          all

obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;

and

(iii)         the

delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

(b)           The

respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:

(i)           the

accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,

in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of

a specific date therein in which case they shall be accurate in all respects or, to the extent representations or warranties are qualified

by materiality or Material Adverse Effect, in all respects) as of such date);

(ii)          all

obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

(iii)         the

delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

(iv)         there

shall have been no Material Adverse Effect with respect to the Company since the date hereof;

(v)          between

the date hereof and the Closing Date, no material adverse event shall have occurred that has had, or would reasonably be expected to

have, a Material Adverse Effect on the Company's digital asset activities, including because of any ban, moratorium, or regulatory action

of general applicability to such activities. For the avoidance of doubt, a de-listing of the Company shall be deemed not to be a material

adverse event for purposes of this clause (v);

(vi)         from

the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company's principal

Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have

been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,

or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities

nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such

magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of

such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing, except that delisting of the Common

Stock from the Nasdaq Capital Markets shall not trigger this provision; and

(vii)        the Company

shall have delivered to the Purchasers final copies of all Disclosure Schedules, which shall be in form and substance reasonable satisfactory

to the Lead Purchaser.

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

3.1           Representations

and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part

hereof and shall qualify any representation made herein to the extent of the disclosure contained in the corresponding section of the

Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:

(a)           Subsidiaries.

The Company owns, directly or indirectly, all of the capital stock or other equity interests of each DAT Subsidiary free and clear of

any Liens. Except as would otherwise not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect

(defined below), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each other Subsidiary

free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each such Subsidiary are validly issued

and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

(b)           Organization

and Qualification. Each of the Company and the DAT Subsidiaries is an entity duly incorporated or otherwise organized, validly existing

and in good standing (if applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization, with

the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted, and neither

the Company nor any DAT Subsidiary is in violation nor in default of any of the provisions of its respective certificate or articles

of incorporation, bylaws or other organizational or charter documents. Except as would otherwise not, individually or in the aggregate,

reasonably be expected to have a Material Adverse Effect, each Subsidiary other than a DAT Subsidiary is an entity duly incorporated

or otherwise organized, validly existing and in good standing (if applicable in such jurisdiction) under the laws of the jurisdiction

of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on

its business as currently conducted, and no such Subsidiary is in violation nor in default of any of the provisions of its respective

certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries

is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which

the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified

or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on

the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations,

assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a

material adverse effect on the ability of the Company or the DAT Subsidiaries to perform in any material respect on a timely basis its

obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding

has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority

or qualification.

(c)           Authorization;

Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated

by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The

execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the

transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further

action is required by the Company, the Board of Directors or the Company's stockholders in connection herewith or therewith other than

in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon

delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute

the valid and binding obligations of the Company enforceable against the Company in accordance with their terms, except (i) as limited

by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application

affecting enforcement of creditors' rights generally, (ii) as limited by laws relating to the availability of specific performance,

injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by

applicable law. The DAT Subsidiaries have the requisite corporate power and authority to enter into and to consummate the transactions

contemplated by the DATS Guaranty, and all exhibits and schedules thereto, and otherwise to carry out its obligations thereunder. The

execution and delivery of the DATS Guaranty and the consummation by it of the transactions contemplated thereby have been duly authorized

by all necessary action on the part of the DAT Subsidiaries and no further action is required by the DAT Subsidiaries in connection therewith

other than in connection with the Required Approvals. The DATS Guaranty has been (or upon delivery will have been) duly executed by the

DAT Subsidiaries and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligations

of the DAT Subsidiaries enforceable against the DAT Subsidiaries in accordance with their terms, except (i) as limited by general

equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting

enforcement of creditors' rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive

relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable

law.

(d)           No

Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which

it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby

do not and will not (i) conflict with or violate any provision of the Company's or any Subsidiary's certificate or articles of incorporation,

bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice

or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the

Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice,

lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise)

or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary

is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation,

order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary

is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary

is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to

result in a Material Adverse Effect.

(e)           Filings,

Consents and Approvals. Except as would otherwise not, individually or in the aggregate, reasonably be expected to have a Material

Adverse Effect, the Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any

filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with

the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing of the Certificate

of Designations with the Secretary of State of the State of Delaware, (ii) the filings required pursuant to Section 4.4 of

this Agreement, (iii) the filing of registration statements with the Commission pursuant to the Registration Rights Agreement, (iv) the

notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the

Conversion Shares and Common Warrant Shares issuable in connection with this Agreement, or trading thereon in the time and manner required

thereby, (v) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of securities and

the listing of shares of Common Stock underlying such securities issuable in connection with the Inducement Agreement, or trading thereon

in the time and manner required thereby, and (vi) the filing of Form D with the Commission and such filings as are required

to be made under applicable state securities laws (collectively, the “Required Approvals”).

(f)           Issuance

of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction

Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than

restrictions on transfer provided for in the Transaction Documents. The Prefunded Warrant Shares and Common Warrant Shares, when issued

in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all

Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved

from its duly authorized capital stock the maximum number of shares of Preferred Stock and Common Stock issuable pursuant to this Agreement.

(g)           Capitalization.

The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(g). The Company has not issued any capital

stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options

under the Company's stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company's employee stock

purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently

filed periodic report under the Exchange Act. No Person, other than Exchanging Holders in connection with the Registration Rights Agreement,

has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated

by the Transaction Documents. Except as set forth on Schedule 3.1(g), there are no outstanding options, warrants, scrip rights

to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into

or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital

stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become

bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale

of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other

than the Purchasers and Exchanging Holders). Except as set forth on Schedule 3.1(g), there are no outstanding securities or instruments

of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or

instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the

Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings

or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.

The Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement.

All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have

been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of

any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder,

the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting

agreements or other similar agreements with respect to the Company's capital stock to which the Company is a party or, to the knowledge

of the Company, between or among any of the Company's stockholders.

(h)           SEC

Reports; Financial Statements. Except as set forth on Schedule 3.1(h), the Company has filed all reports, schedules, forms,

statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant

to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company

was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated

by reference therein, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received

a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their

respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,

as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material

fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which

they were made, not misleading. The Company is not currently subject to Rule 144(i) under the Securities Act. The financial

statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the

rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have

been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods

involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except

that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial

position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows

for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

(i)           Material

Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included within

the SEC Reports, except as set forth on Schedule 3.1(i), (i) there has been no event, occurrence or development that has

had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities

(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent

with past practice and (B) liabilities not required to be reflected in the Company's financial statements pursuant to GAAP or disclosed

in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared

or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase

or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,

except pursuant to existing Company stock option plans. Except for the issuance of the Securities contemplated by this Agreement or as

set forth on Schedule 3.1(i), no event, liability, fact, circumstance, occurrence or development has occurred or exists or is

reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties,

operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the

time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this

representation is made.

(j)           Litigation.

Except as set forth on Schedule 3.1(j), there is no action, suit, inquiry, notice of violation, proceeding or investigation pending

or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties

before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)

(collectively, an “Action”). None of the Actions set forth on Schedule 3.1(j), (i) adversely affects or

challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there

were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary,

nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal

or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not

pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the

Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed

by the Company or any Subsidiary under the Exchange Act or the Securities Act.

(k)           Labor

Relations. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees

of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company's or its Subsidiaries'

employees is a member of a union that relates to such employee's relationship with the Company or such Subsidiary, and neither the Company

nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their

relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is,

or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information

agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and

the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with

respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign

laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except

where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse

Effect.

(l)           Compliance.

Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been

waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company

or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit

agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not

such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other

governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority,

including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health

and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected

to result in a Material Adverse Effect.

(m)           Environmental

Laws. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution

or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),

including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or

hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to

the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as

all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,

permits, plans or regulations, issued, entered, promulgated or approved thereunder (“Environmental Laws”); (ii) have

received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;

and (iii) are in compliance with all terms and conditions of any such permit, license or approval except where in each clause (i),

(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse

Effect.

(n)           Regulatory

Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,

state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except

where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material

Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or

modification of any Material Permit.

(o)           Title

to Assets. Except as set forth in the SEC Reports, the Company and the Subsidiaries have good and marketable title in fee simple

to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business

of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect

the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company

and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made

therefor in accordance with GAAP and the payment of which is neither delinquent nor subject to penalties. Any real property and facilities

held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company

and the Subsidiaries are in compliance.

(p)           Patents

and Trademarks. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark

applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and

similar rights necessary or material for use in connection with their respective businesses as described in the SEC Reports and which

the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None

of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights

has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the

date of this Agreement, except where such expiration, termination or abandonment would not reasonably be expected to have a Material

Adverse Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included

within the SEC Reports, a notice (written or otherwise) of a claim or otherwise has any knowledge that the Intellectual Property Rights

violate or infringe upon the rights of any Person, except as could not have, or reasonably be expected to not have a Material Adverse

Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement

by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures

to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually

or in the aggregate, reasonably be expected to have a Material Adverse Effect.

(q)           Insurance.

The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in

such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not

limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will

not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers

as may be necessary to continue its business without a significant increase in cost.

(r)           Transactions

With Affiliates and Employees. Except as set forth on Schedule 3.1(r), none of the officers or directors of the Company or

any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any

transaction with the Company or any Subsidiary (other than for services or separation from services as employees, officers and directors),

including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real

or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to

or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any

such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess

of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses

incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan

of the Company.

(s)           Sarbanes-Oxley;

Internal Accounting Controls. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable

requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules and

regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company

and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions

are executed in accordance with management's general or specific authorizations, (ii) transactions are recorded as necessary to

permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets

is permitted only in accordance with management's general or specific authorization, and (iv) the recorded accountability for assets

is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company

and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))

for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed

by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the

time periods specified in the Commission's rules and forms. The Company's certifying officers have evaluated the Company's effectiveness

of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the Company's most

recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in

its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of

the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been

no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries

that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company

and its Subsidiaries.

(t)           Certain

Fees. No brokerage or finder's fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial

advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated

by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by

or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions

contemplated by the Transaction Documents.

(u)           Private

Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration

under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.

(v)           Investment

Company. Based on the Company's current assessment of applicable law as of the date of this Agreement, the Company is not, and is

not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an “investment

company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner

so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

(w)           Registration

Rights. Other than as set forth on Schedule 3.1(w) and with respect to each of the Purchasers and Exchanging Holders,

no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities

of the Company or any Subsidiary.

(x)           Listing

and Maintenance Requirements. Other than as set forth on Schedule 3.1(x), the Common Stock is registered pursuant to Section 12(b) or

12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect

of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission

is contemplating terminating such registration. The Common Stock is currently eligible for electronic transfer through the Depository

Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company

(or such other established clearing corporation) in connection with such electronic transfer.

(y)           Application

of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable

any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar

anti-takeover provision under the Company's certificate of incorporation (or similar charter documents) or the laws of its state of incorporation

that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising

their rights under the Transaction Documents, including without limitation as a result of the Company's issuance of the Securities and

the Purchasers' ownership of the Securities.

(z)           Disclosure.

Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms

that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information

that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers

will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by

or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions

contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement

of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances

under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date

of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to

be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made

and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties

with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

(aa)           No

Integrated Offering. Assuming the accuracy of the Purchasers' representations and warranties set forth in Section 3.2, neither

the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or

sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities

to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration

of any such securities under the Securities Act, or (ii) any applicable stockholder approval provisions of any Trading Market on

which any of the securities of the Company are listed or designated.

(bb)           Solvency.

Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company

of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company's assets exceeds the amount

that will be required to be paid on or in respect of the Company's existing debts and other liabilities (including known contingent liabilities)

as they mature, (ii) the Company's assets do not constitute unreasonably small capital to carry on its business as now conducted

and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted

by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow

of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account

all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required

to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing

and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead

it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within

one year from the Closing Date. Schedule 3.1(bb) sets forth as of the date hereof all outstanding secured and unsecured Indebtedness

of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, “Indebtedness”

means (x) any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in

the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of

others, whether or not the same are or should be reflected in the Company's consolidated balance sheet (or the notes thereto), except

guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business;

and (z) the present value of any lease payments in excess of $100,000 due under leases required to be capitalized in accordance

with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.

(cc)           Tax

Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material

Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and

all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has

paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,

reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes

for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material

amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no

basis for any such claim.

(dd)           No

General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities

by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and

certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

(ee)           Foreign

Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other

person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions,

gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment

to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate

funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its

behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.

(ff)           Accountants.

The Company's accounting firm is set forth on Schedule 3.1(ff) of the Disclosure Schedules. To the knowledge and belief of the

Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express

its opinion with respect to the financial statements to be included in the Company's Annual Report for the next fiscal year.

(gg)           No

Disagreements with Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably anticipated

by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company

is current with respect to any fees owed to its accountants and lawyers which could affect the Company's ability to perform any of its

obligations under any of the Transaction Documents.

(hh)           Acknowledgment

Regarding Purchasers' Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting solely in

the capacity of an arm's length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company

further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with

respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their

respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely

incidental to the Purchasers' purchase of the Securities. The Company further represents to each Purchaser that the Company's decision

to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions

contemplated hereby by the Company and its representatives.

(ii)           Acknowledgment

Regarding Purchaser's Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for

Sections 3.2(g) and 4.14 hereof), it is understood and acknowledged by the Company that, other than with respect to Purchasers that

are Affiliates of the Company: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed,

to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based on securities

issued by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by

any Purchaser, specifically including, without limitation, Short Sales or “derivative” transactions, before or after the

closing of this or future private placement transactions, may negatively impact the market price of the Company's publicly-traded securities,

(iii) any Purchaser, and counter-parties in “derivative” transactions to which any such Purchaser is a party, directly

or indirectly, presently may have a “short” position in the Common Stock and (iv) each Purchaser shall not be deemed

to have any affiliation with or control over any arm's length counter-party in any “derivative” transaction. The Company

further understands and acknowledges that, other than with respect to Purchasers that are Affiliates of the Company, (y) one or

more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without

limitation, during the periods that the value of the Prefunded Warrant Shares and Common Warrant Shares are deliverable with respect

to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders'

equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that

such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.

(jj)           Regulation

M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,

any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate

the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of,

any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other

securities of the Company.

(kk)           FDA.

As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal

Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled,

tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a “Pharmaceutical Product”),

such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance

with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use,

premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices,

product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would

not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any

lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or

any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication

from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval

of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of

any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders

the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold

on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company

or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any

of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its

Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and

operations of the Company have been and are being conducted in accordance with all applicable laws, rules and regulations of the

FDA, except where the failure to be in compliance would not have a Material Adverse Effect. The Company has not been informed by the

FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced

or marketed by the Company nor has the FDA expressed any written concern as to approving or clearing for marketing any product being

developed or proposed to be developed by the Company.

(ll)           Stock

Option Plans. Each stock option granted by the Company under the Company's stock option plan was granted (i) in accordance with

the terms of the Company's stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common

Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company's

stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice

to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public

announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.

(mm)           Cybersecurity.

(i)(x) There has been no security breach or other compromise of or relating to any of the Company's or any Subsidiary's information

technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,

vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, “IT Systems and Data”)

and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably

be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries

are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or

arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security

of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification,

except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have

implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity,

continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented

backup and disaster recovery technology consistent with industry standards and practices.

(nn)           Compliance

with Data Privacy Laws. With respect to compliance with Privacy Laws (as defined below), except as would otherwise not, individually

or in the aggregate, reasonably be expected to have a Material Adverse Effect, the (i) The Company and the Subsidiaries are, and

at all times during the last three (3) years were, in material compliance with all applicable state, federal and foreign data privacy

and security laws and regulations, including, without limitation and to the extent applicable to Company, the European Union General

Data Protection Regulation (“GDPR”) (EU 2016/679) (collectively, “Privacy Laws”); (ii) the

Company and the Subsidiaries have in place, materially comply with, and take appropriate steps reasonably designed to ensure compliance

with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling and analysis

of Personal Data (as defined below) (the “Policies”); (iii) to the extent required by Privacy Laws, the Company

provides and/or makes available accurate notice of its collection, storage, use, disclosure, handling and analysis of Personal Data to

its customers, employees, third party vendors and representatives as required by the Privacy Laws. “Personal Data”

means (i) a natural person's name, street address, telephone number, email address, photograph, social security number, bank information,

or customer or account number; (ii) any information which would qualify as “personally identifying information” under

the Federal Trade Commission Act, as amended; (iii) “personal data” as defined by GDPR; and (iv) any other piece

of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of

any identifiable data related to an identified person's health or sexual orientation. To the knowledge of Company, (i) none of such

disclosures made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws

and (ii) the execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or

Policies. Neither the Company nor the Subsidiaries (i) to the knowledge of the Company, has received written notice of any actual

or potential liability of the Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries

of, any of the Privacy Laws; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation or

other corrective action pursuant to any regulatory request or demand pursuant to any Privacy Law; or (iii) is a party to any order,

decree, or agreement by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation or liability

under any Privacy Law.

(oo)           Office

of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent,

employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign

Assets Control of the U.S. Treasury Department (“OFAC”).

(pp)           U.S.

Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning

of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser's request.

(qq)           Bank

Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of

1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal

Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent

(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank

or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or

Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and

to regulation by the Federal Reserve.

(rr)           Money

Laundering. Except as would otherwise not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,

the operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping

and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes

and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no Action or

Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary

with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

(ss)           Digital

Assets and DAT Subsidiaries. Schedule 3.1(ss) sets forth a complete and accurate list of all digital assets, cryptocurrencies,

virtual currencies, tokens, stablecoins, and similar assets (including, without limitation, BNB-denominated trust units) and cash held

by the Company and each DAT Subsidiary as of the date hereof, including the type, quantity, and custodian or wallet address for each

such asset and the entity holding such asset. All such digital assets are held in custody arrangements that are commercially reasonable

and consistent with industry standards. The Company and each Subsidiary has implemented reasonable security measures and protocols to

safeguard such digital assets from theft, loss, or unauthorized access, (ii) neither the Company nor any Subsidiary is subject to

any pending or threatened enforcement action, investigation, or inquiry by any federal, state, or foreign regulatory authority relating

to the Company’s or any Subsidiary’s holding, trading, or use of digital assets, (iii) each Subsidiary that holds any

Digital Assets or portion of the Digital Asset Treasury is a guarantor party to the DATS Guaranty, and (iv) there is no action,

suit, proceeding or investigation pending or, to the knowledge of the Company, threatened against the DAT Subsidiaries before any court,

arbitrator or governmental authority that could reasonably be expected to have a material adverse effect on the DAT Subsidiaries ability

to perform their obligations under the DATS Guaranty.

(tt)           No

Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities

Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company

participating in the offering hereunder, any beneficial owner of 20% or more of the Company's outstanding voting equity securities, calculated

on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the

Company in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered

Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under

the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or

(d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.

The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the

Purchasers a copy of any disclosures provided thereunder.

(uu)           Other

Covered Persons. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly

or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.

(vv)           Notice

of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification

Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become

a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.

3.2           Representations

and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the

date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate

as of such date):

(a)           Organization;

Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing

under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company

or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise

to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such

Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,

limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a

party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute

the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited

by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application

affecting enforcement of creditors' rights generally, (ii) as limited by laws relating to the availability of specific performance,

injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by

applicable law.

(b)           Own

Account. Such Purchaser understands that the Securities are “restricted securities” and have not been registered under

the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with

a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state

securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable

state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the

distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty

not limiting such Purchaser's right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable

federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.

(c)           Purchaser

Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which

it exercises any Common Warrants or Prefunded Warrants, it will be an “accredited investor” as defined in Rule 501(a)(1),

(a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.

(d)           Experience

of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience

in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,

and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the

Securities and, at the present time, is able to afford a complete loss of such investment.

(e)           General

Solicitation. Such Purchaser is not, to such Purchaser's knowledge, purchasing the Securities as a result of any advertisement, article,

notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television

or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.

(f)           Access

to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits

and schedules thereto including the Disclosure Schedules), the SEC Reports, and the Inducement Agreement and has been afforded (i) the

opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning

the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access

to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient

to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses

or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.

(g)           Certain

Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has

any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or

sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first

received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms

of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the

case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser's

assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other

portions of such Purchaser's assets, the representation set forth above shall only apply with respect to the portion of assets managed

by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other

Persons party to this Agreement or to such Purchaser's representatives, including, without limitation, its officers, directors, partners,

legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made

to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for

the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect

to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.

The Company acknowledges and agrees that the

representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser's right to rely on the Company's

representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document

or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions

contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation

or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions

in the future.

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

4.1           Transfer

Restrictions.

(a)           The

Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities

other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection

with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion

of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably

satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the

Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and

the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration

Rights Agreement.

(b)           The

Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following

form:

NEITHER THIS SECURITY NOR THE SECURITIES

INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION

OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE

SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS

EXERCISABLE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL

INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED

BY SUCH SECURITIES.

The Company acknowledges

and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or

grant a security interest in some or all of the Securities to a financial institution that is an “accredited investor” as

defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer

pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company

and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no

notice shall be required of such pledge. At the appropriate Purchaser's expense, the Company will execute and deliver such reasonable

documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,

including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of

any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities

Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.

(c)           Certificates

evidencing the Conversion Shares and Common Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof),

(i) while a registration statement (including the Registration Statement) covering the resale of such security is effective under

the Securities Act, (ii) following any sale of such security pursuant to Rule 144 (assuming cashless exercise of the Common

Warrants), (iii) if such security is eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants),

without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such

securities and without volume or manner-of-sale restrictions or (iv) if such legend is not required under applicable requirements

of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall

cause its counsel to issue a legal opinion to the Company or its Transfer Agent, if required, to effect the removal of the legend hereunder,

or if requested by a Purchaser, respectively. If all or any portion of a Common Warrant is exercised or Preferred Stock is converted

into Common Stock at a time when there is an effective registration statement to cover the resale of the Common Warrant Shares or Conversion

Shares, or if such Common Warrant Shares or Conversion Shares may be sold under Rule 144 and the Company is then in compliance with

the current public information required under Rule 144 (assuming cashless exercise of the Common Warrants), or if the Conversion

Shares or Common Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the

current public information required under Rule 144 as to such Conversion Shares or Common Warrant Shares or if such legend is not

otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued

by the staff of the Commission) then such Common Warrant Shares and Conversion Shares shall be issued free of all legends. The Company

agrees that at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) one

(1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following

the delivery by a Purchaser to the Company of a certificate representing Conversion Shares or Common Warrant Shares, as the case may

be, issued with a restrictive legend (such date, the “Legend Removal Date”), deliver or cause to be delivered to such

Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation

on its records that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Securities subject to legend

removal hereunder shall be issued and delivered (or caused to be delivered) by the Company to the Purchaser. As used herein, “Standard

Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company's primary Trading

Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Conversion Shares or Common

Warrant Shares, as the case may be, issued with a restrictive legend.

(d)           In

addition to such Purchaser's other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated

damages and not as a penalty, for each $1,000 of Conversion Shares or Common Warrant Shares (based on the VWAP of the Common Stock on

the date such Securities are submitted to the Company) delivered for removal of the restrictive legend and subject to Section 4.1(c),

$10 per Trading Day (increasing to $20 per Trading Day three (3) Trading Days after the Legend Removal Date) for each Trading Day

after the Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue

and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered

to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such

Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such

Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all

or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive

legend, then, an amount equal to the excess of such Purchaser's total purchase price (including brokerage commissions and other out-of-pocket

expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any)

(the “Buy-In Price”) over the product of (A) such number of Conversion Shares or Common Warrant Shares that the

Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of

the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the

applicable Conversion Shares or Common Warrant Shares (as the case may be) and ending on the date of such delivery and payment under

this clause (ii).

(e)           Each

Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities

pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or

an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the

plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities

as set forth in this Section 4.1 is predicated upon the Company's reliance upon this understanding.

4.2           Furnishing

of Information; Public Information.

(a)           Until

the time that no Prefunded Warrants remain outstanding, the Company covenants to maintain the registration of the Common Stock under

Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within

the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even

if the Company is not then subject to the reporting requirements of the Exchange Act.

(b)           At

any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of

the Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without

restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public

information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or

becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a “Public

Information Failure”) then, in addition to such Purchaser's other available remedies, the Company shall pay to a Purchaser,

in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities,

an amount in cash equal to two percent (2.0%) of the aggregate Subscription Amount of such Purchaser's Securities on the day of a Public

Information Failure and on every thirtieth (30th) day (pro rated for periods totaling less than thirty days) thereafter until

the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer

required for the Purchasers to transfer the Conversion Shares and Common Warrant Shares pursuant to Rule 144. The payments to which

a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as “Public Information Failure

Payments.” Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month

during which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day after the event

or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information

Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated

for partial months) until paid in full. Nothing herein shall limit such Purchaser's right to pursue actual damages for the Public Information

Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation,

a decree of specific performance and/or injunctive relief.

4.3           Integration.

The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in

Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require

the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities

for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing

of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.

4.4           Securities

Laws Disclosure; Publicity. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms

of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as

exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release,

the Company represents to the Purchasers (other than with respect to Purchasers that are Affiliates of the Company), that it shall have

publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries,

or any of their respective officers, directors, employees, Affiliates or agents, in connection with the transactions contemplated by

the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any

and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries

or any of their respective officers, directors, agents, employees, Affiliates or agents, on the one hand, and any of the Purchasers (other

than Purchasers that are Affiliates of the Company) or any of their Affiliates on the other hand, shall terminate and be of no further

force or effect. The Company understands and confirms that each such Purchaser shall be relying on the foregoing covenant in effecting

transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases

with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor

otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser,

or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably

be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other

party with prior notice of such public statement or communication, or if such disclosure is consistent with Form 8-K. Notwithstanding

the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing

with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as

required by federal securities law in connection with (i) any registration statement contemplated by the Registration Rights Agreement

and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by

law or regulations of the Trading Market the Common Stock is then traded on, in which case the Company shall provide the Purchasers with

prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.

4.5           Shareholder

Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser

is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution

under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser

could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents

or under any other agreement between the Company and the Purchasers.

4.6           Non-Public

Information. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,

which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting

on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes

constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information

and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be

relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its

Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information

to a Purchaser without such Purchaser's consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty

of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or

agents, including, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates

or agents, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable

law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information

regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the

Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on

the foregoing covenant in effecting transactions in securities of the Company.

4.7           Use

of Proceeds; Contribution of Digital Assets. Except as may be set forth on Schedule 4.7 attached hereto, the Company shall

use the General Proceeds in excess of $2,300,000 solely for contributions to the DAT Subsidiaries. The Company shall promptly, but in

any case no later than forty-five (45) days following the Closing Date, contribute or cause to be contributed, any cash (other than cash

set forth on Schedule 1.1) and Digital Assets owned or held by the Company or any of its subsidiaries that are not DAT Subsidiaries

to a DAT Subsidiary that is a guarantor party to the DATS Guaranty. In the case of Digital Assets acquired by the Company or any of its

subsidiaries that are not DAT Subsidiaries, the Company shall contribute or cause such Digital Asset to be contributed, to a DAT Subsidiary

that is a guarantor party to the DATS Guaranty on or immediately following the date of acquisition).

4.8           Indemnification

of Purchasers. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,

officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person

holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning

of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents,

members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding

a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any

and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in

settlements, court costs and reasonable attorneys' fees and costs of investigation that any such Purchaser Party may suffer or incur

as a result of or relating to (a) any material breach of any of the representations, warranties, covenants or agreements made by

the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in

any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser

Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material

breach of such Purchaser Party's representations, warranties or covenants under the Transaction Documents or any agreements or understandings

such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws

or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).

If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such

Purchaser Party shall promptly notify the Company in writing, and, the Company shall have the right to assume the defense thereof with

counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate

counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense

of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in

writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in

such action there is, in the reasonable opinion of counsel a material conflict on any material issue between the position of the Company

and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable, actual and documented fees

and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for

any settlement by a Purchaser Party effected without the Company's prior written consent, which shall not be unreasonably withheld or

delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party's

breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement and other Transaction

Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the

course of the investigation or defense, as and when bills are received or are incurred; provided, however, that if it is subsequently

determined by a final, non-appealable judgment of a court of competent jurisdiction that a Purchaser Party was not entitled to receive

such periodic payments, such Purchaser Party shall promptly (but in no event later than five Business Days) return such payments to the

Company. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party

against the Company or others and any liabilities the Company may be subject to pursuant to law.

4.9           Reservation

of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at

all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue

Conversion Shares pursuant to this Agreement and Common Warrant Shares pursuant to any exercise of the Common Warrants.

4.10           Listing

of Common Stock. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common

Stock on a Trading Market, and concurrently with the Closing, the Company shall apply to list or quote all of the Conversion Shares and

Common Warrant Shares on the Trading Market on which it is currently listed and promptly secure the listing of all of the Conversion

Shares and Common Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock

traded on any other Trading Market, it will then include in such application all of the Conversion Shares and Common Warrant Shares,

and will take such other action as is necessary to cause all of the Conversion Shares and Common Warrant Shares to be listed or quoted

on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing

and trading of its Common Stock on a Trading Market and will comply in all respects with the Company's reporting, filing and other obligations

under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic

transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment

of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer. The

Company shall promptly notify the Purchasers in writing of (i) any notice received from any Trading Market regarding the Company’s

compliance with listing or maintenance requirements, (ii) any determination by the Company to list on a different Trading Market,

and (iii) any delisting, suspension of trading, or threatened delisting or suspension affecting the Common Stock. Any information

filed or furnished by the Company with the Commission and delivered to the Lead Purchaser that includes the information required by this

Section  4.10(i), (ii) or (iii) within the timeframe required by the Commission and the applicable Trading Market, shall

constitute prompt written notice to the Purchasers by the Company required by this Section 4.10.

4.11           Maintenance

of Digital Assets. The Company acknowledges and agrees that the digital assets, cryptocurrencies, virtual currencies, tokens, stablecoins,

and similar assets (including, without limitation, BNB-denominated trust units) set forth on Schedule 3.1(ss), together with any

such assets (or similar assets), subsequently acquired by the Company or any Subsidiary shall be held solely in a DAT Subsidiary, and

(b) each DAT Subsidiary will be (at all times during which it holds such assets) a guarantor party to the DATS Guaranty.

4.12           Subsequent

Equity Sales. From the date hereof until 30 days after the Effective Date, neither the Company nor any Subsidiary shall issue, enter

into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents other

than as contemplated in Section 2.1(b). Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt

Issuance.

4.13           Equal

Treatment of Purchasers/Most Favored Nations.

(a)           No

consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to

a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties

to the respective Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser

by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall

not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of

Securities or otherwise.

(b)           If

the Company enters into any amendment, modification, or waiver of the Inducement and Agreement or any Transaction Document (as defined

therein) that provides the Exchanging Holders with rights or benefits more favorable than those provided to the Purchasers hereunder

or under the Transaction Documents (as defined herein), the Company shall promptly (and in any event within five (5) Business Days)

notify the Purchasers of such amendment, modification, or waiver and offer to amend this Agreement and the applicable Transaction Documents

to provide the Purchasers with such more favorable rights or benefits, which amendment shall be effective upon the written consent of

the Lead Purchaser.

4.14           Certain

Transactions and Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it,

nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short

Sales, of any of the Company's securities during the period commencing with the execution of this Agreement and ending at such time that

the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4.

Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated

by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such

Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure

Schedules (other than as disclosed to its legal and other representatives). Notwithstanding the foregoing and notwithstanding anything

contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,

warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the

transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4,

(ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance

with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced

pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality

or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors,

employees, Affiliates or agent, after the issuance of the initial press release as described in Section 4.4. Notwithstanding the

foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate

portions of such Purchaser's assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio

managers managing other portions of such Purchaser's assets, the covenant set forth above shall only apply with respect to the portion

of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

4.15           Form D;

Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and

to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably

determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under

applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly

upon request of any Purchaser.

4.16           Exercise

Procedures. The form of Notice of Exercise included in the Prefunded Warrants and Common Warrants set forth the totality of the procedures

required of the Purchasers in order to exercise such warrants. No additional legal opinion, other information or instructions shall be

required of the Purchasers to exercise their Prefunded Warrants or Common Warrants. Without limiting the preceding sentences, no ink-original

Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of

Exercise form be required in order to exercise the Prefunded Warrants or Common Warrants. The Company shall honor exercises of the Prefunded

Warrants and Common Warrants and shall deliver Prefunded Warrant Shares and Common Warrant Shares in accordance with the terms, conditions

and time periods set forth in the Transaction Documents.

4.17           Tax

Treatment. The Company (i) makes no representation or warranty of any kind whatsoever with respect

to the tax treatment of the Purchaser's purchase of Securities hereunder and (ii) makes no representation, warranty or covenant

of any kind with respect to any action or position it may take in the future with respect to the foregoing. Unless the Purchaser has

obtained a written opinion of a nationally recognized tax counsel or tax accountant, in the form and substance reasonably satisfactory

to the Company, to the effect that the purchase of the Securities is, at a “should” level of confidence, treated as a nonrecognition

transaction pursuant to Section 351(a) of the Internal Revenue Code of 1986, as amended (the “Code”), the

Company shall not be required to report or take any position on its tax return (or otherwise) that the purchase of the Securities is

treated as a nonrecognition transaction pursuant to Section 351(a) of the Code.

ARTICLE V.

MISCELLANEOUS

5.1           Termination.

This Agreement may be terminated (i) by any Purchaser, as to such Purchaser's obligations hereunder only and without any effect

whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Initial Closing

has not been consummated on or before the second Trading Day following the date hereof and (ii) by the Company as to a Purchaser's

obligations hereunder only and without any effect whatsoever on the obligation between the Company and the other Purchaser, by written

notice to such Purchaser if such Purchaser has not delivered its Subscription Amount on or before the tenth (10th) Trading Day following

the Closing Date applicable to such Purchaser; provided, however, that no such termination under either clause will affect

the right of any party to sue for any breach by any other party (or parties).

5.2           Fees

and Expenses. The Company shall reimburse one counsel for the Purchasers and Exchanging Holders, up to a maximum of $50,000 for the

reasonable attorney’s fees and costs incurred in connection with this Agreement and the Inducement Agreement. Except as expressly

set forth in this Section 5.2 and in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its

advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,

preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without

limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered

by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.

5.3           Entire

Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties

with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect

to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

5.4           Notices.

Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall

be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via

email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York

City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered

via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day

or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the

date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom

such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached

hereto.

5.5           Amendments;

Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in

the case of an amendment, by the Company, and Purchasers which purchased at least 50.1% in interest of the Conversion Shares and Common

Warrant Shares based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in

the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification

or waiver disproportionately and adversely impacts a Purchaser (or multiple Purchasers), the consent of such disproportionately impacted

Purchaser (or at least 50.1% in interest of such multiple Purchasers) shall also be required. Notwithstanding the foregoing, no amendment,

modification or waiver shall reduce the number or amount of Securities issuable or deliverable to any Purchaser, reallocate any portion

of any Purchaser’s Subscription Amount or otherwise alter the type or amount of Securities to be received by any Purchaser without

the prior written consent of such Purchaser. No waiver of any default with respect to any provision, condition or requirement of this

Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision,

condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the

exercise of any such right. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and

holder of Securities and the Company.

5.6           Headings.

The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any

of the provisions hereof.

5.7           Successors

and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.

The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser

(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns

or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,

by the provisions of the Transaction Documents that apply to the “Purchasers.”

5.8           No

Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted

assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in

Section 4.8 and this Section 5.8.

5.9           Governing

Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed

by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts

of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions

contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,

directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts

sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts

sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with

any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),

and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the

jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party

hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing

a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect

for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice

thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the

obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing

party for its reasonable attorneys' fees and other costs and expenses incurred with the investigation, preparation and prosecution of

such Action or Proceeding.

5.10           Survival.

The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

5.11           Execution.

This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement

and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that

the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a “.pdf”

format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature

is executed) with the same force and effect as if such “.pdf” signature page were an original thereof.

5.12           Severability.

If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,

void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force

and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts

to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,

covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining

terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or

unenforceable.

5.13           Rescission

and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any

of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document

and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind

or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in

whole or in part without prejudice to its future actions and rights; provided, however, that, in the case of a rescission

of an exercise of a Prefunded Warrant or Common Warrant, the applicable Purchaser shall be required to return any shares of Preferred

Stock or Common Stock, as applicable, subject to any such rescinded exercise notice concurrently with the return to such Purchaser of

the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser's right to acquire such shares

pursuant to such Purchaser's Prefunded Warrant or Common Warrant (including, issuance of a replacement warrant certificate evidencing

such restored right).

5.14           Replacement

of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall

issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of

and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company

of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable

third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.

5.15           Remedies.

In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers

and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may

not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and

hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law

would be adequate.

5.16           Payment

Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a

Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or

any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or

are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,

without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such

restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect

as if such payment had not been made or such enforcement or setoff had not occurred.

5.17           Independent

Nature of Purchasers' Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not

joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance

of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,

and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,

a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group

with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently

protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction

Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.

Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The

Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not

because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained

in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company

and the Purchasers collectively and not between and among the Purchasers.

5.18           Liquidated

Damages. The Company's obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is

a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been

paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are

due and payable shall have been canceled.

5.19           Saturdays,

Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or

granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business

Day.

5.20           Construction.

The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents

and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party

shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference

to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,

stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

5.21           WAIVER

OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES

EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY

AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

5.22           Equitable

Remedies. The Company acknowledges and agrees that a breach by the Company of any provision of this Agreement would cause irreparable

harm to the Purchaser for which monetary damages alone would not be an adequate remedy. Accordingly, in the event of any such breach

or threatened breach by the Company, the Purchaser shall be entitled, in addition to all other rights and remedies available at law or

in equity (including recovery of damages), to seek and obtain equitable relief, including a decree of specific performance and temporary,

preliminary, and permanent injunctive relief, without the necessity of proving actual damages or the inadequacy of monetary damages,

and without being required to post any bond or other security. The Company hereby irrevocably waives any defense that a remedy at law

would be adequate and any requirement for the posting of a bond or other security in connection with any such action or proceeding. The

rights and remedies provided in this Section are cumulative and shall not be exclusive of any other rights or remedies available

to the Purchaser under this Agreement, any other Transaction Document, or applicable law.

(Signature Pages Follow)

IN WITNESS WHEREOF, the parties

hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first

indicated above.

BNB PLUS CORP.   Address

for Notice:

25

Health Sciences Drive

Stony

Brook, NY 11790

By:

Email:

Name:

Title:

With a copy to (which shall not constitute notice):

Harter Secrest & Emery LLP

1600 Bausch & Lomb Pl,

Rochester, NY 14604

Attention: Alex McClean

E-mail: ***

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

[PURCHASER SIGNATURE PAGES TO

BNB PLUS CORP. SECURITIES PURCHASE AGREEMENT]

IN WITNESS WHEREOF, the undersigned

have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated

above.

Name

of Purchaser:

Signature

of Authorized Signatory of Purchaser:

Name

of Authorized Signatory:

Title

of Authorized Signatory:

Email

Address of Authorized Signatory:

Address for Notice to Purchaser:

Address for Delivery of Securities to Purchaser (if not same as address

for notice):

Subscription Amount: $_________________

Shares of Preferred Stock: _________________

Prefunded Warrant Shares:

______________ Beneficial Ownership Blocker ¨ 4.99% ¨ 9.99%

or ¨ 19.99%

Common Warrant Shares: ______________

Beneficial Ownership Blocker ¨ 4.99%

or ¨9.99

or ¨ 19.99%

EIN Number: _______________________

[SIGNATURE PAGES CONTINUE]

Exhibit A

Form of Joinder Agreement

JOINDER TO BNB PLUS CORP.

SECURITIES PURCHASE AGREEMENT

(a) Joinder. By execution of

this Joinder Agreement, the undersigned Purchaser hereby agrees to become a party to, and to be bound by and comply with, the

provisions of the Securities Purchase Agreement, dated as of May 26, 2026 (the “Agreement”), among BNB Plus

Corp, a Delaware corporation (the “Company”) and the Purchasers party thereto, to the same extent as if the

undersigned were an original signatory to the Agreement. Capitalized terms used but not defined herein shall have the meanings

ascribed to them in the Agreement.

(b) Subscription Amount; Securities.

The undersigned Purchaser hereby agrees to purchase from the Company, and the Company agrees to sell to the undersigned Purchaser, the

securities of the Company set forth on the signature page hereof for an aggregate Subscription Amount of $_______________,

on the effective date set forth below, subject to the terms and conditions of the Agreement.

(c) Representations and Warranties. The

undersigned Purchaser hereby makes, as of the date hereof and as of the effective date set forth below, each of the representations and

warranties set forth in Section 3.2 of the Agreement (Representations and Warranties of the Purchasers) to the same extent as if

such representations and warranties were set forth in full herein.

(d) Benefit of Rights. Upon execution

hereof and consummation of the Closing contemplated hereby and in the Agreement, the undersigned Purchaser shall be entitled to all of

the rights of a “Purchaser” under the Agreement and each other Transaction Document, including, without limitation, (i) registration

rights pursuant to the Registration Rights Agreement, and (ii) any other rights expressly granted to Purchasers thereunder, in each

case on the same terms and conditions applicable to the original Purchasers.

(e) Obligations. The undersigned

Purchaser shall be subject to all obligations of a “Purchaser” under the Agreement and each other Transaction Document, arising

from and after the consummation of the Closing contemplated hereby and in the Agreement.

(f) Additional Closing Date. The

Closing with respect to the undersigned Purchaser shall occur on _________, 2026, subject to satisfaction or waiver of the conditions

set forth in Section 2.3 of the Agreement.

IN WITNESS WHEREOF, the parties

hereto have caused this Joinder to the Agreement to be duly executed by their respective authorized signatories as of the date first

indicated above.

BNB PLUS CORP.   Address

for Notice:

25

Health Sciences Drive

Stony

Brook, NY 11790

By:

Email:

Name:

Title:

With a copy to (which shall not constitute notice):

Harter Secrest & Emery LLP

1600 Bausch & Lomb Pl,

Rochester, NY 14604

Attention: Alex McClean

E-mail: ***

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

PURCHASER SIGNATURE PAGE FOR JOINDER FOLLOWS]

[PURCHASER SIGNATURE PAGE TO

JOINDER TO BNB PLUS CORP. SECURITIES PURCHASE

AGREEMENT]

IN WITNESS WHEREOF, the undersigned

have caused this Joinder to the Agreement to be duly executed by their respective authorized signatories as of the date first indicated

above.

Name

of Purchaser:

Signature

of Authorized Signatory of Purchaser:

Name

of Authorized Signatory:

Title

of Authorized Signatory:

Email

Address of Authorized Signatory:

Address for Notice to Purchaser:

Address for Delivery of Securities to Purchaser (if not same as address

for notice):

Subscription Amount: $_________________

Shares of Preferred Stock: _________________

Prefunded Warrant Shares: ______________

Beneficial Ownership Blocker ¨ 4.99%

¨ 9.99% or ¨

19.99%

Common Warrant Shares: ______________

Beneficial Ownership Blocker ¨4.99%

or ¨ 9.99 or ¨

19.99%

EIN Number: _______________________

Exhibit B

Form of Series B-1 Preferred Stock Certificate

of Designation

Exhibit C

Form of Series F Common Stock Purchase

Warrant

Exhibit D

Form of Series B-1 Prefunded Warrants

Exhibit E

Form of Guaranty Agreement

Exhibit F

Form of Registration Rights Agreement

EX-10.2 — EXHIBIT 10.2

EX-10.2

Filename: tm2615620d1_ex10-2.htm · Sequence: 9

Exhibit 10.2

BNB

PLUS CORP.

25 Health Sciences Drive

Stony Brook, NY 11790

May 26, 2026

Holders of Series E Common Stock Purchase

Warrants

Re:

Warrant Inducement and Exchange Agreement

Dear Holder:

BNB Plus Corp. (the “Company”)

is pleased to offer to you (a “Holder”, “you” or similar terminology) the opportunity to receive

securities of the Company pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities Act”),

and Rule 506(b) of Regulation D promulgated thereunder, in consideration for you exercising for cash certain common stock purchase

warrants and exchanging such shares of common stock and other securities of the Company for certain shares of preferred stock and other

securities of the Company, as further outlined below under the headings Warrant Exercise and Exchange of Securities.

In connection with the Company’s

cash private placement, which closed on October 3, 2025, and/or the Company’s cryptocurrency private placement, which closed

on October 23, 2025 (collectively the “October Private Placement”), the Holder, or its assigns, was issued

shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) and/or pre-funded warrants

in lieu thereof to purchase shares of the Company’s common stock at a per share exercise price of $0.0001 per share (the “October Pre-Funded

Warrants”), and Series E-1 Common Stock Purchase Warrants and/or Series E-2 Common Stock Purchase Warrants, each to

purchase shares of Common Stock at a per share exercise price of $3.82 (collectively the “Series E Warrants”).

Warrant Exercise

For the consideration set

forth below, the Holder hereby agrees that at the Execution Time, the Holder will exercise for cash a percentage of all Series E

Warrants issued to the Holder, or its assigns, in the October Private Placement, at the exercise price of $3.82 per share of Common

Stock, as set forth on the Notice of Exercise and Irrevocable Written Notice of Exchange to this letter agreement (the Holder’s

“Signature Page”). To the extent a Holder determines, in its sole discretion, that the exercise of the Holder’s

Series E Warrants would cause such Holder (together with such Holder’s Affiliates, and any Person acting as a group together

with such Holder or any of such Holder’s Affiliates) to exceed the beneficial ownership limitation set forth in the Series E

Warrants, in lieu of receiving the shares of Common Stock issuable upon the exercise of the Series E Warrants above such beneficial

ownership limitation (the “Limited Shares”), the Holder may elect to receive Series B-2 Prefunded Preferred Stock

Purchase Warrants, defined below, exercisable for a number of shares of Series B-2 Preferred Stock, defined below, equal to the number

of Limited Shares.

The Holder agrees that it

will exercise at least 13% (the “Minimum Percentage”) of its Series E Warrants. The Holder may choose to exercise

more than the Minimum Percentage (an “Excess Exercise”) in the Holder’s sole discretion; provided, however, that

notwithstanding the foregoing, if (x) the aggregate amounts payable to the Company after giving effect to the Holder’s Warrant

Exercise Price, defined below, and after giving effect to the sum of the aggregate Warrant Exercise Price delivered to the Company by

other holders of Series E Warrants plus (y) the aggregate Subscription Amounts payable to the Company pursuant to the Securities

Purchase Agreement, as defined in Annex A, would exceed $5.0 million, then to maintain such aggregate amount at or below $5.0 million,

the total Series E Warrants the Holder may exercise pursuant to this letter agreement may be reduced to any percentage (the “Reduced

Percentage”), at the Company’s sole discretion, on a pro-rata basis with the other holders exercising their Series E

Warrants pursuant to this letter agreement, and any Warrant Exercise Price delivered by the Holder pursuant to this letter agreement in

excess of the Warrant Exercise Price that would have been due for the exercise by the Holder of its Series E Warrants at the Reduced

Percentage shall be returned to the Holder by the Company without interest as soon as reasonably practical and without undue delay. Any

Series E Warrants that the Holder elects to exercise under this letter agreement above a Reduced Percentage shall be deemed to not

have been exercised by the Holder, which warrants shall remain outstanding pursuant to their terms. The aggregate shares of Common Stock

issuable upon exercise of the Series E Warrants, including Limited Shares, if any, is referred to herein as the “Total Series E

Warrant Exercise Shares”. The shares of Common Stock issuable upon exercise of the Series E Warrants, excluding the Limited

Shares, is referred to herein as the “Exercise Shares” while the portion of the Exercise Shares received as a result

of an Excess Exercise is referred to herein as the “Excess Exercise Shares”.

As consideration for exercising

the Series E Warrants at the Execution Time, the Company hereby offers to issue you, pursuant to Section 4(a)(2) of the

Securities Act and Rule 506(b) of Regulation D promulgated thereunder, a number of shares of Series B-1 Convertible Preferred

Stock, par value $0.001 per share, which preferred stock is convertible into shares of Common Stock and shall be governed by the Delaware

Certificate of Designation of the Series B-1 Convertible Preferred Stock in the form of Exhibit A attached hereto (the

“Series B-1 Preferred Stock”); provided, however, that, to the extent a Holder determines, in its

sole discretion, that such Holder (together with such Holder’s Affiliates, and any Person acting as a group together with such Holder

or any of such Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation, or as such Holder

may otherwise choose, in lieu of receiving Series B-1 Preferred Stock, such Holder may elect to receive Series B-1 Prefunded

Preferred Stock Purchase Warrants (the “Series B-1 Prefunded Warrants”) exercisable for shares of Series B-1

Preferred Stock (the “Series B-1 Warrant Shares”). The “Beneficial Ownership Limitation” shall

be 4.99% (or, at the election of the Holder at Closing, 9.99% or 19.99%) of the number of shares of the Common Stock outstanding immediately

after giving effect to the issuance and exchange of the securities on the Closing Date. Additionally and notwithstanding anything herein

to the contrary, the Company may re-allocate a portion of the Series B-1 Preferred Stock issuable to the Holder to Series B-1

Prefunded Warrants in lieu of Series B-1 Preferred Stock solely to the lesser of (x) the amount in excess of 19.99% and (y) the

minimum extent necessary to avoid a violation of the rules and regulations of any of the following markets or exchanges on which

the Common Stock is listed or quoted for trading on the date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq

Global Select Market, the New York Stock Exchange, the NYSE American, the OTCQX Market, or the OTCQB Market (or any successors to any

of the foregoing) or, for a period no longer than 15 consecutive Trading Days, the OTCID Basic Market within the Pink Open Market, while

the Company’s application to the OTCQX or OTCQB is being processed (the principal “Trading Market”); provided,

that the Company shall give the Holder prior written notice of any such re-allocation, identify the applicable rule or regulation

requiring such re-allocation, and use commercially reasonable efforts to structure such re-allocation in a manner that preserves the economic

and voting position that the Holder would have received absent such re-allocation. The Holder’s calculation of its beneficial ownership

for purposes of this paragraph shall be conclusive absent manifest error.

The Series B-1 Prefunded

Warrants will have an exercise price of $0.0001 per share, subject to customary adjustments as provided in the Series B-1 Prefunded

Warrants, will be exercisable immediately upon issuance and can be exercised at any time after their issuance until exercised in full.

The Series B-1 Prefunded Warrants shall be substantially in the form as set forth in Exhibit B hereto.

The number of shares of Series B-1

Preferred Stock (including Series B-1 Preferred Stock underlying Series B-1 Prefunded Warrants, if applicable) issuable to the

Holder shall equal the quotient by dividing [A - (B x C)] by (X), where:

(A) = the Warrant

Exercise Price (defined below);

(B) = the Total

Series E Warrant Exercise Shares;

(C) = $0.38

(the “Market Price”); and

(X) = $1.05.

In addition, for any Excess

Exercise Shares, the Holder may choose, in its sole discretion, to (i) include such Excess Exercise Shares as Exchange Shares (defined

below); (ii) retain the Excess Exercise Shares for the Holder’s own account and receive a transferable right to exchange a

number of shares of Common Stock equal to the Excess Exercise Shares for Series B-2 Preferred Stock, subject to the terms of the

Transferable Rights Agreement set forth in Exhibit C hereto, or (iii) a combination of (i) or (ii) above.

The resale of the shares of

Common Stock underlying the Series E Warrants has been registered pursuant to the registration statement on Form S-1, as amended

(File No. 333-291156) (the “Registration Statement”). The Registration Statement is currently effective and, upon

exercise of the Series E Warrants pursuant to this letter agreement, will be effective for the issuance of the Exercise Shares. The

Series B-1 Preferred Stock, Series B-1 Prefunded Warrants, if applicable, and Series B-2 Prefunded Warrants, if applicable,

to be issued to the Holder shall be issued pursuant to Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation

D promulgated thereunder, on the books and records of the Company as of the Closing.

Exchange of Securities

Subject to the other provision

of this letter agreement, (1) all of the Holder’s shares of Common Stock (i) received by the Holder in the October Private

Placement, (ii) issued upon exercise of the Series E Warrant up to the Minimum Percentage, and (iii) issued upon exercise

of the Series E Warrant above the Minimum Percentage that the Holder elects to exchange at Closing, as set forth on the Holder’s

Signature Page hereto (the “Exchange Shares”), shall be exchanged for an equal number of shares of Series B-2

Convertible Preferred Stock, par value $0.001 per share, which preferred stock is convertible into shares of Common Stock and shall be

governed by the Delaware Certificate of Designation of the Series B-2 Convertible Preferred Stock in the form of Exhibit D

attached hereto (the “Series B-2 Preferred Stock”); and (2) all of the Holder’s October Pre-Funded

Warrants issued to the Holder, or its assigns, in the October Private Placement shall be exchanged for an equal number of Series B-2

Prefunded Preferred Stock Purchase Warrants (the “Series B-2 Prefunded Warrants”) exercisable for shares of Series B-2

Preferred Stock (the “Series B-2 Warrant Shares”) (collectively the “Exchange”). To the extent

a Holder determines, in its sole discretion, that such Holder (together with such Holder’s Affiliates, and any Person acting as

a group together with such Holder or any of such Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership

Limitation, or as such Holder may otherwise choose, in lieu of receiving Series B-2 Preferred Stock pursuant to this paragraph, such

Holder may elect to receive Series B-2 Prefunded Warrants. Additionally and notwithstanding anything herein to the contrary, the

Company may re-allocate a portion of the Series B-2 Preferred Stock issuable to the Holder to Series B-2 Prefunded Warrants

in lieu of Series B-2 Preferred Stock solely to the lesser of (x) the amount in excess of 19.99% and (y) the minimum extent

necessary to avoid a violation of the rules and regulations of the principal Trading Market the Common Stock is then traded on; provided,

that the Company shall give the Holder prior written notice of any such re-allocation, identify the applicable rule or regulation

requiring such re-allocation, and use commercially reasonable efforts to structure such re-allocation in a manner that preserves the economic

and voting position that the Holder would have received absent such re-allocation. The Holder’s calculation of its beneficial ownership

for purposes of this paragraph shall be conclusive absent manifest error.

The Series B-2 Prefunded

Warrants will have an exercise price of $0.0001 per share, subject to customary adjustments as provided in the Series B-2 Prefunded

Warrants, will be exercisable immediately upon issuance and can be exercised at any time after their issuance until exercised in full.

The Series B-2 Prefunded Warrants shall be substantially in the form as set forth in Exhibit E hereto.

The Exchange will be deemed

to be effective as of the close of business on the Closing Date (as defined below) and the Exchange Shares shall be deemed to be automatically

cancelled on the books and records of the Company and such Common Stock shall have no further rights or privileges and shall no longer

be deemed to be outstanding Common Stock of the Company for any purpose from and after the close of business on the Closing Date and the

Series B-2 Preferred Stock to be issued in the Exchange shall be deemed to be automatically issued to the Holder, pursuant to Section 4(a)(2) of

the Securities Act and Rule 506(b) of Regulation D promulgated thereunder, on the books and records of the Company as of the

close of business on the Closing Date. The Holder agrees that prior to the Closing Date it will promptly return to the Company all Exchange

Shares held by it in a brokerage account.

The Series B-1 Preferred

Stock and Series B-2 Preferred Stock, are collectively referred to herein as the “Preferred Stock”. The Series B-1

Prefunded Warrants and Series B-2 Prefunded Warrants are collectively referred to herein as the “Prefunded Warrants”.

The shares of Preferred Stock issuable upon exercise of the Prefunded Warrants are collectively referred to herein as the “Prefunded

Warrant Shares.”

As further consideration for

the transactions described above under the headings Warrant Exercise and Exchange of Securities, Build & Build,

LLC, a Delaware limited liability company, and BNBX Ltd., a British Virgin Islands business company, wholly owned subsidiaries of the

Company and wholly owned subsidiaries that may be formed hereafter to hold Digital Assets or may become additional guarantors pursuant

to the DATS Guaranty, defined below, (the “DAT Subsidiaries”), shall enter into the irrevocable and unconditional guarantee

in favor of the Holder and the purchasers party to the Securities Purchase Agreement, in the form of Exhibit F attached hereto

(the “DATS Guaranty”). For the avoidance of doubt, the DAT Subsidiaries shall guarantee, on a joint and several basis,

all Guaranteed Obligations to the Guaranteed Parties, as and when the same shall become due and payable by the Company under the Certificate

of Designations of the Preferred Stock, the Securities Purchase Agreement, the Inducement Agreement, or any other Transaction Document,

as each defined term in this sentence is defined in the DATS Guaranty.

Expressly subject to the paragraph

below immediately following this paragraph, Holder may accept this offer by signing the Holder’s Signature Page, with such acceptance

constituting Holder’s exercise of the percentage of Series E Warrants for an aggregate exercise price set forth on the Holder’s

Signature Page hereto (the “Warrant Exercise Price”) before 4:00 p.m., Eastern Time, on June 11, 2026 (the

“Execution Time”) and the transactions contemplated by the Exchange hereby.

The Company agrees to the

representations, warranties and covenants set forth on Annex A attached hereto. Holder represents and warrants that, as of the

date hereof it is, or on which it exercises any Prefunded Warrants it will be, an “accredited investor” as defined in Rule 501

of Regulation D promulgated under the Securities Act, and agrees that the Preferred Stock and Prefunded Warrants will contain restrictive

legends when issued, and the Preferred Stock, Prefunded Warrants and Prefunded Warrant Shares, and Rights (in the form attached to the

Transferable Rights Agreement) will not be registered under the Securities Act. Also, Holder represents and warrants that it is acquiring

the Preferred Stock, Prefunded Warrants, and any Rights as principal for its own account and has no direct or indirect arrangement or

understandings with any other persons to distribute or regarding the distribution of the Preferred Stock, Prefunded Warrants, Prefunded

Warrant Shares, any Rights (this representation is not limiting Holder’s right to sell the Prefunded Warrant Shares in compliance

with applicable federal and state securities laws).

The Company agrees that nothing

herein shall be interpreted as a waiver by the Holder of the Company’s obligations pursuant to Section 2(d) of the Series E

Warrants to deliver new Series E Warrants remaining for any partial exercise, if applicable, and to deliver any Exercise Shares that

are not included as Exchange Shares that are to be retained by the Holder, in the manner contemplated by the Series E Warrants.

Additionally, pursuant to

Section 5(l) of the Series E Warrants, the Holder hereby expressly waives the delivery obligations set forth in Section 2(d) of

the Series E Warrants for any Exercise Shares or Limited Shares required to be delivered hereunder, and the Holder expressly acknowledges

and agrees that the Company shall not be required to deliver any shares of Common Stock issuable upon exercise of the Series E Warrants

that are Exercise Shares or Limited Shares; provided, that the Company shall concurrently deliver to the Holder Series B-2

Preferred Stock (or Series B-2 Prefunded Warrants, if applicable) in lieu of such Exercise Shares and Series B-2 Prefunded Warrants

in lieu of such Limited Shares, which Series B-2 Prefunded Warrants shall be immediately exercisable, subject only to the applicable

Beneficial Ownership Limitation, and shall otherwise provide the Holder with the same economic position as the Exercise Shares and Limited

Shares. Delivery by the Company to the Holder of Series B-2 Preferred Stock (or Series B-2 Prefunded Warrants, if applicable)

in lieu of such Exercise Shares and Series B-2 Prefunded Warrants in lieu of such Limited Shares shall constitute the full and complete

delivery obligations for such shares pursuant to the Series E Warrants, except to the extent the number of Exercise Shares, Series B-2

Preferred Stock, Limited Shares or Series B-2 Prefunded Warrants have been incorrectly calculated or such Series B-2 Preferred

Stock and Series B-2 Prefunded Warrants are not delivered in accordance with this paragraph.

The Holder understands that

while the Company hereby agrees to enter into a Registration Rights Agreement with the Holder for the registration of the Common Stock

underlying the Preferred Stock and the Prefunded Warrant Shares, substantially in the form as Exhibit G, issuance of the Preferred

Stock, Prefunded Warrants, Prefunded Warrant Shares, and Rights is not, and may never be, registered under the Securities Act, or the

securities laws of any state and, accordingly, each certificate, if any, representing such securities shall bear a legend substantially

similar to the following:

“NEITHER

THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION

OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED

(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION

REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES INTO WHICH

THIS SECURITY IS EXERCISABLE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER

LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT

OR OTHER LOAN SECURED BY SUCH SECURITIES.”

Any statement evidencing the

Preferred Stock, Prefunded Warrants, or Prefunded Warrant Shares, shall not contain any legend (including the legend set forth above),

(i) following any sale of such Preferred Stock, Prefunded Warrants, and Prefunded Warrant Shares or transfer of Rights pursuant to

Rule 144 under the Securities Act, or (ii) if such legend is not required under applicable requirements of the Securities Act

(including judicial interpretations and pronouncements issued by the staff of the Securities and Exchange Commission (the “Commission”)

and the earliest of clauses (i) and (ii), the “Delegend Date”)). The Company shall cause its counsel to issue

a legal opinion to the Company or its transfer agent, if required, promptly after the Delegend Date if required to effect the removal

of the legend hereunder, or at the request of the Holder, which opinion shall be in form and substance reasonably acceptable to the Company.

The Company shall not impose, any additional documentation, opinion, representation or other requirement on the Holder as a condition

to legend removal or delivery except to the extent required by applicable law. From and after the Delegend Date, such Preferred Stock,

Prefunded Warrants, or Prefunded Warrant Shares shall be issued free of all such legends. The Company agrees that following the Delegend

Date or at such time as such legend is no longer required under this Section, it will, no later than one (1) Trading Day (such first

(1st) Trading Day, the “Legend Removal Date”), deliver or cause to be delivered to the Holder a certificate representing

such securities that is free from all restrictive and other such legends.

No later than 9:00 a.m. (New

York City time), on the Trading Date following the date this letter agreement is first signed, the Company shall issue a press release

disclosing the material terms of the transactions contemplated hereby and shall file a Current Report on Form 8-K with the Commission

disclosing all material terms of the transactions contemplated hereunder, including the filing with the Commission of this letter agreement

as an exhibit thereto within the time required by the Exchange Act. From and after the dissemination of such press release, the Company

represents to you that it shall have publicly disclosed all material, non-public information delivered to you by the Company, or any of

its respective officers, directors, employees or agents in connection with the transactions contemplated hereunder. In addition, effective

upon the dissemination of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations

under any agreement, whether written or oral, between the Company, any of its subsidiaries or any of their respective officers, directors,

agents, employees or Affiliates on the one hand, and you and your Affiliates on the other hand, shall terminate. Except for the Holders

obligations pursuant to this letter agreement, the Company represents, warrants and covenants that, upon acceptance of this offer, the

Exercise Shares shall be issued at Closing free of any legends or restrictions on resale by the Holder.

The Company shall provide

the Holder and its counsel a reasonable opportunity to review and comment on any press release, Current Report on Form 8-K or other

public disclosure that names the Holder or describes the Holder’s participation in the transactions contemplated hereby, and the

Company shall consider in good faith any comments received from the Holder or its counsel. Following dissemination of the press release

and filing of the Current Report on Form 8-K contemplated by this paragraph, the Company shall not, and shall cause its subsidiaries

and their respective officers, directors, employees and agents not to, provide the Holder or its Affiliates with any material, non-public

information regarding the Company or its subsidiaries without the Holder’s prior written consent.

No later than the fifth (5th)

Trading Day following the date all of the conditions to closing described below have been met by both parties, the closing (“Closing

Date”) shall occur at such location as the parties shall mutually agree. The parties hereby agree that notwithstanding anything

herein to the contrary, all shares of Preferred Stock and all Prefunded Warrants issuable pursuant to this letter agreement shall be delivered

to the Holder in certificated form by the Company in the name of the Holder or its designee.

The obligations of the Holder

to consummate the transactions contemplated hereby shall be subject to the satisfaction, or waiver in writing by the Holder, of the following

conditions on or prior to the Closing Date: (i) the representations and warranties of the Company contained in this letter agreement

and Annex A shall be true and correct in all material respects as of the Closing Date, except for representations and warranties

that are qualified by materiality or Material Adverse Effect, which shall be true and correct in all respects; (ii) the Company and

the DAT Subsidiaries shall have performed or complied in all material respects with all covenants and agreements required to be performed

or complied with by them on or prior to the Closing Date; (iii) no Material Adverse Effect shall have occurred and be continuing;

(iv) all Required Approvals shall have been obtained or made and shall remain in full force and effect; (v) the Certificate

of Designations for the Preferred Stock shall have been duly filed with and accepted by the Secretary of State of the State of Delaware;

(vi) the Securities Purchase Agreement, Registration Rights Agreement, DATS Guaranty, Prefunded Warrants and, if applicable, Transferable

Rights Agreement shall have been duly executed and delivered by each applicable Company party and shall be in full force and effect; (vii) the

Common Stock shall not have been suspended from trading on the principal Trading Market, except that delisting of the Common Stock from

the Nasdaq Capital Markets shall not trigger this provision; and (viii) the Company shall have delivered, or caused to be delivered,

all items required to be delivered by the Company under this letter agreement.

On or prior to the Closing

Date, the Holder shall deliver or cause to be delivered to the Company or its designee:

(i)            all

October Pre-Funded Warrants issued to the Holder, or its assigns, in the October Private Placement (or an affidavit of lost

warrant and indemnity agreement in lieu of the Pre-Funded Warrants in a form acceptable to the Company);

(ii)           a

duly executed copy of the notice of exercise accompanying the Series E Warrants and payment of the Warrant Exercise Price;

(iii)          all

Exchange Shares held in a brokerage account by the Holder; and

(iv)          if

applicable, a duly executed copy of the Transferable Rights Agreement.

On or prior to the Closing Date the Company shall

deliver or cause to be delivered to the Holder:

(i)            a

certified copy of the effective Series B-1 Preferred Stock Certificate of Designation filed with the Secretary of State of Delaware;

(ii)           a

certified copy of the effective Series B-2 Preferred Stock Certificate of Designation filed with the Secretary of State of Delaware;

(iii)          a

copy of the fully executed stock certificate evidencing the Preferred Stock issuable hereunder as registered in the name of the Holder,

which shall be promptly delivered to the Holder after the Closing Date;

(iv)          a

copy of the fully executed Series B-1 Prefunded Warrant in the name of the Holder, which shall be promptly delivered to the Holder

after the Closing Date;

(v)           a

copy of the fully executed Series B-2 Prefunded Warrant in the name of the Holder, which shall be promptly delivered to the Holder

after the Closing Date;

(vi)          if

applicable, a Transferable Rights Agreement duly executed by the Company;

(vii)         the

Registration Rights Agreement duly executed by the Company; and

(viii)        the

DATS Guaranty duly executed by the Company and the DAT Subsidiaries.

The Company shall pay all

transfer agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Exercise Shares. This letter

agreement shall be construed and enforced in accordance with the laws of the State of Delaware, without regards to conflicts of laws principles.

Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough

of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby.

Indemnification

The Company shall indemnify

and hold harmless the Holder and its Affiliates and their respective and its directors, officers, shareholders, members, partners, employees

and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title

or any other title), each Person who controls such Holder (within the meaning of Section 15 of the Securities Act and Section 20

of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a

functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling

persons (each, a “Holder Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages,

costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys' fees and costs of investigation

that any such Holder Party may suffer or incur as a result of or relating to (a) any material breach of any of the representations,

warranties, covenants or agreements made by the Company in this letter agreement or in the other Transaction Documents or (b) any

action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of

the Company who is not an Affiliate of such Holder Party, with respect to any of the transactions contemplated by the Transaction Documents

(unless such action is solely based upon a material breach of such Holder Party's representations, warranties or covenants under the Transaction

Documents or any agreements or understandings such Holder Party may have with any such stockholder or any violations by such Holder Party

of state or federal securities laws or any conduct by such Holder Party which is finally judicially determined to constitute fraud, gross

negligence or willful misconduct). If any action shall be brought against any Holder Party in respect of which indemnity may be sought

pursuant to this letter agreement, such Holder Party shall promptly notify the Company in writing, and, the Company shall have the right

to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Holder Party. Any Holder Party shall have

the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel

shall be at the expense of such Holder Party except to the extent that (i) the employment thereof has been specifically authorized

by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel

or (iii) in such action there is, in the reasonable opinion of counsel a material conflict on any material issue between the position

of the Company and the position of such Holder Party, in which case the Company shall be responsible for the reasonable, actual and documented

fees and expenses of no more than one such separate counsel. The Company will not be liable to any Holder Party under this letter agreement

(y) for any settlement by a Holder Party effected without the Company's prior written consent, which shall not be unreasonably withheld

or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Holder Party's

breach of any of the representations, warranties, covenants or agreements made by such Holder Party in this letter agreement and other

Transaction Documents. The indemnification required by this Section shall be made by periodic payments of the amount thereof during

the course of the investigation or defense, as and when bills are received or are incurred; provided, however, that if it is subsequently

determined by a final, non-appealable judgment of a court of competent jurisdiction that a Holder Party was not entitled to receive such

periodic payments, such Holder Party shall promptly (but in no event later than five Business Days) return such payments to the Company.

The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Holder Party against the

Company or others and any liabilities the Company may be subject to pursuant to law.

Equitable Remedies

The Company acknowledges and

agrees that any breach or threatened breach by the Company or any of its subsidiaries of this letter agreement or any other Transaction

Document may cause irreparable harm to the Holder for which monetary damages would not be an adequate remedy. Accordingly, in addition

to any other rights and remedies available at law or in equity, the Holder shall be entitled to seek specific performance, injunctive

relief and other equitable relief to enforce the terms of this letter agreement and the other Transaction Documents, without the necessity

of proving actual damages or posting any bond or other security. The Company further agrees that it shall not oppose the granting of such

relief on the basis that an adequate remedy at law exists.

Successors and Assigns

This letter agreement shall

be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this letter

agreement or any rights or obligations hereunder without the prior written consent of each Holder (other than by merger); provided,

that any successor to the Company by merger or similar transaction shall expressly assume in writing all obligations of the Company under

this letter agreement and each other Transaction Document, including all delivery, registration, indemnification and guarantee-related

obligations, and no such merger or similar transaction shall impair the rights or remedies of the Holder hereunder or thereunder. Any

Holder may assign any or all of its rights under this letter agreement to any Person to whom such Holder assigns or transfers any Preferred

Stock or Prefunded Warrants, provided that such transferee agrees in writing to be bound, with respect to the transferred securities,

by the provisions of this letter agreement that apply to the Holder.

Maintenance of Digital

Assets

The Company acknowledges and

agrees that the Digital Assets owned by the Company or any of its subsidiaries on the date hereof, together with any such Digital Assets

(or similar digital assets) subsequently acquired by the Company or any subsidiary, shall be held solely by (a) the Company or (b) a

DAT Subsidiary, and each DAT Subsidiary will be, at all times during which it holds such assets, a guarantor party to the DATS Guaranty.

The Company shall not, and shall cause each DAT Subsidiary not to, transfer any such Digital Assets to any Person other than the Company

or a DAT Subsidiary that is then a guarantor party to the DATS Guaranty, permit any subsidiary that is not a guarantor party to the DATS

Guaranty to hold any such assets, or create, incur, assume or permit to exist any Lien, as defined in Annex A, on any such assets, except

for Liens expressly permitted under the Transaction Documents.

(Signature Pages Follow)

Sincerely yours,

BNB PLUS CORPORATION

By:

Name:

Title:

[Holder Signature Page Follows]

Notice of Exercise and

Irrevocable Written Notice of Exchange

Accepted and Agreed to:

Name of Holder: ________________________________________________________

Signature of Authorized Signatory of Holder:

_________________________________

Name of Authorized Signatory: _______________________________________________

Title of Authorized Signatory: ________________________________________________

The abovesigned hereby irrevocably constitutes

and appoints any officer of BNB Plus Corp. as the attorney of the undersigned, with full power of substitution and re-substitution in

the premises, solely to take ministerial actions that are necessary to exchange the Exchange Shares and October Pre-Funded Warrants

to be delivered to the Company subject to this Notice of Exchange and Irrevocable Written Notice of Exchange on the books of BNB Plus

Corp. for Series B-2 Preferred Stock and/or Series B-2 Prefunded Warrants, as applicable, on the books of BNB Plus Corp., in

each case strictly in accordance with this Notice of Exercise and Irrevocable Written Notice of Exchange and the executed Holder’s

Signature Page. The foregoing power of attorney shall not authorize any officer of BNB Plus Corp. to amend, modify, waive or release any

right of the undersigned, make any election on behalf of the undersigned, or take any action inconsistent with the terms of this letter

agreement or the Holder’s Signature Page, and shall terminate automatically upon completion of the Exchange.

Securities issued to Holder in October Private Placement

A

Common Stock:

B

October Pre-Funded Warrants:

Series E-1 and Series E-2 Warrants:

Series E Warrant Exercise

Exercise Percentage of Series E Warrants*:

%

* Total Exercise Percentage will be applied pro-rata between Series E-1

and Series E-2 Warrants, if applicable.

Series E Warrants Beneficial Ownership Blocker

☐ 4.99% or ☐ 9.99%

C

Common Stock to be issued below Series E Warrant Beneficial Ownership Blocker:

D

Series B-2 Prefunded Warrants to be issued in lieu of Common Stock issuable above Series E Warrant Beneficial Ownership Blocker:

E

Total Series E Warrant Exercise Shares (C+D):

F

Warrant Exercise Price ($3.82 x E):

$

Unless indicated below, Holder is electing to include all Excess Exercise Shares as Exchange Shares.

G

Holder hereby elects to receive Transferable Rights relating to __________ Excess Exercise Shares.

H

Series B-1 Inducement ([F-(E x Market Price)]/1.05):

I

Series B-1 Preferred Stock to be issued to Holder:

Series B-1 Prefunded Warrants to be issued to Holder (H-I):

J

Exchange Shares (A+C-G):

K

Series B-2 Preferred Stock to be issued to Holder:

Series B-2 Prefunded Warrants to be issued to Holder (B+D+J-K):

Prefunded Series B-1 Preferred Stock Purchase Warrants Beneficial

Ownership Blocker ☐ 4.99% ☐ 9.99% or ☐ 19.99%

Prefunded Series B-2 Preferred Stock Purchase Warrants Beneficial

Ownership Blocker ☐ 4.99% ☐ 9.99% or ☐ 19.99%

[Holder Signature Page to BNB Plus Corp.

Warrant Inducement and Exchange Agreement]

Annex A

Representations, Warranties

and Covenants of the Company. The Company hereby makes the following representations, warranties and covenants to the Holder:

a)

SEC Reports; Financial Statements. Except as set forth on Schedule A, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company is not currently subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

b)

Organization and Qualification. Each of the Company and the DAT Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing (if applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted, and neither the Company nor any DAT Subsidiary is in violation nor in default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Except as would otherwise not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, each subsidiary of the Company, including any direct or indirect subsidiary of the Company formed or acquired after the date hereof (each a “Subsidiary”) other than a DAT Subsidiary, is an entity duly incorporated or otherwise organized, validly existing and in good standing (if applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted, and no such Subsidiary is in violation nor in default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the ability of the Company or the DAT Subsidiaries to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

c)

Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this letter agreement and each of the Prefunded Warrants, the Rights, the Transferable Rights Agreement, the Registration Rights Agreement, and the DATS Guaranty, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder (the “Transaction Documents”) and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this letter agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company's stockholders in connection herewith or therewith other than in connection with the Required Approvals. This letter agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligations of the Company enforceable against the Company in accordance with their terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors' rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. The DAT Subsidiaries have the requisite corporate power and authority to enter into and to consummate the transactions contemplated by the DATS Guaranty, and all exhibits and schedules thereto, and otherwise to carry out its obligations thereunder. The execution and delivery of the DATS Guaranty and the consummation by it of the transactions contemplated thereby have been duly authorized by all necessary action on the part of the DAT Subsidiaries and no further action is required by the DAT Subsidiaries in connection therewith other than in connection with the Required Approvals. The DATS Guaranty has been (or upon delivery will have been) duly executed by the DAT Subsidiaries and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligations of the DAT Subsidiaries enforceable against the DAT Subsidiaries in accordance with their terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors' rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

d)

Issuance of the Securities. The Preferred Stock, Prefunded Warrants, Prefunded Warrant Shares, and Rights are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares of Preferred Stock and Common Stock issuable pursuant to this letter agreement. As used herein “Liens” means any mortgage, deed of trust, pledge, hypothecation, security interest, encumbrance, lien, charge, claim, attachment, garnishment, levy or other restriction of any kind, whether arising by agreement, operation of law or otherwise, including any conditional sale or other title retention agreement, any lease in the nature thereof, any restriction on transfer or disposition, and any agreement to create or suffer any of the foregoing, and including any asserted or pending claim, litigation, proceeding or demand that could reasonably be expected to result in the imposition of any of the foregoing on any asset or property of the Company or any subsidiary, including any Subsidiary holding digital assets.

e)

No Conflicts. The execution, delivery and performance by the Company of this letter agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Preferred Stock, Prefunded Warrants and Rights and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company's or any Subsidiary's certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

f)

Filings, Consents and Approvals. Except as would otherwise not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing of the Certificate of Designations for the Preferred Stock with the Secretary of State of the State of Delaware, (ii) the filings required by this letter agreement, (iii) the filing of registration statements with the Commission pursuant to the Registration Rights Agreement, (iv) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the securities and the listing of the Common Stock underlying such securities issuable in connection with the Securities Purchase Agreement between the Company and the purchasers party thereto, or trading thereon in the time and manner required thereby, (v) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of securities and the listing of shares of Common Stock underlying such securities issuable in connection with this letter agreement, or trading thereon in the time and manner required thereby, and (vi) the filing of Form D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

g)

Listing of Common Stock. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common Stock on a Trading Market, and concurrently with the Closing, the Company shall apply to list or quote all of the Common Stock issuable upon conversion of the Preferred Stock and shares of Common Stock issuable upon conversion of the Prefunded Warrant Shares (the “Conversion Shares”) on the Trading Market on which it is currently listed and promptly secure the listing of all of the Conversion Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Conversion Shares, and will take such other action as is necessary to cause all of the Conversion Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company's reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.  The Company shall promptly notify the Holder in writing of (i) any notice received from any Trading Market regarding the Company’s compliance with listing or maintenance requirements, (ii) any determination by the Company to list on a different Trading Market, and (iii) any delisting, suspension of trading, or threatened delisting or suspension affecting the Common Stock. Any information filed or furnished by the Company with the Commission and delivered to (a) purchasers party to the Securities Purchase Agreement which purchased at least 50.1% in interest of the Conversion Shares and Common Warrant Shares, as defined in the Securities Purchase Agreement, based on the initial subscription amounts thereunder, or (b) the designee or delegate thereof, that includes the information required by this Annex A Section (g)(i), (ii), or (iii) within the timeframe required by the Commission and the applicable Trading Market, shall constitute prompt written notice to the Holder by the Company required by this Annex A Section (g).

Exhibit A

Form of Delaware Certificate of Designation

of the Series B-1 Preferred Stock

Exhibit B

Form of Series B-1 Prefunded Preferred

Stock Purchase Warrants

Exhibit C

Form of Transferable Rights Agreement

Exhibit D

Form of Delaware Certificate of Designation

of the Series B-2 Preferred Stock

Exhibit E

Form of Series B-2 Prefunded Preferred

Stock Purchase Warrants

Exhibit F

Form of DATS Guaranty

Exhibit G

Form of Registration Rights Agreement

EX-10.3 — EXHIBIT 10.3

EX-10.3

Filename: tm2615620d1_ex10-3.htm · Sequence: 10

Exhibit 10.3

GUARANTY AGREEMENT

(Treasury Subsidiary Guaranty of Series B-1

and Series B-2 Convertible Preferred Stock Obligations)

THIS TREASURY SUBSIDIARY GUARANTY

AGREEMENT (this “Agreement”), dated as of May 26, 2026, is made by BNBX Ltd., a British Virgin Islands

business corporation and Build & Build LLC, a Delaware limited liability company, both wholly-owned subsidiaries of BNB Plus

Corp, a Delaware corporation (the “Company”), (each of which is referred to herein as a “Guarantor”,

and collectively with any additional Guarantors added pursuant to Section 25 hereof, the “Guarantors”),

in favor of KGPLA Holdings LLC, solely in its capacity as lead investor pursuant to Section 10 hereof (together with its designee

or delegate, the “Lead Investor”), in connection with that certain Securities Purchase Agreement, dated as of

the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “SPA”) and

the Warrant Inducement and Exchange Agreement hereof (as amended, restated, supplemented or otherwise modified from time to time, the

“Inducement Agreement”), each among the Company, and the purchasers party thereto (the “Purchasers”),

and the Certificate of Designations (as defined below).

W I T N E S S E T H:

WHEREAS, pursuant to the SPA and Inducement

Agreement, the Company has agreed to issue and sell to the Purchasers (i) shares of the Company's Series B-1 Convertible Preferred

Stock, par value $0.001 per share (the “Series B-1 Preferred Stock”), and (ii) shares of the Company's

Series B-2 Convertible Preferred Stock, par value $0.001 per share (the “Series B-2 Preferred Stock”,

and together with the Series B-1 Preferred Stock, the “Convertible Preferred Stock”), in each case having

the rights, preferences, privileges and restrictions set forth in the Certificate of Designations;

WHEREAS, each Guarantor will materially

benefit from the issuance of the Convertible Preferred Stock under the SPA and the Certificate of Designations, and, in connection with

the issuance of the Convertible Preferred Stock and as express consideration for such Guarantor’s entry into this Agreement, the

Guarantors in existence as of the Closing (as defined in the SPA), will receive from the Company certain contributions to capital (the

“Capitalization”) with a portion of the proceeds of the issuance of the Convertible Preferred Stock; and

WHEREAS, it is a condition precedent to

the obligations of the Purchasers under the SPA and Inducement Agreement, and a material inducement to the Purchasers’ investment

decision, that each Guarantor enter into this Agreement to guarantee the Guaranteed Obligations (as defined below) of the Company with

respect to the Convertible Preferred Stock for the benefit of all Guaranteed Parties.

NOW, THEREFORE, in consideration of the

premises, the Capitalization, and mutual covenants herein contained and for other good and valuable consideration, the receipt and sufficiency

of which are hereby acknowledged, the parties agree as follows:

1. Definitions.

The following terms shall have the meanings set

forth below. Capitalized terms used but not defined in this Agreement shall have the meanings given to them in the SPA, Inducement

Agreement or the Certificate of Designations, as applicable.

“Capitalization” is defined

in the preamble hereto.

“Certificate of Designations”

means, as the context requires, the certificate of designation for the Series B-1 Preferred Stock of the Company or the certificate

of designation for the Series B-2 Preferred Stock of the Company, or both, each filed with the Secretary of State of the State of

Delaware on or about the date hereof (as amended, restated, supplemented or otherwise modified from time to time).

“Collateral Value” means, as

of any date of determination, the sum of (a) the aggregate amount of cash held by the Guarantors (or any replacement or supplemental

cash assets) plus (b) the aggregate fair market value of the Digital Assets held by Guarantor, in each case determined in accordance

with the Valuation Methodology, and including all proceeds, replacement or supplemental assets.

“Digital Assets” means (a) cryptocurrencies,

virtual currencies, digital currencies, coins, tokens and stablecoins; (b) native blockchain or protocol assets; (c) tokenized

securities, tokenized commodities and tokenized real-world assets; (d) utility tokens, governance tokens, staking tokens, liquid

staking tokens and wrapped, bridged or synthetic digital assets; (e) any digital or cryptographic asset, property or store of value

that is recorded, represented or transferred using distributed ledger technology, blockchain technology, cryptographic systems or similar

technology; (f) BNB-denominated trust units, (g) any rights to receive, acquire, stake, validate, delegate, earn, mine or otherwise

obtain any of the foregoing; (h) any proceeds, products, distributions, rewards, fees, interest, yield, airdrops, forks or other

property derived from or attributable to any of the foregoing; and (i) any replacements, substitutions, modifications, successors

or forks of any of the foregoing, in each case of (a) through (h), whether now existing or hereafter arising.

“Digital Asset Treasury” means

the immediately available liquid assets of the Company and its subsidiaries, including but not limited to any Digital Assets and any cash

at the DAT Subsidiaries; provided, however, that notwithstanding the foregoing the Digital Asset Treasury shall be deemed not to include:

(i) the General Proceeds; (ii) cash at the Company in an amount equal to $600,000; (iii) accounts receivable of the Company

in an amount equal to $700,000; and (iv) all operating cash flows attributable to the LineaRx business.

“General Proceeds” means proceeds

from the issuance of Series B-1 Preferred Stock and proceeds from the warrant exercise and exchange for Series B-2 Preferred

Stock as set forth in the Inducement Agreement, in an aggregate cumulative amount not in excess of $2,300,000.

“Guaranteed Obligations” means,

collectively, (a) all cash-payment obligations of the Company to the Guaranteed Parties under the Certificate of Designations, the

SPA, the Inducement Agreement and the other Transaction Documents in respect of the Convertible Preferred Stock or otherwise, whether

now existing or hereafter arising, including, without limitation: (i) all accrued and unpaid Dividends (whether or not declared),

including but not limited to Compounded Dividends, with respect to the Convertible Preferred Stock, as and when payable under the Certificate

of Designations; (ii) the Holder Redemption Price, (iii) the Liquidation Preference and any Participating Amount (not to exceed

the Maximum Return) payable with respect to the Convertible Preferred Stock upon a Liquidation Event (as defined in the Certificate of

Designations); and (iv) any other monetary amount payable by the Company to any Guaranteed Party pursuant to the Certificate of Designations

or the SPA or any other Transaction Document; and (b) to the extent legally enforceable as a guaranty under applicable law, the economic

damages suffered by any Guaranteed Party as a result of the Company’s failure to honor any right of exercise or conversion (or right

associated therewith) of such Guaranteed Party under the Certificate of Designations, the Warrant Inducement Exchange Agreement, the Warrants

or PreFunded Warrants that is not susceptible to cash performance by Guarantor, in each case measured by the fair market value, on the

date of the Company’s failure, of the property the Company was required to deliver and failed to deliver.

“Guaranteed Parties” means,

at any time, all Persons who are, at such time, registered holders of shares of the Convertible Preferred Stock or pre-funded warrants

to acquire such shares of Convertible Preferred Stock on the books and records of the Company or its transfer agent, as applicable, and

their respective permitted successors, assigns, and transferees who become registered holders of Convertible Preferred Stock. The identity

of the Guaranteed Parties from time to time shall be conclusively determined by reference to the stock register of the Company or the

books and records of the transfer agent for the Convertible Preferred Stock.

“Lead Investor” has the meaning

set forth in the preamble. The Lead Investor is not a trustee, custodian, or institutional agent and owes no fiduciary duties to any Guaranteed

Party other than those expressly and specifically set forth in this Agreement.

“Majority-in-Interest” means,

at any time, Guaranteed Parties holding more than 50% of the aggregate Liquidation Preference (as defined in the Certificate of Designations)

of the then-outstanding shares of Series B-1 Preferred Stock.

“Person” means any individual,

partnership, corporation, limited liability company, trust, unincorporated organization, governmental authority or other entity.

“Solvent” means, with respect

to any Person on any date, that on such date (a) the present fair saleable value of the assets of such Person is not less than the

amount that will be required to pay the probable liability of such Person on its debts as they become absolute and matured, and (b) such

Person does not intend to, and does not believe that it will, incur debts or liabilities beyond such Person's ability to pay as such debts

and liabilities mature.

“Valuation Methodology” means,

with respect to any Digital Asset, (a) if such Digital Asset is listed on at least two nationally recognized cryptocurrency exchanges

in the United States, the average of the daily trading prices on the two exchanges with the highest trading volume for such Digital Asset

over the preceding five (5) Business Days, or (b) if clause (a) does not apply, the fair market value as determined in

good faith by the Company in consultation with the Lead Investor based on the most recent available market data, third-party valuation,

or other commercially reasonable methodology and in accordance with the Treasury Procedures.

2. Guaranty. Each Guarantor hereby irrevocably,

absolutely, unconditionally and jointly and severally with all other Guarantors, guarantees, as a primary obligor and not merely as a

surety, the full and prompt payment in cash of all Guaranteed Obligations to the Guaranteed Parties, as and when the same shall become

due and payable by the Company under the Certificate of Designations, the SPA, the Inducement Agreement or any other Transaction Document,

whether by lapse of time, upon the occurrence of a Redemption Event,), upon Liquidation Event, by declaration, upon acceleration pursuant

to Section 12(b) hereof, or otherwise (including, to the extent legally enforceable, any Dividend accruing during the pendency

of any bankruptcy, insolvency, receivership, or other similar proceeding affecting the Company, regardless of whether allowed or allowable

as a claim in such proceeding). Each Guarantor’s guaranty hereunder is a guarantee of payment and not of collection. Each Guarantor

further agrees that the Guaranteed Obligations may be extended or renewed by the Company, in whole or in part, without notice to or further

assent from any Guarantor, and that each Guarantor will remain bound upon its guaranty notwithstanding any extension or renewal of any

Guaranteed Obligation.

3. Obligations Not Waived. To the fullest

extent permitted by applicable law, each Guarantor waives presentment or protest to, demand of or payment from the Company of any of the

Guaranteed Obligations, and also waives notice of acceptance of its guarantee and notice of protest for nonpayment. To the fullest extent

permitted by applicable law, the obligations of each Guarantor hereunder shall not be affected by (i) the failure of the Lead Investor

or any Guaranteed Party to assert any claim or demand or to enforce or exercise any right or remedy against the Company under the provisions

of the Certificate of Designations, the SPA, the Inducement Agreement any other Transaction Document or otherwise, (ii) any rescission,

waiver, amendment or modification of, or any release from any of the terms or provisions of, this Agreement, the Certificate of Designations,

the SPA, the Inducement Agreement any other Transaction Document or any other agreement, (iii) the failure to perfect any security

interest in, or the release of, any of the security held by or on behalf of the Lead Investor for the ratable benefit of the Guaranteed

Parties, or (iv) the unenforceability or invalidity of any of the Certificate of Designations, the SPA, the Inducement Agreement

any other Transaction Document or the Convertible Preferred Stock itself, in whole or in part, it being agreed that no invalidity, illegality,

irregularity, or unenforceability of all or any part of the Guaranteed Obligations or of the Convertible Preferred Stock shall affect,

impair, or be a defense to this guaranty, and this guaranty shall be primary, absolute, and unconditional notwithstanding the occurrence

of any event or the existence of any other circumstances which might constitute a legal or equitable discharge of a surety or guarantor

except payment in full in cash of the Guaranteed Obligations.

4. Security. Each Guarantor authorizes

the Lead Investor, acting for the ratable benefit of the Guaranteed Parties, to (a) take and hold security, with the consent of such

Guarantor (such consent not to be unreasonably withheld, conditioned or delayed), for payment of this Agreement and the Guaranteed Obligations,

and exchange, enforce, waive and release any such security, (b) apply such security, if any, and direct the order or manner of sale

thereof as the Lead Investor, acting at the direction of the Majority-in-Interest, in its sole discretion may determine and (c) release

or substitute any one or more endorsees, other guarantors or other obligors.

5. Guaranty of Payment. Each Guarantor

further agrees that its guaranty constitutes a guaranty of payment when due and not of collection, and waives any right to require that

any resort be had by the Lead Investor or any Guaranteed Party to any of the security held for payment of the Guaranteed Obligations or

to any other asset of the Company or any other Person.

6. No Discharge or Diminishment of Guaranty.

The obligations of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any

reason (other than the indefeasible payment in full in cash of the Guaranteed Obligations), including any claim of waiver, release, surrender,

alteration or compromise of any of the Guaranteed Obligations, and shall not be subject to any defense or setoff, counterclaim, recoupment

or termination whatsoever by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations, the Convertible Preferred

Stock, the Certificate of Designations, the SPA, the Inducement Agreement or any other Transaction Document or otherwise. Without limiting

the generality of the foregoing, the obligations of any Guarantor hereunder shall not be discharged or impaired or otherwise affected

by the failure of the Lead Investor or any Guaranteed Party to assert any claim or demand or to enforce any remedy under the Certificate

of Designations, the SPA, the Inducement Agreement or any other Transaction Document or any other agreement, by any waiver or modification

of any provision of any thereof, by any default, failure or delay, willful or otherwise, in the performance of the Guaranteed Obligations,

or by any other act or omission that may or might in any manner or to any extent vary the risk of the Guarantor or that would otherwise

operate as a discharge of the Guarantor as a matter of law or equity (other than the indefeasible payment in full in cash of all the Guaranteed

Obligations).

7. Defenses Waived. To the fullest extent

permitted by applicable law, each Guarantor waives any defense based on or arising out of any defense of the Company or the unenforceability

of the Guaranteed Obligations or any part thereof from any cause, or the cessation from any cause of the liability of the Company, other

than the final and indefeasible payment in full in cash of the Guaranteed Obligations. The Lead Investor, acting at the direction of the

Majority-in-Interest, may, at its election, foreclose on any security held by it by one or more judicial or nonjudicial sales, accept

an assignment of any such security in lieu of foreclosure, compromise or adjust any part of the Guaranteed Obligations, make any other

accommodation with the Company, without affecting or impairing in any way the liability of each Guarantor hereunder except to the extent

the Guaranteed Obligations have been fully, finally and indefeasibly paid in cash or fully-liquid Digital Assets. Pursuant to applicable

law, each Guarantor waives any defense arising out of any such election even though such election operates, pursuant to applicable law,

to impair or to extinguish any right of reimbursement or subrogation or other right or remedy of each Guarantor against the Company or

any security, whether arising under Delaware law or otherwise.

8. Agreement to Pay; Subordination. In

furtherance of the foregoing and not in limitation of any other right that the Lead Investor or any Guaranteed Party has at law or in

equity against each Guarantor by virtue hereof, upon the failure of the Company to pay any Guaranteed Obligation when and as the same

shall become due (subject to any applicable cure period), whether upon a Dividend, Redemption Event, upon a Liquidation Event, upon conversion

of the Convertible Preferred Stock or upon exercise of the Warrants, by acceleration, or otherwise, each Guarantor hereby promises to

and will forthwith pay, or cause to be paid, for pro rata distribution to the Guaranteed Parties in accordance with Section 9, in

cash the amount of such unpaid Guaranteed Obligation. Upon payment by any Guarantor of any sums for pro rata distribution to the Guaranteed

Parties in accordance with Section 9, all rights of such Guarantor against the Company arising as a result thereof by way of right

of subrogation, contribution, reimbursement, indemnity or otherwise shall in all respects be subordinate and junior in right of payment

to the prior indefeasible payment in full in cash of all the Guaranteed Obligations. In addition, any indebtedness of the Company now

or hereafter held by any Guarantor is hereby subordinated in right of payment to the prior payment in full in cash of the Guaranteed Obligations.

If any amount shall erroneously be paid to a Guarantor on account of (i) such subrogation, contribution, reimbursement, indemnity

or similar right, or (ii) any such indebtedness of the Company, such amount shall be held in trust for the benefit of the Guaranteed

Parties and shall forthwith be paid for pro rata distribution to the Guaranteed Parties in accordance with Section 9 to be credited

against the payment of the Guaranteed Obligations, whether matured or unmatured, in accordance with the terms of this Agreement.

9. Pro Rata Sharing Among Guaranteed Parties.

(a) Ratable Benefit. Notwithstanding

anything to the contrary in this Agreement, (i) all proceeds received pursuant to actions of the Lead Investor from a Guarantor in

accordance with this Agreement (whether from payment on the Guaranteed Obligations, realization on any collateral, or otherwise) shall

be for the ratable benefit of all Guaranteed Parties, and (ii) all such proceeds shall be distributed by the Company or Guarantors

to the Guaranteed Parties on a pro rata basis, based upon the ratio that the aggregate Guaranteed Obligations then owed to each Guaranteed

Party bears to the aggregate Guaranteed Obligations then owed to all Guaranteed Parties.

(b) Turnover. If any Guaranteed Party

shall, by exercise of any right of setoff, counterclaim, or otherwise, obtain payment in respect of any Guaranteed Obligation in excess

of such Guaranteed Party’s ratable share as determined pursuant to this Section 9, then such Guaranteed Party shall promptly

purchase, for cash, such participations in the Guaranteed Obligations as shall be necessary to cause such Guaranteed Party to share such

excess with each other Guaranteed Party in accordance with its ratable share.

(c) No Race to Enforce. No Guaranteed

Party shall, individually, have the right to commence any action or proceeding against any Guarantor to enforce this Agreement, except

through the Lead Investor acting pursuant to Section 10 hereof; the sole enforcement right and standing with respect to this Agreement

shall be vested in the Lead Investor acting at the direction of the Majority-in-Interest.

10. Lead Investor; Duties, Governance, and Limitations.

(a) Appointment and Duties. The Guaranteed

Parties, by acquiring and holding from time to time any Convertible Preferred Stock, appoint the Lead Investor as their representative

for purposes of this Agreement. The duties of the Lead Investor shall be limited to the following, and no other duties, fiduciary or otherwise,

shall be implied by this Agreement:

(i)  distributing notices

to the Guarantors on behalf of the Guaranteed Parties;

(ii) delegating (in its

reasonable discretion) all or any portion of the obligations and benefits of Lead Investor hereunder;

(iii) enforcing this

Agreement against any or all Guarantors at, and only at, the written direction of the Majority-in-Interest;

(iv) holding any security

interest, lien, pledge, account control, or other collateral package granted by any Guarantor under or in connection with this Agreement

(including as to the Digital Asset Treasury) for the ratable benefit of all Guaranteed Parties, and administering any enforcement or release

of such collateral at the direction of the Majority-in-Interest; and

(v)  acting as the sole

party with standing and authority to bring any enforcement action, suit, or proceeding with respect to this Agreement; no individual Guaranteed

Party shall have independent standing to sue any Guarantor hereunder, but shall rely upon the Lead Investor for enforcement in accordance

with this Section 10.

(b) No Fiduciary Duties. The Lead

Investor shall have no fiduciary duties to any Guaranteed Party. The Lead Investor shall be entitled to rely upon any notice, certificate,

or other document reasonably believed by it to be genuine. The Lead Investor shall not be liable for any action taken or omitted at the

direction of the Majority-in-Interest.

(c) Indemnification. The Guarantors

shall indemnify the Lead Investor (and any delegate thereof) from and against any losses, claims, damages, liabilities, and expenses (including

reasonable attorneys’ fees) incurred by the Lead Investor in connection with its duties under this Agreement, other than losses

arising from the Lead Investor’s own gross negligence or willful misconduct. To the extent such indemnification is unavailable as

a matter of law, the Guaranteed Parties shall, on a pro rata basis based on respective aggregate Guaranteed Obligations held, indemnify

the Lead Investor (and any delegate thereof) from and against any losses, claims, damages, liabilities, and expenses (including reasonable

attorneys’ fees) incurred by the Lead Investor in connection with its duties under this Agreement, other than losses arising from

the Lead Investor’s own gross negligence or willful misconduct; provided, however, that the maximum amount for which

each Guaranteed Party shall be liable pursuant to this provision shall equal its respective aggregate amounts of Liquidation Preferences

and Dividends payable to it from the Company.

(d) Resignation; Successor. The Lead

Investor may resign upon thirty (30) days’ prior written notice to the Guarantors and the Guaranteed Parties. Upon such resignation,

any delegation of its obligations and benefits shall automatically terminate, and a successor Lead Investor shall be appointed by the

Majority-in-Interest. If no successor Lead Investor has been appointed within forty-five (45) days after notice of resignation, the resigning

Lead Investor may petition a court of competent jurisdiction for the appointment of a successor.

(e) Conflicts of Interest. The Guaranteed

Parties acknowledge that the Lead Investor is itself a Guaranteed Party and may have interests that differ from those of other Guaranteed

Parties. The Lead Investor shall not be required to act in a manner contrary to its own interests in its capacity as a Guaranteed Party,

except as required by the provisions of this Agreement requiring action at the direction of the Majority-in-Interest.

11. Consent, Amendment, and Waiver Thresholds.

(a) Majority-in-Interest Actions.

The following actions may be taken by the Lead Investor only at the written direction of the Majority-in-Interest: (i) declaring

an Event of Default under Section 12 and accelerating the Guaranteed Obligations; (ii) directing enforcement of this Agreement

or realization on any collateral; (iii) entering into any non-material amendment or waiver of this Agreement; (iv) appointing

or removing a successor Lead Investor; and (v) consenting to any amendment, waiver, release, or modification of this Agreement if

the effect of such amendment, waiver, release, or modification is to: (A) release any Guarantor from all or substantially all of

the Guaranteed Obligations; (B) subordinate the Guaranteed Obligations to any other obligation of any Guarantor; (C) reduce

the amount or extend the time for payment of any Guaranteed Obligation; (D) release any material portion of the collateral securing

the Guaranteed Obligations; (E) amend the definition of “Majority-in-Interest”, “Guaranteed Obligations”,

Guaranteed Parties”; or (F) amend this Section 11 or the pro rata sharing provisions of Section 9.

(b) Equal Treatment. No amendment,

waiver, or consent hereunder shall differentiate among the Guaranteed Parties in any manner other than by reference to their respective

pro rata shares of the aggregate Guaranteed Obligations. Any side letter, private agreement, or other arrangement between any Guarantor

(or the Company) and any individual Guaranteed Party that would alter such Guaranteed Party’s rights under this Agreement shall

be void ab initio.

12. Events of Default and Acceleration.

(a) Events of Default. Each of the

following shall constitute an “Event of Default” under this Agreement:

(i)  the failure of the

Company to pay any Guaranteed Obligation when and as the same shall become due and payable under the Certificate of Designations;

(ii) the failure of any

Guarantor to pay any amount due under this Agreement following demand by the Lead Investor, which failure continues for five (5) Business

Days after the Lead Investor’s written demand; provided, however, that to the extent Digital Assets required to satisfy such amount

due are subject to delays in availability incurred pursuant to the Digital Asset Treasury Procedures, failure to pay such amount as soon

as such Digital Assets can be available;

(iii) any breach by any

Guarantor of any of its covenants under section 16(c) of this Agreement;

(iv) any breach by any

Guarantor of any of its representations, warranties, or covenants (other than a breach of its covenants under Section 16(c)) under

this Agreement that is not cured within ten (10) Business days after written notice from the Lead Investor;

(v) the commencement

of any voluntary or involuntary bankruptcy, insolvency, receivership, or similar proceeding by or against any Guarantor (with any involuntary

proceeding that remains undismissed for sixty (60) days constituting an Event of Default);

(vi) the dissolution,

liquidation, or termination of existence of any Guarantor other than as expressly permitted by this Agreement and the Certificate of Designations;

(vii) any Guarantor ceases

to be a wholly-owned direct or indirect subsidiary of the Company;

(viii) any Event of Default

(as defined in the Certificate of Designations or other Transaction Document) that is not cured within any applicable cure period;

(ix) the Digital Asset

Treasury is operated or maintained in a manner not in compliance with the Digital Asset Treasury Procedures;

(x) the occurrence of

any material adverse change in the financial condition, operations, or assets of a Guarantor that, in the reasonable determination of

the Lead Investor (acting at the direction of the Majority-in-Interest), materially impairs the ability of Guarantor to perform its obligations

hereunder;

(xi) [reserved];

(xii) any Guarantor amends

its organizational documents in a manner that adversely affects the Certificate of Designations or its obligations under this Agreement

or its performance thereof without the prior written consent of the Majority-in-Interest;

(xiii) a court of competent

jurisdiction determines, or any governmental authority asserts in a formal proceeding, that any Guarantor is not a separate legal entity

from the Company or that a Guarantor’s assets should be substantively consolidated with those of the Company;

(xiv) any Guarantor fails

to comply with a Repatriation request from the Lead Investor within the time period specified in Section 16(b)(xviii); or

(xv) (A) any non-US

Guarantor fails to maintain an agent for service of process in New York following a request by the Lead Investor or its designee, or (B) any

governmental authority in a non-US jurisdiction takes any action that would prevent or materially delay the enforcement of this Agreement

or the transfer of any asset in the Digital Asset Treasury.

(b) Acceleration. Upon the occurrence

and continuance of any Event of Default, the Lead Investor, at the direction of the Majority-in-Interest, may, by written notice to any

Guarantor, declare all Guaranteed Obligations to be immediately due and payable, whereupon such Guaranteed Obligations shall become immediately

due and payable without further demand or action of any kind, all of which are hereby waived by all Guarantors to the fullest extent permitted

by applicable law; provided, however, that upon the occurrence of an Event of Default described in clause (a)(v), (a)(vi), (a)(viii),

(a)(xii), (a)(xiii) or (a)(xv), all Guaranteed Obligations shall automatically become immediately due and payable without any further

notice or action of any kind.

13. Information and Reporting.

(a) Guarantor’s Duty to Stay Informed.

Each Guarantor assumes all responsibility for being and keeping itself informed of the Company’s financial condition and assets,

and of all other circumstances bearing upon the risk of nonpayment of the Guaranteed Obligations and the nature, scope and extent of the

risks that each such Guarantor assumes and incurs hereunder, and agrees that neither the Lead Investor nor any other Guaranteed Party

will have any duty to advise Guarantor of information known to it regarding such circumstances or risks.

(b) Periodic Reporting. Until all

Guaranteed Obligations are indefeasibly paid in full in cash and no shares of Convertible Preferred Stock remain outstanding, the Guarantors

shall cause to be delivered to the Lead Investor:

(i) promptly, and in

any event within two (2) Business Days, written notice of (A) the occurrence of any Event of Default or any event that with

the passage of time or giving of notice would constitute an Event of Default, (B) any decline in Collateral Value of twenty percent

(20%) or more from the most recently reported Collateral Value, or (C) any actual or threatened claim, action, or proceeding affecting

any Guarantor or any material portion of its assets; and

(ii) such other information

regarding each Guarantor, its assets, or its financial condition as the Lead Investor may reasonably request from time to time.

(c) Inspection Rights. Upon reasonable

prior notice, the Lead Investor (or its designated representatives) shall have the right to (i) inspect and copy the books, records,

and accounts of any or all Guarantors, (ii) verify the existence, location, and custody arrangements for all assets in the Digital

Asset Treasury, in accordance with the Digital Asset Treasury Procedures and (iii) meet with officers and representatives of any

Guarantor to discuss such Guarantor’s financial condition and operations.

(d) Monitoring. Guarantor shall provide

the Lead Investor continuous read-only access (via API, portal, or other electronic means) to view on a real time basis the balances and

transaction history of all accounts and wallets holding any portion of the Digital Asset Treasury, all in accordance with the Digital

Asset Treasury Procedures. Each Guarantor shall promptly execute any authorizations or instructions necessary to effect such access.

Notwithstanding any provision of this Agreement

to the contrary, all rights of any Guarantor under Section 8 and all other rights of indemnity, contribution or subrogation under

applicable law or otherwise shall be fully subordinated to the indefeasible payment in full in cash of the Guaranteed Obligations. No

failure on the part of the Company or any Guarantor to make the payments required under applicable law or otherwise shall in any respect

limit the obligations and liabilities of any Guarantor with respect to its obligations hereunder, and each Guarantor shall remain liable

for the full amount of the obligations of such Guarantor hereunder.

14. Termination. The guaranty made hereunder

(a) shall terminate when all the Guaranteed Obligations have been satisfied in full and no shares of the Convertible Preferred Stock

remain outstanding, and (b) shall continue to be effective or be reinstated, as the case may be, if at any time payment, or any part

thereof, of any Guaranteed Obligation is rescinded or must otherwise be restored by the Lead Investor or any Guaranteed Party or any Guarantor

upon the bankruptcy or reorganization of the Company, a Guarantor or otherwise. In connection with the foregoing, the Lead Investor at

the direction of the Majority-in-Interest shall execute and deliver to each Guarantor or Guarantor’s designee, at Guarantor’s

expense, any documents or instruments which such Guarantor shall reasonably request from time to time to evidence such termination and

release.

15. Binding Effect; Assignments; Automatic Benefit to Transferees.

(a) Whenever in this Agreement any of the

parties hereto is referred to, such reference shall be deemed to include the successors and assigns of such party; and all covenants,

promises and agreements by or on behalf of a Guarantor that are contained in this Agreement shall bind and inure to the benefit of each

party hereto and their respective successors and assigns. This Agreement shall become effective as to any Guarantor when a counterpart

hereof executed on behalf of such Guarantor shall have been delivered to the Lead Investor, and thereafter shall be binding upon such

Guarantor and the Lead Investor and their respective successors and assigns, and shall inure to the benefit of such Guarantor, the Lead

Investor, each Guaranteed Party, and their respective successors and assigns, except that no Guarantor shall have the right to assign

its rights or obligations hereunder or any interest herein (and any such attempted assignment shall be void ab initio) except with

the written consent of the Lead Investor at the direction of the Majority-in-Interest. For the avoidance of doubt, the Guaranteed Parties

are third party beneficiaries of this Guaranty and shall have direct rights of enforcement against each Guarantor.

(b) Automatic Benefit to Transferees.

The rights and benefits of this Agreement shall automatically run with the Convertible Preferred Stock. Any Person that becomes a registered

holder of Convertible Preferred Stock on the books and records of the Company or its transfer agent (as applicable) shall, by virtue of

such registration and without the need for any further action, joinder, or assignment, become a Guaranteed Party hereunder and shall be

bound by and entitled to the benefit of this Agreement on the same terms as the transferor Guaranteed Party. Each Guaranteed Party, and

each transferee of Convertible Preferred Stock, is deemed to have agreed, as a condition of holding Convertible Preferred Stock, to be

bound by the provisions of Sections 9 (Pro Rata Sharing), 10 (Lead Investor), and 11 (Consent Thresholds) of this Agreement. At any time,

without any notice to any Guarantor, the Lead Investor, acting at the direction of the Majority-in-Interest, may sell, assign, transfer,

negotiate, grant participations in, or otherwise dispose of all or any part of the Lead Investor’s rights or interests herein to

any Person. Each Guarantor hereby authorizes the Lead Investor to provide, without any notice to such Guarantor, any information concerning

such Guarantor, including information pertaining to such Guarantor’s financial condition, business operations or general creditworthiness,

to any Person which may succeed to or participate in all or any part of the Lead Investor’s interest herein.

16. Representations and Warranties; Covenants of Guarantor.

(a)  Each Guarantor, jointly and severally,

represents and warrants to the Lead Investor and each Guaranteed Party that:

(i) it is duly authorized

to execute and deliver this Agreement and to perform its obligations under this Agreement;

(ii) this Agreement has

been duly executed and delivered on behalf of Guarantor by its duly authorized representatives;

(iii) this Agreement

is legal, valid, binding and enforceable against such Guarantor in accordance with its terms except as enforceability may be limited by

bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and

by general equitable principles;

(iv) such Guarantor’s

execution, delivery and performance of this Agreement do not violate or constitute a breach of any of its organizational documents, any

material agreement or instrument to which such Guarantor is a party, or any law, order, regulation, decree or award of any Governmental

Authority or arbitral body to which it or its properties or operations is subject;

(v) such Guarantor has

been duly formed as a special-purpose entity solely for the purpose of holding all or a portion of the Digital Asset Treasury, and has

no other business operations, material liabilities, or material assets;

(vi) immediately following

the Capitalization, such Guarantor is Solvent, is not engaged in business for which it has unreasonably small capital, and does not intend

to incur, and does not believe it has incurred, debts beyond its ability to pay such debts as they mature;

(vii) a portion of the

Digital Asset Treasury has been or shall be duly contributed by the Company to such Guarantor, and is and will be held by such Guarantor

free and clear of all liens, pledges, encumbrances, and adverse claims, other than any security interest granted to the Lead Investor

for the benefit of the Guaranteed Parties;

(viii) such Guarantor

has received reasonably equivalent value, and fair consideration, for its execution and delivery of this Agreement, including, without

limitation, the Capitalization and the indirect benefits arising from the Company’s issuance of the Convertible Preferred Stock;

(ix) all Digital Assets

held by such Guarantor or the Company are maintained consistent with the Digital Asset Treasury Procedures;

(x) such Guarantor has

no subsidiaries and does not own any equity interests in any other Person; (xi) such Guarantor has no employees, and all services

to such Guarantor are provided by the Company or third parties pursuant to written agreements;

(xi) [reserved]

(xii) [reserved];

(xiii) since its formation,

such Guarantor has at all times (A) maintained its own separate books and records, bank accounts, and financial statements, (B) held

itself out as an entity separate from the Company and its other affiliates, (C) conducted its limited business in its own name, (D) observed

all organizational formalities, and (E) not commingled its assets with those of any other Person;

(xiv) there are no pending

or, to such Guarantor’s knowledge, threatened claims, actions, or proceedings against such Guarantor or any portion of its cash

or Digital Assets that could reasonably result in a material adverse effect thereon;

(xiv) such Guarantor

has no creditors other than trade creditors incurred in the ordinary course of business and the Lead Investor and the Guaranteed Parties;

(xv) Guarantor has adequate

capital to conduct its limited business operations and pay its debts as they become due; and

(xvi) with respect to

any Guarantor organized under the laws of a jurisdiction outside the United States, (A) the execution, delivery, and performance

of this Agreement by such Guarantor does not violate any law of its jurisdiction of organization or any other jurisdiction in which it

conducts business, (B) all governmental and regulatory approvals, consents, and filings required in its jurisdiction of organization

for such Guarantor to execute, deliver, and perform this Agreement have been obtained or made and are in full force and effect, (C) this

Agreement constitutes a legal, valid, and binding obligation of such Guarantor enforceable against it in its jurisdiction of organization,

(D) no portion of the Digital Asset Treasury held by such Guarantor are subject to any exchange control, capital control, or similar

restrictions that would prevent or delay the transfer of such assets to a Guarantor in the United States or to another Person in the United

States as the Lead Investor may otherwise direct consistent with the Digital Asset Treasury Procedures and (E) such Guarantor hereby

irrevocably submits to the exclusive jurisdiction of the courts of the State of New York and the United States District Court for the

Southern District of New York, and has waived any objection to such jurisdiction or venue for the sole purpose of the enforcement of this

Agreement and the resolution of any claims or disputes arising from, or otherwise connected with, this Agreement or any other Transaction

Document.

(b) Affirmative Covenants. Until all

Guaranteed Obligations are indefeasibly paid in full in cash and no shares of Convertible Preferred Stock remain outstanding, each Guarantor

shall:

(i) preserve and maintain

its corporate existence and its qualification to do business in each applicable jurisdiction;

(ii) maintain compliance

with all Digital Asset Treasury Procedures;

(iii) comply in all material

respects with applicable law and regulation, including without limitation applicable anti-money laundering, sanctions, and know-your-customer

laws and regulations;(iv) maintain its status as a special-purpose entity, including by (A) maintaining separate books, records,

and bank accounts from the Company and its other affiliates, (B) not commingling its assets with the assets of any other Person,

(C) conducting its business in its own name, (D) maintaining adequate capital for its business purposes, (E) holding itself

out as a separate entity, and (F) observing all organizational formalities;

(v) cause all contracts,

invoices, checks, and correspondence of Guarantor to be in such Guarantor’s own name and not use the name, stationery, or insignia

of the Company or any affiliate in a manner that could create the appearance that such Guarantor is a division or department of the Company;

(vi) allocate and pay

fairly and reasonably any overhead or shared expenses with the Company or any affiliate;

(vii) maintain arm’s

length relationships with the Company and all affiliates;

(viii) not guarantee

or become obligated for the debts of any other Person (other than pursuant to this Agreement) or hold out its credit as being available

to satisfy the obligations of any other Person;

(ix) not acquire (A) obligations

of the Company or any affiliate or (B) securities or assets of the Company or any affiliate except in accordance with the Digital

Asset Treasury Procedures;

(x) file its own tax

returns wherever required;

(xi) upon the written

request of the Lead Investor (acting at the direction of the Majority-in-Interest), transfer or cause to be transferred all assets included

in the Digital Asset Treasury then held by any non-US Guarantor to a Guarantor organized under the laws of the United States or any state

thereof within thirty (30) days of such request (a “Repatriation”), and such Guarantor shall cooperate fully

and take all actions necessary to effect such Repatriation, including obtaining any governmental approvals, executing any transfer documents,

and instructing any custodians to effect such transfers; and

(xii) with respect to

any Guarantor organized under the laws of a jurisdiction outside the United States, promptly notify the Guaranteed Parties of any change

in the laws of its jurisdiction of organization known to the Company or Guarantor that could materially adversely affect the enforceability

of this Agreement or the rights of the Guaranteed Parties hereunder.

Any action taken in violation

of this Section shall be null and void ab initio to the fullest extent permitted by applicable law.

(c) Negative Covenants. Without the

prior written consent of the Majority-in-Interest, no Guarantor shall:

(i) create, incur, assume,

or suffer to exist any indebtedness or guaranty, endorse, or become contingently liable for any indebtedness of any other Person, except

payables incurred in the ordinary course of business consistent with past practice and indebtedness under this Agreement;

(ii) grant, suffer, or

permit to exist any lien, pledge, encumbrance, or security interest on any of its assets (including any assets in the Digital Asset Treasury),

except any security interest granted to the Lead Investor for the benefit of the Guaranteed Parties;

(iii) unless determined

by the board of directors of the Company to be required to satisfy its fiduciary duties, make any dividend, distribution, loan, or advance

to the Company or any affiliate (including, without limitation, all payments, redemptions, repurchases, distributions or similar actions

in respect of any Guarantor’s equity interests), other than (A) distributions, if any, in accordance with the Digital Asset

Treasury Procedures and (B) payments of the Guaranteed Obligations in accordance with this Agreement;

(iv) engage in any business

or activity other than managing the Digital Asset Treasury in accordance with the Digital Asset Treasury Procedures, and performing its

obligations under this Agreement;

(v) consolidate, merge,

or dissolve, except as permitted by Section 9(b)(i)(3) of the Certificate of Designations or with the consent of the Majority-in-Interest;

(vi) unless determined

by the board of directors of the Company to be required to satisfy its fiduciary duties, sell, transfer, or otherwise dispose of any material

portion of the Digital Assets, or suffer Digital Assets to be held by any Person other than Guarantor, except (A) to pay or satisfy

Guaranteed Obligations, (B) in accordance with the Digital Asset Treasury Procedures, or (C) with the prior written consent

of the Majority-in-Interest;

(vii) issue, sell, or

grant any equity interests, membership interests, partnership interests, or other ownership interests in Guarantor to any Person;

(viii) amend, modify,

or waive any provision of its organizational documents in any manner that could adversely affect the rights of the Guaranteed Parties,

without the prior written consent of the Lead Investor;

(ix) enter into any transaction

with the Company or any affiliate except on arm’s length terms and in the ordinary course of Guarantor’s limited business

purpose;

(x) permit the occurrence

of a Treasury Value Event, as defined in the Certificate of Designations;

(xi) permit any officer,

director, manager, or member of the Company or any affiliate to take any action on behalf of any Guarantor with respect to any bankruptcy

or insolvency matter;

(xii) change the jurisdiction

of organization of any Guarantor, or redomicile any Guarantor, to a jurisdiction outside the United States;

(xiii) with respect to

any non-US Guarantor, (A)  amend its organizational documents to remove or limit the submission to US jurisdiction or the waiver

of objections to venue, or (B) take any action that would subject any assets in the Digital Asset Treasury to exchange controls,

capital controls, or similar restrictions in any non-US jurisdiction; or

(xiv) fail to comply

with a Repatriation request from the Lead Investor within the time period specified in Section 16(b)(xi).

(d) Digital Asset Treasury Procedures.

Without limiting the generality of the foregoing provisions of this Section 16, each Guarantor agrees to at all times comply with

the Digital Asset Treasury Procedures. For the avoidance of doubt, the Digital Asset Treasury Procedures are anticipated to include, without

limitation:

(i) custodial arrangements

for the Guarantors;

(ii) yield generating

strategies;

(iii) insurance applicable

to the Guarantors’ assets and business operations; and

(iv) the preservation

of the Digital Asset Treasury in a manner reasonably designed to avoid a Treasury Value Event.

(e)  No Waiver. No failure or delay

of the Lead Investor of any kind in exercising any power or right hereunder shall operate as a waiver thereof, nor shall any single or

partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude

any other or further exercise thereof or the exercise of any other right or power. The rights of the Lead Investor hereunder and under

the Certificate of Designations, SPA, Inducement Agreement or other Transaction Documents are cumulative and are not exclusive of

any rights or remedies that it would otherwise have. No waiver of any provision of this Agreement or consent to any departure by a Guarantor

therefrom shall in any event be effective unless the same shall be permitted by Section 11, and then such waiver and consent shall

be effective only in the specific instance and for the purpose for which given. No notice or demand on any Guarantor in any case shall

entitle such Guarantor to any other or further notice in similar or other circumstances. Neither this Agreement nor any provision hereof

may be waived, amended or modified except pursuant to a written agreement entered into between the Guarantors and the Lead Investor (acting

at the direction of the Majority-in-Interest, as required under Section 11).

(e) Closing Deliverables. As a condition

to the effectiveness of this Agreement, each Guarantor shall deliver or cause to be delivered to the Lead Investor or its designee, on

behalf of the Guaranteed Parties, the following:

(i) on or prior to the

Closing Date, an officer-certified copy of such Guarantor’s certificate of formation or certificate of incorporation, as applicable,

and all amendments thereto;

(ii) on or prior to the

Closing Date, an officer-certified copy of Guarantor’s limited liability company agreement or bylaws, as applicable;

(iii) on or prior to

the Closing Date, a certificate of good standing for each Guarantor from the Secretary of State of Delaware (or other applicable jurisdiction)

dated not more than ten (10) days prior to the Closing Date; provided, however, that any good standing certificate for BNBX Ltd.

may be obtained within ten (10) days after the Closing Date;

(iv) a certificate of

an officer of such Guarantor certifying: (A) within 10 Business Days following the Closing Date, (1) the names and true signatures

of the officers or managers authorized to sign this Agreement and the other documents to be delivered hereunder, and (2) that attached

thereto are true, correct, and complete copies of the resolutions adopted by the members or managers of such Guarantor authorizing the

execution, delivery, and performance of this Agreement and the transactions contemplated hereby, and (B) on or prior to the Closing

Date, that no event has occurred that would constitute an Event of Default or would, with the giving of notice or lapse of time, constitute

an Event of Default;

(v) within 10 Business

Days following the Closing Date, evidence satisfactory to the Lead Investor or its designee of the contribution of assets to the Digital

Asset Treasury; and

(vi) within 10 Business

Days following the Closing Date, such other documents, certificates, and information as the Lead Investor may reasonably request to confirm

the accuracy of the representations and warranties herein and the satisfaction of the conditions to the effectiveness of this Agreement.

17. Governing Law. THIS AGREEMENT SHALL BE CONSTRUED IN ACCORDANCE

WITH AND BE GOVERNED BY THE LAW (WITHOUT GIVING EFFECT TO THE CONFLICT-OF-LAW PRINCIPLES THEREOF) OF THE STATE OF NEW YORK.

18. Notices. All notices, requests and

other communications to any Guarantor or the Lead Investor hereunder shall be delivered in the manner required by the SPA and shall be

sufficiently given to the Lead Investor or such Guarantor if addressed or delivered to them at, in the case of the Lead Investor and the

Company, its addresses and email addresses specified in the SPA, and in the case of any Guarantor, at the address of the Company specified

in the SPA unless another address is provided. The Guarantors shall deliver any material notice to the Guaranteed Parties and the Lead

Investor.

19. Survival of Agreement; Severability.

(a)  All covenants, agreements, representations

and warranties made by each Guarantor herein and in the certificates or other instruments prepared or delivered in connection with or

pursuant to this Agreement or the other Transaction Documents shall be considered to have been relied upon by the Lead Investor and each

Guaranteed Party and shall survive the issuance of the Convertible Preferred Stock regardless of any investigation made by the Lead Investor

or any Guaranteed Party, and shall continue in full force and effect as long as any share of Convertible Preferred Stock remains outstanding

or any Guaranteed Obligation remains unpaid.

(b)  In the event one or more of the provisions

contained in this Agreement, the Certificate of Designations, SPA or other Transaction Documents should be held invalid, illegal or unenforceable

in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way

be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall

not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations

to replace the invalid, illegal or unenforceable provisions with valid provisions, the economic effect of which comes as close as possible

to that of the invalid, illegal or unenforceable provisions.

20. Counterparts. This Agreement may be

executed in counterparts, each of which shall constitute an original, but all of which when taken together shall constitute a single contract

(subject to Section 15-Binding Effect), and shall become effective as provided in Section 15. Delivery of an executed signature

page to this Agreement by facsimile transmission or in electronic “PDF” format shall be as effective as delivery of a

manually executed counterpart of this Agreement.

21. Jurisdiction; Consent to Service of Process.

(a)  Each Guarantor hereby irrevocably and

unconditionally submits, for itself and its property, to the exclusive jurisdiction of the United States District Court for the Southern

District of New York and of any New York state court sitting in the Borough of Manhattan, City of New York and any appellate court from

any thereof, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby or thereby,

or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all

claims in respect of any such action or proceeding may be heard and determined in such New York state court or, to the extent permitted

by applicable law, such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall

be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this

Agreement, the Certificate of Designations, SPA or any other Transaction Documents shall affect any right that the Lead Investor may otherwise

have to bring any action or proceeding relating to this Agreement, the Certificate of Designations, SPA or any other Transaction Documents

against Guarantor or its properties in the courts of any jurisdiction.

(b)  Each Guarantor irrevocably and unconditionally

waives any objection which it may now or hereafter have to the laying of venue of any such suit, action or proceeding described in paragraph

(a) of this Section and brought in any court referred to in paragraph (a) of this Section. Each of the parties hereto irrevocably

waives, to the fullest extent permitted by applicable law, the defense of an inconvenient forum to the maintenance of such action or proceeding

in any such court.

(c)  Each party to this Agreement irrevocably

consents to service of process in the manner provided for notices in Section 18. Nothing in this Agreement will affect the right

of any party to this Agreement to serve process in any other manner permitted by law.

22. WAIVER OF JURY TRIAL. EACH PARTY HERETO

IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING

DIRECTLY OR INDIRECTLY ARISING OUT OF THIS AGREEMENT, THE CERTIFICATE OF DESIGNATIONS, SPA OR ANY OTHER TRANSACTION DOCUMENT OR THE TRANSACTIONS

CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).

23. Right of Setoff; Beneficiaries. If

an Event of Default shall have occurred and be continuing, the Lead Investor and each Guaranteed Party are hereby authorized at any time

and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or

demand, provisional or final) at any time held and other indebtedness at any time owing by the Lead Investor or such Guaranteed Party

to or for the credit or the account of such Guarantor against any or all the obligations of such Guarantor now or hereafter existing under

this Agreement and the other Transaction Documents, irrespective of whether or not the Lead Investor or such Guaranteed Party shall have

made any demand under this Agreement or any other Transaction Document and although such obligations may be unmatured; provided that any

amount set off or applied hereunder shall be subject to the pro rata sharing requirements of Section 9. The rights of the Lead Investor

and the Guaranteed Parties under this Section 23 are in addition to other rights and remedies (including other rights of setoff)

which the Lead Investor or such Guaranteed Party may have.

24. Savings Clause.

(a)  It is the intent of each Guarantor and

the Lead Investor (and each Guaranteed Party) that such Guarantor’s maximum obligations hereunder shall be, but not in excess of:

(i)  in a case or proceeding

commenced by or against a Guarantor under the provisions of Title 11 of the United States Code, 11 U.S.C. §§101 et seq. (the

“Bankruptcy Code”) on or within one year from the date on which any of the Guaranteed Obligations are incurred,

the maximum amount which would not otherwise cause the Guaranteed Obligations (or any other obligations of Guarantor owed to the Lead

Investor or any Guaranteed Party) to be avoidable or unenforceable against Guarantor under (i) Section 548 of the Bankruptcy

Code or (ii) any state fraudulent transfer or fraudulent conveyance act or statute applied in such case or proceeding by virtue of

Section 544 of the Bankruptcy Code; or

(ii) in a case or proceeding

commenced by or against a Guarantor under the Bankruptcy Code subsequent to one year from the date on which any of the Guaranteed Obligations

are incurred, the maximum amount which would not otherwise cause the Guaranteed Obligations (or any other obligations of Guarantor to

the Lead Investor or any Guaranteed Party) to be avoidable or unenforceable against such Guarantor under any state fraudulent transfer

or fraudulent conveyance act or statute applied in any such case or proceeding by virtue of Section 544 of the Bankruptcy Code; or

(iii) in a case or proceeding

commenced by or against a Guarantor under any law, statute or regulation other than the Bankruptcy Code (including, without limitation,

any other bankruptcy, reorganization, arrangement, moratorium, readjustment of debt, dissolution, liquidation or similar debtor relief

laws), the maximum amount which would not otherwise cause the Guaranteed Obligations (or any other obligations of such Guarantor to the

Lead Investor or any Guaranteed Party) to be avoidable or unenforceable against such Guarantor under such law, statute or regulation including,

without limitation, any state fraudulent transfer or fraudulent conveyance act or statute applied in any such case or proceeding.

(b)  The substantive laws under which the

possible avoidance or unenforceability of the Guaranteed Obligations (or any other obligations of a Guarantor to the Lead Investor or

any Guaranteed Party) as may be determined in any case or proceeding shall hereinafter be referred to as the “Avoidance Provisions”.

To the extent set forth in Section 24(a) (i), (ii), and (iii), but only to the extent that the Guaranteed Obligations would

otherwise be subject to avoidance or found unenforceable under the Avoidance Provisions, if such Guarantor is not deemed to have received

valuable consideration, fair value or reasonably equivalent value for the Guaranteed Obligations, or if the Guaranteed Obligations would

render such Guarantor insolvent, or leave such Guarantor with an unreasonably small capital to conduct its business, or cause such Guarantor

to have incurred debts (or to have intended to have incurred debts) beyond its ability to pay such debts as they mature, in each case

as of the time any of the Guaranteed Obligations are deemed to have been incurred under the Avoidance Provisions and after giving effect

to the contribution by such Guarantor, the maximum Guaranteed Obligations for which such Guarantor shall be liable hereunder shall be

reduced to that amount which, after giving effect thereto, would not cause the Guaranteed Obligations (or any other obligations of such

Guarantor to the Lead Investor or any Guaranteed Party), as so reduced, to be subject to avoidance or unenforceability under the Avoidance

Provisions.

(c)  This Section 24 is intended solely

to preserve the rights of the Lead Investor and the Guaranteed Parties hereunder to the maximum extent that would not cause the Guaranteed

Obligations of any Guarantor to be subject to avoidance or unenforceability under the Avoidance Provisions, and neither any Guarantor

nor any other Person shall have any right or claim under this Section 24 as against the Lead Investor or any Guaranteed Party that

would not otherwise be available to such Person under the Avoidance Provisions.

25. Additional Guarantors.

(a) Each Guarantor shall use best efforts

to cause each existing and future direct or indirect Subsidiary of the Company that is not a Guarantor hereunder that owns, holds or controls

any assets comprising part of the Digital Asset Treasury to execute and deliver to the Lead Investor on behalf of the Guaranteed Parties

a joinder agreement substantially in the form attached hereto as Exhibit A (a “Guarantor Joinder”),

pursuant to which such Subsidiary shall become a Guarantor hereunder.

(b) Such joinder shall be executed and delivered

no later than five (5) Business Days following the earliest of (i) the transfer by the Company of assets comprising part of

the Digital Asset Treasury to a Subsidiary not already a Guarantor under this Agreement, whether such Subsidiary is formed or acquired

and (ii) upon the acquisition by the Company of a Subsidiary that has assets that would comprise part of the Digital Asset Treasury;

(c) Upon execution and delivery of a Guarantor

Joinder, such Subsidiary shall automatically constitute a Guarantor for all purposes under this Agreement and the other Transaction Documents

and shall be jointly and severally liable for the Guaranteed Obligations.

(d) The failure of any required Subsidiary

to become a Guarantor in accordance with this Section 25 shall constitute an Event of Default.

[SIGNATURES PAGES FOLLOW]

IN WITNESS WHEREOF, the parties

hereto have duly executed this Agreement as of the day and year first above written.

GUARANTOR:

BUILD & BUILD LLC, a Delaware limited liability company

BNB PLUS CORP., its sole Member

By:

Name:

Title:

[SIGNATURE PAGES CONTINUE]

IN WITNESS WHEREOF, the parties

hereto have duly executed this Agreement as of the day and year first above written.

GUARANTOR:

BNBX Ltd., a British Virgin Islands business corporation

By:

Name:

Title:

[SIGNATURE PAGES CONTINUE]

ACCEPTED AND ACKNOWLEDGED:

LEAD INVESTOR:

KGPLA HOLDINGS LLC

By:

Name:

Title:

[SIGNATURE PAGES CONTINUE]

ACCEPTED AND ACKNOWLEDGED:

GUARANTEED PARTY:

Name of Party:

By:

Name:

Title:

[SIGNATURE PAGES CONTINUE]

Exhibit A

GUARANTOR JOINDER AGREEMENT

Reference is hereby made to

the Guaranty Agreement (the “Guaranty Agreement”), by BNBX Ltd., a British Virgin Islands business corporation

and Build & Build LLC, a Delaware limited liability company, both wholly-owned subsidiaries of BNB Plus Corp., a Delaware corporation

(the “Company”) (each of which is referred to as a “Guarantor”, and collectively with

any additional Guarantors added pursuant to Section 25 of the Guaranty Agreement, the “Guarantors”), in

favor of the Lead Investor (as defined the Guaranty Agreement), in connection with that certain Securities Purchase Agreement (the “SPA”),

dated as of May 26, 2026, and the Warrant Inducement Agreement (the “Inducement Agreement”), dated of May 26,

2026. Pursuant to and in accordance with Section 25 of the Guaranty Agreement, the undersigned hereby acknowledges that it has received

and reviewed a complete copy of the Guaranty Agreement. By its execution hereof, the undersigned agrees to become a party to and to be

fully bound by, and subject to, all of the covenants, terms, and conditions of the Guaranty Agreement as if it were an original signatory

thereto as a Guarantor. Upon the satisfaction of the conditions set forth in Section 25 of the Guaranty Agreement, the undersigned

shall be admitted as a Guarantor.

Capitalized terms used herein without definition

shall have the meanings ascribed thereto in the Guaranty Agreement.

IN WITNESS WHEREOF, the undersigned

has executed this Joinder Agreement as of ___________, ______.

[ADDITIONAL GUARANTOR NAME]

[By:]

[Name:]

[Title:]

Address:

[Agreed to and accepted this ___ day of ___________, ______:

[LEAD INVESTOR NAME]

By: [GENERAL PARTNER NAME], as General Partner

By:

Name:

Title:

EX-10.4 — EXHIBIT 10.4

EX-10.4

Filename: tm2615620d1_ex10-4.htm · Sequence: 11

Exhibit 10.4

REGISTRATION RIGHTS AGREEMENT

This Registration Rights

Agreement (this “Agreement”) is made and entered into as of May 26, 2026, between BNB Plus Corp., a Delaware corporation

(the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser”

and, collectively, the “Purchasers”).

This Agreement is made pursuant

to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser a party thereto (the “Purchase

Agreement”) and the Warrant Inducement Exchange Agreement, dated as of the date hereof, between the Company and each Purchaser

a party thereto (the “Inducement Agreement”). The Purchase Agreement and Inducement Agreement are sometimes referred

to herein as the “Transaction Agreements”.

The Company and each Purchaser

hereby agrees as follows:

1. Definitions.

Capitalized terms used and not otherwise

defined herein that are defined in Transaction Agreements shall have the meanings given such terms in the Transaction Agreement respective

to each Purchaser and as dictated by context. As used in this Agreement, the following terms shall have the following meanings:

“Advice”

shall have the meaning set forth in Section 6(c).

“Conversion

Shares” means the shares of Common Stock issuable upon the conversion of the Preferred Stock and the shares of Common Stock

issuable upon conversion of the Prefunded Warrant Shares.

“Common

Warrants” means, collectively, the Series F Common Stock Purchase Warrants delivered to the Purchasers pursuant to the

terms of the Purchase Agreement.

“Common

Warrant Shares” means the shares of Common Stock issuable upon exercise of the Common Warrants.

“Effectiveness

Date” means, with respect to the Initial Registration Statement required to be filed hereunder, the 60th calendar

day following the date hereof (or, in the event of a “full review” by the Commission, the 90th calendar day following

the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or

Section 3(c), the 60th calendar day following the date on which an additional Registration Statement is required to be

filed hereunder (or, in the event of a “full review” by the Commission, the 90th calendar day following the date

such additional Registration Statement is required to be filed hereunder); provided, however, that in the event the Company

is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further

review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which

the Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls

on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.

“Effectiveness

Period” shall have the meaning set forth in Section 2(a).

“Event”

shall have the meaning set forth in Section 2(d).

“Event

Date” shall have the meaning set forth in Section 2(d).

“Filing

Date” means, with respect to the Initial Registration Statement required hereunder, the 30th calendar day following

the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or

Section 3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration

Statement related to the Registrable Securities.

“Holder”

or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

“Indemnified

Party” shall have the meaning set forth in Section 5(c).

“Indemnifying

Party” shall have the meaning set forth in Section 5(c).

“Initial

Registration Statement” means the initial Registration Statement filed pursuant to this Agreement.

“Losses”

shall have the meaning set forth in Section 5(a).

“Plan

of Distribution” shall have the meaning set forth in Section 2(a).

“Preferred

Stock” means the Series B-1 Preferred Stock delivered to the Purchasers pursuant to the Transaction Agreements and the

Series B-2 Preferred Stock delivered to the Purchasers pursuant to the Inducement Agreement.

“Prefunded

Warrants” means, collectively, the Series B-1 Prefunded Preferred Stock Purchase Warrants delivered to the Purchasers pursuant

to the Transaction Agreements and the Series B-2 Prefunded Preferred Stock Purchase Warrants delivered to the Purchasers pursuant

to the Inducement Agreement.

“Prefunded

Warrant Shares” means the shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock issuable upon exercise

of the Prefunded Warrants.

“Prospectus”

means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously

omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission

pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of

any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,

including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

“Registrable

Securities” means, as of any date of determination, (a) all Conversion Shares then issued and issuable upon exercise of

Preferred Stock (assuming on such date the Prefunded Warrants are exercised in full without regard to any exercise limitations therein),

(b) all Common Warrant Shares then issued and issuable upon exercise of the Common Warrants (assuming on such date the Common Warrants

are exercised in full without regard to any exercise limitations therein) and (c) any securities issued or then issuable upon any

stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; provided, however,

that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness

of any, or file another, Registration Statement hereunder with respect thereto) (1) during the Effectiveness Period for so long as

(a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under

the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration

Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities

become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144

as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders

(assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which,

such securities were issued or are issuable, were at no time held by any Affiliate of the Company, and all Common Warrants are exercised

by “cashless exercise” as provided in Section 2(c) of each of the Common Warrants), as reasonably determined by

the Company, upon the advice of counsel to the Company, and (2) upon the termination of the Effectiveness Period.

“Registration

Statement” means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional

registration statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments

and supplements to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto,

and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement.

2

“Rule 415”

means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from

time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect

as such Rule.

“Rule 424”

means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from

time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect

as such Rule.

“Selling

Stockholder Questionnaire” shall have the meaning set forth in Section 3(a).

“SEC Guidance”

means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the

Commission staff and (ii) the Securities Act.

2. Shelf Registration.

(a)            On

or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all

of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous

basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then

eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate

form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least

51% in interest of the Holders) substantially the “Plan of Distribution” attached hereto as Annex A and substantially

the “Selling Stockholder” section attached hereto as Annex B; provided, however, that no Holder

shall be required to be named as an “underwriter” without such Holder's express prior written consent. Subject to the terms

of this Agreement, the Company shall use commercially reasonable efforts to cause a Registration Statement filed under this Agreement

(including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after

the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration

Statement continuously effective under the Securities Act until the earliest of the date that all Registrable Securities covered by such

Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale

restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information

requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed

and acceptable to the Transfer Agent and the affected Holders, or (iii) the two year anniversary of the Closing of the respective

Transaction Agreements (the “Effectiveness Period”). The Company shall telephonically request effectiveness of a Registration

Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via e-mail of the

effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission,

which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City

time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required

by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure to

file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).

(b)            Notwithstanding

the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities

cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement,

the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the

Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered

by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering,

subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the

provisions of Section 2(d) with respect to the payment of liquidated damages; provided, however, that prior to

filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of

all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation

612.09.

3

(c)            Notwithstanding

any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission

or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration

Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the

registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable

Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:

a.              First,

the Company shall reduce or eliminate any securities to be included other than Registrable Securities;

b.             Second,

the Company shall reduce Registrable Securities represented by Common Warrant Shares (applied, in the case that some Common Warrant Shares

may be registered, to the Holders on a pro rata basis based on the total number of unregistered Common Warrant Shares held by such Holders);

c.              Third,

the Company shall reduce Registrable Securities represented by Prefunded Warrant Shares (applied, in the case that some Prefunded Warrant

Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered shares of Common Stock issuable

upon conversion of Prefunded Warrant Shares held by such Holders); and

d.              Fourth,

the Company shall reduce Registrable Securities represented by shares of Common Stock issuable upon conversion of Preferred Stock (applied,

in the case that some shares of Common Stock issuable upon conversion of Preferred Stock may be registered, to the Holders on a pro rata

basis based on the total number of unregistered shares of Common Stock issuable upon conversion of Preferred Stock held by such Holders).

In the event of a cutback hereunder,

the Company shall give the Holder at least three (3) Trading Days prior written notice along with the calculations as to such Holder's

allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its

best efforts to file with the Commission, as promptly as allowed by the Commission or SEC Guidance provided to the Company or to registrants

of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those

Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.

(d)            If:

(i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration

Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein

or the Company subsequent withdraws the filing of the Registration Statement, the Company shall be deemed to have not satisfied this clause

(i) as of the Filing Date), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration

Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the

date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will

not be “reviewed” or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement,

the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of

such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that such

amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering

for resale all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration

Statement (provided that, if the Registration Statement does not allow for the resale of Registrable Securities at prevailing market prices

(i.e., only allows for fixed price sales), the Company shall have been deemed to have not satisfied this clause) or (v) after the

effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all

Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein

to resell such Registrable Securities, for more than fifteen (15) consecutive calendar days or more than an aggregate of twenty (20) calendar

days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an “Event”,

and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which

such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day

period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable,

is exceeded being referred to as “Event Date”), then, in addition to any other rights the Holders may have hereunder

or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall

not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial

liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate Subscription Amount paid by such Holder.

The parties agree that the maximum aggregate liquidated damages payable to a Holder shall be 6% of the aggregate Subscription Amount.

If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable,

the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable

law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon,

are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of

a month prior to the cure of an Event.

4

(e)            If

Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register

the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on

Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement

then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective

by the Commission.

(f)             Notwithstanding

anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any

“underwriter” without the prior written consent of such Holder.

3.            Registration

Procedures.

In connection with the Company's

registration obligations hereunder, the Company shall:

(a)            Not

less than two (2) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior

to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed

to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be

filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such

Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries

as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the

meaning of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements

thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in writing in good faith, provided that,

the Company is notified of such objection in writing no later than one (1) Trading Day after the Holders have been so furnished copies

of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments

or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement

as Annex C (a “Selling Stockholder Questionnaire”) on a date that is not less than two (2) Trading Days

prior to the Filing Date or by the end of the fourth (4th) Trading Day following the date on which such Holder receives draft

materials in accordance with this Section.

(b)            (i) Prepare

and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used

in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities

for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for

resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented

by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant

to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a

Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies

of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information

contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply

in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of

all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this

Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in

such Prospectus as so supplemented.

5

(c)            If

during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock

then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the

applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable

Securities.

(d)            Notify

the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied

by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible

(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person)

confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus

supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the

Company whether there will be a “review” of such Registration Statement and whenever the Commission comments in writing on

such Registration Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has

become effective, (ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements

to a Registration Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal

or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the

Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification

with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any

jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage

of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made

in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any

material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration

Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material

fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,

not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the Company that the

Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow

continued availability of a Registration Statement or Prospectus; provided, however, that in no event shall any such notice

contain any information which would constitute material, non-public information regarding the Company or any of its Subsidiaries, and

the Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of its Subsidiaries and shall not

have any duty to the Company or any of its Subsidiaries not to trade on the basis of such information, provided that the Holders shall

remain subject to applicable law.

(e)            Use

its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness

of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable

Securities for sale in any jurisdiction, at the earliest practicable moment.

(f)            Furnish

to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including

financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested

by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)

promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or

successor thereto) need not be furnished in physical form.

6

(g)            Subject

to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by

each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any

amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).

(h)            Prior

to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with

the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of such

Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States

as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the

Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of

the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally

to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction

where it is not then so subject or file a general consent to service of process in any such jurisdiction.

(i)            If

requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable

Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted

by the Transaction Agreements, as applicable, of all restrictive legends, and to enable such Registrable Securities to be in such denominations

and registered in such names as any such Holder may request.

(j)            Upon

the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into

account the Company's good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure

of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to

the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document

so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material

fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances

under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of

Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then

the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be

resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j) to suspend

the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant

to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.

(k)            Otherwise

use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act

and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any

supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in

writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as

a result thereof, the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take

such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.

(l)            The

Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration

of the resale of Registrable Securities.

(m)            The

Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially

owned by such Holder (including shares of Common Stock underlying Preferred Stock, Prefunded Warrants, and Common Warrants) and, if required

by the Commission, the natural persons thereof that have voting and dispositive control over the shares. During any periods that the Company

is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities solely because any Holder fails

to furnish such information within three (3) Trading Days of the Company's written request (which request shall specify in reasonable

detail the information required), any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any

Event that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered

to the Company; provided that the Company shall have made reasonable prior attempts to obtain such information from such Holder before

any such tolling shall apply.

7

4.            Registration

Expenses. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by

the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to

in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,

fees and expenses of the Company's counsel and independent registered public accountants) (A) with respect to filings made with the

Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for

trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including,

without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the

Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable

Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities

Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the

Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible

for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including,

without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any

annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange

as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to

the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.

5. Indemnification.

(a)            Indemnification

by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the

officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a

result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons

with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each

of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the

Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally

equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person,

to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,

without limitation, reasonable attorneys' fees) and expenses (collectively, “Losses”), as incurred, arising out of

or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus

or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to

any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the

case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any

violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or

regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the

extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing

to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder's

proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly

for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has

approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi),

the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing

that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of

the Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of

any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such

indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall

survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(f).

8

(b)            Indemnification

by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents

and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of

the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable

law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement

of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary

prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary

to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were

made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information

so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii) to

the extent, but only to the extent, that such information relates to such Holder's information provided in the Selling Stockholder Questionnaire

or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly

for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus

or in any amendment or supplement thereto.

(c)            Conduct

of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder

(an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the

“Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including

the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection

with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party

of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a

court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially

and adversely prejudiced the Indemnifying Party.

An Indemnified

Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and

expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed

in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding

and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such

Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified

Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified

Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to

employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense

thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).

The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent

shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,

effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes

an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

Subject to the

terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent

incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall

be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that

the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions

for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal

or further review) not to be entitled to indemnification hereunder.

9

(d)            Contribution.

If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified

Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party,

in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with

the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative

fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in

question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has

been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties' relative

intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or

payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable

attorneys' or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been

indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance

with its terms.

The parties hereto

agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation

or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding

paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount

of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of

any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged

omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.

The indemnity and

contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the

Indemnified Parties.

6.            Miscellaneous.

(a)            Remedies.

In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the

Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery

of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that

monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions

of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall

not assert or shall waive the defense that a remedy at law would be adequate.

(b)            Limited

Piggyback on Registrations. Neither the Company nor any of its security holders (other than the Holders in such capacity pursuant

hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities.

(c)            Discontinued

Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the

occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition

of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”) by the

Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its

best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges

that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject

to the provisions of Section 2(d).

10

(d)            Amendments

and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,

and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the

Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes

any Registrable Securities issuable upon exercise or conversion of any security), provided that, if any amendment, modification or waiver

disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group

of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or

amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall

be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted

from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect

to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights

of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates;

provided, however, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance

with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any Person to amend

or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the

parties to this Agreement.

(e)            Notices.

Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth

in the Transaction Agreements, as applicable.

(f)            Successors

and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the

parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder

without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective

rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement and Section titled

“Successors and Assigns” in the Inducement Agreement, respectively.

(g)            No

Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company

or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would

have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except

as set forth on Schedule 6(g), neither the Company nor any of its Subsidiaries has previously entered into any agreement granting

any registration rights with respect to any of its securities to any Person that have not been satisfied in full.

(h)            Execution

and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered

one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,

it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery

of a “.pdf” format data file or any electronic signature complying with the U.S. federal ESIGN Act of 2000 (e.g., www.docusign.com),

such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with

the same force and effect as if such “.pdf” signature page were an original thereof.

(i)            Governing

Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in

accordance with the provisions of the Transaction Agreements, as applicable.

(j)            Cumulative

Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

11

(k)            Severability.

If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,

void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force

and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts

to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,

covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining

terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

(l)            Headings.

The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or

affect any of the provisions hereof.

(m)            Independent

Nature of Holders' Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the obligations

of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder

hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder

pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind

of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to

such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders

are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.

Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,

and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of

a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or

decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by

any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder,

solely, and not between the Company and the Holders collectively and not between and among Holders.

********************

(Signature Pages Follow)

12

IN WITNESS WHEREOF, the parties

have executed this Registration Rights Agreement as of the date first written above.

BNB PLUS CORP.

By:

Name:

Title:

[SIGNATURE PAGE OF HOLDERS FOLLOWS]

[SIGNATURE

PAGE OF HOLDERS TO BNBX RRA]

Name of Holder: __________________________

Signature of Authorized Signatory of Holder: __________________________

Name of Authorized Signatory: _________________________

Title of Authorized Signatory: __________________________

[SIGNATURE PAGES CONTINUE]

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: tm2615620d1_ex99-1.htm · Sequence: 12

Exhibit 99.1

BNB Plus Corp. (BNBX) Secures Initial

Commitments for $4.1M in Strategic Financing

Silvermine Capital

Leads New and Existing Investor Group in Partnership with GlobalStake to Support Strategic Review of Digital Asset and Biotechnology

Businesses

Additional Commitments

Expected with the Company Targeting $5m in Total Proceeds

NEW YORK - BNB

Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced it has secured initial commitments for $4.1M

of convertible preferred stock financing, with additional commitments anticipated to bring total proceeds to $5.0 million (the "Financing").

Proceeds from the Financing will be used to bolster the Company’s digital asset treasury and will provide working capital in support

of a comprehensive strategic review. With the anticipated proceeds, the Company expects to hold over $16.4M in cash and digital assets,

as valued on May 23, 2026.

Investors in the

Financing include Comstock Multichain Fund, an investment vehicle managed by Silvermine Capital Advisors, LLC (“Silvermine”),

and other new and existing digital-asset-native institutional investors that specialize in the monetization of undervalued assets, including

Off the Chain, LP. In conjunction with the Financing, the Company will enter into an advisory arrangement

with GlobalStake Infrastructure, LLC ("GlobalStake"), a SOC 2 Type II certified Web3 infrastructure company, which will

lead the strategic review of the Company's business, assets, and capital structure. GlobalStake currently operates cutting-edge bare

metal infrastructure in tier 4 and 5 data centers across the globe.

"This financing

marks a deliberate step forward for BNBX and reflects investor confidence in our operational trajectory and the distinct value proposition

of our business," said Clay Shorrock, Chief Executive Officer of BNB Plus. “With a reduced cost structure and our LineaRx

subsidiary (therapeutic DNA production services segment) recently achieving profitability in Q2

FY2026, we believe we have the operational foundation and now the capital resources to pursue a comprehensive strategic review

focused on maximizing shareholder value.”

Strategic Review

Objectives

The strategic review

will prioritize evaluating two potential primary value creation pathways:

· Digital

Asset and Related Infrastructure Opportunities: The review will propose a path to unlock

strategic opportunities in digital asset and AI infrastructure, including institutional yield

generation and the intersection of agentic AI with digital asset payment mechanisms.

· Monetization

of LineaRx, Inc. (LRx): The Company’s biotech

subsidiary, LRx, will undergo a structured assessment to identify potential monetization

opportunities, which may include partnerships, licensing arrangements, asset sales,

or other transactions designed to realize value for shareholders.

The

review will be led by Richard Shorten, Founder of Silvermine and Chairman of GlobalStake. Mr. Shorten brings more than 30 years of experience

across institutional finance, corporate law, and emerging technology. Mr. Shorten has served on multiple public company boards and has

an established record as a turnaround operator across telecom, media, and digital asset sectors. Shorten noted “As crypto markets

rapidly evolve, digital asset treasury companies require increasingly sophisticated strategies to deliver shareholder value. I look forward

to working closely with management and the Board to architect a path to realize the Company’s full potential in this dynamic industry.”

Transaction

Summary

The Financing consists

of two series of convertible preferred stock, both senior to common stock and convertible into common shares on a 1-for-1 basis, with

obligations guaranteed by the Company's digital asset treasury subsidiaries. The Series B-1 Preferred Stock (or pre-funded B-1 Preferred

Stock purchase warrants in-lieu thereof) is priced at $1.05 per share (representing a 176% premium over the closing price of the Company’s

common stock on May 22, 2026), carries an 8.0% annual dividend and a 1.5x liquidation preference, and will be issued to new investors

and to existing investors who exercise certain outstanding warrants for cash.

The Series B-2

Preferred Stock (or pre-funded B-2 Preferred Stock purchase warrants in-lieu thereof) is priced at $0.38 per share, carries a 6.0% annual

dividend and a 1.0x liquidation preference, and will be issued to existing investors who exchange their existing common stock, common

stock issued upon exercise of existing warrants, and certain pre-funded warrants. Certain existing investors may also elect to receive

transferable rights to exchange common stock for Series B-2 Preferred Stock on a 1-for-1 basis with respect to shares issuable upon exercise

of existing warrants not otherwise exchanged in the Financing.

For the first two

years following closing, the Company has the option to satisfy dividend obligations of the preferred stock by accreting the dividend

amount into the principal value of each series rather than paying in cash, providing the Company with near-term financial flexibility

as it executes its strategic review.

In connection with

the Financing, investors in the Series B-1 Preferred Stock will receive warrants to purchase additional shares of the Company's common

stock, with coverage equal to 100% of the shares and/or prefunded warrants underlying their preferred investment, at an exercise price

equal to $0.76, and exercisable over a three-year period. Additional details regarding the terms of the Financing will be disclosed in

a Current Report on Form 8-K filed with the SEC.

Securities Disclaimer

The Financing is

being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended

(the "Securities Act"), and/or Regulation D promulgated thereunder, and applicable state securities laws. Accordingly, the

securities offered in the private placement may not be offered or sold in the United States except pursuant to an effective registration

statement or an applicable exemption from the registration requirement of the Securities Act and such applicable state securities laws.

This press release

shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities

in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification

under the securities laws of any such state or other jurisdiction.

About BNB Plus

Corp.

BNB Plus unlocks

streamlined access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of

blockchain through a transparent, actively managed BNB treasury. The Company's differentiated strategy blends sophisticated DeFi yield

generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded

from the space. Formerly Applied DNA Sciences, Inc., BNB Plus continues to commercialize the Company's proprietary nucleic acid production

solutions for the biopharmaceutical and diagnostics markets. For more information, visit www.bnb.plus/.

About Silvermine

Capital Advisors, LLC

Silvermine Capital

Advisors, LLC brings more than 20 years of investment experience across technology and digital assets, with over $500 million deployed

across its transactions. Since 2019, the firm has focused almost exclusively on digital asset infrastructure and early-stage innovation,

with a particular emphasis on interoperability and decentralized finance.

About

GlobalStake

GlobalStake

is a SOC 2 Type II certified Web3 infrastructure company that provides validator operations, yield generation, and strategic advisory

services to protocol foundations, institutional investors, custodians, and exchanges. GlobalStake operates sovereign bare-metal infrastructure

across major blockchain networks and is a trusted staking yield partner to many of the world's leading custodians, exchanges, and wallet

providers. For more information, visit www.globalstake.io.

Forward Looking

Statements

This press release

includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the

Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as

"believe," "continues," "focus," "intend," "may," "will," and other words

of similar meaning. Forward-looking statements are statements other than historical facts and address various matters including, without

limitation, expectations regarding the Company's strategic review process, statements relating to the anticipated benefits and timing

of the completion of the proposed offering and related transactions, the intended use of proceeds from the offering, the entry into or

completion of any strategic alternative transaction and the ability to maximize shareholder value, as well as other projections or statements

of plans and objectives.

These forward-looking

statements are based on current expectations, estimates, assumptions, and projections, and involve known and unknown risks, uncertainties,

and other factors, many of which are beyond the Company's control, that may cause actual results, performance, or achievements to differ

materially from those expressed or implied by such statements. Each forward-looking statement contained in this press release is subject

to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable

risks and uncertainties include, among others, the risk that the proposed transaction described herein may not be completed in a timely

manner or at all, risks related to the review of strategic alternatives, including the ability to identify or consummate a suitable strategic

alternative, the Company's ability to regain compliance with the Nasdaq listing requirements, including without limitation, the minimum

closing bid price requirement for its common stock, the Company's ability to maintain its listing of securities on Nasdaq, failure to

realize the anticipated benefits of its digital asset treasury strategy; changes in business, market, financial, political and regulatory

conditions, risks relating to the Company's operations and business, including the highly volatile nature of the price of BNB and other

cryptocurrencies, the illiquidity of the OBNB trust units owned by the Company, risks related to the Company's ability to raise and deploy

capital effectively, risks relating to an unproven yield generation strategy, the risk that the price of the Company's common stock may

be highly correlated to the price of the digital assets that it holds, risks related to a determination that the Company's digital assets

are classified as a "security" under federal securities laws and/or the Company is inadvertently deemed an "investment

company" under the Investment Company Act of 1940, as amended, risks related to increased competition in the industries in which

the Company does and will operate, risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital

assets generally, risks relating to the treatment of crypto assets for U.S. and foreign tax purposes, risks related to the unknown returns,

liquidity and/or token accumulation that the Company's BNB treasury strategy will generate, risks relating to market volatility, cybersecurity

and custody of digital assets, potential changes in laws or accounting standards relating to cryptocurrency, and regulatory developments

affecting BNB or other digital assets, as well as those risks and uncertainties identified in the Company's filings with the Securities

and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company

undertakes no obligation to update or revise any of these statements.

Investor Relations contact:

John Ragozzino Jr., CFA

BnB@icrinc.com

GRAPHIC

GRAPHIC

Filename: tm2615620d1_ex3-1img001.jpg · Sequence: 16

Binary file (4924 bytes)

Download tm2615620d1_ex3-1img001.jpg

GRAPHIC

GRAPHIC

Filename: tm2615620d1_ex3-1img002.jpg · Sequence: 17

Binary file (7210 bytes)

Download tm2615620d1_ex3-1img002.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 19

v3.26.1

Cover

May 26, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

May 26, 2026

Current Fiscal Year End Date

--09-30

Entity File Number

001-36745

Entity Registrant Name

BNB Plus Corp.

Entity Central Index Key

0000744452

Entity Tax Identification Number

59-2262718

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

25 Health Sciences Drive

Entity Address, City or Town

Stony Brook

Entity Address, State or Province

NY

Entity Address, Postal Zip Code

11790

City Area Code

631

Local Phone Number

240-8800

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $0.001 par value

Trading Symbol

BNBX

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name:

dei_CurrentFiscalYearEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:gMonthDayItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration